Deal Nov 1, 2026
Dublin-based Davion Healthcare agreed October 27 to pay $8 million in cash and $5.5 million in shares at $13 each for Philadelphia home care provider Healthcare Stat Homecare, with completion expected by December 31.
Why it matters A small technology company is buying delivery capacity rather than building it, at roughly 1.2 times the target's gross receipts. Target financials are unaudited.
Rule · now Nov 1, 2026
The Labor Department's EBSA final rule requires PBMs and affiliated brokers and consultants to disclose direct and indirect compensation to fiduciaries of large self-insured plans, with an estimated $818.4 million a year in lower drug costs.
Why it matters Employers that self-fund drug coverage will be able to see how much their PBM and its brokers are paid. The savings figure is the department's own assumption, so watch how contracts change at renewal.
Rule · now Nov 1, 2026
FDA reissued draft guidance on how makers of drug delivery devices and combination products should organize drug-delivery performance data, replacing a July 2024 draft, with comments due January 28, 2027.
Why it matters Draft guidance is not binding, but it shows the format FDA reviewers expect. Comments close in 88 days.
Rule · now Nov 1, 2026
FDA proposed changing required levels of iodine, vitamin A, vitamin D and manganese under Operation Stork Speed, with estimated annualized costs of $17.6 million against benefits of $80.9 million.
Why it matters Formula nutrient standards have not been updated in decades. Watch the comment period and the three-year compliance runway after the final rule.
Record Nov 1, 2026
An independent review of MaineHealth's plan to end births at Lincoln Hospital in Damariscotta is due December 11, a week before the December 18 closure.
Why it matters A local closure of a labor and delivery unit is under review, and a petition invokes a state 120-day notice law. It is unclear whether the law applies.
Rule Nov 1, 2026
A federal judge in Massachusetts struck CMS's stricter medically frail test for Medicaid work requirements in a suit by 25 states and DC, while the January 1, 2027 start stands.
Why it matters Medicaid expansion adults aged 19 to 64 face work requirements starting January 1, 2027, but the stricter frailty test is out. Watch for a CMS appeal and whether the injunction reaches only plaintiff states.
Report Nov 1, 2026
The same PESP tracker identifies 223 REIT-owned hospital properties, 144 of them PE-owned, with Medical Properties Trust the largest landlord at 105, and at least 129 PE-owned hospitals operating as joint ventures, 67 at Lifepoint.
Why it matters Who owns the building and who shares control can matter as much as the name over the door. State review laws covering outright acquisitions can miss joint ventures.
Report Nov 1, 2026
The Private Equity Stakeholder Project's fall 2026 tracker counts 561 PE-owned hospitals as of June 2026, 11.9% of private hospitals and 33.6% of for-profit ones, with Apollo holding about 200 and Welsh Carson 124.
Why it matters About one in eight private hospitals is now PE-owned. The count comes from an advocacy group, so watch for independent verification.
Deal Nov 1, 2026
Select Medical Holdings filed its Massachusetts notice of material change on October 15, 106 days after its July 1 take-private by Stallion Intermediate Corporation, against a 60-day pre-closing notice requirement, and the state review remains open.
Why it matters A deal can clear federal antitrust review and still owe the state a timely notice. Watch whether the Health Policy Commission opens a Cost and Market Impact Review.
Deadline Oct 31, 2026
CMS says enrollment runs November 1, 2026 through January 15, 2027, with more than 75% of HealthCare.gov buyers finding premiums of $50 or less, though it published no average premium and KFF found a 14% median proposed increase in preliminary filings.
Why it matters The $50 figure comes without an average premium and may not mean prices fell, since early filings pointed up. Compare what you would pay after subsidies before choosing a plan.
Earnings Oct 31, 2026
Alignment Healthcare reported October 29 that Q3 revenue rose 36.7% to $1,358.3 million but its medical benefits ratio rose about 240 basis points to 89.5%, and it now guides adjusted EBITDA of at least $100 million versus $145 million to $163 million in July.
Why it matters Fast membership growth at a Medicare Advantage insurer did not protect margins, because medical costs ran above plan. Watch whether other plans report the same pattern.
Earnings Oct 31, 2026
CareDx reported October 29 that Q3 revenue rose 39% to $139.4 million on about 75,900 tests, and raised 2026 revenue guidance to $520 million to $530 million and adjusted EBITDA guidance to $90 million to $100 million.
Why it matters A transplant diagnostics company is accelerating on volume growth, with testing services revenue up 65%. Watch whether the reimbursement mix behind that growth becomes clear.
Rule Oct 31, 2026
CMS has not posted the final CY2027 OPPS and ASC rule as of October 31, leaving the proposed 2.4% ASC update, 638 services removed from the inpatient-only list and about 618 ASC list additions as the working numbers.
Why it matters Surgery center payments for 2027 still rest on a proposal. The final rule usually arrives in early November.
Rule Oct 31, 2026
CMS-3409-F keeps the two performance measures and three tiers, decertifies any OPO whose service areas are all tier 3, defines unsound medical practices for immediate decertification, and requires incumbents to cooperate with successor OPOs.
Why it matters More than 100,000 Americans are waiting for a transplant, so how organ procurement groups are held accountable affects who gets an organ. Watch for the effective date, which CMS did not state.
Rule Oct 31, 2026
A DEA interim final rule published October 30 places centanafadine and its salts and isomers in Schedule III, effective immediately, for the ADHD drug FDA approved as Simtriyo on July 24, 2026, with comments due November 30.
Why it matters Controls on the new ADHD drug apply now while comments stay open until November 30.
Rule Oct 31, 2026
A Federal Register notice published October 30 extends for the third time the effective date of FDA's May 27, 2026 final resolution for DESI 7661 from November 4, 2026 to May 4, 2027.
Why it matters The products face no change from the action before May 4, 2027, though the notice does not detail the underlying action.
Approval Oct 31, 2026
The first U.S. plasmid DNA-based immunotherapy was approved for adults, based on 7 of 26 patients with at least three prior surgeries needing none in the following year in a 32-adult open-label trial.
Why it matters Approval rests on fewer surgeries, an intermediate endpoint, so confirmatory trials must show real benefit. FDA gave no price.
Earnings Oct 31, 2026
On its October 27 call HCA reported ASC volumes down 5.4%, hospital outpatient surgery down 2.9% and total surgical volume down 1.4%, with its CFO citing patients who lost ACA exchange coverage.
Why it matters The biggest hospital operator saw fewer surgeries, and it pointed to people losing marketplace insurance. Watch whether other operators report the same coverage-gap effect.
Earnings Oct 31, 2026
Healthcare Realty Trust reported October 29 that Q3 same-store cash NOI grew 5.1% and lifted 2026 same-store guidance to 5.00% to 5.25%, while selling $68 million of assets and repurchasing $75 million of stock.
Why it matters A major medical office landlord is posting solid rent growth while selling buildings and buying back shares. Watch whether capital recycling continues as it exits markets like Chicago.
Deal Oct 31, 2026
HealthSpan Partners, a Bon Secours Mercy Health affiliate, will pay $23.50 per share in cash for Surgery Partners, with Bain Capital rolling its roughly 39% stake and closing expected in the first quarter of 2027.
Why it matters A nonprofit health system is buying one of the largest surgery center companies, and an analyst says nonprofits are paying more than the market gives Tenet's USPI.
Deal Oct 31, 2026
Modern Healthcare reports Quorum Health is lining up a roughly $1.3 billion municipal bond sale to complete its conversion to a nonprofit, while an advocacy group puts the sale to Healthside Partners at $957 million.
Why it matters A hospital chain owned by a credit fund is trying to become a nonprofit with municipal debt. Watch whether the offering document is published and whether investors fund it.
Funding Oct 31, 2026
CMS lists $39.7 million for 26 Missouri rural providers and more than $19 million for West Virginia from the $50 billion Rural Health Transformation Program, which CMS says runs four more years.
Why it matters Awards go to named providers, not whole communities, so check recipient lists before assuming a local hospital is funded.
Enforcement Oct 31, 2026
Surgeon Jason Montone received one year of supervised release and must forfeit $379,000 in sham consulting fees from SpineFrontier after pleading guilty to Anti-Kickback Statute conspiracy and obstruction.
Why it matters Payments from device makers to surgeons remain a live kickback theory in spine cases.
Earnings Oct 31, 2026
On its October 28 call, Universal Health Services said orthopedic and GI procedures are moving to ASCs and offices, calling its weaker surgical mix an acceleration of existing trends and doubting the inpatient-only list phase-out is the main cause.
Why it matters Operators see the same site-of-care shift from opposite sides, with the inpatient-only list a possible but disputed driver.
Earnings Oct 31, 2026
Tenet reported USPI same-facility cases down 1.5% and net revenue per case up 6.1% in the third quarter, with Ambulatory Care adjusted EBITDA of $537 million, up 9.1%, at a 39.2% margin.
Why it matters Fewer cases but higher revenue per case suggests mix, not demand, is driving results.
Deadline Oct 30, 2026
The CDC is soliciting nominations for up to 19 ACIP members, including consumer or community representatives, and will not consider nominations received after December 31, 2026 for the current cycle.
Why it matters Who sits on ACIP shapes which vaccines are recommended and covered. The notice gives no meeting date, so watch for who gets appointed.
Alert · now Oct 30, 2026
The amended CDC order requires an attestation from everyone on flights arriving from a foreign country, including aircraft crew, effective 11:59 p.m. Eastern November 3 and running through December 18, 2026 unless changed or rescinded sooner.
Why it matters The CDC's Ebola flight attestation now has a defined end date of December 18, 2026 and covers crew as well as passengers. It can still be extended or rescinded by a new order.
Rule Oct 30, 2026
CMS set the 2027 ESRD base rate at $297.52 per treatment, up $15.81, with $12.85 of that from folding in phosphate binders, and doubled the low-volume threshold to 8,000 treatments with six tiers.
Why it matters This sets what Medicare pays for dialysis next year, which affects the roughly 7,600 facilities that treat kidney failure patients. Watch how the budget-neutral low-volume change shifts money between small and large clinics.
Rule Oct 30, 2026
The July proposal would raise aggregate Medicare home health payments 2.4 percent ($420 million) with a temporary 3.0 percent PDGM cut, lower the outlier loss ratio from 0.37 to 0.29, and shorten the OASIS submission deadline from 4.5 months to 45 days.
Why it matters Medicare's 2027 home health payment rule is not final with an effective date of January 1, so agencies are budgeting against the July proposal.
Earnings Oct 30, 2026
DaVita reported October 29 that U.S. revenue per treatment was $415.25 against $280.22 of care cost per treatment, lifted adjusted EPS guidance to $14.30 to $15.20, and posted just 0.4% normalized treatment growth.
Why it matters Dialysis profits are being driven by what each treatment earns, not by more patients. Watch whether commercial rate pressure, which the company flags, narrows that spread.
Deal Oct 30, 2026
Nonprofit Deaconess Associations closed its purchase of 24 home health and 7 hospice locations from HCA Healthcare across eight states, mostly Texas and Florida, with about 1,000 employees hired and the price undisclosed.
Why it matters A nonprofit is taking over 31 hospital-owned home health and hospice agencies, showing consolidation through divestitures while new agency entry is frozen.
Earnings Oct 30, 2026
Encompass reported October 28 that discharges rose 5.7% and revenue per discharge rose 4.0% to $22,543, and lifted full-year adjusted EBITDA guidance to $1.395 billion to $1.415 billion.
Why it matters Inpatient rehab is growing on both volume and price at once. The company does not explain the per-discharge increase, so watch for that detail.
Deadline Oct 30, 2026
CMS's chief operating officer said at the National Alliance for Care at Home meeting that any extension of the hospice and home health enrollment freeze must be a full six months, with no Federal Register extension notice found and the freeze set to lapse November 13.
Why it matters The freeze on new Medicare hospice and home health agencies ends in two weeks unless CMS extends it for a full six months, so watch for a Federal Register notice.
Rule · now Oct 30, 2026
HHS published an enforcement discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for pharmacy compounding while FDA writes a formal 503A list, with comments reportedly due November 13.
Why it matters HHS is promising not to enforce against compounding six unapproved peptides, but says that does not make them approved or safe. Watch the FDA's formal list and state responses.
Earnings Oct 30, 2026
Cigna reports third-quarter 2026 results November 5 and Humana reports at 6:00 a.m. Eastern November 6, with Humana's last guide at a 92.75% insurance benefit ratio plus or minus 25 basis points.
Why it matters The insurer side of the payer-mix question reports next. Watch medical cost trends and full-year guidance.
Enforcement Oct 30, 2026
Federal prosecutors in Los Angeles charged 15 defendants on October 22 in cases alleging about $2 billion in losses, including a $138 million hospice scheme across four California hospices with a live-discharge rate above 85 percent.
Why it matters Prosecutors allege a large hospice billing scheme in Los Angeles; these are allegations and defendants are presumed innocent.
Funding Oct 30, 2026
CMS announced $87 million for 129 rural providers in Texas and $233.6 million for California, both fiscal year 2026 awards from the $50 billion Rural Health Transformation Program.
Why it matters Federal rural health money is starting to reach states, with Texas and California targeting chronic disease, workforce, telehealth and equipment. Watch which entities actually receive funds.
Enforcement Oct 30, 2026
Six Sankar Nephrology Group dialysis limited partnerships agreed to pay about $2 million to resolve False Claims Act allegations over Provider Relief Fund payments, with the majority owner guaranteeing the settlement.
Why it matters A small settlement shows COVID-era relief money is still being audited years later. The listing does not describe the alleged false claims or admit liability.
Earnings Oct 30, 2026
Teladoc reported October 28 that BetterHelp revenue fell 13% to $206.6 million, Integrated Care rose 2% to $398.5 million, and $997.6 million of convertible notes are now current liabilities.
Why it matters Teladoc's cash-pay consumer business is shrinking while the insurance-covered side holds. The refinancing of about $998 million in notes is the item to watch.
Earnings Oct 30, 2026
Chemed's VITAS hospice unit reported third-quarter average daily census of 24,428, admissions up 7.2 percent to 18,995, and net patient revenue up 12.2 percent to $457.4 million, with Medicare cap accrual of $828,000 versus $6.1 million a year earlier.
Why it matters VITAS gives hospice operators a benchmark: census growth of 9.4 percent alongside a sharply lower Medicare cap accrual.
Earnings Oct 29, 2026
Community Health Systems lost $86 million in Q3 as revenue fell 10.7% to $2.757 billion after hospital sales and adjusted EBITDA fell 25.5% to $280 million.
Why it matters Rural and mid-size hospitals are under strain, and sold or closed facilities can change local access to care.
Rule Oct 29, 2026
The DEA's final special registration rule for prescribing controlled substances by telemedicine went to OIRA on August 25, 2026, while the temporary flexibilities expire December 31, 2026 and the January 2025 proposal drew more than 6,400 comments.
Why it matters Virtual prescribing of controlled substances faces a December 31 cliff unless the rule is finalized or the flexibilities are extended a fifth time. The final text is not public.
Report Oct 29, 2026
Florida's October 6 Medicaid integrity announcement projects annual Medicaid autism therapy spending of $2.88 billion in fiscal 2026-27, down from $3.86 billion, after moving ABA into managed care, and reports more than 220 providers terminated in 2025.
Why it matters Florida says moving ABA into managed care cut projected spending about 25 percent. This is the state's own projection, not realized savings.
Record Oct 29, 2026
Universal Health Services saw acute care revenue per adjusted admission fall 1.7% on 4.9% more admissions, while Tenet rose 0.2% and HCA and Community Health Systems pointed to payer mix.
Why it matters Hospitals are busier but not earning more per patient, which points to a payer mix problem across the sector rather than one company.
Earnings Oct 29, 2026
Humana affirmed 2026 adjusted EPS guidance of at least $9.00 while warning that GAAP guidance may change from unquantified strategic initiatives, with Q3 results due November 6 and an investor update on December 10.
Why it matters The company says its adjusted profit target holds, but reported earnings may differ, so the cost of its strategic initiatives is the open question.
Enforcement Oct 29, 2026
Federal prosecutors allege a Los Angeles father and son ran more than 20 addiction treatment centers that billed commercial insurers about $1.62 billion and collected over $210 million between May 2020 and May 2026, with EKRA and health care fraud counts.
Why it matters This is the largest substance abuse treatment fraud case the Justice Department has charged, and it shows how patient brokering and fake group therapy get scaled. These are allegations, and no pleas have been entered.
Rule Oct 29, 2026
CMS's June 1, 2026 interim final rule on Medicaid community engagement requires compliance by January 1, 2027, and secondary summaries say its substance use exemption excludes people in recovery five years or longer.
Why it matters Medicaid enrollees in recovery may lose coverage over paperwork if the exemption is narrower than the statute. The rule is interim and could change.
Deal Oct 29, 2026
Houston-based PsychPlus acquired Precision Psychiatric Services on October 27, adding more than 100 psychiatrists who staff emergency departments, inpatient units and addiction facilities; the price was not disclosed.
Why it matters Psychiatry staffing for hospital contracts is consolidating, and sale chatter is rising for sponsor-backed behavioral platforms with 2027 hold deadlines.
Earnings Oct 29, 2026
Tenet reported Q3 adjusted EBITDA up 23.3% to $1.355 billion and lifted full-year adjusted EBITDA guidance to $5.05 billion to $5.20 billion, while revenue per adjusted admission rose only 0.2%.
Why it matters A strong headline quarter, but the footnotes show timing items and flat price per patient, so watch whether the margin holds once those fade.
Rule · now Oct 28, 2026
The Federal Register entry for CMS-9873-P published October 27 sets the comment deadline as November 27, 2026, correcting an earlier estimate of November 26, with the proposed rule requiring Exchanges to verify income, family size, citizenship, other coverage, and residence before paying advance premium tax credits or cost-sharing reductions.
Why it matters If you plan to comment on the ACA subsidy verification proposal, the Federal Register date of November 27 is controlling. Thanksgiving falls on November 26, so do not rely on that date.
Record Oct 28, 2026
Dividing the $2.4 billion enterprise value by AON's more than 350 providers gives a ceiling near $6.9 million per provider, our own arithmetic that includes up to $100 million in contingent payments and counts every provider.
Why it matters A rough yardstick for what a community oncology network might be worth, not a valuation multiple.
Rule · now Oct 28, 2026
The CDC issued an order requiring every passenger boarding a U.S.-bound flight to sign a statement that they have not been in the Democratic Republic of the Congo in the past 21 days, with airlines required to confirm attestations, deny boarding to non-compliant passengers, and retain records for at least 42 days after arrival.
Why it matters Starting November 3, any passenger on a U.S.-bound flight must sign an individual CDC attestation about travel to the DRC. This includes U.S. citizens and connecting passengers, and false statements carry federal prosecution risk under 18 U.S.C. 1001.
Deal Oct 28, 2026
Cencora agreed October 21 to buy American Oncology Network, a 350+ provider community oncology group in 21 states, at a $2.4 billion enterprise value, with no closing date and a stockholder vote and regulatory clearance still required.
Why it matters A drug distributor is set to own one of the largest community cancer networks, so watch how drug purchasing and physician control are governed after closing.
Rule Oct 28, 2026
CMS's July 2 proposed 2027 OPPS rule would pay 340B-purchased drugs at average sales price minus 33.4 percent, with a trade-press estimate of a $4.55 billion first-year cut in Medicare drug payments redistributed to non-drug services, and the final rule is expected later this year.
Why it matters If finalized, hospitals that buy discounted 340B drugs would be paid far less for them, shifting money to other outpatient services.
Approval Oct 28, 2026
FDA approved Keytruda and subcutaneous Keytruda Qlex for TMB-high solid tumors on October 16, Jemperli for dMMR or MSI-high rectal cancer on October 19 under accelerated approval, and Talzenna with enzalutamide for HRR-mutated metastatic prostate cancer on October 26.
Why it matters New uses for three cancer drugs landed in ten days, including a subcutaneous Keytruda option that replaces an infusion.
Enforcement Oct 28, 2026
Jeremiah Yzaguirre and Maria Luisa Yzaguirre, both 47, of Harlingen, Texas, were sentenced to 110 and 80 months in prison for defrauding Medicare through their durable medical equipment company and ordered to pay $9,248,976 in restitution.
Why it matters A married couple operating a DME company in Harlingen, Texas received prison terms and a $9.2 million restitution order for Medicare fraud, underscoring continued OIG enforcement against equipment billing fraud in South Texas.
Deal Oct 28, 2026
New Jersey business press now dates Horizon Blue Cross Blue Shield of New Jersey's agreement to buy the Summit Health physician group to October 21, with a reported value above $1 billion, undisclosed terms and regulatory approval pending.
Why it matters A large insurer buying a physician group is a notable consolidation move, and the corrected date means it is a week-old deal now entering review. Watch for regulatory filings.
Earnings Oct 28, 2026
Tenet reports third-quarter results Thursday after raising 2026 adjusted EBITDA guidance to $4.83 billion to $5.03 billion in July, while HCA cut its range to $15.4 billion to $16.1 billion and cited about $400 million of pretax exchange losses in Q3.
Why it matters Two large hospital operators moved guidance in opposite directions this year, so Tenet's report is a test of which pattern holds. This is a preview, not a result.
Rule Oct 28, 2026
Medicare's first negotiated Part B prices start January 1, 2028, but the four cancer drugs selected (Erleada, Kisqali, Lenvima, Verzenio) are oral Part D drugs, and CMS draft guidance would have manufacturers either ensure providers' acquisition price is no higher than the negotiated price or refund the difference.
Why it matters The first Part B negotiated prices are coming, but the cancer drugs picked so far are pills, so clinic infusion economics are not hit yet.
Enforcement Oct 28, 2026
Herbert Leon Kimble, 60, of Chicago, was sentenced to 20 years in prison and ordered to pay more than $199 million in restitution to Medicare after being convicted of conspiracy to defraud the United States and failure to appear in what the OIG describes as an international healthcare fraud scheme.
Why it matters A fugitive who evaded capture and ran an international Medicare fraud scheme received a 20-year sentence and a $199 million restitution order. Actual recovery is uncertain because the OIG listing does not say how much can be collected from a former fugitive.
Rule Oct 28, 2026
The Office of the National Coordinator for Health Information Technology released the final HTI-5 rule on October 26, cutting 14 EHR certification criteria, revising seven, dropping the AI source-attribute display requirement, and projecting savings of more than $1.5 billion for developers beginning in 2027.
Why it matters This rule reduces federal oversight of health IT software by removing certification testing and reporting requirements. Watch whether the dropped AI transparency requirement changes how vendors disclose how their clinical decision tools work.
Earnings Oct 28, 2026
Universal Health Services reported Q3 net revenues up 5.3% to $4.733 billion while net income fell to $308.7 million from $373.0 million, with acute care revenue per adjusted admission down 1.7% and behavioral health up 1.7%.
Why it matters Hospital volume is growing but the revenue earned per patient is shrinking in acute care, which is a sign of payer mix pressure. Watch whether other operators show the same pattern.
Rule · now Oct 27, 2026
CMS's Exchange Pre-Eligibility Verification proposal (CMS-9873-P) appeared in the Federal Register October 27, requiring Exchanges to verify income, family size, citizenship or immigration status, other coverage and residence before paying advance premium tax credits or cost-sharing reductions.
Why it matters If you buy coverage on an ACA Exchange, subsidies could depend on proving your details up front. Watch the notice for the exact comment deadline, which by our count falls on Thanksgiving Day.
Rule Oct 27, 2026
CMS proposes exceptions to the Ambulatory Specialty Model, starting January 1, 2027, for participants who redesignate into a heart-failure-excluded subspecialty or change TIN, plus a voluntary electronic prior authorization measure in 2027 that becomes required in 2028.
Why it matters A mandatory payment model for heart failure care starts January 1. A proposed exit ramp exists for specialists placed in it by mistake, but it is not final.
Earnings Oct 27, 2026
Centene ended September with 3,403,300 Marketplace members versus 5,828,100 a year earlier, yet lifted 2026 adjusted diluted EPS guidance to more than $5.20 on $50.6 billion of third-quarter revenue.
Why it matters The expired enhanced subsidies are visible in enrollment: millions fewer people hold Marketplace coverage, even as the insurer's margins improve. Watch 2027 enrollment, since no guidance was given.
Funding Oct 27, 2026
CMS and all 50 states launched a $275 million program, funded by nursing home civil monetary penalties, offering nurses up to $40,000 in loan repayment or a $10,000 stipend for a three-year commitment in rural or high-shortage nursing homes.
Why it matters The program funds recruiting but does not change staffing minimums or Medicaid rates. Watch uptake in the first 90 days, October 26 to January 24, 2027.
Rule Oct 27, 2026
CMS proposes cutting work values by 10 to 28 percent on several cardiology procedures and lowering the conversion factor to $32.8409 from $33.4009 for most clinicians, while ACC projects overall cardiovascular payment up about 1 percent.
Why it matters Medicare's proposed 2027 doctor payment rule trims pay for several heart procedures. The final rule could arrive within days.
Enforcement Oct 27, 2026
The Justice Department Civil Division and HHS announced a pilot on October 22 letting companies self-report False Claims Act violations and repay at 1.25 to 1.6 times damages, with submissions open through April 22, 2027.
Why it matters Companies that find billing errors get a lower-cost path to come clean, which may mean more voluntary disclosures. Watch how many take it.
Deal Oct 27, 2026
HealthSpan Partners agreed October 26 to buy Surgery Partners for about $5.7 billion including debt, while an HCA call transcript summary says its surgery center book shows exchange pressure similar to its hospitals.
Why it matters The buyer is paying for outpatient surgery volume just as a large operator reports that volume weakening. The exchange coverage loss is reaching outpatient settings.
Earnings Oct 27, 2026
HCA reported third-quarter revenue up 3.6% to $19.849 billion and net income down 3.9% to $1.579 billion, attributing a payer mix shift to patients who lost exchange coverage, and now expects full-year results in the upper half of its July ranges.
Why it matters Volume is growing while the payer mix pays less, which is the subsidy loss showing up on a provider income statement. Watch whether uninsured volume keeps rising.
Deal Oct 27, 2026
Horizon Blue Cross Blue Shield of New Jersey is reported to be buying Summit Health's New Jersey operations, including 39 CityMD urgent care sites, in a deal reported above $1 billion and subject to regulatory review.
Why it matters An insurer owning care sites is payer-provider integration at the state level. The regulatory review is where the deal gets tested, and terms remain unconfirmed.
Record Oct 27, 2026
Compounding the proposed 10 percent work value cut to code 33340 with the 1.68 percent lower conversion factor gives roughly an 11.5 percent drop in the work component's dollars, by our arithmetic and excluding practice expense and malpractice.
Why it matters One number shows how two proposed changes stack. Total payment moves less than the work component alone.
Enforcement Oct 27, 2026
Prosecutors announced October 22 charges against 15 people, including six medical professionals, led by a case alleging more than $1.6 billion billed for sham substance-abuse treatment, plus $134 million in atherectomy billing, $138 million in hospice billing and a $270 million Medi-Cal pharmacy indictment.
Why it matters These are allegations and billed amounts, not proven losses, and every defendant is presumed innocent. Watch for pleas and trial outcomes.
Rule Oct 27, 2026
CMS lists national coverage analysis CAG-00430R3 for transcatheter aortic valve replacement in aortic regurgitation as open, with comment reportedly closing October 10 and a proposed decision reportedly due by March 10, 2027.
Why it matters Medicare is deciding whether to cover a catheter-based valve fix for leaking aortic valves. Watch for the proposed decision, reportedly due by March 2027.
Record Oct 27, 2026
The Transcatheter Cardiovascular Therapeutics meeting runs October 31 to November 3 in San Diego with 28 late-breaking studies, including PROGRESS on TAVR in moderate aortic stenosis, and no results are public yet.
Why it matters A major heart meeting opens Saturday with trials that could shape future Medicare coverage. No results are out yet.
Enforcement Oct 27, 2026
A telemedicine company owner who led a Medicare fraud conspiracy lasting more than six years was sentenced to 20 years in prison, with $17,942,402 in restitution and $10,431,463 in forfeiture.
Why it matters A 20-year term signals how prosecutors treat telemedicine-linked fraud. The listing does not name the defendant or the court.
Deadline Oct 26, 2026
Missouri, Nevada, Virginia and Idaho vote November 3 on abortion measures, including a Missouri amendment that would repeal the 2024 abortion-rights amendment, per the KFF tracker.
Why it matters Where abortion is protected or restricted in four states may change on November 3. Constitutional amendments are far harder to reverse than statutes.
Rule Oct 26, 2026
CMS proposed rule CMS-9873-P would have Exchanges verify income, family size, citizenship or immigration status, other coverage and residence before paying advance premium tax credits or cost-sharing reductions, with a first verification window opening August 1, 2027 for 2028 coverage.
Why it matters If you buy coverage on an Exchange, subsidies could depend on proving your details up front. Watch the published comment deadline, since CMS gives no estimate of coverage loss.
Deadline Oct 26, 2026
California voters decide November 3 on a one-time 5% tax on billionaire net worth that the Legislative Analyst says would probably raise tens of billions of dollars, with 90% required for health care services.
Why it matters A single ballot measure could direct tens of billions of dollars to health care, but the yield depends on stock prices and billionaire behavior. Watch the November 3 result and later collections.
Deal Oct 26, 2026
Labcorp agreed October 20 to buy Myriad Genetics' prenatal testing business for $210 million plus inventory, and an EQT-led bidder offered EUR 46.50 a share for QIAGEN on October 21, about EUR 10.8 billion in enterprise value.
Why it matters Two large diagnostics and lab-tools deals are in early review at the same time as the Surgery Partners deal. Watch which clear first and how regulators treat each.
Deal Oct 26, 2026
HealthSpan Partners, a Bon Secours Mercy Health affiliate, agreed to acquire Surgery Partners at $23.50 a share in cash, with Bain Capital rolling its roughly 39% stake and closing expected in Q1 2027 pending a shareholder vote and regulatory approvals.
Why it matters A nonprofit-linked buyer is taking over a leveraged, investor-owned surgery center chain, which runs against the sector's usual direction. Watch how regulators review a hospital-affiliated buyer gaining a national outpatient footprint.
Enforcement Oct 26, 2026
A federal grand jury in the Northern District of Illinois indicted Schaumburg laboratory owner Rajesh Patel, 52, for allegedly billing for hundreds of thousands of COVID-19 tests that were never performed, per an HHS OIG listing dated October 20.
Why it matters Prosecutors allege a $66.2 million billing scheme for tests never performed. These are allegations, and the defendant is presumed innocent until convicted.
Rule Oct 25, 2026
CMS has not released the final 2027 Medicare physician fee schedule, whose proposal would set the conversion factor at $32.84, down 1.68 percent, and cut pay for same-day office visits billed with a global procedure.
Why it matters The rule that sets Medicare payment for most physician services is overdue relative to last year's October 31 release. Watch for the final conversion factor and any softening of the same-day visit cut.
Enforcement Oct 25, 2026
California's Attorney General filed 103 felony cases against In-Home Supportive Services providers over more than $4.5 million in alleged Medi-Cal fraud, while trade press reports CMS deferred another $1.2 billion in federal Medicaid payments.
Why it matters The criminal cases and the deferral measure very different things: the $4.5 million alleged is under 0.4% of the $1.2 billion delayed. A deferral delays payment until the state documents its claims, and does not cancel the money.
Earnings Oct 25, 2026
Centene reports third-quarter results October 27 at about 6:00 a.m. Eastern, after a second-quarter health benefits ratio of 89.6%, Medicaid at 93.9%, adjusted EPS of $2.51 and at-risk membership of 25.89 million, down from 28.00 million.
Why it matters Centene's report opens a three-day run of insurer and hospital earnings. Watch whether its Medicaid care ratio holds as Marketplace membership keeps shrinking.
Rule · now Oct 25, 2026
CMS proposed a rule on October 16 implementing sections 6219, 6220 and 6224 of the Consolidated Appropriations Act, 2026, paying Part D PBMs flat fair-market-value fees, with comments due 5 p.m. Eastern on December 15, 2026.
Why it matters This is the first federal text on what pharmacy benefit managers may keep in Part D. The comment window runs to mid-December.
Enforcement Oct 25, 2026
CVS agreed to pay $315 million to resolve Controlled Substances Act and False Claims Act allegations over opioid fills from October 2013 to December 2025 and signed a DEA memorandum of agreement, with no determination of liability.
Why it matters The settlement lists specific dispensing practices the government calls unlawful, and it is allegations only. It reads as a compliance checklist for pharmacies.
Funding Oct 25, 2026
CMS announced October 23 that Georgia gets nearly $219 million and Florida $193.7 million from the $50 billion Rural Health Transformation Program, with neither release naming recipients or splitting dollars by initiative.
Why it matters Two large states now have rural health money on paper, but the releases do not say who gets paid or when. Watch for sub-award rules from each state.
Earnings Oct 25, 2026
HCA and Universal Health Services report October 27 (UHS moved its release to after the close) and Tenet reports October 29, after HCA cut 2026 adjusted EBITDA guidance to $15.4 billion to $16.1 billion in July while Tenet raised its range to $4.83 billion to $5.03 billion.
Why it matters Two hospital operators saw the same exchange losses in July and gave opposite guidance. This week shows whether that gap narrowed or widened.
Record Oct 25, 2026
Roseland Community Hospital in Chicago stops labor and delivery on October 31, as Prime Healthcare closes or has closed maternity units at three metro-area hospitals citing finances and a falling birthrate.
Why it matters Obstetric closures are reaching urban safety-net and mid-size community hospitals, not only rural units. Watch where displaced deliveries go.
Report Oct 25, 2026
HHS's Kidney Care National Plan, released October 20, says two dialysis chains hold about 74% of the U.S. market, up from roughly 59% in 2006, and that end-stage kidney disease cost Original Medicare about $24.4 billion and Medicare Advantage $27.7 billion in 2023.
Why it matters This is a statement of policy direction, not a rule. It sets no new payment rates, coverage requirements or deadlines, so watch for any follow-on proposed rule.
Enforcement Oct 25, 2026
A federal jury convicted a Maryland laboratory owner in an $18.7 million Medicare scheme billing for respiratory tests on nursing home residents that were unneeded, unordered or never performed.
Why it matters The case shows prosecutors still pursuing pandemic-era testing fraud. The $18.7 million is what prosecutors alleged billed, not necessarily what Medicare paid.
Enforcement Oct 25, 2026
Missouri surgeon Jason Montone received one year of supervised release and must forfeit $379,000 in consulting fees from SpineFrontier, Inc., after pleading guilty to Anti-Kickback Statute conspiracy and obstruction.
Why it matters The forfeiture equals the fees, which shows prosecutors treating the payments themselves as the proceeds of the scheme. A distributor in the same case was also sentenced, but that sentence was not given.
Rule Oct 25, 2026
Enforcement discretion letting insurers use the 2021 qualifying payment amount method ended September 30, and CMS lists no successor guidance while arbitration closed 784,352 disputes in August and September.
Why it matters The benchmark behind out-of-network payment disputes lost its temporary relief with nothing posted to replace it. Watch for successor guidance after the TMA III litigation.
Rule Oct 24, 2026
CMS proposed requiring Exchange enrollees to pass eligibility verification before receiving advance premium tax credits, with the first window opening August 1, 2027 for 2028 coverage.
Why it matters Subsidies would depend on passing verification first, which could shrink enrollment. The comment deadline is not yet set.
Report Oct 24, 2026
A Pharmaceutical Strategies Group survey of 250 benefits leaders covering about 144 million lives found 69% included a non-Big Three PBM in their latest RFP while satisfaction with alternatives fell to 7.3 from 7.9.
Why it matters Employers are testing smaller PBMs even as satisfaction with them slips. Survey samples differ, so these are not market shares.
Rule · now Oct 24, 2026
CMS proposed on October 16 that Part D PBMs be paid only flat, itemized, fair-market-value fees not tied to drug prices, rebates, formulary placement or volume, implementing Section 6224 of the Consolidated Appropriations Act, 2026.
Why it matters This is the first federal text defining what a PBM may keep in Part D. Watch the comment period and whether the rebate pass-through exemption survives.
Enforcement Oct 24, 2026
CVS agreed to pay $315 million to resolve Justice Department allegations that it illegally filled controlled-substance prescriptions from October 2013 to December 2025 and billed federal programs, and signed a DEA agreement requiring a reporting hotline and dispensing monitoring.
Why it matters The settlement lists specific dispensing red flags and a monitoring agreement. The claims are allegations only and no liability was determined.
Rule Oct 24, 2026
The Labor Department rule requiring PBMs to disclose compensation to self-insured employer plans finished White House budget office review on October 21, per Law360, with final status and publication date unreported.
Why it matters Employers would see what PBMs earn from manufacturers and pharmacies. Watch when the text publishes and whether it is final.
Rule Oct 24, 2026
DOJ and HHS launched a six-month False Claims Act self-disclosure pilot offering a coordinated civil release and a 1.25 to 1.6 damages multiplier, with submissions accepted through April 22, 2027.
Why it matters Companies that find their own billing errors now have a defined, cheaper path than waiting to be caught. Watch how DOJ applies the multiplier in practice.
Earnings Oct 24, 2026
HCA Healthcare holds its third-quarter call October 27 at 10:00 a.m. Eastern after widening its 2026 Exchange coverage headwind to $1.0 billion to $1.2 billion in July and lowering adjusted EBITDA guidance to $15.4 billion to $16.1 billion.
Why it matters The largest US hospital operator will show how many patients who lost Exchange coverage are arriving uninsured. Watch whether the July headwind estimate holds.
Enforcement Oct 24, 2026
Prosecutors charged 15 defendants, including six medical professionals, in schemes covering more than $1.8 billion in claims, led by a $1.6 billion addiction treatment scheme.
Why it matters Billed is not lost and charged is not convicted; the headline figure is where the case starts. Watch for pleas and final recoveries.
Funding Oct 24, 2026
CMS and states launched Nurses for Nursing Homes, offering up to $40,000 in loan repayment and a $10,000 stipend for a three-year commitment, funded by nursing home penalties.
Why it matters The industry's own fines are funding its staffing gap. Watch uptake over the first 90 days.
Alert · now Oct 24, 2026
Quest Diagnostics restored its Quanum Lab Services Manager portal and two other paused systems on October 23, and its notice now states that some patient data inside Quanum LSM was accessed, with no patient count, data types or notification date given.
Why it matters If you or your doctor use Quest for lab tests, a system that holds your test orders and results was accessed without authorization. Watch for Quest's notice on who was affected and what data was involved.
Report Oct 24, 2026
Drug Channels Institute projects $933 billion in 2026 revenue for the Big Three wholesalers and reports they have spent over $20 billion on stakes in physician management services organizations.
Why it matters Drug distributors are moving into physician practice ownership. Watch who captures margin on provider-administered drugs.
Funding Oct 24, 2026
CMS announced a $205 million Rural Health Transformation Program award for Wyoming, with $91.8 million for emergency care, labor and delivery, and trauma, $56.3 million for workforce, $38.6 million for primary and behavioral health, and $16.9 million for telehealth.
Why it matters Rural emergency and workforce money is flowing to Wyoming, but no recipients are named. Watch for subgrant announcements.
Rule Oct 23, 2026
Comments closed Oct 22 on the Accreditation Council for Graduate Medical Education proposal to delete emergency medicine's specific resident-hour and faculty-ratio rules, and no final text has been found.
Why it matters A looser standard would change how much emergency department coverage residents can supply. Watch for the final text.
Funding Oct 23, 2026
CMS announced nearly $249 million in Rural Health Transformation Program funding for Alaska across 254 projects, including village telehealth, portable X-ray units and remote monitoring in Nome and 15 villages.
Why it matters A quarter of a billion dollars is headed to rural Alaska, but no recipients or per-project amounts were named. Watch for the list of who is funded.
Rule Oct 23, 2026
Executive Order 14437 directs HHS to create a Women's Health Division at NIH within 90 days, forms a White House Women's Health Task Force, and revokes Executive Order 14120 and a November 2023 memorandum.
Why it matters The order sets a direction for women's health research, but no dollars are attached and it depends on appropriations.
Rule · now Oct 23, 2026
The FDA published draft guidance setting cadmium action levels for processed foods intended for babies and children under 2, with comments due December 22, 2026; the numeric levels were not confirmed.
Why it matters The FDA is moving to lower cadmium in baby food, but this is draft guidance that does not bind industry.
Rule Oct 23, 2026
The FDA finalized its question-and-answer guidance on mandatory cosmetics recalls, covering criteria, process and expectations, and finalizing a draft published December 18, 2025.
Why it matters Cosmetics companies now have a final document describing how an FDA-ordered recall works. The notice lists no effective date or comment deadline.
Record Oct 23, 2026
The FDA announced the Neuroscience Advancement and Innovation Nexus to coordinate its drug, biologics and device centers on neurologic and psychiatric products, starting with an Alzheimer's Prevention Accelerator.
Why it matters This signals where the FDA is heading on brain-related products, but it announces no dollars, deadlines or rules.
Deal Oct 23, 2026
Hackensack Meridian Health signed a definitive agreement to take in Hunterdon Health, pledging $200 million plus $30 million to fund Epic, with state regulatory approval and federal antitrust review still needed.
Why it matters A New Jersey system is absorbing a smaller nonprofit with a 184-bed flagship, and Fitch calls the deal credit neutral. Watch for state and federal antitrust review.
Enforcement Oct 23, 2026
Two Plano, Texas clinics and their owner physician agreed to pay $20 million to resolve False Claims Act allegations that nasal swab visits were billed to the COVID-19 Uninsured Program as higher-level E/M codes instead of 99211.
Why it matters The case shows how the government argues visit-level inflation: the chart does not match the code. It resolves allegations only.
Report Oct 23, 2026
CMS data show 750,022 federal disputes initiated and 784,352 closed from Aug 1 through Sept 30, a net reduction of 34,330 after June and July grew the queue by 41,096, while September filings rose 9 percent to 390,602.
Why it matters The arbitration system showed it can clear volume, but filings are still climbing. A closed dispute is a decision, not a payment.
Rule Oct 23, 2026
The federal enforcement relief in FAQ Part 73 for insurers using the 2021 qualifying payment amount method covered services from Feb 1 through Sept 30, 2026, and no replacement guidance was found, while the agencies met all 17 certified arbitration entities on Oct 1.
Why it matters The benchmark behind out-of-network emergency pay is now less settled, since the relief lapsed and the next guidance is tied to the TMA III litigation. Watch for a successor FAQ.
Alert · now Oct 23, 2026
Quest Diagnostics said in an October 22 8-K that it learned October 21 of unauthorized access to its Quanum Lab Services Manager and believes an unauthorized party accessed certain patient records, with scope still under investigation.
Why it matters A major lab's ordering and results portal was accessed without authorization, and no patient count or record types have been given. Watch for the scope disclosure.
Deal Oct 23, 2026
Kaiser Permanente-backed Risant Health signed to take in Oklahoma's largest system, which runs 10 acute care and 10 specialty hospitals and expects to lose over $130 million of revenue in 2026; terms and closing date were not disclosed.
Why it matters A thin-margin regional system is trading independence for outside capital, and Integris says it will keep its name, medical staff and leadership. Watch for regulatory approval and any disclosure of terms.
Report Oct 23, 2026
The UNC Sheps Center tracker lists 56 hospitals operating as Rural Emergency Hospitals in 21 states, including 26 former critical access hospitals, with Sturgis Hospital in Michigan and St. Mark's Medical Center in Texas labeled closed.
Why it matters Rural Emergency Hospital status trades every inpatient bed for a monthly facility payment. Two of 56 converters have already closed, which is a small sample.
Funding Oct 23, 2026
CMS announced $8 million for 28 rural Texas providers under Rural Texas Strong, targeting chronic disease care, recruiting physicians and emergency staff, and replacing aging equipment.
Why it matters More rural Texas money was announced, but CMS does not say how it fits the earlier Texas announcement or the state total.
Rule Oct 22, 2026
The CY2027 Medicare Physician Fee Schedule proposal supports new unbundled maternity codes but also adds 15 HCPCS G-codes mirroring the legacy global package, and ACOG wants them dropped.
Why it matters The final rule will decide whether Medicare runs one obstetric billing system or two starting January 1. Watch for the November final rule.
Rule Oct 22, 2026
Amazon, Axon Enterprise, Google, Meta and Oracle signed a CMS and Labor Department statement urging outside administrators of self-funded plans to meet the 2025 insurer pledge, with no deadline attached.
Why it matters The statement is a signal, not a mandate. The binding date to watch is January 1, 2027, when the federal prior authorization rule starts for certain payers.
Record Oct 22, 2026
A Federal Register Privacy Act notice describes a CMS computer matching program with the Veterans Health Administration to identify dually enrolled beneficiaries, recover duplicate payments and flag potential fraud.
Why it matters Records matching could surface people whose care is billed to both CMS and the VA. The full notice was not retrieved, so scale and duration are unconfirmed.
Enforcement Oct 22, 2026
A Northern District of Illinois grand jury charged Rajesh Patel with five counts of wire fraud for allegedly faking results for at least 380,000 tests billed to the HRSA Uninsured Program, which paid about $44.1 million.
Why it matters An indictment is an allegation, and Patel is presumed innocent. The case shows how pandemic-era programs for the uninsured are still being audited.
Record Oct 22, 2026
Roseland Community Hospital in Chicago will stop delivering babies October 31 despite a $16 million state grant, and Lane Regional in Zachary, Louisiana closed its inpatient unit October 11.
Why it matters Delivery units are closing in urban safety-net and mid-size community hospitals, not only rural ones, so some patients will travel farther to give birth. Watch where Roseland's volume lands, since the hospital has not said.
Earnings Oct 22, 2026
Intuitive Surgical booked a one-time $450 million antitrust class action settlement charge in Q3, leaving GAAP EPS at $1.49 against $3.00 non-GAAP, while revenue rose 22% to $3.05 billion on about 14% procedure growth and 546 da Vinci placements.
Why it matters A surgical robot maker took a large settlement charge yet kept growing, so the quarter's headline earnings differ sharply from its underlying results. The release does not say who the plaintiffs were or how the money is distributed.
Earnings Oct 22, 2026
Molina reported a 92.9% Q3 medical care ratio against 92.6% a year earlier, with premium revenue down 4% to $10.46 billion and net income down 52% to $38 million, while reaffirming 2026 guidance of about $42 billion in premium revenue and adjusted EPS of at least $5.25.
Why it matters A Medicaid insurer is spending more of each premium dollar on care while covering fewer people, which is the squeeze to watch across managed Medicaid. Watch whether second-half cost trends let its guidance hold.
Funding Oct 22, 2026
CMS announced 60 Rural Health Transformation Program awards for Mississippi, about $32 million, to recruit primary care physicians, expand training and open three psychiatric emergency units beside hospital ERs.
Why it matters The awards are funded, but CMS named no recipients, no unit locations and no per-award amounts. Members of Congress cite $32.6 million.
Report Oct 22, 2026
A Health Affairs Scholar study of New York and Texas Medicaid claims from 2019 to 2023 found the 12-month postpartum extension increased outpatient care for women with diabetes or hypertensive disorders of pregnancy, with the largest effect in Texas.
Why it matters Longer postpartum coverage appears to get high-risk mothers into follow-up care, just before federal work reporting rules start January 1, 2027. Watch state eligibility handling.
Enforcement Oct 22, 2026
A federal jury convicted Patrick Britton-Harr of five counts of health care fraud and one count of money laundering for billing Medicare more than $18.7 million for unneeded respiratory panels, of which Medicare paid more than $7.2 million.
Why it matters Tests aimed at nursing home residents that were not needed, not physician-ordered and often not performed drew a criminal conviction. Sentencing has not been scheduled.
Earnings Oct 22, 2026
Quest Diagnostics reported Q3 revenue of $3.10 billion, up 10.0%, and adjusted EPS of $3.00, up 15.4%, with requisition volume up 14.5% and revenue per test down 4.2%, and raised full-year guidance to $12.065 billion to $12.105 billion in revenue.
Why it matters The nation's largest lab is winning volume while collecting less per test, the pattern of a consolidator absorbing hospital testing. Watch how many more health systems sell outreach labs.
Report Oct 22, 2026
The Center for Healthcare Quality and Payment Reform reports 146 rural hospitals have stopped delivering babies or announced they will since the end of 2020, a 14 percent reduction, and that fewer than one-third still do in 12 states.
Why it matters Only about 40 percent of US rural hospitals still offer labor and delivery, so rural families increasingly travel to give birth. The count predates the October closures.
Rule Oct 21, 2026
CMS proposed cutting work RVUs for total knee from 19.11 to 15.94, total hip from 19.11 to 15.37 and total shoulder from 21.58 to 17.49, projecting a 7 percent drop in allowed charges for orthopedic surgery, with comments closed September 14 and a final rule expected around November 1.
Why it matters Medicare's payment to surgeons for knee and hip replacements could fall roughly 17 to 20 percent in work value. Watch the final rule, expected around November 1, for how much of the cut survives.
Deal Oct 21, 2026
Cencora agreed to buy the roughly 96% of American Oncology Network it does not own, a physician-led network of more than 350 oncology providers in 21 states, for $2.3 billion at closing plus up to $100 million in contingent value rights.
Why it matters A drug wholesaler is moving deeper into running cancer practices, which can shift who has leverage when drug prices and contracts are negotiated. Watch for the closing timeline and any antitrust review, neither of which is stated.
Rule Oct 21, 2026
CMS finalized CJR-X in the FY 2027 inpatient rule, requiring most acute care hospitals to be accountable for 90-day episodes of hip, knee and ankle replacement in inpatient and outpatient settings, with TEAM, Maryland and critical access hospitals exempt.
Why it matters Most Medicare hospitals will be paid under a mandatory 90-day bundle for joint replacements starting in 2028. Watch how site-neutral pricing for low-acuity cases shapes where surgeries happen.
Earnings Oct 21, 2026
Elevance reported a 90.6% third-quarter benefit expense ratio versus 91.3%, operating revenue of $50.4 billion up 0.7%, adjusted EPS of $6.99, and Medicare Advantage membership down 15.5% to 1.9 million.
Why it matters The insurer's medical cost ratio improved on a smaller, repriced book rather than on revenue growth. Watch whether membership losses in Medicare Advantage and Medicaid continue.
Rule Oct 21, 2026
The FDA finalized guidance on when software paired with prescription drugs counts as drug labeling, placing device-connected apps in prescribing information and treating most standalone app content as promotional material unless essential or clinically meaningful.
Why it matters The guidance draws a line between an app that is part of the drug label and one that is marketing. Watch how companies reclassify existing apps.
Approval Oct 21, 2026
The FDA approved Zydus Pharmaceuticals (USA)'s once-weekly estradiol and levonorgestrel patch, the first generic of Bayer's Climara Pro, for hot flashes and postmenopausal osteoporosis prevention in women with an intact uterus.
Why it matters A first generic usually starts price competition, but no price or savings figure was released. Watch for launch timing and pricing.
Approval Oct 21, 2026
The FDA approved GSK's Hibsago (bepirovirsen), a 24-week subcutaneous injection added to antiviral therapy, with 24% of trial patients able to stop existing medicine versus none on placebo and a boxed warning for liver reactions and low platelets.
Why it matters This is the first antisense drug approved for chronic hepatitis B and aims at a treatment-free period, which is new. Price and U.S. patient count are not yet public, so watch for both.
Rule Oct 21, 2026
HHS published a Federal Register notice saying civil monetary penalty amounts get no cost-of-living increase for 2026, following OMB guidance issued April 17, 2026, so 2025 maximums stay in place.
Why it matters Federal penalty ceilings for health care violations stay where they were last year. Watch whether the full notice lists which penalty categories are covered.
Deal Oct 21, 2026
Hologic signed a definitive agreement to acquire Reveal Genomics, the Barcelona company behind the HER2DX test for HER2-positive breast cancer, with closing subject to Spanish regulatory approval and no price disclosed.
Why it matters A diagnostics maker is adding a genomic test that helps guide HER2-positive breast cancer therapy. With no price disclosed, there is no read on valuation; watch the closing timeline.
Rule Oct 21, 2026
In the proposed fee schedule CMS states post-operative visits during the global period are not occurring, proposes to pause MACRA section 523 visit-reporting data collection and will post a file of imputed RVUs for 10 and 90 day visits.
Why it matters CMS is saying Medicare pays for follow-up visits that do not happen. A RAND study found surgeons reported 38 percent of expected visits. Watch whether global packages are repriced next.
Enforcement Oct 21, 2026
Providence and MultiCare agreed to settle two class actions brought by more than 2,000 patients each of neurosurgeon Dr. Jason Dreyer, with court approval still pending and both systems denying wrongdoing.
Why it matters Two large health systems will pay $155.5 million over one surgeon's spine operations. Watch for court approval, expected after January 1.
Record Oct 21, 2026
South Texas Spinal Clinic sued Surgery Partners on October 9 in Texas Business Court seeking more than $5 million, alleging acquisition talks were used to learn productivity data and recruit four physicians.
Why it matters A lawsuit alleges a buyer used sale talks to recruit a practice's surgeons. These are allegations, and no Surgery Partners response was found.
Record Oct 21, 2026
Multiplying the proposed 3.17 work RVU drop by the proposed $32.84 non-qualifying conversion factor gives about $104 of surgeon work value lost per total knee and about $123 per total hip, before practice expense and geographic adjustment.
Why it matters This is our arithmetic on work value only, so the final check may differ. Watch the final rule around November 1.
Enforcement Oct 21, 2026
Negril Inc. and its owners will pay $1,817,910.60 under an October 19 settlement with the U.S. Attorney's Office for the Western District of Virginia, resolving False Claims Act and Virginia Fraud Against Taxpayers Act allegations over Virginia Medicaid claims.
Why it matters Federal and state Medicaid dollars are being recovered under both laws at once. The underlying billing conduct was not described.
Rule Oct 20, 2026
AbbVie, Bristol-Myers Squibb and Boehringer Ingelheim filed on October 14 to join the hospitals' suit against the HHS 340B rebate pilot, and PhRMA filed its own motion, citing $40 million in duplicate-discount losses at Bristol-Myers.
Why it matters A court fight over how a $100 billion drug discount program is paid could change hospital cash flow. Watch whether the court lets the drugmakers in.
Deal Oct 20, 2026
Capitol Imaging Services, a 60-center Southeast chain, acquired Impression Imaging's four South Florida outpatient sites and named its medical director chief medical officer of molecular imaging, with terms undisclosed.
Why it matters Imaging operators are buying PET sites and physician leaders while therapy isotope supply is still being contracted.
Rule · now Oct 20, 2026
CMS proposed rule CMS-4214-P would limit PBM pay tied to Part D drug use, set Medicare Advantage provider directory duties from contract year 2028, and cut the generic copay to $0 for the poorest dual-eligibles from 2028.
Why it matters This is the formal start of the public comment clock on how PBMs are paid in Medicare Part D. Watch the December 15 deadline and whether CMS adds a cost estimate or an effective date for the PBM provisions.
Enforcement Oct 20, 2026
Dr. Steven Murphy and two Stamford practices agreed on October 16 to pay $866,539 and accept a three-year federal health program exclusion to settle False Claims Act allegations with the District of Connecticut.
Why it matters A physician and two practices will pay and be barred from federal programs for three years. The underlying conduct and billing period were not stated.
Deal Oct 20, 2026
The two value-based care enablement companies project about 500,000 members and $3 billion in medical spending in 2027 across nearly 100 FQHCs, over 300 independent practices and more than 20 payers in nine states, with terms undisclosed.
Why it matters Two enablement companies serving safety-net clinics are combining for scale. Terms were not disclosed, so economics are unknown.
Approval Oct 20, 2026
FDA granted accelerated approval on October 19 to GSK's Jemperli for untreated stage II or III dMMR or MSI-H locally advanced rectal cancer, based on a 154-patient interim analysis of the AZUR-1 trial.
Why it matters A small group of rectal cancer patients may avoid surgery, radiation and chemotherapy, though responses still need longer follow-up. Watch for durability data and the confirmatory trial.
Record Oct 20, 2026
ACR joined a coalition on October 5 opposing the H-1B visa fee, noting international medical graduates make up 11 percent of United States diagnostic radiology trainees.
Why it matters A visa fee could slow a radiology training pipeline that is already short of readers. Near-term hiring effect is uncertain.
Report Oct 20, 2026
A Neiman Institute study of 24.2 million Medicare fee-for-service office visits from 2021 to 2023 found visits with only self-interpreting clinicians had 188 percent higher odds of imaging, and the authors estimate office imaging could fall 17 percent without self-interpretation.
Why it matters Who reads the image is linked to how often it is ordered. The finding is observational, so causation is not proven.
Rule · now Oct 20, 2026
The American College of Radiology opposes Rep. Frank Pallone's Lower Premiums, Faster Payments Act, which would eliminate independent dispute resolution and use insurer-calculated rates, while CMS IDR submission guides take effect November 13, 2026.
Why it matters The fight is over who sets out-of-network payment rates when a surprise bill is disputed. Providers won 88 percent of disputes in the latest CMS data.
Enforcement Oct 20, 2026
The U.S. Attorney's Office for the District of Puerto Rico created an Interagency Fraud Enforcement Task Force on October 16, naming no agencies, dollar figures or health-specific targets.
Why it matters A new local task force signals more coordinated fraud scrutiny in Puerto Rico. How much will target Medicare or Medicaid is not confirmed.
Rule Oct 20, 2026
Sen. Roger Marshall's S. 5672 would reinstate Medicare's Appropriate Use Criteria program for CT, MRI and PET orders and tie physician payment updates to the Medicare Economic Index, and it sits in Senate Finance with no hearing reported.
Why it matters A rescinded rule that made doctors check decision support before ordering advanced scans is back on the table, though only as a marker bill. Watch for cosponsors or a hearing.
Funding Oct 20, 2026
CMS announced $16.4 million from the $50 billion Rural Health Transformation Program for Maryland apprenticeships, certification support, recruitment and retention, and student pipeline programs.
Why it matters Rural Maryland gets money to train and keep health workers. Watch for which organizations receive subawards, since CMS named no grantees.
Enforcement Oct 20, 2026
After ACR revoked accreditation over image quality, the FDA required Summerlin Hospital Medical Center to stop mammography on December 11, 2025 and notify patients examined from October 24, 2023, and Nevada found 14 of 30 reviewed cases unacceptable.
Why it matters A failed image-quality review led to a federal shutdown and patient notification. Patient counts and penalties have not been disclosed.
Deal Oct 20, 2026
TriGemX Bio, developer of the oral Phase 3 migraine drug elismetrep, agreed to merge with Nasdaq-listed TCGX Acquisition Corp. with a $160 million private placement and about $86 million in trust, and closing is expected in the first quarter of 2027.
Why it matters A migraine drug developer without Phase 3 results is heading to public markets through a SPAC. Watch redemptions and shareholder votes.
Rule Oct 19, 2026
AbbVie, Bristol Myers Squibb, Boehringer Ingelheim and PhRMA moved to intervene in the hospitals' Maine suit against the 340B rebate pilot covering 21 drugs from 10 manufacturers, set to start January 1, 2027.
Why it matters The fight over who fronts the cost of discounted drugs at safety-net hospitals is now a three-way court case. Watch for a ruling on the intervention motions and on the request to block the pilot before January 1.
Alert · now Oct 19, 2026
For the week ending October 10, 2,270 of 45,331 specimens were positive for flu, 97.9% of positives were influenza A, and hospitals recorded 4,024 admissions with no pediatric deaths reported yet.
Why it matters Flu activity is low but rising, slightly ahead of a typical year, with the most activity on the West Coast. It is early, so watch the next weekly CDC reports.
Earnings Oct 19, 2026
Elevance Health reports third-quarter results on October 21, with UnitedHealth's 88.4% medical care ratio, which included $610 million of favorable reserve development and fell alongside Medicare Advantage membership of 7.6 million versus 8.4 million, as the benchmark.
Why it matters An insurer can improve its ratio by shedding members and repricing. Watch Elevance's ratio excluding reserve releases.
Rule Oct 19, 2026
Through March 31, 2027, Medicare contractors will apply the fiscal 2026 timing standard and will not deny IRF claims solely for a late first interdisciplinary team meeting, provided the team meets at least weekly.
Why it matters CMS is giving rehab hospitals six months before the fiscal 2027 four-day team-meeting rule can be used to deny claims. All other coverage and documentation rules still apply.
Deal Oct 19, 2026
Merck KGaA will pay $20.00 per ADS in cash for U.K.-based siRNA developer Silence Therapeutics, a 130% premium, via a U.K. scheme of arrangement expected to close in the first quarter of 2027.
Why it matters A 130% premium for a drug with only Phase 2 data shows how much buyers will pay for rare-disease assets. Watch whether the scheme clears shareholder and court votes.
Deal Oct 19, 2026
The FTC sent both companies a Second Request on October 15, so the waiting period now runs until 30 days after both substantially comply, which pushes back the year-end close targeted at signing.
Why it matters A Second Request does not block a deal, but it makes the calendar the biggest risk. Watch for a new timing disclosure or a settlement.
Deadline Oct 19, 2026
CMS opened a five-business-day window on October 16 to petition against recertification of Maximus Federal Services, ProPeer Resources, C2C Innovative Solutions, Medical Evaluators of Texas ASO, and Federal Hearings and Appeals Services.
Why it matters These five companies decide payment disputes between insurers and out-of-network providers under the No Surprises Act. Anyone can file, and CMS says more entities will be posted for petition.
Deadline Oct 19, 2026
OPM published a Federal Register notice proposing a new information collection, the FEHB Protection Act Portal, for family-member documentation, with comments due December 18, 2026.
Why it matters A new online portal would collect documentation for family members in the federal employee health program. The number of enrollees affected and any coverage consequence are not confirmed.
Deal Oct 19, 2026
Suki raised a $90 million Series E led by new investors Healthier Capital, Crosslink Capital and Hercules Capital to build agents for referrals, scheduling and prior authorization, bringing total funding past $250 million.
Why it matters Voice scribes are being pitched as back-office automation. Watch whether agents for referrals and prior authorization show up in real health system deployments.
Deal Oct 18, 2026
Abby Care, a Medicaid home-care provider that trains family members to become paid caregivers, raised an $82 million Series C led by Transformation Capital with CVS Health Ventures among new investors.
Why it matters A startup is betting that paying family members can fill a staffing gap in home care. CVS Health Ventures cited a 65% fill rate for authorized private duty nursing shifts.
Report Oct 18, 2026
CMS 2024 data puts the ASC improper payment rate at 14.7 percent, about $656.3 million, with insufficient documentation at 58.8 percent of errors, no documentation at 34 percent, and incorrect coding at 7.2 percent.
Why it matters Most Medicare payment errors at surgery centers come from missing or thin records, not coding mistakes.
Rule Oct 18, 2026
CMS proposes a 2027 conversion factor of $32.84 for clinicians outside qualifying APMs, down from $33.40, and $33.17 for those inside them, down 1.19 percent from $33.57, mainly because the one-year 2.5 percent increase from Public Law 119-21 expires.
Why it matters The multiplier on every Medicare physician service is proposed to drop. No final rule yet; last year's came October 31, so it could lock within weeks.
Rule Oct 18, 2026
The Justice Department and HHS-OIG announced that a company disclosing possible criminal health care conduct to DOJ's National Fraud Enforcement Division earns credit under both the department's Corporate Enforcement Policy and OIG's Self-Disclosure Protocol, while an OIG-only disclosure generally will not qualify for a declination.
Why it matters Where a company reports suspected criminal health care fraud first now determines what credit it gets. Watch how the Justice Department applies the policy in practice.
Deal Oct 18, 2026
Duke Health and CaroMont Health filed certificate of need applications for a 120-bed and an 80-bed hospital in Mecklenburg County, to be held in a 50-50 joint company, with a state decision expected by the end of March 2027.
Why it matters A third competitor is trying to enter a Charlotte market dominated by Atrium and Novant. The state decision, expected by the end of March 2027, is the date to watch.
Deadline Oct 18, 2026
The six-month Medicare moratoria CMS announced May 13, 2026 expire November 13, and CMS has not said whether it will extend them despite reportedly promising at least 60 days' notice.
Why it matters A nationwide freeze on new Medicare hospice and home health enrollment ends in 26 days unless CMS extends it. Watch for a Federal Register notice.
Enforcement Oct 18, 2026
A Kansas health care software company owner was sentenced to 19 years in prison for a scheme in which his platform generated false doctors' orders that led to more than $1 billion in billings to Medicare and other federal programs.
Why it matters A 19-year sentence shows the scale of penalties for order-generation fraud billed to federal programs. Watch for restitution figures, which were not stated.
Record Oct 18, 2026
The National Association of Benefits and Insurance Professionals sued HHS in Maryland federal court on October 15 to lift a freeze that bars about 19,000 new agents from selling 2027 ACA plans on HealthCare.gov.
Why it matters The freeze covers all of open enrollment, November 1 to January 15 in most states. A court ruling before November 1 is the date to watch.
Report Oct 18, 2026
OIG report OAS-25-09-021 estimates Medicare improperly paid about $15.2 million for 134,526 of 186,842 sessions from October 2023 through September 2024, including 46,711 billed as therapeutic that should have been diagnostic.
Why it matters A federal audit found most sampled sacroiliac injection sessions did not meet Medicare rules, and CMS declined a national coverage policy.
Earnings Oct 18, 2026
UnitedHealth Group's third quarter 2026 release shows Optum Health revenue of $22.9 billion versus $25.4 billion and earnings from operations of $735 million versus $41 million, and trade coverage says Optum named surgery centers and home health as units to deepen.
Why it matters Optum Health is earning more on less revenue, and says it will deepen surgery centers and home health in existing markets.
Deal Oct 18, 2026
Parkview Health, a 16-hospital Indiana nonprofit, agreed to buy Ovation Healthcare, a shared-services firm serving more than 500 hospitals in 48 states, with no price disclosed and closing expected in the coming weeks.
Why it matters A health system is taking ownership of a vendor that other hospitals rely on for back-office work. Watch how Ovation's independent clients react once the deal closes.
Enforcement Oct 17, 2026
The administration ended Marketplace subsidies for about 189,000 enrollees flagged as having duplicate Medicare or Medicaid coverage or as deceased, including roughly 120,000 Medicaid and 58,000 Medicare duplicates, with 30 days to dispute.
Why it matters If you were flagged, you have 30 days to dispute or cancel other coverage, and officials say no one loses existing Medicare or Medicaid. HHS Secretary Kennedy acknowledged a data match does not prove fraud.
Report Oct 17, 2026
CMS data from 2024 show Medicare's ASC improper payment rate at 14.7 percent, about $656.3 million, with 58.8 percent of errors from insufficient documentation, 34 percent from no documentation, and 7.2 percent from incorrect coding.
Why it matters Most Medicare surgery center payment errors come from missing paperwork rather than coding mistakes.
Record Oct 17, 2026
Centene announced a National Performance-Based Gold Card Program starting in November that lets more than 160,000 qualifying providers submit a pre-notification instead of seeking prior authorization for select outpatient services.
Why it matters Prior authorization is one of the most disliked parts of insurance, and a large insurer easing it for proven providers is a notable shift. Watch whether the services covered and the savings or denial figures are ever disclosed.
Rule Oct 17, 2026
CMS proposed a 2.4 percent ASC payment update for 2027 using the hospital market basket (3.2 percent less a 0.8 point productivity adjustment), with spinal cord stimulator generator payment up 14.8 percent and lumbar epidurals down 3.8 percent per a specialty society read.
Why it matters Medicare's proposed 2027 surgery center pay raise is modest and uneven by procedure. The final rule, expected in November, is the date to watch.
Record Oct 17, 2026
CMS and the Small Business Administration promoted CHOICE Arrangements, the new name for ICHRAs, at an October 16 Ohio employer event with Administrator Oz, with no new rule or figures.
Why it matters This is promotion of an existing option that lets employers give workers a tax-advantaged sum toward individual coverage. Minimal direct impact; watch for enrollment figures.
Rule Oct 17, 2026
CMS proposed on October 16 that Medicare Advantage plans verify provider directories every 90 days and report public accuracy scores, that PBMs report compensation tied to fair market value of services, and that the generic copay for the lowest-income dual-eligibles drop from $1 to $0 in plan year 2028.
Why it matters Directory errors that leave patients with surprise out-of-network bills would shift cost to plans, and PBM pay would be reported to plan sponsors and CMS. Watch the final rule text for the PBM fee details and the comment deadline.
Deal Oct 17, 2026
CommonSpirit Health created CommonSpirit Ambulatory Ventures, which owns all or part of 80 ASCs, while Ascension-owned AMSURG announced October 13 it acquired the two-site Euclid Endoscopy Center in San Diego and El Cajon, lifting its California total to 25 centers.
Why it matters Health systems and their subsidiaries are now major ASC buyers, alongside insurers and sponsors, which changes who owns outpatient surgery.
Deal Oct 17, 2026
MultiCare, a 13-hospital Washington system, will add Oregon's five-hospital Samaritan Health Services on November 1 with a $700 million, 10-year capital pledge after Oregon regulators approved the final piece covering Samaritan's health plans.
Why it matters Rural and regional hospitals are trading local control for capital, and this deal shows the pattern across state lines. Watch the access conditions Oregon attached to its approval.
Report Oct 17, 2026
OIG report OAS-25-09-021 found 72 of 100 sampled sessions noncompliant and estimated 134,526 of 186,842 sessions improperly paid from October 2023 through September 2024, and CMS declined to adopt a national coverage policy.
Why it matters A federal audit shows a large share of a common pain procedure was paid improperly, mostly on documentation and billing rules.
Earnings Oct 17, 2026
Optum Health reported Q3 revenue of $22.9 billion, down 10 percent, with earnings from operations of $735 million (a 3.2 percent margin versus 0.2 percent a year ago), and its CEO named ASCs as a line to deepen in existing markets.
Why it matters A major insurer-owned care company is signaling more investment in surgery centers, which could shift where outpatient surgery is delivered and who controls it. Watch for ASC-specific disclosures, since none were given.
Funding Oct 17, 2026
CMS announced $92 million for Ohio, more than $11 million for New Hampshire and $3.63 million for Montana from the $50 billion Rural Health Transformation program, with Ohio's split across care networks, maternal care and 22 rural hospital upgrades.
Why it matters Rural hospitals, EMS agencies and maternal care networks in three states get new money, though the full state awards are not stated so the share is unknown. Watch for the remaining state announcements.
Report Oct 17, 2026
Studies presented ahead of the American College of Surgeons Clinical Congress project surgeon supply falling 4.2 percent by 2038 while demand rises 12.8 percent, meeting only 84.3 percent of need across 10 specialties.
Why it matters A projected surgeon shortage could limit access to surgery, especially in counties that already have no surgeon.
Rule Oct 16, 2026
Alignment Healthcare filed suit in federal court on October 9, arguing CMS used 10 quality measures that bypassed formal rulemaking to set its 2027 Star Ratings, causing its share of members in 4-star-plus plans to fall from 98% to 25% and costing it an estimated $200 million in 2028 payments.
Why it matters A Medicare Advantage insurer is asking a federal court to throw out the 2027 Star Ratings and order a recalculation before the 2028 selling season. If it wins, quality bonus payments could shift across the entire MA industry.
Rule · now Oct 16, 2026
The CDC extended its public health order under sections 362 and 365 of the Public Health Service Act suspending entry of certain people from countries with a quarantinable disease, running through November 10, 2026, though the specific countries and diseases covered were not confirmed in reporting.
Why it matters The federal government has extended a border health order restricting entry from certain countries where a quarantinable disease exists. The specific countries and diseases are not confirmed in our review; check the Federal Register notice before relying on its scope.
Deadline Oct 16, 2026
A Federal Register notice published October 16 designates eight new high-severity eCTD validation checks, two for version 3.2.2 and six for version 4.0, and FDA will reject any submission that fails them beginning January 16, 2027.
Why it matters If your organization submits drug or biologic applications to FDA, you have until January 16, 2027 to ensure your publishing software passes eight new electronic format checks. A failed submission will not be accepted for review.
Deal Oct 16, 2026
H1, an AI platform for finding doctors, acquired Defacto Health, a payer network data company, with terms undisclosed and its two former CAQH co-founders joining H1.
Why it matters Provider directory accuracy is becoming a data-vendor business as rules tighten. Watch how plans use the combined product.
Rule · now Oct 16, 2026
CMS's six-month nationwide moratoria on new Medicare hospice and home health agency enrollment, imposed May 13, 2026, expire November 13, and CMS has not said whether it will extend them despite promising at least 60 days' notice.
Why it matters Whether the freeze lapses or is extended decides if new hospices and home health agencies can enter Medicare in 2027. Watch for a Federal Register extension notice.
Report Oct 16, 2026
The Braff Group projects 44 hospice transactions in 2026, about 30 of them platform or bolt-on acquisitions, up from 25 in 2023, with buyers now ranking regulatory compliance as the top criterion and urging pre-sale audits.
Why it matters Hospice dealmaking is recovering, but buyers are pricing in regulatory risk first. Watch how compliance findings affect closings.
Enforcement Oct 16, 2026
Lawyers say federal fraud screens are hitting legitimate hospices, with revocations carrying 10-year re-enrollment bans, while CMS has suspended payments to about 800 Los Angeles hospices and home health agencies and extended prepayment review to Georgia and Ohio.
Why it matters Fraud screening aimed at bad actors is also catching honest providers, which can disrupt hospice care access. The pressure is documented in CMS's own suspension figures.
Rule Oct 16, 2026
CMS announced Special Enrollment Period access, Medicare equipment replacements, Part D out-of-network pharmacy coverage, and 1135 waivers for providers in Florida and Alabama following Hurricane Isaias public health emergency declarations.
Why it matters If you live or work in the hurricane-affected areas of Florida or Alabama, federal health coverage rules have been relaxed. People who missed an Obamacare enrollment deadline because of the storm may qualify for a Special Enrollment Period of up to 60 days after the federal disaster period ends.
Report Oct 16, 2026
KFF estimates individual health insurance enrollment fell from 25.2 million in June 2025 to 20.5 million in June 2026, a loss of more than 4.6 million people tied to expired enhanced premium tax credits and other policy changes.
Why it matters Fewer covered people and higher proposed premiums point to a shrinking, sicker individual market. Watch 2027 open enrollment.
Deal Oct 16, 2026
Labcorp agreed to pay $722 million in cash, plus up to $150 million tied to 4Kscore revenue, for OPKO Health's BioReference clinical, women's health, urology and corrections testing businesses and more than 80 patient service centers.
Why it matters The largest national lab keeps absorbing a regional rival one piece at a time, which can reshape lab competition without any single large merger filing. Watch whether regulators look at the cumulative result.
Report Oct 16, 2026
MedPAC staff presented a workplan on October 9 to test whether the Patient-Driven Groupings Model aligns pay with patient costs, looking at patient selection and coding changes, with results not expected until fall 2027.
Why it matters The advisory body to Congress is questioning whether home health is paid accurately. Findings are a year off, but they shape the next round of rate debates.
Earnings Oct 16, 2026
On its October 13 third-quarter call, UnitedHealth Group said Optum home health visits grew 10 percent year over year and described expanding post-acute risk management with a payer partner, while Optum Health revenue fell 10 percent to $22.9 billion and operating earnings rose to $735 million from $41 million.
Why it matters One of the largest health companies is calling home health a growth line even as its value-based footprint shrinks.
Deal Oct 16, 2026
Rush University System for Health and Endeavor Health plan to merge into a 12-hospital Chicago-area system with nearly $11 billion in annual revenue, with close expected in early 2027 pending regulatory review.
Why it matters Two profitable systems are combining for scale, not rescue, which could shift bargaining power in the Chicago market. Watch the regulatory review.
Funding Oct 16, 2026
CMS awarded $78 million to 216 rural health care providers in Texas under the Rural Health Transformation Program for chronic disease prevention, workforce development, and equipment and facility upgrades, as part of a $50 billion national fund.
Why it matters If you work for or receive care from a rural health provider in Texas, your facility may have received federal money for chronic disease programs, new staff, or updated equipment. The awards are part of a $50 billion national fund.
Approval Oct 15, 2026
FDA approved Anktiva (nogapendekin alfa inbakicept-pmln) with BCG on October 14 for adults with high-grade, papillary-only non-muscle invasive bladder cancer unresponsive to BCG, based on a 77-patient study showing a 62% complete response rate.
Why it matters Adults with high-grade papillary bladder cancer that has not responded to BCG now have an FDA-approved immunotherapy option; the evidence base is partly indirect, drawing on carcinoma in situ data from an earlier approval.
Enforcement Oct 15, 2026
A federal court sentenced an Arizona addiction treatment clinic owner on September 17, 2026 to 14 years in prison, ordering nearly $55 million in restitution and more than $16 million in forfeitures after prosecutors showed she billed Arizona Medicaid more than $69 million in under a year by concentrating claims in a higher-rate Native American health program and paying referral fees to sober-home operators.
Why it matters A 14-year sentence for a $69 million Medicaid scheme illustrates the primary investigative trigger: a billing ramp reaching tens of millions in under a year, concentrated in one higher-paying program. Investigators do not need a tip when the claims data tells that story.
Report Oct 15, 2026
CMS announced October 14 that 189,000 marketplace enrollees appear to be already covered by Medicare, Medicaid or CHIP or are recorded as deceased, and that flagged individuals have 30 days to dispute before their subsidies and plans are ended.
Why it matters CMS is now running eligibility checks at least twice a year; if you or a patient is flagged as having duplicate coverage or being deceased, a 30-day dispute window applies before marketplace subsidies end.
Rule Oct 15, 2026
Nine states, most recently Tennessee as of September 1, 2026, are now issuing interstate practice privileges to licensed counselors under the Counseling Compact, covering both in-person and telehealth care, while roughly 30 additional states that have enacted the compact have not yet gone live.
Why it matters Nine states now let a licensed counselor practice across state lines without a separate license in each destination state; for patients, this expands access to telehealth mental health care from out-of-state counselors. About 30 enacting states are still not issuing privileges.
Enforcement Oct 15, 2026
The Justice Department announced October 13 that CVS agreed to pay $315 million to resolve a 2024 civil suit alleging pharmacists filled unlawful opioid prescriptions billed to Medicaid and other federal programs, with the government contending that short staffing and volume-based incentive pay drove dispensing without legitimacy checks.
Why it matters This settlement established that pharmacy staffing levels and pharmacist incentive pay tied to prescription volume can serve as the basis of a federal fraud theory under the False Claims Act. Any pharmacy operator with similar structures now faces scrutiny under the same legal theory.
Earnings Oct 15, 2026
Three major healthcare companies report Q3 2026 results in the next three weeks, with Elevance Health starting from an 89.7% Q2 benefit expense ratio and Humana's November 6 call being the first since the CenterWell clinic recapitalization with BlackRock was announced.
Why it matters Three major healthcare earnings calls land in the next three weeks: Elevance Health on October 21, HCA Healthcare on October 27, and Humana on November 6. Together they will set the industry's read on utilization, payer mix, and insurer cost ratios heading into year-end.
Record Oct 15, 2026
FDA announced an initiative to build a fit-for-purpose review framework for rare diseases, noting that only about 5% of rare conditions have an approved treatment, with a public meeting at the White Oak campus on October 28 co-run with the Reagan-Udall Foundation.
Why it matters FDA is rethinking how it reviews rare disease drugs, including manufacturing inspections and evidence standards for small patient populations; the October 28 meeting is the next milestone, and outcomes could eventually include new guidance or rule changes.
Record Oct 15, 2026
Focused Behavior Solutions, operating autism therapy clinics in Washington and Nebraska, filed Chapter 11 bankruptcy on October 15, 2026, citing a cash shortfall from delayed commercial and Medicaid reimbursements on an otherwise viable patient-demand base.
Why it matters A viable ABA clinic with real patient demand can fail on working capital when reimbursement cycles are long; the creditors' meeting on November 13 is the next date to watch.
Deal Oct 15, 2026
Galderma signed an agreement October 13 to acquire ZO Skin Health, a physician-dispensed skincare brand majority-owned by Blackstone since 2020, at a reported enterprise value of $1.5 billion that could not be confirmed against the full release because the source page was blocked.
Why it matters Galderma's acquisition of ZO Skin Health consolidates two brands in the physician-dispensed skincare market. Practices that currently carry ZO products should expect potential changes to distribution terms, pricing, and brand positioning after closing.
Deal Oct 15, 2026
BlackRock's HPS Investment Partners takes majority ownership of the CenterWell clinic portfolio by buying Welsh, Carson, Anderson & Stowe's stake at approximately $2.8 billion, with no put option in the new structure and CenterWell retaining a minority stake and management control.
Why it matters The removal of the put option is the structurally significant term: the old arrangement could have forced Humana to buy out its partner, creating a contingent liability. Watch for Humana's November 6 earnings call for the first quantification of the balance sheet and cost-of-capital effect.
Rule Oct 15, 2026
CMS's calendar year 2027 hospital outpatient proposed rule (CMS-1850-P) would set the Medicare per-diem rate for a three-service intensive outpatient mental health day at $349.52 in a hospital outpatient department and $139.81 in a community mental health center, a 2.5-to-1 gap for identical services driven entirely by site of service.
Why it matters Medicare's proposed 2027 intensive outpatient payment is 2.5 times higher in a hospital outpatient department than at a community mental health center for the same clinical day; site of service, not clinical quality, sets the revenue. The final rule is expected in early November.
Rule Oct 15, 2026
EBSA's Field Assistance Bulletin 2026-03, issued September 8, 2026, directs auditors to focus on three areas under MHPAEA: separate or blanket MH/SUD coverage limits, prior authorization and medical necessity review, and network adequacy through admission standards and reimbursement methods.
Why it matters The Labor Department just told group health plans exactly where enforcement attention is going for mental health parity: separate coverage limits, prior authorization, and network rates. If you rely on employer coverage for behavioral health, these are the fights regulators will prioritize.
Rule · now Oct 15, 2026
A Treasury proposed rule published October 15 would require filers to repay the full amount of any overpaid advance premium tax credit beginning with tax year 2026, ending the income-based repayment cap and affecting an estimated 15.6 million people.
Why it matters This proposed rule would require anyone who received more ACA subsidy than they were entitled to repay the full excess at tax time, starting for 2026 income. The comment period closes November 30, and about 15.6 million people are affected.
Deal Oct 15, 2026
Rogers Behavioral Health, a Wisconsin nonprofit, issued $83.3 million in tax-exempt municipal bonds in October 2026 and used part of the proceeds to acquire Sebastian Family Psychology Practice in Milwaukee, its first acquisition since 2014, while also funding new outpatient clinics planned in Ohio, Wisconsin, Iowa, Missouri, and New Jersey.
Why it matters A Wisconsin nonprofit psychiatric system used tax-exempt bond financing to refinance debt, fund new facilities, and acquire a practice, showing that nonprofit buyers with access to cheap municipal capital are now a competitive force in behavioral health consolidation.
Approval Oct 15, 2026
A Federal Register notice published October 15 covers four emergency animal drug authorizations issued August 7 through September 3 by Elanco, Zoetis, Bimeda, and Sergeant's Pet Care for prevention and treatment of New World screwworm in cattle, other livestock, dogs, and cats.
Why it matters Four more animal drugs are now authorized for emergency use against New World screwworm, giving ranchers and pet owners more approved prevention and treatment options under an HHS emergency determination from August 2025.
Rule Oct 14, 2026
A final CMS rule published August 13 and effective October 13 prohibits federal matching funds for sex-rejecting procedures for Medicaid enrollees under 18 and CHIP enrollees under 19, with a six-month grace period for current hormone therapy patients ending April 13, 2027; 21 state attorneys general and Pennsylvania's governor have filed suit.
Why it matters Federal matching funds for gender-transition procedures for Medicaid and CHIP minors ended October 13; states can continue funding these services with their own dollars, and current hormone therapy patients retain federal match through April 13, 2027.
Funding Oct 14, 2026
CMS announced October 13 awards from the $50 billion Rural Health Transformation Program totaling more than $177 million for Nebraska, funding provider contracts in 51 counties and over 200 community health worker positions, and more than $2.3 million for Missouri, supporting rural worker childcare and the state's first certified nurse midwife training program.
Why it matters Nebraska gets over $177 million and Missouri over $2.3 million from the national $50 billion rural health fund, targeting workforce recruitment, remote monitoring technology, and maternal care training.
Rule · now Oct 14, 2026
A DEA notice published October 14 sets a 1 milligram per gram concentration line above which 7-hydroxymitragynine and mitragynine pseudoindoxyl would be classified Schedule I under a temporary two-year order that can be published on or after November 13.
Why it matters Products above the 1 mg/g line would become federally illegal to sell or distribute once the DEA order publishes on or after November 13; the order lasts two years with a possible one-year extension and does not schedule mitragynine itself.
Earnings Oct 14, 2026
Elevance Health reports third-quarter results October 21, with its second-quarter benefit expense ratio of 89.7%, up 80 basis points, as the starting line.
Why it matters The benefit expense ratio shows how much of each premium dollar goes to medical care. Watch whether it keeps climbing after UnitedHealth's 88.4% on October 13.
Rule Oct 14, 2026
A Federal Register notice published October 14 moves the section 1128(b) permissive exclusion powers to the CMS Administrator immediately, allowing CMS to bar providers from federal health programs without a conviction, while the HHS Inspector General retains its existing exclusion authority.
Why it matters A second federal official, the CMS Administrator, can now bar providers from Medicare and Medicaid without a criminal conviction; the Inspector General keeps its own authority, meaning two agencies can now initiate permissive exclusions.
Earnings Oct 14, 2026
J&J's device unit grew 2.5% to $8.6 billion in the third quarter, below management's own standard, while the DePuy Synthes orthopaedics separation remains targeted for mid-2027.
Why it matters Slow device growth plus a planned orthopaedics separation signals a reshaping of one of the largest medtech portfolios. Watch the December 8 business review for detail.
Earnings Oct 14, 2026
Johnson & Johnson's third-quarter net earnings fell 95.9% to $210 million from $5.15 billion after it booked its proposed $5.5 billion talc settlement, yet it raised 2026 adjusted EPS guidance to $11.05 to $11.15.
Why it matters A company can report a near-zero quarter and a higher forecast at once. Watch whether lead plaintiff firms reach the 95% sign-up threshold on the roughly 76,000 remaining claims.
Deal Oct 14, 2026
Zocdoc closed its purchase of insurance-eligibility software company Sohar Health on October 2, its first acquisition in nearly 20 years, with the price not disclosed.
Why it matters The booking front door and the benefits check now sit under one company, which should shorten the gap between a booked appointment and confirmed coverage.
Rule Oct 13, 2026
Alignment Healthcare sued CMS in D.C. federal court arguing the 2027 star ratings methodology needed rulemaking, putting the 2028 payment hit above $200 million, per Healthcare Dive.
Why it matters A court may decide whether the star ratings method is a rule that needed notice and comment. The outcome could reach every Medicare Advantage plan's quality bonus.
Rule Oct 13, 2026
CMS published the final Ambulatory Specialty Model heart-failure participant list with 2,215 cardiologists; the ACC says electrophysiologists, interventionalists, and advanced heart-failure specialists remain incorrectly listed despite the reduction.
Why it matters The final heart-failure ASM participant list locks in 2,215 cardiologists facing mandatory Part B payment swings of up to 9 percent beginning January 1, 2027. An exception process for wrongly listed specialties is proposed but not yet final, so check the list now.
Report Oct 13, 2026
CMS rated 508 Medicare Advantage contracts and found 188 earning 4 or more stars, with the enrollment-weighted average slipping to 3.99 from 4.01; the ratings determine 2028 quality bonus payments, and CMS raised the weight of physical and mental health improvement measures from one to three.
Why it matters The 2027 Star Ratings set 2028 Medicare Advantage bonus payments and show a modest overall quality improvement; if you are in Medicare, October 15 to December 7 is your window to review and change plans.
Rule Oct 13, 2026
The proposed CY2027 physician fee schedule sets the conversion factor at $32.84 for clinicians outside qualifying APMs, down from $33.40, with the ACC projecting roughly 1 percent overall cardiology payment growth on service mix depending on procedure and visit distribution.
Why it matters CMS's proposed 2027 physician fee schedule cuts the base conversion factor by 1.68 percent to $32.84 for most clinicians, with the final rule expected around October 31. ACC projects cardiology payment up about 1 percent on typical service mix, so your net impact depends on your specific imaging, procedure, and visit distribution.
Rule Oct 13, 2026
The final guidance, which finalizes a July 2024 draft and aligns with the ICH Q5E standard, extends manufacturing-change reporting principles to interchangeable biosimilars and clarifies how makers can reuse comparison data from original applications.
Why it matters FDA now has a single set of guidance principles covering postapproval manufacturing changes for both biosimilars and the swappable interchangeable versions; the practical compliance burden is unclear until the full text is reviewed.
Rule · now Oct 13, 2026
FDA amended 80 standards of identity and extended changes to 59 others by cross-reference, letting food manufacturers substitute potassium chloride, yeast extract, MSG, or amino acids for salt without losing a product's legal name.
Why it matters FDA's voluntary rule gives food makers a path to cut sodium in 139 standardized products without rebranding; watch whether manufacturers actually reformulate, since there is no requirement and no new labeling rule.
Rule Oct 13, 2026
CMS's FY2027 hospital inpatient rule, effective October 1, approved seven of eleven cardiovascular New Technology Add-on Payment applications under the Breakthrough Device Alternative Pathway, denied the CARA System, and repealed that pathway for 2028 applicants.
Why it matters The FY2027 inpatient rule took effect October 1, granting add-on payments to seven new cardiovascular devices while closing the Breakthrough fast track for future applications. Overall inpatient payment rises 2.3 percent, and the WiSE CRT implant moves to the leadless pacemaker payment group.
Deadline Oct 13, 2026
The Interagency Autism Coordinating Committee is accepting suggested research articles for its 2025-2026 Summary of Advances through October 23, while HRSA's Healthy Start Evaluation and Quality Improvement data collection request is open for OMB public comment through November 12.
Why it matters Two minor federal comment windows are open; the one most likely to matter for you is the IACC window if you work in autism research or policy.
Deal Oct 13, 2026
iRhythm paid $237.5 million in cash plus up to 423,334 shares to acquire VitalConnect, combining the Zio ECG patch with mobile cardiac telemetry and a 30-day multi-vital-sign wearable under one company.
Why it matters iRhythm now owns both the Zio long-term ECG patch and VitalConnect's mobile cardiac telemetry platform, consolidating the two main tiers of outpatient cardiac monitoring under one supplier. Practices billing codes 93241 to 93248 and 93228 to 93229 should watch for changes to per-study pricing and referral-workflow defaults.
Report Oct 13, 2026
SELUTION4SFA and SirPAD data presented at VIVA 2026 on October 5 showed sirolimus-coated balloons outperforming plain angioplasty on repeat revascularization and restenosis at one year, coinciding with a proposed 19.5 percent Medicare cut to drug-coated balloon angioplasty.
Why it matters Two industry-funded trials support sirolimus-coated balloons for peripheral artery disease, building an evidence base at the same time CMS proposes cutting Medicare payment for drug-coated balloon angioplasty by 19.5 percent. Neither device's US regulatory status was disclosed at the conference.
Deal Oct 13, 2026
Suki raised a $90 million Series E from Healthier Capital, Crosslink Capital, Hercules Capital and existing investors to build agents for referrals, prior authorizations, orders and follow-up scheduling.
Why it matters AI documentation tools are moving beyond note-taking into the administrative work that follows a visit. Watch whether the agents deliver measurable time savings.
Earnings Oct 13, 2026
UnitedHealth's third quarter medical care ratio fell to 88.4% from 89.9% with $610 million of favorable reserve development, and the company now expects 2026 adjusted earnings of at least $20.50 per share.
Why it matters The largest US health insurer is paying out less of each premium dollar on care, but part of the improvement came from a one-time reserve release. Watch the ratio after reserve effects.
Rule Oct 12, 2026
Alignment Healthcare disclosed in an October 8 SEC filing that its California HMO contract will fall from 4.0 to 3.5 stars for 2027, reducing 2028 quality bonuses, and that it plans administrative appeals and a federal lawsuit challenging the ratings methodology.
Why it matters CMS Medicare Advantage star ratings are being challenged in federal court by multiple insurers. A May 2026 ruling in a Clover Health case may be opening the door to recalculations with real dollar consequences, and Alignment's new suit adds to that pressure.
Record Oct 12, 2026
FDA withdrew approval of 37 generic drug applications from Par Health and affiliated applicants, plus Amneal's celecoxib capsules, at the companies' request because the products are no longer marketed, meaning those specific products can no longer legally ship.
Why it matters Withdrawn generic approvals mean those specific products can no longer legally ship. If you purchase from the affected product list, verify your ordering system with your GPO or distributor.
Rule Oct 12, 2026
FDA's final order effective October 9 codified at-home STI nucleic acid test kits as class II devices under 21 CFR 866.3385, allowing competitors to seek 510(k) clearance using LetsGetChecked's Simple 2 Test as the predicate device instead of filing a full De Novo request.
Why it matters FDA lowered the regulatory bar for companies launching at-home STI test kits. Rivals can now file a 510(k) using LetsGetChecked's Simple 2 Test as the comparison device instead of going through a more expensive De Novo process.
Rule Oct 12, 2026
FDA's final order effective October 9 classified over-the-counter infant pulse rate and blood oxygen monitors as class II devices, allowing competitors to seek 510(k) clearance using Owlet's Dream Sock as the predicate, with special controls requiring skin-pigmentation testing and alarm validation.
Why it matters FDA made it easier for competitors to enter the OTC infant pulse oximetry market. Rivals can now file a 510(k) using the Owlet Dream Sock as the comparison device instead of a full De Novo request.
Deal Oct 12, 2026
Healthcare Services Group signed a membership interest purchase agreement on October 6 to buy NexDine, LLC and Xendella, LLC from Real Artisan Brands for approximately $93.5 million in cash, plus contingent payments tied to later performance.
Why it matters Hospital and senior-care facility dining services are consolidating under a single vendor. Watch how contract leverage and pricing shift when NEXDINE clients renew under Healthcare Services Group.
Rule · now Oct 12, 2026
HHS published a Federal Register notice on October 13 seeking public comment through November 12 on new step-count and muscle-strengthening guidance that will inform a 2027 supplement to the Physical Activity Guidelines for Americans.
Why it matters HHS is accepting public comment through November 12 on new step-count and muscle-strengthening guidance. The numbers HHS settles on will be cited in school, community health, and benefit programs for years.
Deal Oct 12, 2026
Ultragenyx agreed October 7 to sell its rare pediatric disease priority review voucher for $210 million, subject to antitrust clearance, while FDA issued a separate voucher to Ionis Pharmaceuticals on October 9 alongside the Zanvastro approval for Alexander disease.
Why it matters FDA rare pediatric disease priority review vouchers now have a market price on the record at $210 million. Watch whether Ionis announces a sale of its Zanvastro voucher and whether the Ultragenyx transaction clears antitrust review.
Deal Oct 12, 2026
Stryker will make a preferred equity investment of roughly $400 million in CMR Surgical and become the exclusive U.S. sales agent for the Versius surgical robot, with an option to acquire the entire company at undisclosed terms.
Why it matters Stryker's investment reshapes who sells and services the Versius robot in U.S. operating rooms. Watch whether sales and service contracting terms shift before any full acquisition.
Rule Oct 11, 2026
The Accreditation Council for Graduate Medical Education has proposed deleting emergency medicine's specialty-specific 60-hour weekly and 12-hour ED shift caps, subjecting EM residents to the general 80-hour standard and reducing the required faculty-to-resident ratio from 1:3 to 1:5, with public comments closing October 22.
Why it matters The body that accredits U.S. residency programs wants to drop emergency medicine's specialty-specific work-hour limits, a change that would reshape how emergency departments are staffed and how many attending hours groups must supply. Public comments are due October 22.
Rule Oct 11, 2026
The American Hospital Association, the Maine Hospital Association, and four safety-net hospitals filed suit October 9 in federal court in Maine to stop a 340B rebate pilot that would require hospitals to pay full drug prices and wait for manufacturer rebates, with AHA estimating added administrative costs above $1 billion a year.
Why it matters Hospitals are fighting a federal pilot that would shift them from buying outpatient drugs at a discount to paying full price and waiting for rebates. Watch for a court ruling on a preliminary injunction before the January 1, 2027 launch date.
Enforcement Oct 11, 2026
CVS agreed to a $440 million settlement with the Justice Department to resolve a roughly $949 million False Claims Act judgment against its bankrupt Omnicare long-term-care pharmacy unit, with $130 million due within 14 days of the agreement's effective date and $310 million due by March 15, 2028.
Why it matters CVS has agreed to pay $440 million to settle federal False Claims Act allegations that its Omnicare unit dispensed drugs to nursing home residents without valid prescriptions. The case is the clearest published price tag yet for that specific pharmacy compliance failure.
Rule Oct 11, 2026
FDA turned its July 2024 draft guidance into final policy, extending its biosimilar manufacturing-change framework to cover interchangeable biosimilars that pharmacists can substitute without calling the prescriber.
Why it matters FDA finalized guidance telling biosimilar and interchangeable biosimilar makers which post-approval plant or process changes require new FDA review before they can ship product. Interchangeable biosimilars, the versions pharmacists can swap at the counter without a prescriber call, are now covered for the first time under this framework.
Rule · now Oct 11, 2026
FDA published draft guidance on October 9 stating it does not plan to enforce certain additional traceability recordkeeping requirements for high-risk foods against some retail food establishments and restaurants, with comments due November 23.
Why it matters FDA signaled it will ease enforcement of some lot-level food traceability recordkeeping requirements for certain grocers and restaurants, and is inviting public comment before finalizing the policy. The draft does not yet confirm which retail categories qualify.
Rule · now Oct 11, 2026
FDA published a request for information on October 5 asking stakeholders for data on dose escalation, cardiac and neurologic monitoring, eligibility, and independent safety oversight for early human trials of ibogaine, capping starting doses at 10 mg/kg, with comments due November 20.
Why it matters FDA is actively building a regulatory framework for early ibogaine trials, a significant step toward a potential treatment for opioid addiction and PTSD. Developers, academic sites, and patients have until November 20 to shape the design standards FDA will use to evaluate investigational applications.
Rule · now Oct 11, 2026
FDA amended standards of identity for 139 standardized foods, including breads and cheeses, to permit voluntary use of salt substitutes without requiring a name change, effective December 14, 2026.
Why it matters FDA cleared the way for food makers to cut sodium in 139 standardized foods without changing the food's legal name. Nothing is required; if a manufacturer uses a substitute, they must disclose it on the label and show potassium on the Nutrition Facts panel when it reaches 2 percent of the daily value per serving.
Enforcement Oct 11, 2026
Around October 5, the FTC sent warning letters to approximately 24 unnamed hospital operators saying incomplete price transparency postings may violate consumer protection law, creating a second federal enforcement track alongside CMS, which has fined 28 hospitals since 2021.
Why it matters Hospital price transparency now has two potential federal enforcers. The FTC letters add consumer protection law as a possible basis for action on top of the CMS administrative fine track. No fines or response deadlines were announced.
Report Oct 11, 2026
A Strata Decision Technology report covering the first half of 2026 found hospital operating margins reached 0.7 percent in June after starting the year negative, with outpatient visits down 7.5 percent in May, inpatient gynecology volume down 8 percent in the half, and inpatient breast health volume up 17.2 percent.
Why it matters Hospital finances improved through the first half of 2026 but remain extremely thin at 0.7 percent in June. That margin leaves almost no cushion against new cost shocks, regulatory or otherwise.
Report Oct 11, 2026
CMS reports 394,140 federal IDR disputes initiated in July 2026 against 371,715 closed, a net gain of 22,425 in one month, confirming the backlog is still growing faster than it is being resolved.
Why it matters The federal queue for resolving surprise-bill disputes grew by more than 22,000 in a single month, meaning any out-of-network provider should expect longer waits before arbitration awards are paid. Track your own days from filing to determination before counting IDR receivables as near-term cash.
Enforcement Oct 11, 2026
The Department of Justice alleged that Independence Blue Cross conducted nurse chart reviews from 2016 to 2020 that identified inaccurate diagnosis codes but did not withdraw them before certifying the data to CMS as accurate; the Philadelphia insurer agreed to pay $22.5 million to resolve the False Claims Act case without admitting wrongdoing.
Why it matters A major regional health plan will pay $22.5 million for allegedly retaining inaccurate Medicare Advantage diagnosis codes after internal chart reviews identified them. The case shows DOJ will pursue MA coding conduct going back up to a decade.
Report Oct 11, 2026
The NCPA 2026 Digest, released October 4, shows independent pharmacies averaged 65,795 prescriptions per store in 2025, down from 67,601 in 2024, while the national store count held near 18,988 and the generic share fell from 84 percent to 81 percent.
Why it matters Independent pharmacies filled about 2,000 fewer prescriptions per store last year even as the number of stores held steady, meaning the squeeze is on volume and mix rather than closures yet. A shrinking generic share adds margin pressure on top of the lower transaction count.
Enforcement Oct 11, 2026
The owner of a Brooklyn social adult day care business pleaded guilty to billing New York Medicaid roughly $65 million for day care and home health services that were never provided, in a case prosecuted by DOJ and listed by HHS OIG on October 2.
Why it matters A Brooklyn day care operator admitted to one of the larger single-operator Medicaid fraud cases in the social adult day care program, billing for $65 million in services never delivered. The plea signals active federal prosecution of billing fraud in Medicaid community programs.
Rule Oct 11, 2026
Rep. Frank Pallone introduced the Lower Premiums, Faster Payments Act to end federal IDR and reprice out-of-network claims to a benchmark calculated from in-network medians, drawing opposition from emergency, anesthesia, and radiology physician groups who cited 2025 federal data showing high insurer default and low-offer rates.
Why it matters A House bill would replace surprise-bill arbitration with a rate the insurer computes from in-network medians, shifting rate-setting power to plans. Physician groups say 2025 federal data shows insurers already default on nearly a quarter of disputes and offer $1 or less on more than 8 percent.
Rule Oct 11, 2026
CMS, Labor, and Treasury finalized rules requiring health plans to file price data organized by provider network rather than by plan, shift to quarterly updates, reduce the out-of-network reporting threshold from 20 claims to 11, and provide personalized cost estimates by phone, effective December 7, 2026.
Why it matters Health plans and employer health plans must restructure their price data files by provider network, update them quarterly instead of monthly, and give members cost-sharing estimates over the phone on request. CMS estimates net savings to plans of about $174.5 million a year once the requirements are fully in effect.
Earnings Oct 11, 2026
UnitedHealth Group will report third-quarter 2026 results on October 13 at 8 a.m. Eastern, with the medical care ratio and Medicare Advantage membership as the primary metrics to watch, alongside a newly opened Texas attorney general investigation into care denials.
Why it matters UnitedHealth's Q3 results will give the first major read on insurer medical costs for the quarter. The medical care ratio and Medicare Advantage membership are the two numbers that will shape expectations for the rest of the insurance sector this earnings season.
Enforcement Oct 10, 2026
Twelve independent Arkansas pharmacies filed suit against Express Scripts on September 15, alleging the PBM paid them below the state's National Average Drug Acquisition Cost floor tens of thousands of times between August 2025 and March 2026, the first case brought under Arkansas Act 990's private right of action.
Why it matters Arkansas pharmacies are testing whether the state's drug price floor has real enforcement teeth. If the theory holds, pharmacies in any state with a NADAC floor law could run their own remittance audits and file suit without waiting for a regulator to act.
Enforcement Oct 10, 2026
CVS's long term care pharmacy subsidiary Omnicare exited Chapter 11 under a plan confirmed September 17 that requires CVS to pay $130 million to the Justice Department within 14 days of the effective date and $310 million more by March 15, 2028, settling False Claims Act allegations tied to nursing home dispensing without valid prescriptions.
Why it matters CVS is about to make the first payment in a $440 million False Claims Act settlement tied to nursing home pharmacy practices. If you follow pharmacy compliance, this is the clearest public price tag yet on dispensing without a valid prescription on file.
Report Oct 10, 2026
IQVIA data presented at the PBMI conference shows 35% of independent pharmacies now decline to fill weight-loss GLP-1 prescriptions, down from 48.5% one year earlier, as weight-loss GLP-1 sales reached $55 billion over the past 12 months, up 75% year over year.
Why it matters Weight-loss GLP-1 prescriptions are now the single largest growth driver in retail pharmacy. Pharmacies that still refuse to fill them are declining the fastest-growing revenue line in the industry, and the refusal rate is dropping quickly.
Report Oct 10, 2026
The National Community Pharmacists Association's 2026 Digest, released October 4, counts about 18,988 independent pharmacies in the United States, essentially flat year over year, but the average store filled 65,795 prescriptions in 2025, down from 67,601 in 2024, a 2.7% decline in per-store volume.
Why it matters Independent pharmacy store counts are holding steady, but each store is filling fewer prescriptions than a year ago. With nearly half of volume coming from government programs and 81% from generics, shrinking per-store revenue is a structural pressure on the sector.
Rule Oct 10, 2026
CMS approved Section 1115 Medicaid reentry demonstrations in Louisiana, Minnesota, and Nevada effective October 1, 2026 through September 30, 2031, allowing Medicaid to pay for health services during the weeks before release from incarceration, while Wisconsin is accepting public comment on a similar proposal through October 31 with a virtual hearing October 14.
Why it matters CMS has now approved Medicaid reentry coverage in roughly 22 states plus DC. Medicaid can pay for pre-release health care in Louisiana, Minnesota, and Nevada jails and prisons for up to 60 to 90 days before release.
Funding Oct 10, 2026
Beginning around October 8, CMS began issuing one-time $90 Part B premium rebates from the Medicare Improvement Fund to approximately 20.8 million Original Medicare enrollees, excluding Medicare Advantage enrollees, dual-eligible beneficiaries whose premiums Medicaid pays, and higher earners subject to IRMAA.
Why it matters About 20.8 million traditional Medicare enrollees are receiving a one-time $90 deposit starting around October 8. The payment is largely offset by a projected $79 rise in the 2027 Part B premium, so net benefit is modest.
Enforcement Oct 10, 2026
Michigan's attorney general filed a complaint in U.S. District Court for the Eastern District of Michigan on October 8 alleging that BCBSM holds 65 percent of the state's commercial insurance market and 79 percent of the PPO market, and that rival Blue plans refused to bid against it for the state employee health contract.
Why it matters Michigan's attorney general is alleging the state's largest insurer used its dominant market position to block competition and overcharge the state employee plan. These are allegations and the case is in its earliest stage.
Alert · now Oct 10, 2026
FDA identified four deaths among evenamide-treated patients versus one on placebo as a possible fatal arrhythmia signal, and Newron disclosed October 8 that the U.S. clinical hold on its phase 3 ENIGMA-TRS 2 trial has remained in place since April 2026.
Why it matters FDA could not rule out a fatal arrhythmia mechanism in evenamide trials, extending a hold in place since April. The drug is not approved or marketed, so current patient care is not affected.
Report Oct 10, 2026
State breach portal filings, cited by Bloomberg and SecurityWeek, indicate Oracle Health's 2025 intrusion into legacy Cerner servers affected approximately 20 million people nationwide, including nearly 3 million Texans, though Oracle has not confirmed a national total.
Why it matters Oracle Health's 2025 breach of old Cerner servers reportedly reached nearly 20 million people, though Oracle has not confirmed that total. State breach portal entries are the evidence base, and the national figure comes from reporting that cites filings not directly reviewed by this publication.
Record Oct 10, 2026
Chicago's Roseland Community Hospital will close its labor and delivery unit by October 31, citing the financial strain facing safety-net hospitals, after seeking emergency state aid and beginning furloughs in July, part of at least 23 maternity service closures nationwide in 2026.
Why it matters Chicago's Roseland Community Hospital will stop delivering babies by October 31, citing the financial pressure common to safety-net hospitals serving low-income communities. Becker's counts 23 maternity service closures nationwide in 2026, so this is part of a trend worth watching for what it signals about safety-net hospital viability.
Funding Oct 10, 2026
CMS announced October 9 that Iowa will receive over $209 million from the Rural Health Transformation Program to fund robotic-assisted orthopedic surgery, the state's first Maternal-Fetal Medicine Telehealth Network, and cancer screening hubs, while Louisiana receives $37.7 million for rural health workforce training and recruitment.
Why it matters Iowa and Louisiana are turning Rural Health Transformation awards into vendor contracts and hiring. CMS is publicizing results state by state, which signals how the broader $50 billion fund will roll out nationally.
Rule Oct 10, 2026
The April 2026 Section 232 presidential proclamation on patented drug and active pharmaceutical ingredient imports now covers every company as of September 29, with a default rate of 100 percent, reduced rates for onshoring plans and country exemptions, and a current carve-out for generics and biosimilars that the Commerce secretary must review within a year.
Why it matters Since September 29, tariffs on patented prescription drug imports apply to every company selling into the U.S. market. The default rate is 100 percent, with lower rates available for onshoring plans, certain trading partners, and HHS pricing deals. Generics are exempt for now, but that exemption is under active review.
Rule Oct 10, 2026
CVS Caremark, Express Scripts, and the Pharmaceutical Care Management Association each filed suit to block Tennessee's law barring companies from owning both a pharmacy benefit manager or health insurer and a pharmacy, which takes effect July 1, 2028, and which CVS says would force it to close 136 locations in the state.
Why it matters Three of the largest PBM players are fighting a state law that would structurally separate pharmacy benefit management from pharmacy ownership. The outcome will shape whether vertical integration in pharmacy can be regulated state by state.
Deal Oct 10, 2026
Viatris announced October 8 it will purchase all shares of Pacira BioSciences at $36.50 per share in cash, giving the maker of non-opioid surgical pain drugs Exparel and Zilretta an equity value of approximately $1.65 billion, with closing expected by year-end 2026.
Why it matters Viatris is buying Pacira BioSciences, the maker of two non-opioid post-surgical pain drugs used widely in hospitals and surgery centers, for about $1.65 billion. Watch whether contracting and pricing for Exparel and Zilretta change once a larger company owns them.
Rule Oct 9, 2026
The Accreditation Council for Graduate Medical Education proposed revising its Common Program Requirements to delete emergency medicine's 60-hour weekly cap, 12-hour shift limit, and 1:3 faculty-to-resident ratio, with public comments closing October 22 and ACEP and EMRA opposing the change.
Why it matters The body that accredits US medical residency programs has proposed removing emergency medicine's specialty-specific protections on resident hours and faculty ratios. If finalized, the change would affect how teaching hospitals staff their emergency departments and how much resident labor covers ED shifts.
Rule · now Oct 9, 2026
CMS published proposed rule CMS-3478-P on October 8, which would for the first time allow laboratory personnel to remotely access digital data, images, and live feeds from an off-site location under the originating lab's CLIA certificate, codifying pandemic-era enforcement discretion while excluding cytology from remote review; comments are due December 7.
Why it matters CMS is proposing to formally allow pathologists and lab staff to review digital test results remotely under the parent lab's CLIA license, codifying a COVID-era flexibility for the first time in federal lab regulation. About 330,000 certified labs would be affected if the rule is finalized, with multi-site hospital networks and commercial lab companies standing to benefit most.
Report Oct 9, 2026
CMS rated 508 Medicare Advantage and Part D contracts for 2027 on October 8, with Humana's share of members in four-star or higher plans rising from 41 percent to 93 percent and Alignment Healthcare's share dropping from 98 percent to 25 percent; Alignment said it will litigate the rating methodology CMS used.
Why it matters CMS's 2027 star ratings set the competitive map for Medicare Advantage open enrollment running October 15 through December 7, and the largest single-year swings in recent memory will shape which plans attract new members this season. Humana's surge and Alignment's collapse are the key storylines to watch as the enrollment window opens.
Rule · now Oct 9, 2026
The CY2027 Medicare Physician Fee Schedule final rule (RIN 0938-AV82) entered Office of Information and Regulatory Affairs review on September 29 as an economically significant rule; the proposed version drew more than 40,000 public comments and would cut the physician conversion factor by 1.68 percent for clinicians outside alternative payment models and 1.19 percent for those inside them.
Why it matters The rule that sets Medicare doctor pay for 2027 is now at the White House in mandatory regulatory review with the November 1 statutory deadline 23 days away. A proposed conversion factor cut of up to 1.68 percent is on the table, and physician groups and ACOs cannot finalize 2027 budgets until the final numbers publish.
Deal Oct 9, 2026
Advent led and Temasek co-led a $555 million Series G within a $1.18 billion financing, with a separate $622 million commitment to buy existing shares expected to close later in the fourth quarter, as Devoted plans 342 new counties and five new states in 2027.
Why it matters A Medicare Advantage insurer is growing fast, from 212,000 members in December to 538,000 in September, funded by large private capital. Watch whether the growth holds as star-rating bonuses and risk-adjusted payments evolve.
Deal Oct 9, 2026
GE HealthCare will pay $945 million in cash to Trilantic North America for a U.S. PET tracer manufacturer with 15 sites and 21 cyclotrons plus U.S. rights to Phase III tracer FAPI-74, with closing expected in the first half of 2027.
Why it matters PET scans depend on short-lived isotopes made close to the scanner, and this deal puts a large share of that U.S. supply chain under an imaging equipment maker. Watch whether supply terms change.
Enforcement Oct 9, 2026
Heal 360 Urgent Care PLLC, Heal 360 Primary Care PLLC, and owner Dr. Mohammed Amer Mohiuddin agreed to pay $20 million to resolve allegations that between January 2021 and March 2022 they billed the federal COVID-19 Uninsured Program for Level 3 and Level 4 evaluation and management visits patients never received, with overseas scribes fabricating the supporting medical records.
Why it matters A North Texas urgent care chain and its owner paid $20 million to resolve False Claims Act charges for billing a COVID-era federal fund for complex exams patients never received. Overseas scribes fabricated the medical records used to justify the higher-level billing codes.
Rule Oct 9, 2026
CMS penalized 2,334 hospitals, about 80 percent of those evaluated, under the Hospital Readmissions Reduction Program effective October 1, shortening the performance window to two years and counting Medicare Advantage readmissions in the measures for the first time, while keeping the payment cut limited to traditional Medicare only.
Why it matters About 80 percent of evaluated US hospitals will see smaller Medicare inpatient payments in fiscal 2027 because patients returned within 30 days too often. Two rule changes matter this cycle: the lookback window shrank from three years to two, and Medicare Advantage readmissions now count in the measurement even though the penalty applies only to traditional Medicare.
Report Oct 9, 2026
CMS data shows 394,140 No Surprises Act federal IDR disputes opened and 371,715 closed in July 2026, a net queue gain of 22,425 in one month, with emergency medicine accounting for roughly 45 percent of all disputes and the filing fee reduced to $15 in June.
Why it matters Federal data shows the No Surprises Act arbitration queue is still growing, not clearing: 22,425 more disputes were opened than closed in July alone. The lower $15 filing fee removes a cost barrier that once suppressed volume, so the pressure on the queue is likely to continue.
Report Oct 9, 2026
After CMS posted 2027 Medicare Advantage Star Ratings, Humana's share of members in plans rated four stars or higher rose from 41 percent to 93 percent while Alignment's fell from 98 percent to 25 percent, and Alignment's California HMO contract dropped from 4.0 to 3.5 stars with litigation expected.
Why it matters Star ratings set quality bonus money two years out, so a rating posted this week decides 2028 revenue for insurers and shapes the plan choices seniors see. Watch Alignment's appeals and any lawsuit over the measures.
Enforcement Oct 9, 2026
A federal jury in Minnesota convicted Sharmaine Meadows, 45, on October 8 on three counts of health care fraud for billing the Minnesota Medicaid Housing Stabilization Services program for in-person housing case management that was never delivered, including hours billed by employees who were overseas or in other states at the time.
Why it matters A Minnesota woman was convicted of defrauding a Medicaid housing program out of $3.6 million by billing for in-person services her employees never provided. Federal prosecutors used data analysis to identify impossible billing patterns including workers billing from multiple locations simultaneously and logging over 20 hours per day.
Rule Oct 9, 2026
The 2025 reconciliation law (P.L. 119-75) eliminated Medicaid and CHIP eligibility for refugees, asylees, and other lawfully present non-citizens effective October 1, requiring states to redetermine coverage for an estimated 281,000 or more enrollees across nine states and the District of Columbia, with Florida reporting the largest at-risk group at roughly 177,000.
Why it matters Federal Medicaid coverage for refugees, asylees, and other lawfully present non-citizens ended October 1. More than 281,000 people across nine states and D.C. must now be redetermined, and many are expected to lose coverage before year end as states work through eligibility verification.
Deal Oct 9, 2026
CD&R would hold about 51 percent and McKesson would invest about $1.4 billion for about 49 percent at $32.05 a share, a roughly 37 percent premium, with closing expected in the first half of 2027.
Why it matters A drug wholesaler with a path to full ownership now sits behind a major home-infusion provider. Watch the stockholder vote and regulatory review.
Rule Oct 9, 2026
Representative Frank Pallone introduced the Lower Premiums, Faster Payments Act to end federal independent dispute resolution under the No Surprises Act and set out-of-network payments at the geographically adjusted in-network median, drawing joint opposition from ACEP, ASA, and ACR, who cite 2025 data showing plans defaulted on 24.5 percent of dispute line items.
Why it matters A House bill would end the federal arbitration process that resolves out-of-network payment disputes and replace it with a formula benchmark the insurer calculates. The bill has no cosponsors and faces organized opposition from major physician groups, so its path is uncertain.
Deal Oct 9, 2026
Japan's Shionogi agreed October 5 to pay $2 billion upfront for Texas-based IntraBio, maker of FDA-approved Niemann-Pick disease type C treatment Aqneursa, with closing expected by the end of this year.
Why it matters Another ultra-rare-disease drug is moving under a larger commercial parent. Watch what the new owner does with pricing and access for Aqneursa.
Enforcement Oct 9, 2026
UnitedHealthcare and TeamHealth dismissed their emergency department upcoding lawsuit with prejudice on September 24 after reaching a confidential settlement, ending UnitedHealthcare's allegation that 62 percent of level-4 and level-5 ED visit codes were unsupported without any court ruling on the merits.
Why it matters The largest-scale private payer challenge to emergency department coding intensity ended in a confidential settlement, so the claim that 62 percent of top-level ED visit codes were unsupported was never adjudicated. The live battleground for ED coding enforcement shifts to payer downcoding programs and state anti-downcoding laws.
Enforcement Sep 28, 2026
CMS canceled approximately 315,000 ACA marketplace enrollments covering over 760,000 people it says were improperly signed up by non-compliant agents and brokers, issued an interim final rule freezing new 2027 Exchange broker registrations, and expects to recover about $2.2 billion in federal subsidies.
Why it matters CMS canceled ACA marketplace coverage for more than 760,000 people it says were enrolled without proper consent or documentation, and it expects to recover $2.2 billion in subsidies already paid. People whose coverage is canceled may not know until they try to use their insurance.
Rule · now Sep 28, 2026
As of September 28, 2026, the CY2027 Medicare Physician Fee Schedule final rule (RIN 0938-AV82) had not appeared on OIRA's public pending-review list, leaving 34 days before the November 1 statutory publication deadline for a rule that would cut the physician conversion factor up to 1.68 percent for clinicians outside alternative payment models.
Why it matters The rule that sets Medicare physician pay for 2027 is legally due before November 1, but it has not yet entered White House review with only 34 days remaining. A late or missed publication deadline means physician practices and ACOs cannot finalize 2027 budgets until the final numbers arrive.
Deadline Sep 28, 2026
CMS announced that 40 states and Puerto Rico have signed binding participation agreements in the GENEROUS Model, with remaining states facing a September 30, 2026 hard deadline to join or permanently opt out of the five-year program projected to save $64.3 billion in federal spending over 10 years.
Why it matters CMS's GENEROUS Model ties Medicaid drug prices to international reference levels and is projected to save $64.3 billion in federal spending over 10 years. States that have not signed by Wednesday are locked out permanently, so the deadline carries real policy stakes.
Rule Sep 28, 2026
The American College of Physicians, American Academy of Pediatrics, and five individual Medicaid enrollees filed suit on September 18, 2026 challenging a June 2026 CMS interim final rule that they allege defines the medical-frailty exemption to Medicaid work requirements more narrowly than the statute authorizes, ahead of the 2027 national rollout.
Why it matters Doctor groups and Medicaid patients are suing CMS, arguing its rule sets a standard for proving medical frailty that is harder to meet than the law requires. If the plaintiffs prevail, more people could qualify for exemptions from Medicaid's incoming work requirements. If they lose, the narrow standard stands for the 2027 rollout.
Report Sep 28, 2026
The HHS Office of Inspector General reported that New York paid Medicaid managed care plans $7,551,670 to cover 1,375 incarcerated enrollees from 2021 to 2024, including $6,164,734 in federal funds, and recommended New York refund the federal share and strengthen its incarceration-record matching procedures.
Why it matters A federal audit found New York paid Medicaid managed care insurers $7.55 million, including $6.16 million in federal money, to cover 1,375 people who were actually in prison from 2021 to 2024. OIG is recommending the federal share be refunded and that New York fix the enrollment matching gap that allowed it.
Rule Sep 28, 2026
A 24-state attorney general coalition led by California AG Rob Bonta filed a comment letter opposing a CMS proposed rule that would replace the uniform 6 percent Medicaid provider-tax hold-harmless threshold with state-specific limits tied to taxes in place as of July 4, 2025, arguing CMS exceeded its statutory authority and imposed an unlawful retroactive records burden on states.
Why it matters Twenty-four state AGs say a CMS rule on provider-tax financing goes further than Congress authorized and would force states to reconstruct financial records and build costly new reporting systems. Part of the same underlying statute takes effect October 1, adding urgency even before the rulemaking is finalized.
Funding Sep 27, 2026
CMS announced on September 24 that Arkansas will receive $54.6 million through the Rural Health Transformation Program, split between $27.4 million for 30 chronic disease and prevention projects and $27.2 million for 24 workforce projects including rural residency programs, nursing and behavioral health training, expanded maternal health staffing, and new EMT and paramedic programs.
Why it matters The federal government awarded $54.6 million to Arkansas rural health programs for chronic disease screening, workforce training, and maternal health expansion as part of a new 50-state, $50 billion program. This is among the first named state tranches and sets the model for the national rollout.
Deal Sep 27, 2026
Ascension is exiting its co-ownership of Mercy Care, which it has held since 1985 and which reported $34 million in income last year, selling to CVS Health-owned Aetna for undisclosed terms, with the deal pending regulatory approval and no closing date set.
Why it matters Ascension is shedding its stake in a profitable Arizona Medicaid insurer to Aetna, continuing the nonprofit system's retreat from insurance risk following years of financial losses and its 2024 cyberattack. Watch whether regulatory approval brings conditions that affect the plan's operations.
Rule Sep 27, 2026
The CMS Innovation Center posted its first participant list for the Long-Term Enhanced ACO Design Model on September 25, naming 79 ACOs in an implementation period ahead of the January 1, 2027 launch, with 65 choosing the Global full-risk track that cannot be reversed once finalized.
Why it matters CMS has named the first ACO cohort for a 10-year Medicare payment model launching January 1, 2027. The detail that matters most: once a renewing ACO selects the Global full-risk track, it cannot switch back for the model's entire decade.
Rule Sep 27, 2026
The CY 2027 Physician Fee Schedule proposed rule, published July 16, 2026, would require remote monitoring services to be furnished by direct employees of the billing practice; UnitedHealth, CVS Aetna, and Kaiser Permanente opposed the ban in comments that closed September 14, while Humana and Blue Cross plans supported it.
Why it matters CMS is proposing to allow Medicare payment for remote monitoring only when performed by direct employees of the billing practice, which would end the outsourced vendor model that has grown rapidly and split large insurers sharply in their public comments. Watch the final rule expected later this year.
Rule Sep 27, 2026
The comment window for the CY2027 Medicare Physician Fee Schedule closed September 14 with the American College of Cardiology seeking to delay a mandatory heart-failure payment model and reverse structural and imaging code cuts, and the American College of Obstetricians and Gynecologists contesting the obstetric billing structure, before CMS is expected to finalize both in a single rule in early November 2026.
Why it matters A single CMS decision expected in early November will simultaneously set cardiology payment model terms and obstetrics billing structure for 2027. Most operators in either specialty probably did not track the September 14 comment deadline, which was the last real input point before finalization.
Rule Sep 27, 2026
A briefing schedule filed September 18 in Elevance Health v. HHS places Elevance's opening brief on September 28 and asks the court for a December 14 ruling, with $115 million in 2027 quality bonus payments at stake, alongside two parallel insurer suits totaling $175 million more.
Why it matters Three health insurers are asking federal courts to force CMS to recalculate Medicare Advantage Star Ratings under a changed methodology. A December ruling across three cases could reshape how quality bonus payments are calculated for 2027 and set precedent for future rating cycles.
Record Sep 27, 2026
Fitzgibbon Hospital in Marshall, Missouri, emerging from bankruptcy after a $10.5 million sale, and Henderson Hospital outside Las Vegas, owned by Universal Health Services, both ended labor and delivery services on September 30: the first driven by rural financial collapse, the second by a profitable chain converting 62 maternity and NICU beds to emergency and medical-surgical capacity.
Why it matters Two hospitals ended labor and delivery the same night for entirely different reasons, demonstrating that maternity unit closures are not only a rural-financial problem. Communities served by either facility face longer transport distances for obstetric emergencies starting October 1.
Enforcement Sep 27, 2026
Simon Grinshteyn, a Florida physician, was sentenced on September 22 to four years of probation, six months of home confinement, and $3,160,809.43 in restitution after pleading guilty to making false statements by signing pre-populated telemedicine orders for patients he never examined, which allowed laboratories and DME suppliers to bill Medicare for unnecessary genetic tests and equipment.
Why it matters A Florida physician received probation rather than prison after signing pre-populated telemedicine orders for patients he never met, enabling over $3 million in Medicare billing for genetic tests and medical equipment. The restitution order is for the full amount billed.
Deal Sep 27, 2026
InnoCare will discover and advance compounds against up to five undisclosed targets with Lilly taking over development and commercialization, receiving $100 million upfront and near-term plus up to $3.25 billion in contingent milestones and tiered single-digit royalties on any eventual sales.
Why it matters This deal illustrates how big pharma secures future pipelines through Chinese biotech licensing, with 97 percent of the headline value contingent on trials that have not started. Watch whether disclosed indications signal where Lilly is placing its next large bets in oncology and autoimmune disease.
Record Sep 27, 2026
Merck notified 340B covered entities on September 23 that hospitals without their own outpatient pharmacy will be restricted to a single designated contract pharmacy for Merck's 340B-priced drugs starting October 1, a unilateral manufacturer restriction taken the same week federal courts upheld state contract pharmacy access laws in New Mexico and Missouri.
Why it matters Merck's restriction shows that manufacturers can narrow 340B access drug by drug, even after courts uphold state laws designed to require broader access. Covered entities that rely on contract pharmacies now face a patchwork: state protections on paper, manufacturer restrictions in practice.
Rule · now Sep 27, 2026
CMS published a formal request for information on September 24 asking pharmacies and pharmacy benefit managers to help define what counts as a reasonable and relevant Medicare Part D pharmacy contract, with comments due November 23 and the resulting standard governing Part D pharmacy network contracts starting the 2028 plan year, effective January 1, 2029.
Why it matters CMS is asking pharmacies and PBMs to help write the rules that will govern their own Medicare contracts starting in 2029. The November 23 comment deadline is the real decision point because whatever standard results will bind network contract terms for multiple years.
Report Sep 27, 2026
OIG sampled enrollee-years from both plans and found 178 of 220 HumanaChoice records and 183 of 250 UnitedHealthcare of Wisconsin records lacked supporting medical documentation, extrapolating to $130.9 million and $46.9 million in overpayments respectively, which both insurers dispute and refuse to repay.
Why it matters A federal watchdog is pressing two major Medicare Advantage insurers to return nearly $180 million it says they collected through unsupported diagnosis codes, and their refusal to pay sets up a potential enforcement escalation alongside an existing DOJ inquiry into UnitedHealth's billing practices.
Report Sep 27, 2026
An HHS OIG report published September 21 found that CMS performs only limited accuracy checks on the four required MLR data elements states must report, does not consistently follow up with states that submit questionable figures, and does not share findings with the staff who set Medicaid managed care capitation rates.
Why it matters A federal watchdog found that the main check on whether Medicaid managed care plans are spending premium dollars on patient care rather than profit is not reliably enforced. CMS agreed with all three OIG recommendations, so tighter oversight procedures are coming.
Enforcement Sep 27, 2026
RegalCare Management Group and associated entities agreed to pay $1 million to resolve False Claims Act allegations that a company executive altered skilled nursing facility patient records to support billing at the highest-reimbursing therapy tier for patients he never assessed or spoke to, covering claims from 2018 through 2023.
Why it matters A Massachusetts nursing home company will pay $1 million after prosecutors said an executive altered patient records, without clinical authorization or patient contact, to justify billing Medicare and Medicaid at the most intensive and highest-paying rehab level.
Rule Sep 27, 2026
CMS finalized its rewritten National Coverage Determination for transcatheter aortic valve replacement on September 10, eliminating the evidence-development registry requirement for symptomatic severe aortic stenosis while requiring individual operators to perform at least 20 transcatheter valve procedures annually (at least 15 TAVR), with hospitals no longer carrying a separate facility-level volume minimum.
Why it matters CMS finalized its TAVR coverage rewrite on September 10, removing the mandatory evidence registry for the most common patient group while placing the volume floor entirely on individual operators. The key thing to watch is whether smaller cardiac programs can keep their TAVR operators credentialed above the new individual threshold.
Report Sep 27, 2026
A Texas HHSC Office of Inspector General audit published September 4 found that the TIERS eligibility system could not reliably confirm Medicaid and CHIP coverage for the roughly 339,000 pregnant and postpartum Texans enrolled annually, with 534 of 2,248 sampled terminations found incorrect and two case-study mothers missing 5 and 10 months of postpartum coverage they were legally owed; the state's system fix is not due until August 2028.
Why it matters Texas' Medicaid computer system incorrectly terminated postpartum coverage for hundreds of new mothers, and the state's own fix is not scheduled until August 2028. Affected Texans may have lost months of legally owed coverage without knowing it, and providers who delivered care during that period may have retroactively billable uncompensated claims.
Deal Sep 26, 2026
The Department of Veterans Affairs selected Abridge on September 22, 2026 for a five-year multiple-award IDIQ contract with a $775.72 million ceiling shared across all eligible vendors, through which individual VA medical centers and regional Veterans Integrated Services Networks can issue task orders for ambient AI documentation services.
Why it matters The VA's $775.72 million IDIQ vehicle is the federal government's formal determination that ambient clinical AI is ready for enterprise deployment at population scale. Commercial health systems and payers will cite this as the benchmark in their own AI procurement and board-level investment decisions.
Report Sep 26, 2026
The Blue Cross Blue Shield Association published an analysis dated September 24, 2026 estimating that AI-assisted coding tools added $942 million to what its member plans paid over three years, with secondary diagnoses driving approximately $650 million by pushing more than 55,000 inpatient stays into higher-paying DRGs at roughly $11,900 per case.
Why it matters BCBSA's $942 million figure gives payers a public dollar anchor to challenge AI-assisted coding practices at contract and audit time. Watch whether hospitals accelerate review of their AI coding vendor agreements in response.
Deal Sep 26, 2026
The Cigna Group and OpenAI announced a partnership on September 25, 2026 to embed OpenAI's frontier reasoning capabilities inside Cigna Healthcare and Accredo Specialty Pharmacy clinical workflows, starting with oncology nurses and case managers managing cancer patients, with no financial terms disclosed.
Why it matters Cigna is the first major US managed care company to embed frontier AI reasoning directly in clinical workflows at the layer that shapes cancer patient support between physician visits. Watch how payers and regulators respond to AI operating inside clinical decision support at this scale.
Rule Sep 26, 2026
CMS announced the Investing in Health Outcomes initiative on September 25, 2026, committing to eliminate 450 reporting requirements across roughly 260 quality measures in 42 states and shift Medicaid quality tracking toward whether patients are actually getting healthier for the program's 73 million enrollees.
Why it matters CMS's shift from process to outcomes measurement will change what providers and plans are required to track and report for Medicaid's 73 million enrollees. Watch for workshops later in 2026 when transition timelines for participating states become clearer.
Enforcement Sep 26, 2026
Hasan Seyhun, former COO of Fast Lab Technologies LLC, pleaded guilty in the Eastern District of Michigan to one count of conspiracy to commit health care fraud for submitting insurance claims for COVID-19 tests before test kits were mailed or that patients never returned, with the scheme totaling more than $500 million in fraudulent billings.
Why it matters A guilty plea in a $500 million COVID test billing fraud case signals continued federal prosecution of pandemic-era healthcare fraud, with one of the largest COVID billing fraud pleas on record. Co-defendant cases, including the CEO and medical director, remain pending.
Approval Sep 26, 2026
The FDA approved obinutuzumab (Gazyva) on September 25, 2026, for patients two years and older with frequently relapsing or steroid-dependent childhood-onset idiopathic nephrotic syndrome in complete remission, based on the INSHORE Phase 3 trial in which 73 percent of treated patients were relapse-free at week 52.
Why it matters This approval gives pediatric nephrologists a targeted option to prevent relapses in children as young as two who have failed or become dependent on steroid treatment for a rare kidney disease affecting 1 to 4 children per 100,000 annually.
Report Sep 26, 2026
CMS confirmed at an August 31 briefing that enrollment in the GLP-1 Bridge demonstration reached approximately 600,000 Medicare beneficiaries, up from about 250,000 in July, covering obesity-diagnosed enrollees who receive Wegovy, Zepbound, or Foundayo at a $50 monthly copay, while an estimated 5.9 million additional Medicare enrollees with GLP-1-relevant diagnoses remain on standard Part D cost sharing.
Why it matters Medicare's GLP-1 Bridge program has enrolled roughly 600,000 seniors at a $50 monthly copay in four months, reaching about 15% of an estimated 3.8 million eligible beneficiaries. The ramp is real, but 85% of the eligible pool and 5.9 million additional GLP-1-relevant patients remain on standard Part D cost sharing.
Rule Sep 26, 2026
Merck notified 340B covered entities on September 23 that, effective October 1, hospitals and consolidated health centers without an in-house outpatient pharmacy may designate only one contract pharmacy for Merck's 340B-priced drugs, with a wholly owned option qualifying only if it is within 40 miles of the parent site.
Why it matters Merck has unilaterally cut most 340B hospitals to one contract pharmacy per drug, effective October 1, even as courts uphold state laws designed to prevent such restrictions. The pattern shows that manufacturer-by-manufacturer restrictions can narrow 340B access regardless of legislative or judicial outcomes.
Rule · now Sep 26, 2026
CMS published a request for information on September 24 under docket CMS-2026-3037 asking pharmacies and PBMs to help define what a fair Part D network pharmacy contract must include, with comments due November 23 and resulting standards set to govern 2028 plan-year contracts effective January 1, 2029.
Why it matters This RFI shapes what pharmacies can contractually require from PBMs in Medicare Part D starting with the 2028 plan year. Your window to influence the outcome closes November 23, 2026.
Report Sep 26, 2026
HHS OIG report A-07-24-03259, issued September 23, 2026, found that Tennessee's Medicaid program claimed $59.3 million in federal reimbursement for targeted case management services that were unallowable because enrollees did not meet eligibility criteria or providers billed early intervention services at the higher TCM federal match rate, and Tennessee agreed to repay the overpayments.
Why it matters A federal audit found Tennessee's Medicaid program improperly claimed $59.3 million in federal reimbursement and the state agreed to pay it back, illustrating the scale of ongoing federal scrutiny of state Medicaid billing practices for case management services.
Deal Sep 26, 2026
Bloomberg reported September 25, 2026 that the Oura Inc. Nasdaq IPO is approximately four times oversubscribed, with Eli Lilly and Dragoneer Investment Group committing roughly $400 million combined as cornerstone investors, pricing expected September 29 and first trade expected September 30 under ticker OURA at a midpoint valuation of approximately $14.1 billion.
Why it matters Oura's four-times oversubscribed IPO is the clearest market signal yet that investors are willing to pay premium valuations for consumer health wearable platforms with recurring revenue and pharma partnership potential. Watch the September 30 debut price versus the $40 to $44 range.
Report Sep 26, 2026
The American Society of Health-System Pharmacists' national workforce survey of 1,497 hospitals found that over 80% of pharmacy directors perceive a shortage of experienced technicians and about 60% report shortages of clinical specialists, with technicians themselves citing pay as the primary retention fix and hourly wages ranging from $16.57 to $24.53.
Why it matters More than 80% of hospital pharmacy directors say they cannot find enough experienced pharmacy technicians, and technicians themselves rank pay as the top fix. This is largely a wage problem that operators can choose to solve, not a structural labor-supply problem they cannot.
Rule Sep 26, 2026
A federal judge approved a consent decree on September 24, 2026, in Texas v. Kennedy that vacates the community integration provisions of HHS's 2024 Section 504 final rule, eliminating the regulatory basis for federal enforcement of community integration requirements that underpinned more than $145 billion in annual Medicaid HCBS waiver spending.
Why it matters The court order removes federal regulatory requirements that pushed providers and states to serve disabled people in home and community settings rather than nursing homes. Olmstead and the ADA remain law, but HHS can no longer use the 2024 Section 504 provisions as the basis for federal compliance action.
Alert · now Sep 26, 2026
The FDA upgraded Vitruvias Therapeutics' recall of Thyroid Tablets USP 30 mg lot 504950 to Class I on September 24, 2026, after determining the tablets may contain excess thyroid hormone, raising the risk of hyperthyroidism, arrhythmias, and serious cardiac events, with approximately 1,955 bottles distributed nationwide and the lot expiring September 30.
Why it matters A Class I recall means FDA believes these tablets are likely to cause serious adverse health consequences; patients, pharmacies, and prescribers have until September 30 to identify and pull affected bottles, making immediate action urgent.
Report Sep 26, 2026
Drug Channels' September 22 preview of its 2026-27 wholesaler economic report found provider-administered biosimilars now generate more than $4 billion in gross profit for McKesson, Cencora, and Cardinal Health, up from $1.4 billion in 2022, while both Cencora and Cardinal Health have used that margin windfall to acquire physician-practice management companies in the same specialties that prescribe those biosimilars.
Why it matters Drug wholesalers now earn 23% of their gross profit from biosimilars that represent just 6% of their revenue, and two of the three largest have used those profits to buy physician practices that prescribe those same biosimilars. The financial incentive and ownership structure are now aligned in ways that did not exist three years ago.
Funding Sep 24, 2026
CMS announced a Rural Health Transformation Program award of more than $45 million to Missouri on September 22, 2026, including $35 million for facility upgrades at 20 rural hospital sites, up to $6.4 million for rapid behavioral health and perinatal consultations, and up to $4.2 million to train 437 EMTs and paramedics.
Why it matters More than $45 million in federal funding is heading to rural Missouri for hospital buildings, faster mental health access, and new paramedic capacity. This is one state's slice of a $50 billion, 50-state rural health program.
Rule · now Sep 24, 2026
CMS published an RFI seeking input on how to define enforceable standard contract terms for Medicare Part D network pharmacies, implementing a Congressional mandate that bars PBMs from excluding any pharmacy willing to meet those terms, with comments due November 23, 2026.
Why it matters CMS is asking the public to help design the rules that will govern how pharmacy benefit managers write contracts with pharmacies in Medicare's drug benefit starting in 2029. The outcome could reshape how easily pharmacies access Part D networks.
Record Sep 24, 2026
The Senate HELP Committee questioned FDA commissioner nominee Dr. Heidi Overton on September 24, 2026, with Chairman Bill Cassidy calling her support for spacing out childhood vaccines 'almost disqualifying' and other senators pressing her on mifepristone access; she needs a committee majority to advance to a full Senate vote.
Why it matters The next FDA commissioner's positions on vaccines and abortion pill access could shape agency priorities for years. The hearing revealed significant bipartisan concern; watch whether the nomination advances out of committee.
Enforcement Sep 24, 2026
The FDA issued a final debarment order effective September 23, 2026, barring Sanjay Kumar from importing or offering to import any drug into the United States for five years, based on his felony conviction for conspiracy to traffic in counterfeit goods.
Why it matters The FDA's debarment system bars individuals convicted of serious crimes from the drug supply chain. This is a routine enforcement action against one individual with no broad market impact.
Deadline Sep 24, 2026
Healthy Blue, owned by Elevance Health, will end its Louisiana Medicaid managed care contract on December 31, 2026, requiring nearly 290,000 enrollees to choose a new plan during a special enrollment window from October 15 through November 16 or be automatically assigned to one of the four remaining Healthy Louisiana plans.
Why it matters If you or someone you know is enrolled in Healthy Blue Louisiana Medicaid, you must pick a new plan between October 15 and November 16 or the state will assign one for you on January 1. This exit is part of a broader Elevance pullback from Medicaid in multiple states.
Alert · now Sep 24, 2026
Otsuka ICU Medical LLC recalled one nationwide lot of 0.9% Sodium Chloride Injection on September 17, 2026, after a customer found a bag labeled as saline actually contained 10 mEq Potassium Chloride Injection, the third overwrap mislabeling recall from this product line since February 2025, with no reported injuries and no formal FDA risk classification yet.
Why it matters Hospitals nationwide should check their IV saline inventory against the recalled lot number immediately. A bag labeled as saline that actually contains potassium chloride could kill a patient if injected by mistake.
Rule Sep 23, 2026
CMS published preliminary Calendar Year 2027 Clinical Laboratory Fee Schedule rates on September 21, 2026, finding Medicare currently pays about 16 percent more than private insurers for the same tests and capping rate reductions at 15 percent per test per year through 2029 to phase in the change.
Why it matters Medicare will start paying labs what private insurers pay for the same tests beginning January 1, 2027, with cuts capped at 15 percent per test per year through 2029. CMS projects the change will save taxpayers about $1 billion annually.
Rule Sep 23, 2026
CMS announced on September 22, 2026 that it canceled roughly 315,000 unauthorized ACA marketplace enrollments affecting more than 760,000 people and paired the action with an Interim Final Rule imposing a moratorium on new agent and broker registrations for the 2027 plan year for anyone without an active 2026 Exchange Agreement.
Why it matters CMS canceled 315,000 unauthorized ACA enrollments and expects to recover $2.2 billion in subsidies paid on those enrollees' behalf. A new Interim Final Rule simultaneously freezes 2027 broker registrations for anyone without an active 2026 Exchange Agreement.
Enforcement Sep 23, 2026
DOJ announced on September 21, 2026 that Crown Medical Solutions LLC and its owners agreed to pay $825,000 to resolve False Claims Act allegations that they billed Medicare for knee braces, heel stabilizers, and back braces that lacked medical necessity or valid physician prescriptions between November 2017 and April 2019.
Why it matters A durable medical equipment supplier and its owners settled for $825,000 after a former employee alleged they billed Medicare for braces patients did not properly qualify for. The whistleblower receives approximately $123,750 of the recovery.
Report Sep 23, 2026
The Oregon Secretary of State's Office found approximately 650 duplicate enrollee ID numbers in Oregon's Medicaid benefit eligibility system that may have triggered duplicate monthly capitation payments to coordinated care organizations, with projected overpayments of up to $4.1 million, landing as the program faces a $421 million budget shortfall.
Why it matters Oregon's state auditor found nearly 650 duplicate Medicaid enrollee IDs that may have triggered up to $4.1 million in double payments to managed care organizations. The finding lands as Oregon's Medicaid program faces a separate $421 million budget shortfall.
Rule Sep 23, 2026
Judge William G. Young heard the government's motion to dismiss a lawsuit filed by HIV physician groups challenging HRSA and HHS funding conditions issued in March and June 2026 that bar Ryan White HIV/AIDS Program grantees from spending program dollars on gender-affirming medical care or acknowledging patients' gender identity.
Why it matters A federal judge heard arguments today on whether the government can strip Ryan White HIV/AIDS Program funding from clinics that refuse to drop gender-affirming care. The program serves more than half of the roughly 1.2 million Americans living with HIV.
Rule Sep 22, 2026
The American College of Cardiology filed comments on September 10, 2026, ahead of the September 14 deadline on the CY2027 Medicare Physician Fee Schedule proposed rule, asking CMS to postpone the January 1, 2027 start of the mandatory Ambulatory Specialty Model for heart failure and to restore reimbursement for left atrial appendage closure, new tricuspid valve repair codes, drug-coated balloon angioplasty, and coronary intravascular ultrasound.
Why it matters The ACC is asking CMS to delay a mandatory new payment model for heart failure and reverse double-digit reimbursement cuts to several structural and imaging heart procedures before the fee schedule finalizes in November. Whether CMS accepts any of these asks will shape cardiology practice economics starting in 2027.
Deal Sep 22, 2026
Clearwater Cardiovascular Consultants, owned by Lee Equity Partners' Cardiovascular Logistics platform, absorbed Pasco Cardiology Center in Trinity, Florida on September 4, 2026, adding cardiac catheterization, pacemaker, and electrophysiology services; financial terms were not disclosed, but market observers say multiple PE-backed cardiology platforms are approaching their second-bite recapitalization phase.
Why it matters A small Florida practice acquisition is a visible signal that PE-backed cardiology platforms are entering a second-bite recapitalization cycle, where original sponsors sell a stake to new investors and inject fresh capital for another round of acquisitions. More bolt-on deals are likely across the sector.
Rule Sep 22, 2026
CMS posted the final participant list for its mandatory Ambulatory Specialty Model on September 15, 2026, naming 5,556 cardiology, anesthesiology, pain management, neurosurgery, orthopedic surgery, and physical medicine specialists who must enter a two-sided payment model for heart failure and low back pain cases beginning January 1, 2027, with no opt-out and payment adjustments ranging from negative 9 to positive 9 percent in year one.
Why it matters CMS is locking 5,556 specialists nationwide into a mandatory payment model that puts up to 9 percent of their Medicare pay at risk based on patient outcomes, with no opt-out. This is one of the largest mandatory specialist payment model launches CMS has attempted.
Record Sep 22, 2026
Aetna expanded its bundled prior authorization program to all cancer types for eligible Medicaid members effective September 1, 2026, replacing an average of four separate approvals for chemotherapy, radiation, imaging, and immunotherapy with a single submission, with full rollout to private and Medicare Advantage plans planned for the first half of 2027.
Why it matters Aetna is replacing four prior authorization requests per cancer episode with one, reducing delays between diagnosis and treatment for members in eligible Medicaid states now. The expansion to private and Medicare Advantage plans in early 2027 will broaden that impact significantly.
Deal Sep 22, 2026
DexCare, whose patient-access platform serves 57 million patients across health systems, acquired Mila Health, an AI care-coordination startup whose conversational agents autonomously handle scheduling, pre-visit preparation, and post-discharge follow-up, for undisclosed financial terms.
Why it matters DexCare's acquisition of Mila Health signals that AI-driven patient engagement is expanding beyond getting patients into appointments toward managing the full care episode. Watch whether health systems adopt the combined platform and how autonomous outreach agents handle sensitive post-discharge situations.
Rule Sep 22, 2026
The Department of Justice revised its Justice Manual on September 18, 2026, reinstating the 2017 Brand Memo policy that bars government enforcement actions based solely on violations of sub-regulatory guidance such as Medicare coverage articles or program manuals, while preserving carve-outs for using guidance to establish a defendant's knowledge of wrongdoing or false certifications of compliance.
Why it matters DOJ has raised the evidentiary bar for False Claims Act suits built solely on violations of agency guidance documents, but providers who certify compliance with guidance they do not actually follow still face full legal exposure under the preserved carve-outs.
Report Sep 22, 2026
The GAO reported on September 15, 2026 that 1,719 of 6,655 Qualified Health Plans sold on ACA exchanges in 2026 covered non-excepted abortion services, reaching an estimated 4.4 million enrollees, and found some issuers are not meeting the ACA's requirement to prominently disclose that coverage to consumers shopping for a plan.
Why it matters A federal watchdog confirmed that about one in four ACA marketplace plans covers abortion services, a larger share than previously documented, and that some insurers are not disclosing it as the law requires. This finding invites CMS or HHS enforcement attention on consumer disclosure practices.
Report Sep 22, 2026
The Heart Rhythm Society published a position statement on September 17, 2026, citing federal audit data showing that most prior-authorization denials for electrophysiology procedures that are appealed are overturned, but that most wrongful denials are never contested; the statement documents denial patterns specific to catheter ablation for AFib, ICD therapy, left atrial appendage occlusion, and CRT-D.
Why it matters Federal data cited by the Heart Rhythm Society show most wrongful insurance denials for heart-rhythm procedures are never appealed, even though most appeals succeed. This is a call to action for EP practices and a signal that payer practices in electrophysiology are drawing growing regulatory and advocacy scrutiny.
Deadline Sep 22, 2026
HRSA is required to issue approvals by September 24, 2026, to drug manufacturers that submitted plans to join the revised 340B Rebate Model Pilot Program, which would shift covered entities from point-of-sale discounts to a rebate-claim model effective January 1, 2027, the government's second attempt after a Maine federal court enjoined the first version.
Why it matters HRSA's September 24 decision determines whether a second version of the 340B rebate model moves forward, reshaping how safety-net hospitals access discounted drug pricing in the affected drug classes starting January 1.
Deal Sep 22, 2026
Lexeo Therapeutics announced a definitive agreement to acquire Mantle Therapeutics for up to $21.3 million, structured as $8.3 million upfront and up to $13.0 million in clinical and regulatory milestones, adding four Friedreich ataxia programs including the oral candidate LX3010 to complement its lead gene therapy LX2006, alongside three new research collaborations announced the same day.
Why it matters Lexeo is consolidating Friedreich ataxia drug development rapidly, combining gene therapy and oral treatment approaches in a single company. Watch LX2006 and LX3010 clinical data as the pipeline advances toward regulatory milestones.
Deal Sep 22, 2026
Oura Inc. filed an amended S-1 for a Nasdaq listing under ticker OURA, offering 50 million shares at $40 to $44 each for a $14.1 billion midpoint valuation, but 36.5 million of those shares are secondary sales by existing investors, leaving the company roughly $6.2 million in net proceeds after equity tax obligations.
Why it matters Oura's IPO illustrates how secondary-heavy public offerings work, where early investors capture most of the capital raised rather than the company itself. Watch whether the $14.1 billion valuation holds once trading opens and how the thin net-proceeds figure shapes Oura's product roadmap.
Report Sep 22, 2026
A 2025 OIG report found Medicare Part B remote patient monitoring payments reached $536 million in 2024, up 31 percent from 2023, with CMS lacking basic data on which devices and conditions drove the growth; OIG has since opened an active audit (project OAS-25-05-008) of the same code family, creating elevated compliance risk for cardiology practices billing into remote monitoring codes.
Why it matters Federal auditors are scrutinizing Medicare's remote patient monitoring billing after payments hit $536 million in 2024, a 31 percent increase, with the government saying it lacks data to explain the growth. Cardiology practices billing cardiac device and rhythm monitoring codes are directly exposed to any audit fallout.
Rule Sep 22, 2026
SCAN Health Plan's reply brief on cross-motions for summary judgment is due September 22 in its DC district court suit against HHS and CMS over the 2026 MA star ratings recalculation, part of a litigation wave that also includes suits by Elevance Health ($115 million) and Alignment Healthcare ($50 million).
Why it matters The outcome of this litigation will determine whether federal courts can compel CMS to recalculate Medicare Advantage quality scores, with at least $290 million collectively at stake across three active suits. Watch for the summary judgment ruling and the Eleventh Circuit appeal of the underlying Georgia decision.
Rule Sep 22, 2026
CMS closed its nine-month reconsideration of the TAVR National Coverage Determination on September 10, 2026, eliminating the Coverage with Evidence Development registry requirement for symptomatic severe aortic stenosis, removing hospital-level volume minimums, and setting an operator-level procedural floor while preserving the multidisciplinary heart team requirement.
Why it matters CMS finalized its rewrite of Medicare's TAVR coverage rules, removing the registry requirement for the sickest patients and shifting volume accountability from hospitals to individual operators. Programs need to assess whether their operators clear the new floor.
Rule Sep 22, 2026
CMS's finalized TAVR National Coverage Determination removes the facility-level volume minimum entirely and places full Medicare eligibility responsibility on individual operators, who must perform at least 20 transcatheter cardiac valve procedures per year with 15 or more being TAVR, or 40 over two years with 30 or more TAVR.
Why it matters CMS's finalized TAVR rule removes the hospital-level volume floor and replaces it with an individual operator requirement. Every proceduralist performing TAVR under Medicare must now independently meet a procedural volume threshold to maintain billing eligibility.
Enforcement Sep 22, 2026
CMS restored nearly $12 billion in Medicaid supplemental hospital payments to Texas on September 17, 2026, ending a freeze that began September 1 over a dispute about how the state raises provider taxes to draw down its federal Medicaid match, with hospitals losing roughly $27 million per day during the stoppage.
Why it matters The restoration confirms that CMS can and will halt supplemental Medicaid hospital payments over state financing disputes, costing hospitals millions of dollars per day, and that political pressure can reverse such freezes. The underlying provider tax dispute has not been formally resolved.
Record Sep 21, 2026
Advocate Health announced September 20, 2026 that it is canceling all real estate liens filed against patients before its 2022 no-lien collections policy, more than 11,500 in total and some over 20 years old, coordinating court by court to release them.
Why it matters The third-largest nonprofit system is canceling more than 11,500 real estate liens tied to old patient medical debt, some more than 20 years old, putting numbers behind an industry retreat from aggressive collections. The cancellation will take time to complete court by court.
Earnings Sep 21, 2026
Ascension reported September 16, 2026 that fiscal 2026 net income reached 1.5 billion dollars and its operating loss narrowed to 120 million dollars from 491 million dollars, with recurring operating EBITDA positive at 1.2 billion dollars, the same week Kaufman Hall flagged weak sector-wide hospital margins.
Why it matters One of the largest nonprofit systems posted 1.5 billion dollars in net income in its first full turnaround year, even as a national benchmark flagged weak hospital margins the same week. Watch whether the gains hold.
Alert · now Sep 21, 2026
A direct review of CMS, HHS-OIG, DOJ, FDA, the Federal Register and SEC EDGAR found no rule, enforcement action or 8-K filing dated September 19 or 20, 2026, leaving two FDA food recalls, for undeclared wheat in GF Blends products and possible Listeria in an Elegant Foods Pecorino Toscano cheese lot, as the only confirmed events in that window.
Why it matters This is a housekeeping catch-up confirming a quiet regulatory weekend; the only real news is two small FDA food recalls, so there is little here to act on.
Rule Sep 21, 2026
The proposed rule rewrites state-specific limits on provider taxes states use to draw down federal Medicaid matching dollars, takes effect October 1, 2026, and CMS actuaries project it will cut federal Medicaid spending by $246 billion through 2035.
Why it matters The rule caps how much states can tax hospitals and nursing homes to draw down federal Medicaid matching dollars, with CMS projecting $246 billion in reduced federal spending through 2035. Watch whether states cut Medicaid services or shift costs to providers as their funding formulas change.
Rule Sep 21, 2026
The CMMI GENEROUS Model ties Medicaid outpatient drug prices to international most-favored-nation benchmarks and projects $64.3 billion in federal and state Medicaid drug savings over ten years, with 40 states already signed and the rest facing a September 30 participation deadline.
Why it matters Near-universal state participation in the GENEROUS Model means most-favored-nation drug pricing could soon apply across the entire Medicaid outpatient drug market. The September 30 deadline for holdout states is the last near-term decision point before the model reaches full scale.
Rule Sep 21, 2026
The Connecticut Insurance Department issued final rate decisions on September 11, 2026 covering roughly 220,000 ACA enrollees, trimming insurer requests but approving double-digit increases for the second consecutive year, with open enrollment starting October 23.
Why it matters Connecticut approved double-digit ACA premium hikes for the second year running, covering roughly 220,000 enrollees, and the state's own insurance commissioner acknowledged the trimmed increases still are not enough to prevent cost hardship. Watch whether sustained hikes drive enrollment attrition when open enrollment starts October 23.
Enforcement Sep 21, 2026
A Texas bankruptcy judge confirmed CVS-owned Omnicare's Chapter 11 plan on September 17, 2026, closing a 440 million dollar settlement that resolves a 948.8 million dollar False Claims Act judgment over 3.3 million improper prescription claims; the plan pays creditors in full and takes effect in October.
Why it matters A Texas judge confirmed CVS-owned Omnicare's bankruptcy plan, closing one of the largest pharmacy fraud cases in memory: a 440 million dollar settlement resolving a 948.8 million dollar False Claims Act judgment over 3.3 million improper prescription claims. The plan pays creditors in full and takes effect in October.
Approval Sep 21, 2026
CMS approved DNV Healthcare USA Inc.'s continued recognition as a Medicare hospital accrediting organization for a full six-year term effective September 26, 2026, preventing a compliance gap for all hospitals DNV accredits nationwide.
Why it matters CMS renewed DNV Healthcare's authority to substitute for a direct Medicare survey at every hospital it accredits, avoiding a compliance cliff that could have forced hundreds of hospitals onto CMS's own survey queue. No immediate action is required for DNV-accredited hospitals.
Deal Sep 21, 2026
HCA Healthcare completed its acquisition of The College of Health Care Professions on September 15, 2026, a deal first agreed May 27, adding an 8,000-student, 10-campus Texas training school to a workforce pipeline that already includes three nursing colleges and 365-plus graduate medical education programs.
Why it matters The largest for-profit hospital operator bought an 8,000-student training college, a sign systems increasingly build their own workforce pipeline rather than compete for scarce staff. Terms were not disclosed.
Rule Sep 21, 2026
Medicaid beneficiaries, the City of Columbus, and physician organizations including the American College of Physicians filed suit against HHS and CMS alleging the interim final rule's narrow medically frail standard exceeds statutory authority, seeking an APA violation declaration and permanent injunction.
Why it matters A second federal lawsuit now challenges the Medicaid work-requirement rule's narrow medically frail exemption, adding legal risk to an already-contested regulation. A 25-state coalition lost its injunction bid in July, but this new case with different plaintiffs could produce a different outcome.
Deal Sep 21, 2026
Telix Pharmaceuticals agreed September 20, 2026 to acquire ITM Isotope Technologies Munich for about 1.65 billion dollars upfront plus up to 700 million dollars in milestones, six weeks after the FDA rejected ITM's lead cancer drug over manufacturing, not the clinical data.
Why it matters A cancer radiopharmaceutical maker turned an FDA rejection into one of the largest deals nuclear medicine has seen, paying up to 2.35 billion dollars for its isotope supplier. Watch whether Telix shareholders approve the dilution in November and whether ITM-11 clears its manufacturing issues.
Deadline Sep 18, 2026
Congressional Democrats set September 18, 2026 as the deadline for the Consumer Product Safety Commission to answer 11 questions about its NEISS-R program, which directs hospitals to send identifiable patient emergency room records including names, birthdates, addresses, and diagnoses to private contractor Konza Health; as of publication, no public CPSC response had been found.
Why it matters A federal product-safety agency is directing hospitals to send identifiable emergency room patient records to a private contractor, and Congress is pressing for answers about the legal basis and privacy safeguards; you may be affected if your hospital is among the 100-plus institutions targeted.
Rule Sep 18, 2026
The House Committee on Ways and Means voted 25 to 15 along party lines on September 16, 2026 to send H.R. 4093, the Apples to Apples Comparison Act of 2025, to the House floor, requiring HHS to publish county-level Medicare spending data and MedPAC to produce annual retrospective spending comparisons between Medicare Advantage and traditional Medicare.
Why it matters If enacted, this bill would require the government's own Medicare advisory body to publish yearly comparisons of what Medicare Advantage costs relative to traditional Medicare, a contested data fight that could shape public and policy debates about MA's value.
Enforcement Sep 18, 2026
HHS OIG posted audit reports on September 15, 2026, finding HumanaChoice (H5216) owes an estimated $130.9 million and UnitedHealthcare of Wisconsin (H5253) owes an estimated $46.9 million for unsupported diagnosis codes submitted for 2020 and 2021 risk-adjustment payments, with both insurers rejecting the findings and declining to commit to repayment.
Why it matters Two of the largest Medicare Advantage insurers are disputing federal audit findings that they were overpaid a combined $177.8 million; CMS, not OIG, has the final say on whether to pursue recoupment.
Enforcement Sep 18, 2026
Remedi SeniorCare Holding Corporation, a Towson, Maryland pharmacy serving assisted living facilities, agreed on September 17, 2026 to pay $5.3 million to resolve DOJ allegations that it dispensed and billed Medicare and Medicaid for prescription drugs lacking valid prescriptions to residents across multiple states from January 2015 through March 2021.
Why it matters A long-term care pharmacy paid $5.3 million to settle claims it billed federal health programs for drugs residents never had valid prescriptions for; the case was surfaced by two former employees, a reminder that qui tam whistleblower actions are an active enforcement tool in the long-term care pharmacy sector.
Funding Sep 18, 2026
CMS distributed $167,299,900.69 across 228 grants to South Carolina hospitals, clinics, and rural providers on September 17, 2026, funding telehealth infrastructure, mobile care units, maternal health, and cybersecurity upgrades as one-time capital awards under a $50 billion, five-year national program.
Why it matters South Carolina is the latest and largest state to receive a Rural Health Transformation Program payout; similar one-time infrastructure grants are rolling out to all 50 states, so if your state has not received its award yet, it is coming.
Deal Sep 17, 2026
Community Healthlink, a UMass Memorial Health affiliate, transferred four Leominster programs and one Worcester community support program to Clinical and Support Options and Behavioral Health Network on September 17, 2026, as part of a phased closure with cumulative WARN Act layoffs reaching 231 employees.
Why it matters A Central Massachusetts behavioral health provider is winding down, transferring its remaining programs to two nonprofits as cumulative layoffs reach 231. This removes significant behavioral health capacity from the regional safety net.
Rule · now Sep 17, 2026
Johnson and Johnson's 340B policy, effective September 15, 2026 for most covered entities and November 3 for federal grantees, requires hospitals and community health centers to submit pharmacy or medical claims documentation within 45 days of dispensing a covered drug and limits 340B discounts to one contract pharmacy within a 40-mile radius, with non-compliance risking suspension of all J&J 340B pricing.
Why it matters Johnson and Johnson is the third major drugmaker in 2026 to impose claims data reporting requirements on 340B covered entities, following Eli Lilly and Novo Nordisk. Hospitals now face a new administrative burden or risk losing discounts that can reduce drug costs 20 to 50 percent.
Report Sep 17, 2026
Kaufman Hall's National Hospital Flash Report found the sector's July 2026 operating margin dropped to 1.4% from 2.2% in May and June, with bad debt and charity care up 14% year over year, while Dartmouth Health disclosed a $52.5 million quarterly operating loss and announced 124 layoffs and elimination of 303 open positions.
Why it matters Hospital operating margins are at their weakest point of 2026, driven by seasonal surgery slowdowns and payer mix erosion. Dartmouth Health's $52.5 million quarterly loss and 124 layoffs show what a 1.4% margin environment looks like at the system level.
Enforcement Sep 17, 2026
The US Bankruptcy Court for the Northern District of Texas held a Chapter 11 plan confirmation hearing on September 17, 2026 to finalize a minimum $440 million False Claims Act settlement resolving a $948.8 million jury verdict against Omnicare for fraudulent prescription billing from 2010 to 2018, with CVS Health paying $130 million and the bankruptcy estate contributing at least $310 million.
Why it matters A $440 million settlement closing out nearly a decade of LTC pharmacy fraud litigation is at a Texas bankruptcy court today. Confirmation would allow DOJ to begin collecting and Omnicare's Chapter 11 estate to wind down.
Deal Sep 17, 2026
Surgery Partners received $797 million in gross proceeds from Intermountain Health for its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital, completing its exit from acute-care hospital ownership to reposition as a pure-play short-stay surgical provider.
Why it matters Surgery Partners has fully exited the hospital business, selling its last two acute-care facilities at a 7x LTM EBITDA multiple. Watch whether its revised guidance range and reduced debt load hold through the back half of 2026.
Rule Sep 16, 2026
CMS announced on September 15, 2026 that its ACCESS Innovation Center model will add tracks for heart failure, COPD, substance use disorder, tobacco cessation, and extended chronic musculoskeletal pain starting April 1, 2027, with existing participating organizations able to offer the new tracks without reapplying.
Why it matters Medicare's ACCESS chronic care model now covers roughly three in four people on the program after adding five new condition tracks opening April 2027. Participating organizations earn full Outcome-Aligned Payments only when their patients hit measurable health targets, not just for delivering services.
Rule Sep 16, 2026
The House Budget Committee held a markup on September 16, 2026 on H.R. 4464, the Preventive Health Savings Act, which would require CBO on request to estimate whether a bill's preventive care provisions would reduce federal spending beyond the standard 10-year budget window and to report those savings separately.
Why it matters Congress is voting today on a bill that would change how the federal government measures the value of preventing disease, potentially making it easier to fund future prevention programs whose savings fall outside the standard 10-year budget window. The bill does not change any current payment rule.
Funding Sep 16, 2026
Governor Tate Reeves announced on September 14, 2026 that Mississippi awarded $104,115,146 across 167 grants to rural hospitals, clinics, and mental health providers for technology upgrades, capital projects, and telehealth connectivity, the first disbursement from the state's federal Rural Health Transformation Program allocation.
Why it matters Mississippi just handed $104 million to 167 rural hospitals, clinics, and mental health providers in a single announcement, the first payout from a multiyear federal rural health program. The money covers technology upgrades, capital projects, and telehealth connectivity.
Record Sep 16, 2026
The HHS Office of Inspector General added two projects to its public Work Plan on September 15, 2026: one examining GLP-1 drug overdispensing under Medicare Part D and one examining how Medicare Advantage organizations use prior authorization to control access to Part B physician-administered drugs, with no findings published yet.
Why it matters A federal watchdog has signaled it is actively scrutinizing two of Medicare's most contested drug spending areas: GLP-1 weight-loss drugs dispensed under Part D and Medicare Advantage's gatekeeping of expensive physician-administered Part B drugs. No findings exist yet, but the audit openings put both areas under heightened oversight.
Earnings Sep 16, 2026
Oscar Health disclosed in a September 16, 2026 8-K that it improved its projected medical loss ratio by 50 basis points to a range of 81.0 to 82.0 percent and raised expected earnings from operations by $100 million to a range of $600 million to $800 million, while reaffirming full-year revenue guidance of $18.7 to $19.0 billion.
Why it matters Oscar Health raised its 2026 profit guidance at its investor day, signaling its ACA exchange business is performing better than expected even as some rivals absorb enrollment and margin headwinds; the contrast with peers cutting guidance on the same coverage is the signal worth watching.
Record Sep 16, 2026
PTAC held its third 2026 public meeting on September 14 and 15, gathering expert testimony on total cost of care models, rural implementation, and AI applications to inform a draft white paper on value-based payment transformation, with the committee's next meeting scheduled for December 8 and 9, 2026.
Why it matters The federal advisory committee that recommends new Medicare physician payment models to HHS spent two days gathering input on a draft roadmap rather than voting on any new model. The committee's next meeting is December 8 and 9, 2026, when concrete recommendations could emerge.
Deal Sep 16, 2026
Sword Health confirmed a definitive agreement to acquire Headspace, the consumer meditation app with 100 million users and enterprise relationships with Cigna and Kaiser Permanente, with the companies declining to disclose a price and the expected close pushed from September 14 to Q4 2026.
Why it matters Sword Health's acquisition of Headspace would pair AI-powered clinical care with one of the largest consumer mental health brands in the world; the deal has not yet closed and the price has not been confirmed by either company, so watch the Q4 2026 timeline and final terms.
Report Sep 16, 2026
TailorCare announced it now covers approximately 1 million Medicare Advantage members under value-based contracts across Texas, Indiana, Georgia, and Colorado, and reported that members on its self-care pathway saw total medical costs fall 79 percent versus a matched cohort, a figure the company has not had independently audited.
Why it matters TailorCare says patients steered toward self-care instead of surgery saw total medical costs fall 79 percent, a figure that, if validated, would represent a meaningful cost-reduction model for musculoskeletal conditions in Medicare Advantage; the numbers are the company's own and have not been independently audited, so treat them as a starting point for due diligence rather than settled fact.
Deal Sep 16, 2026
CommonSpirit Health agreed to pay Tenet Healthcare approximately $2.7 billion comprising $1.9 billion over three years to terminate its Conifer service contract plus $540 million to divest its approximately 24 percent ownership stake, with Conifer filing a Texas WARN notice for 1,037 employees effective November 2, 2026.
Why it matters One of the largest outsourced revenue cycle relationships in U.S. health care is being unwound: CommonSpirit paid $2.7 billion to exit Conifer and more than 1,000 workers are losing their jobs as a result. The transaction signals both the rising cost of exiting long-term RCM outsourcing deals and the ongoing shift toward AI and offshoring in that segment.
Deal Sep 15, 2026
Addus HomeCare agreed to buy AccentCare's personal care operations across 10 states for approximately $275 million in cash, adding roughly $280 million in annualized revenue and an average daily census of 13,700 customers.
Why it matters The Addus-AccentCare deal adds roughly 13,700 daily personal care customers and $280 million in annualized revenue to the largest publicly traded personal care company. Watch whether the deal accelerates wage competition and rate pressure in the 10 acquired states.
Enforcement Sep 15, 2026
Helen Boerman of Brentwood, Tennessee, was sentenced September 10, 2026, to 42 months in federal prison and ordered to repay $6,970,583.50 after admitting she submitted approximately $11 million in false Medicare claims and collected about $6.9 million by splitting single-use wound care products across multiple patients, billing for phantom appointments, and submitting false claims to TennCare and the Federal Employees Health Benefits Program between March 2020 and October 2024.
Why it matters A Tennessee eye doctor received 42 months in federal prison for submitting $11 million in false Medicare and TennCare claims by reusing single-use wound care supplies across patients and billing for phantom appointments. The case is a concrete example of how Medicare and Medicaid fraud prosecutions reach individual practitioners.
Rule Sep 15, 2026
The CY 2027 Medicare Physician Fee Schedule proposed rule, which sets the nonqualifying APM conversion factor at $32.84 and reduces baseline physician payment 2.5 percent because a temporary 2026 Congressional boost expires, closed its public comment period September 14, 2026, one day before a House Energy and Commerce subcommittee examined 16 bills that could reverse the cut.
Why it matters Medicare physician payment rates are on track to fall 2.5 percent on January 1, 2027, because a one-year Congressional boost for 2026 expires and is not extended in the proposed rule. Whether Congress passes a fix before year-end is the key variable to watch.
Report Sep 15, 2026
The HHS Office of Inspector General posted a report September 14, 2026, finding that Medicare Advantage organizations conduct far less screening of out-of-network DMEPOS suppliers than in-network ones, that the CMS Preclusion List has exploitable structural gaps, and recommending CMS require stronger vetting and mandatory Medicare enrollment for all DMEPOS suppliers billing MA; CMS concurred with or said it would consider all recommendations.
Why it matters The federal government's health care watchdog found Medicare Advantage insurers are not doing enough to screen the medical equipment suppliers most likely to commit fraud, and that the federal tool meant to block bad actors has gaps that can be exploited. CMS agreed with the key recommendations, so binding requirements could follow.
Rule Sep 15, 2026
President Trump signed Executive Order 14426 on September 8, 2026, directing the Department of Defense to update its IT systems so departing service members' full military health and personnel records automatically transfer to the VA at separation, with a separate 120-day window for DOD and VA to review existing IT systems and contracts, and a directive to develop AI tools for faster benefits-claim processing.
Why it matters Departing service members' full medical records will be required to automatically transfer to the VA under a new executive order, addressing a longstanding gap that has slowed veterans' benefits claims. Implementation depends on the Pentagon meeting a 30-day IT update mandate and a 120-day government-wide systems review.
Record Sep 15, 2026
Jackson Hospital, a 344-bed Montgomery, Alabama trauma center, emerged from Chapter 11 bankruptcy on September 14, 2026, supported by a four-year Blue Cross Blue Shield of Alabama reimbursement agreement, $40 million in state capital funding from Governor Kay Ivey, and roughly $25 million in combined new city and county support.
Why it matters A 344-bed Alabama trauma center's exit from Chapter 11 shows that targeted state funding and a multi-year insurer rate deal can stabilize a distressed safety-net hospital. Watch whether the BCBS rate structure is sustainable and whether physician recruitment succeeds.
Earnings Sep 15, 2026
LifeStance Health Group executives told investors at the Jefferies Healthcare Services and Technology Conference on September 15, 2026 that Q2 revenue grew 26 percent year over year, adjusted EBITDA grew 94 percent, and full-year guidance was raised by $70 million cumulatively.
Why it matters LifeStance's 26 percent revenue growth and 94 percent adjusted EBITDA growth show that outpatient mental health at scale can achieve meaningful operating leverage. Watch whether its expansion of TMS and Spravato clinics drives further margin improvement or requires heavy capital investment.
Rule Sep 15, 2026
Section 71109 of the One Big Beautiful Bill Act narrows which noncitizens qualify for full Medicaid coverage effective October 1, 2026; people without lawful permanent resident status holding certain parolee and special immigrant categories, including domestic-violence parolees under VAWA, may lose eligibility, while green card holders and lawfully present noncitizens who are pregnant or under 19 remain covered, and Nebraska DHHS is actively notifying affected enrollees.
Why it matters A federal law change takes effect October 1 that narrows which lawfully present noncitizens qualify for full Medicaid coverage. People without a green card holding certain parolee statuses could lose benefits, and Nebraska is among the states actively notifying affected enrollees before the deadline.
Deal Sep 15, 2026
Sanofi agreed to transfer 20 mature medicines including ex-US Lovenox and Clexane, plus manufacturing sites in Hungary, Singapore, and France to Cheplapharm Arzneimittel, receiving a 26.4 percent equity stake in Cheplapharm in return, with the commercial transfer beginning Q1 2027 and closing targeted by Q3 2027.
Why it matters Sanofi is converting older drug assets into a minority equity stake in Cheplapharm, signaling that major pharma companies will increasingly restructure portfolios around innovative medicines rather than managing legacy products internally. Watch whether this model spreads to other large mature-medicine holders.
Deal Sep 12, 2026
Abarca Health and LucyRx completed their strategic combination on August 20, 2026, forming a combined pharmacy benefit manager serving more than 9 million commercial and government members, with both brands operating as wholly owned subsidiaries of Healthcare Revolution Partners.
Why it matters The independent PBM market now has a scaled competitor to the Big Three. Abarca Health and LucyRx merged on August 20, 2026, creating a combined entity serving more than 9 million members that pairs Abarca's government-program compliance expertise with LucyRx's employer-market book.
Rule Sep 12, 2026
The American Medical Association released the 2027 Current Procedural Terminology code set on September 9, 2026, adding 299 new codes effective January 1, 2027, including 10 for AI applications and a full restructuring of maternity care billing into four distinct phases.
Why it matters The 2027 CPT code set adds 299 new billing codes, including 10 for AI, effective January 1; insurers, hospitals, and physician practices must update their systems and contracts before year-end.
Funding Sep 12, 2026
The ADVOCATE program aims to develop a clinical AI system capable of assessing symptom severity, prescribing medications and ordering labs that ARPA-H wants the FDA to eventually authorize as a partially autonomous member of the care team.
Why it matters The federal government is funding AI that could one day prescribe drugs and order labs for heart failure patients with less doctor involvement in every step, a meaningful test case for how far regulators will let autonomous AI go in direct patient care.
Deadline Sep 12, 2026
The September 10, 2026 deadline for state Medicaid agencies to apply to CMS's GENEROUS Model passed after two extensions, with participating states required to finalize their agreements with CMS by September 30, 2026 for a program that pegs Medicaid drug prices to most-favored-nation benchmarks through 2030.
Why it matters If enough states joined, the GENEROUS Model could hold down Medicaid drug costs through 2030 by pegging prices to what other wealthy countries pay; CMS has not yet published participation figures, so the model's actual scale is still unknown.
Enforcement Sep 12, 2026
Creditors in Omnicare's Chapter 11 case voted on its reorganization plan by September 11, 2026, with a bankruptcy court confirmation hearing scheduled for September 17 before Judge Stacey Jernigan in the Northern District of Texas, the last formal step before the $440 million FCA settlement with DOJ and the sale to GenieRx Holding can close.
Why it matters CVS Health's long-term care pharmacy subsidiary Omnicare is one bankruptcy court hearing away from closing a $440 million False Claims Act settlement with DOJ. The case covers more than 3.3 million prescriptions dispensed without valid orders between 2010 and 2018, and the September 17 confirmation hearing is the last formal step.
Rule Sep 12, 2026
The FDA published a final order on September 11, 2026 classifying cardiovascular machine learning-based notification software into Class II, setting special controls that future devices in this category must meet instead of the costlier premarket approval process.
Why it matters FDA's new Class II category for cardiovascular AI notification software sets a clearer, lower-cost path to market for future devices that flag heart problems for clinicians, signaling that the agency is actively building a governance framework for clinical AI software.
Deal Sep 12, 2026
The private equity firms bought out prior owners HGGC and Snapdragon Capital Partners in a deal announced September 10, 2026, days after wearable partner Oura filed for a Nasdaq IPO seeking a valuation above 16 billion dollars.
Why it matters A fast-growing health platform just changed hands for an undisclosed sum, and its growth case leans on Oura's wearable data pipeline into clinician workflows, which looks more valuable now that Oura itself is going public. Watch whether the deal price ever surfaces once Oura's IPO prices.
Rule Sep 12, 2026
U.S. District Judge John Tharp declined on September 10 to block Illinois' End-of-Life Options for Terminally Ill Patients Act, allowing it to take effect September 12 as the first aid-in-dying law in the Midwest, while two lawsuits remain pending.
Why it matters Illinois becomes the first Midwestern state where physicians can prescribe life-ending medication to terminally ill adults; the law is now in effect but two active lawsuits mean the legal landscape could still change.
Report Sep 12, 2026
NCPA's 2025 Digest found a net loss of 24 independent community pharmacies nationally between June 2024 and July 2025, far below the commonly cited one-per-day closure figure, while simultaneously reporting a 10-year low in gross profits, a 10-year high in sales, and a 10-year high in average prescription volume per store.
Why it matters Independent pharmacies are under more margin pressure than the closure count alone suggests. The US lost a net 24 independent pharmacies over 13 months, not one per day, but 2024 brought a 10-year low in gross profits alongside a 10-year high in sales, meaning surviving stores are processing more prescriptions for less profit per script.
Rule Sep 12, 2026
CMS's GLP-1 Bridge demonstration went live July 1, 2026, covering Wegovy, Zepbound, and Foundayo at a flat $50 monthly copay for qualifying Medicare Part D enrollees through December 31, 2027, while CMS has not released any uptake figures and FDA has not yet finalized a rule barring large-scale compounding of semaglutide and tirzepatide.
Why it matters Medicare is now paying toward GLP-1 weight loss drugs at a $50 monthly copay outside the normal deductible and out-of-pocket cap structure. CMS projects total Medicare spend anywhere from $1.3 billion to $10 billion over the 18-month program, but has not published any enrollment data as of this issue.
Rule Sep 12, 2026
The Pharmacy Coalition met with CMS officials to discuss what reasonable and relevant contract terms between PBMs and Part D network pharmacies should mean under the Consolidated Appropriations Act of 2026, with CMS confirming a formal RFI is imminent and new contract standards targeted for plan year 2028 and effective January 1, 2029.
Why it matters CMS is building the rulebook for what PBMs must offer pharmacies in Part D networks. The next formal step is a public comment opportunity via RFI; the practical deadline for operators is plan year 2028 contract negotiations, with new standards effective January 1, 2029.
Rule · now Sep 12, 2026
The Pennsylvania Insurance Department stated on September 11, 2026 that state law limits its authority to rejecting individual rate filings that lack actuarial justification, not to imposing a blanket freeze, as insurers seek average increases of 17.1 percent in the individual market and 11.5 percent in the small group market, with final rates due before November 1 open enrollment.
Why it matters Pennsylvania's insurance regulator cannot block 2027 premium increases outright; final approved rates will be set before November 1, affecting hundreds of thousands of residents who are already leaving marketplace plans over expiring federal subsidies.
Report Sep 12, 2026
The University of Minnesota Rural Health Research Center found 57 percent of rural hospitals lacked a birthing unit as of 2024 and tied the closures to Medicaid, which finances about 41 percent of U.S. births and faces further cuts under last year's One Big Beautiful Bill Act.
Why it matters Nearly 36,000 births in 2024 happened at a hospital that would close its maternity ward the following year, and the program paying for more than four in ten U.S. births is about to get cut, a combination that points toward fewer birthing options in more places.
Record Sep 12, 2026
At a September 8, 2026 investor conference, UHS CFO Steve Filton said the unfavorable earnings impact from lost ACA exchange coverage widened to 85 million dollars for 2026, and the company cut its full-year admissions and behavioral health patient-day growth guidance.
Why it matters One of the country's largest hospital and behavioral health operators just told investors that people losing ACA marketplace coverage aren't finding other insurance, they're becoming unpaid patients instead, a warning sign for how the broader ACA subsidy cliff is playing out in hospital finances.
Record Sep 12, 2026
The Department of Veterans Affairs named Amwell to help power a digital health infrastructure modernization potentially covering more than 9 million veterans, though the letter of intent is not yet a signed contract.
Why it matters A struggling publicly traded telehealth company just got a potential government lifeline. Watch whether the letter of intent converts into a signed VA contract, since that step is not guaranteed.
Deal Sep 11, 2026
Axogen announced September 10, 2026 that it will acquire BioCircuit Technologies for $200 million in cash to add NerveTape, the first FDA-cleared sutureless device for peripheral nerve repair, in a deal expected to close in the fourth quarter of 2026 and funded in part by a same-day $208.7 million stock offering.
Why it matters A nerve-repair device maker is paying $200 million to lock up the only sutureless technology of its kind before a competitor can build one, a bet on consolidating a niche surgical device market.
Rule Sep 11, 2026
CMS shared draft 2027 Star Rating cutpoints with Medicare Advantage insurers this week, with an independent analysis finding roughly half of the thresholds harder to reach than before, putting billions in annual quality bonus payments at risk for plans near the 4-star threshold.
Why it matters CMS's draft 2027 thresholds will determine whether Medicare Advantage plans earn a share of more than $12.7 billion in annual quality bonuses. Tougher cutpoints could shift hundreds of millions of dollars between plans and affect enrollee benefits funded by those bonuses.
Rule Sep 11, 2026
CMS's proposed Calendar Year 2027 Medicare Physician Fee Schedule sets conversion factors of 33.16 dollars for APM participants and 32.84 dollars for all others, a net cut of roughly 1.25 percent for non-participating emergency physicians per ACEP analysis, proposes three new MIPS Value Pathways including the first for hospitalists, and would sunset traditional MIPS after 2028, with the public comment period closing September 14, 2026.
Why it matters Emergency physicians face a roughly 1.25 percent Medicare pay cut next year under a proposed federal rule, and hospital medicine is getting its first national quality performance track. The public comment window closes September 14, three days after this edition publishes.
Deal Sep 11, 2026
Holders of Definitive Healthcare's tax receivable agreement waived their early-termination payment right if the company signs a merger agreement by December 31, 2026, clearing a cost hurdle days after Advent International's September 1, 2026 non-binding proposal to take the healthcare-data company private at $1.02 per share, a 36 percent premium.
Why it matters A healthcare data company used by drugmakers and hospitals cleared a legal obstacle to a possible sale, a sign the private equity buyout process is moving forward even though no deal is final.
Record Sep 11, 2026
Elevance Health's CFO told the Wells Fargo healthcare conference on September 10, 2026 that third-quarter earnings are tracking ahead of plan and reaffirmed 2026 guidance of at least $27.00 adjusted EPS, sending shares up about 5 percent the same week UnitedHealth fell 3 percent on separate news.
Why it matters Two big insurers gave similar reassurances at the same investor conference this week and got opposite stock reactions, a sign investors are judging turnaround credibility as much as the numbers.
Rule Sep 11, 2026
CMS proposed rule CMS-2449-P, published May 22, 2026, would cap targeted Medicaid supplemental payments to ground emergency medical transport, air ambulance, and non-emergency medical transport providers at the equivalent Medicare Ambulance Fee Schedule rate, with the cap effective for rating periods beginning January 1, 2029.
Why it matters A federal rule would cap what state Medicaid programs can pay ambulance services starting in 2029. Many rural ambulance services depend on GEMT supplemental payments to stay solvent, and the cap would reduce that revenue for systems currently paid above the Medicare rate floor.
Record Sep 11, 2026
Henry Ford Health ended emergency and inpatient services at River District Hospital in East China Township, Michigan, effective September 1, 2026, citing infrastructure repair costs that made continued acute operations unsustainable, leaving the nearest Henry Ford emergency department about 18 miles away.
Why it matters An entire hospital emergency room has closed near the Detroit metro area because the building itself was failing, not because of a funding fight. Residents in East China Township now face an 18-mile drive to the nearest Henry Ford emergency department.
Rule Sep 11, 2026
Indiana House Enrolled Act 1271, effective July 1, 2026, prohibits health plans from using automated processes or AI as the sole basis for downcoding a claim, also requiring physician notification of any downcode, barring diagnosis-only downcoding, and limiting recoupment lookbacks to 180 days except in fraud cases.
Why it matters Indiana has made it illegal for insurers to let AI alone cut a doctor's payment without a human reviewing the actual medical chart. This is part of a growing state movement that has already reached Maryland, Arkansas, and Virginia, with six more states debating similar bills.
Enforcement Sep 11, 2026
Zakia Khan was sentenced September 10, 2026 to 76 months in federal prison for leading a Medicaid fraud and kickback scheme run through two Brooklyn adult daycare centers and a home health staffing company from 2017 to 2024, and ordered to pay $56 million in restitution and forfeit $5 million in assets.
Why it matters The sentencing closes the criminal phase of a $68 million Medicaid fraud built on billing for care that was never delivered. With eight total defendants, this case shows federal prosecutors pursuing broad indictments in home and community-based services fraud.
Record Sep 11, 2026
Leapfrog filed its opening brief September 10, 2026 in the Eleventh Circuit, challenging a March 2026 Florida federal court ruling that its methodology for grading non-participating hospitals was deceptive under Florida law and ordering deletion of grades for five Florida hospitals.
Why it matters The appeal puts Leapfrog's methodology for grading non-participating hospitals before a federal appellate court. The outcome could reshape how hospital safety information is publicly available to patients, payers, and employers.
Deal Sep 11, 2026
S&P Global Ratings downgraded Norman Regional Health System to D, its lowest rating, after the Oklahoma hospital system missed a $7.1 million principal and $4.9 million interest payment due September 1, 2026, on $247.45 million in outstanding revenue bonds, triggering a technical default now awaiting a $40 million rescue financing expected to close by September 15, 2026.
Why it matters An Oklahoma hospital system's bond troubles just became an actual credit default, a warning sign for how much financial stress is building in nonprofit hospital debt this year.
Approval Sep 11, 2026
HHS OIG posted Advisory Opinion 26-18 on September 9, 2026, finding it would not impose Anti-Kickback Statute sanctions on a proposed service connecting patients needing specialized ear and hearing care with hearing professionals, binding only the requesting company but signaling the agency's current enforcement posture on similar referral arrangements.
Why it matters OIG's favorable opinion signals which types of patient referral arrangements the agency currently views as low-risk under the Anti-Kickback Statute. Companies building similar referral models in any specialty should review the opinion's reasoning.
Rule Sep 11, 2026
PeaceHealth abandoned its plan to replace Eugene Emergency Physicians with Atlanta-based ApolloMD at three Lane County emergency departments in May 2026, after the physicians sued under Oregon Senate Bill 951, the 2025 law barring management services organizations from exercising de facto control over a physician practice's business or clinical decisions.
Why it matters Oregon's 2025 law protecting doctors from corporate practice takeovers just passed a real-world test, and the local physicians won. The outcome shows state legislation can materially constrain hospital staffing outsourcing decisions, and Washington lawmakers are already citing it as precedent.
Report Sep 11, 2026
Sturgis Hospital in Michigan converted to Rural Emergency Hospital status in 2023 but closed in June 2026 after emergency department visits fell 13 percent, while Clifton-Fine Hospital in New York reduced annual losses from 2.5 million dollars to 600,000 dollars under the same program.
Why it matters The federal Rural Emergency Hospital program produces sharply different results depending on whether local ED volume is stable. If your community depends on a converting hospital, the Sturgis case shows that conversion can delay closure without reversing a volume decline.
Deal Sep 11, 2026
UnitedHealth disclosed on September 8, 2026 that it sold private equity firm TPG an undisclosed-value interest in part of Optum Health's WellMed primary care clinic network in Florida, the same value-based care business whose 2025 cost overruns drove UnitedHealth's leadership shakeup.
Why it matters UnitedHealth brought in a private equity partner for the exact Florida clinic business that hurt its earnings last year, and investors read that as a mixed signal about how fixed the turnaround really is.
Rule Sep 11, 2026
Washington's Office of the Insurance Commissioner approved an average 22.2 percent rate increase for 2027 individual marketplace plans, trimming insurers' 22.4 percent request, with the increase driven in part by the expiration of enhanced federal ACA premium tax credits worth about $1,330 a year per enrollee.
Why it matters Washington's 22.2 percent rate approval signals what expiring ACA subsidies mean in practice for the roughly 250,000 residents who buy their own coverage. Watch whether other states face similar dynamics as enhanced tax credits lapse nationwide.
Funding Sep 10, 2026
The Administration for Community Living announced a $226,000 single-source fiscal year 2026 supplement to the Northeast Iowa Area Agency on Aging, which operates the Senior Medicare Patrol Resource Center, bringing its total 2026 award to $1.23 million to support volunteer Medicare fraud education and reporting.
Why it matters The federal government is adding money to the national volunteer network that helps Medicare patients identify and report suspected fraud, the same week as a $270 million Medicaid fraud sentencing. The program is small but represents the community-facing end of federal fraud prevention.
Rule Sep 10, 2026
Trade analysis of CMS-1848-P found CMS proposes valuing the new labor-and-delivery codes 15 percent above the work RVUs the AMA's RUC recommended, reallocating roughly 11,810 work RVUs from four antepartum evaluation-and-management visit codes into delivery-event codes.
Why it matters CMS wants to pay new labor-and-delivery codes 15 percent more than obstetricians' own coding committee recommended, funded by cutting reimbursement for four antepartum visit codes per pregnancy. This is a revenue-timing shift that affects every OB practice, hospital system, and insurer that uses per-visit obstetric coding in 2027.
Rule Sep 10, 2026
CMS-1848-P, published July 14, 2026, would allow insurers to keep using 15 legacy G-codes alongside new per-visit obstetric codes in 2027, and ACOG and the Ob Hospitalist Group are pressing CMS to end the parallel option entirely before the comment window closes September 14.
Why it matters CMS is deciding whether Medicare runs one obstetric billing system or two in 2027, and the comment window closes September 14, 2026. The outcome determines how every OB practice and insurer codes and pays for prenatal and delivery care next year, with a final rule expected in early November.
Record Sep 10, 2026
CVS Health raised its full-year 2026 adjusted EPS guidance to 7.90 to 8.10 dollars in its August earnings release, and at the September 9 Wells Fargo conference Aetna's president said the insurer is running about 2,000 cost-control initiatives but is not assuming meaningful improvement in elevated Medicare Advantage cost trend.
Why it matters CVS is telling investors its 2026 turnaround plan is working even as its own executives admit Medicare Advantage medical costs remain stubbornly elevated, a split worth watching heading into 2027.
Record Sep 10, 2026
At the same Wells Fargo healthcare investor conference, HCA reported a 6 percent drop in first-half 2026 elective surgical volumes tied to ACA coverage losses, Tenet raised its full-year guidance on its ambulatory-surgery-center mix, and Community Health Systems cut its outlook citing uninsured visits and slower payer payments.
Why it matters This shows how differently exposed hospital systems are handling the ACA coverage losses running through 2026: the same trend produced a guidance raise at one chain and a guidance cut at another. Watch which model, inpatient-heavy versus ASC-heavy, better weathers uninsured growth.
Report Sep 10, 2026
The HHS Office of Inspector General found that the Indian Health Service has allocated $2.6 billion of a $3.5 billion IIJA appropriation toward 702 tribal water and sanitation projects, but rising per-project costs and IHS staffing shortages mean the remaining funds will not complete all unfunded work.
Why it matters A federal watchdog confirmed that a one-time infrastructure law appropriation for tribal water and sewer systems will not close the funding gap, leaving many American Indian and Alaska Native homes without safe water and sanitation even after all the money is spent. Closing the gap would require additional congressional action.
Deal Sep 10, 2026
Lincoln Property Company and PGIM Real Estate announced on September 10, 2026 the acquisition of the 13,957-square-foot, five-operating-room Surgery Center of Gilbert in Mesa, Arizona, leased to Banner Health, Atlas Healthcare Partners and physician partners, on undisclosed terms.
Why it matters A real estate investor's bet that ambulatory surgery keeps growing lines up with hospital executives' own accounts of patients and procedures moving to outpatient settings, reinforcing that the shift toward lower-cost outpatient care is a durable trend, not a one-quarter blip.
Rule Sep 10, 2026
A three-judge Fifth Circuit panel heard oral arguments September 9, 2026 in Louisiana's challenge to the FDA's 2023 decision allowing mifepristone to be prescribed via telehealth and delivered by mail, with no ruling yet issued and a prior Supreme Court stay keeping mail delivery legal in the meantime.
Why it matters A federal appeals court is deciding whether one state can effectively block access to the abortion pill by mail nationwide, three years after the FDA extended that access. The outcome could reach the Supreme Court again and would affect how mifepristone is prescribed and dispensed across the country.
Record Sep 10, 2026
Rochester Regional Health suspended inpatient labor and delivery, newborn nursery, and postpartum services at Newark-Wayne Community Hospital on September 3, 2026, redirecting patients to Rochester General Hospital as a national count reached 146 rural hospital L&D closures since the end of 2020.
Why it matters Rochester Regional Health closed the Marshall Birthing Center on September 3, 2026, joining a national count of 146 rural hospitals that have stopped delivering babies since 2020, a 14 percent reduction that leaves fewer than half of rural US hospitals still offering the service. Watch whether federal standby-payment proposals gain legislative traction in response.
Deal Sep 10, 2026
The Bill and Melinda Gates Foundation committed $20 million upfront and up to $15 million more in milestone payments to ProFound Therapeutics on August 27, 2026, to fund AI-driven discovery of new protein biomarkers and drug targets for preeclampsia and eclampsia.
Why it matters The Gates Foundation committed up to $35 million to ProFound Therapeutics to find better diagnostics and drug targets for preeclampsia, a pregnancy complication that remains a leading cause of maternal death. This is a preclinical research investment with no near-term clinical or policy impact.
Enforcement Sep 10, 2026
Paul Richard Randall, owner of Monte Vista Pharmacy in Orange, California, was sentenced September 9, 2026 to 360 months in federal prison and ordered to pay $178.7 million in restitution for billing Medi-Cal for medically unnecessary and often undispensed drugs obtained through kickbacks.
Why it matters A 30-year federal prison sentence in a $270 million Medicaid fraud case signals that prosecutors are willing to pursue and win historically long sentences in large-scale healthcare fraud. Watch for increased DOJ scrutiny of pharmacy billing in high-reimbursement generic drug categories.
Record Sep 10, 2026
United Hospital District in Blue Earth, Minnesota grew deliveries from roughly 50 per year to 178 in 2025 by joining the Headwaters rural hospital network, cross-training staff to cover multiple clinical roles, and using profitable outpatient surgery volume to offset the maternity unit's losses.
Why it matters A critical access hospital in rural Minnesota nearly quadrupled its birth volume in 2025 without new federal funding, offering a network-based operational model that other rural hospitals can study as an alternative to closing their maternity units.
Record Sep 10, 2026
The Seattle-area Catholic nonprofit system filed a WARN notice on September 9, 2026 eliminating 24 virtual-care positions effective November 10, its second telehealth layoff round after cutting 116 jobs in June, with leadership citing Washington state budget cuts and tax increases.
Why it matters A second round of telehealth layoffs at the same system in three months shows how state budget and tax pressure, not just national telehealth demand, can drive virtual-care retrenchment at an individual health system.
Deal Sep 9, 2026
Miami private equity firm Eir Partners acquired life-sciences regulatory SaaS platform Accumulus Technologies and AI-powered provider-data company H1 acquired provider-network intelligence firm Defacto Health, both announced September 9, 2026, for undisclosed sums, illustrating a broader shift toward platform and data infrastructure deals as care-delivery M&A slows.
Why it matters Two health-data acquisitions closing within hours of each other signal that private capital is chasing healthcare's back-office data infrastructure. The trend framing is that platform and product businesses are transacting while care delivery M&A slows and becomes more distress-driven.
Report Sep 9, 2026
HHS OIG reported on September 3, 2026 that California did not properly report and return $99.3 million in federal Medicaid overpayments that its own Medicaid Fraud Control Unit had already identified in 26 closed cases from federal fiscal year 2023.
Why it matters A federal audit found California owes the federal government $99.3 million in Medicaid overpayments its own fraud investigators had already identified. The finding points to a broken coordination process between the state fraud unit and the state Medicaid agency.
Enforcement Sep 9, 2026
CMS announced on September 8, 2026 that it identified and barred 11 durable medical equipment suppliers from billing Medicare Advantage and Part D after finding more than $3.4 billion in suspected fraudulent billing, including claims submitted for deceased beneficiaries.
Why it matters CMS barred 11 medical equipment suppliers from Medicare Advantage and Part D after finding $3.4 billion in suspected fraud, including billing for deceased patients. This shows CMS is now actively cross-referencing supplier billing across program lines.
Earnings Sep 9, 2026
Speaking at the Wells Fargo Healthcare Conference on September 9, UnitedHealthcare CFO Wayne DeVeydt said 2026 Medicare Advantage margins are now in the upper half of the 2 to 4 percent target range, and the insurer is weighing exits from 34 additional counties on top of its previously disclosed 109-county pullback, while Elevance Health and Centene echoed a dual-eligible-first strategy for 2027.
Why it matters UnitedHealth's Medicare Advantage retreat is one of the largest enrollment reductions in MA history, and its CFO says margins are recovering on a smaller, more profitable book. Watch whether 2027 pricing attracts members back or confirms a permanent contraction of MA's reach.
Rule Sep 9, 2026
A federal judge heard arguments on September 4, 2026 on whether to block Illinois's End-of-Life Options for Terminally Ill Patients Act before its scheduled September 12 effective date, with a ruling expected imminently and a separate court already exempting religiously affiliated providers from the law's patient discussion requirement.
Why it matters Illinois is set to become the first Midwestern state allowing doctor-prescribed life-ending medication, but a federal judge could block the law before its September 12 start. Watch for the court ruling in the days ahead.
Deal Sep 9, 2026
Korsana Biosciences merged with public shell Cyclerion Therapeutics on September 8, 2026, and simultaneously closed a $380 million private placement from Fairmount, Venrock Healthcare Capital Partners, and General Atlantic, with shares beginning trading September 9 under Nasdaq ticker KRSA and approximately $475 million in combined cash extending operations through 2029.
Why it matters A preclinical Alzheimer's biotech just obtained $380 million and a public market listing in one transaction. The key dates to watch are mid-2027 for Phase 1 data on KRSA-028 and late 2027 or early 2028 for proof-of-concept data.
Report Sep 9, 2026
HHS OIG reported on September 3, 2026 that three of five South Carolina Medicaid managed care organizations could not provide accurate prior authorization data showing they treat mental health and substance use disorder services the same as medical and surgical care, more than six years after the federal parity deadline.
Why it matters Three of South Carolina's five Medicaid health plans still cannot show they treat mental health and addiction claims the same as medical claims, six years after federal parity rules took effect. This is a persistent compliance failure with direct patient access consequences.
Rule Sep 9, 2026
U.S. District Judge Vince Chhabria ruled on September 8, 2026 that a coalition of states led by California, Arizona, and Pennsylvania has standing to challenge the January 5, 2026 CDC decision removing rotavirus, meningococcal, hepatitis A, hepatitis B, influenza, COVID-19, and RSV vaccines from the universally recommended childhood schedule, rejecting the government's motion to dismiss.
Why it matters A federal judge ruled September 8 that a state coalition can keep suing over the CDC's removal of seven childhood vaccines from the recommended schedule. The case will proceed, keeping the policy uncertain for providers and payers who have already revised protocols.
Record Sep 9, 2026
A Michigan WARN notice shows Trinity Health eliminating 557 information-technology positions between October 25 and November 29, 2026, after the 23-state Catholic nonprofit system handed its IT support desk to an outside technology partner, with a class-action firm now investigating whether the required 60-day advance notice was given.
Why it matters A 557-person IT layoff at a 23-state Catholic nonprofit system is a significant workforce event, and an early WARN Act investigation adds legal risk. Watch whether other large nonprofit health systems follow a similar IT outsourcing path and whether the class-action inquiry matures into formal litigation.
Report Sep 8, 2026
The American College of Physicians published revised breast cancer screening guidance on April 17, 2026 recommending biennial mammography for average-risk women aged 50 to 74 and shared decision making for ages 40 to 49, drawing a sharp rebuttal from the American College of Radiology, which says the guidance relies on outdated evidence and could contribute to up to 10,000 additional breast cancer deaths annually.
Why it matters Two major professional societies are publicly at odds over how often average-risk women should be screened for breast cancer. The ACP's biennial recommendation contradicts the ACR and USPSTF positions, leaving breast imaging programs to choose a protocol while the evidence debate continues.
Deal Sep 8, 2026
Black Pearl Equities completed a tender offer paying $5.75 per share after roughly 90.93% of Selectis Health shareholders tendered their stock, taking the eight-property Arkansas and Oklahoma post-acute operator private on September 1, 2026.
Why it matters A small, publicly traded nursing-home operator just went private, another sign that small post-acute companies are choosing to exit public markets rather than navigate a difficult reimbursement environment as a standalone public company.
Deal Sep 8, 2026
Curium US Holdings agreed on August 3, 2026 to acquire all outstanding Lantheus Holdings shares for $102.50 per share in cash plus contingent value rights of up to $12.00 per share tied to commercial milestones, a transaction valued at up to $8 billion that combines two major radiopharmaceutical suppliers and their manufacturing and distribution infrastructure.
Why it matters This $8 billion deal consolidates two of the largest radiopharmaceutical suppliers, combining PET tracer manufacturing with a growing radioligand therapy pipeline. For imaging operators building out theranostics and PET service lines, isotope supply concentration is now the key constraint to watch.
Rule Sep 8, 2026
CMS is soliciting comment through September 14, 2026 on whether to keep, reduce, or eliminate the 50% cut to facility-based indirect practice expense payments first adopted for 2026, a decision that determines reimbursement for most hospital-based and outpatient department radiology billing, with a final rule expected in early November.
Why it matters The comment window closes September 14 on the most consequential near-term reimbursement question for hospital-based imaging: whether CMS keeps, reduces, or eliminates the 50% cut to facility-based indirect practice expense payments. A final rule is expected in early November and takes effect January 1, 2027.
Report Sep 8, 2026
Doximity's 2026 Physician Compensation Report, released August 25, 2026 from nearly 23,000 physician surveys, found interventional radiology posted a 10.8% year-over-year compensation increase to an average of $634,658 and diagnostic radiology rose 6.6% to $609,684, making radiology the only specialty to rank in the top ten for compensation growth in both 2024 and 2025, while overall physician pay grew just 2%.
Why it matters Radiology is the only specialty to rank in the top ten for compensation growth in both 2024 and 2025, running several times the physician-wide 2% average even as per-study reimbursement keeps falling. This is the current market clearing price for radiology coverage.
Deadline Sep 8, 2026
Humana, UnitedHealth, Elevance Health and Centene disclosed Medicare Advantage plan exits affecting well over 2 million members on earnings calls months before CMS's October 2 deadline for insurers to send members their own non-renewal notices.
Why it matters The insurers already told Wall Street which Medicare Advantage plans are ending in 2027; if you or a family member is on one of these plans, you likely will not find out from your insurer until October 2, leaving 66 days before Open Enrollment closes.
Deal Sep 8, 2026
Radiology Partners signed a definitive agreement on August 25, 2026 to acquire Everlight Radiology, which covers the UK, Ireland, Australia, New Zealand, and South Africa, reportedly for about $1 billion, folding Everlight's international radiologist network into RP's vRad unit to create round-the-clock cross-border overnight and weekend coverage.
Why it matters This deal creates the first global teleradiology network from the largest US private equity-backed radiology group, expanding overnight and weekend read capacity across five countries. Watch how this reshapes pricing and contract leverage for independent US groups that currently buy rather than staff their own overnight coverage.
Deal Sep 8, 2026
Tarsus Pharmaceuticals closed its purchase of Alkeus Pharmaceuticals on September 4, 2026, paying $450 million upfront plus up to $350 million in milestones for gildeuretinol, an oral therapy for the untreatable inherited blindness Stargardt disease.
Why it matters A drugmaker just paid up to $800 million for the leading treatment candidate for Stargardt disease, an inherited blindness with no approved treatment today, which matters most to patients and families watching for a first approved therapy.
Report Sep 8, 2026
At least 37 states carry federal Medicaid state directed payments to hospitals exceeding the new 2025 reconciliation law caps by a combined $60 billion, with Texas hospitals already losing $27 million a day after CMS withheld $9.8 billion in payments.
Why it matters This is about whether the federal government follows through on a scheduled cut to hospital Medicaid funding, and Texas shows what happens when it does: real, immediate revenue loss and rural hospital closures. Watch whether other high-exposure states follow the Texas trajectory.
Report Sep 8, 2026
The VA Office of Inspector General reported on August 5, 2026 that four of five full-time radiologists at the VA Washington DC Healthcare System, including the chief of radiology, resigned between July and December 2025 after a return-to-office mandate, producing imaging backlogs, a finding that facility leaders failed to follow required quality management notification protocols, and an open OIG recommendation for a sustainable VA radiology staffing plan.
Why it matters This case documents how quickly a radiology department collapses when coverage depth is thin and a single workforce policy triggers mass departures. The OIG's open recommendation for a national VA radiology staffing plan signals continued federal scrutiny of shortage-driven imaging backlogs.
Rule Sep 7, 2026
CMS's proposed Calendar Year 2027 Medicare Physician Fee Schedule would cut the conversion factor by up to 1.68 percent because a one-year 2.50 percent statutory boost to 2026 payments is not being renewed, and the public comment period closes September 14, 2026.
Why it matters If this rule finalizes as proposed, some Medicare-participating physicians would see lower per-service payments starting January 2027; the comment window to weigh in closes September 14.
Rule Sep 7, 2026
Representative Greg Landsman and three bipartisan cosponsors introduced H.R. 10210 on September 1, 2026 to require a licensed clinician to independently review every medical-necessity denial and force insurers to disclose when AI played a role.
Why it matters A bill like this could change how insurance denials work by requiring a human clinician's sign-off, but it is an early-stage bill referred to committee, not law.
Rule Sep 7, 2026
The FDA issued final guidance effective September 4, 2026 letting more pharmacies compound standardized starter parenteral nutrition for newborns without full outsourcing-facility registration after the two main suppliers announced permanent closure.
Why it matters Explains why hospitals may have easier access to newborn IV nutrition without a supply gap; watch whether more pharmacies actually step up to compound it.
Report Sep 7, 2026
A federal judge granted a preliminary injunction August 19, 2026 blocking HHS from cutting 53 of 66 Teen Pregnancy Prevention Program grants worth roughly $67 million after finding the agency's justification cited studies that do not appear to exist.
Why it matters If a federal program you rely on gets defunded, this case shows courts can block agency cuts when the stated justification does not hold up, here because cited research appears fabricated.
Deadline Sep 7, 2026
Governor Josh Stein and NCDHHS launched a public-information campaign warning that federal rules effective October 1, 2026 will end full Medicaid coverage for refugees, asylum recipients, trafficking survivors and other lawfully present immigrants among the state's roughly 740,000 Medicaid expansion enrollees.
Why it matters If you or someone you know is a refugee, asylee, or trafficking survivor on Medicaid, coverage could end October 1; watch for state notices about redetermination.
Deadline Sep 6, 2026
Twelve congressional Democrats gave the Consumer Product Safety Commission until September 18 to answer eleven questions and explain why its NEISS-R program still collects identifiable emergency-department records from up to 100 hospitals through contractor Konza Health.
Why it matters Congress is pressing federal regulators to explain why a data-collection program is still gathering identifiable emergency-room records, including names and diagnoses, from hospitals, even after admitting participation is voluntary. Watch for CPSC's response by the September 18 deadline.
Enforcement Sep 6, 2026
Kenneth Kessler and Michael Gomez were sentenced to 33 and 24 months in federal prison for running DME companies that billed Medicare $34.8 million for unnecessary orthotic braces obtained through illegal kickbacks and continued billing through shell companies after payment suspension.
Why it matters This is a reminder that Medicare fraud involving unnecessary medical equipment gets prosecuted and can result in years of federal prison time, not just fines. Watch for related civil recoveries or additional defendants tied to the same scheme.
Enforcement Sep 6, 2026
Louisiana's attorney general alleged Express Scripts and Prime Therapeutics coordinated pharmacy reimbursement rates under a 2019 agreement, following a similar suit Florida filed against the same two companies a week earlier.
Why it matters Two state attorneys general have now accused the same two pharmacy benefit managers of colluding to fix reimbursement rates, signaling a broadening multistate legal campaign against PBM practices that could affect drug costs and independent pharmacy survival nationwide. Watch for additional states joining or a consolidated response from Express Scripts and Prime Therapeutics.
Approval Sep 6, 2026
The FDA granted accelerated approval to AstraZeneca's camizestrant for ESR1-mutated metastatic breast cancer, its first cancer approval guided by a liquid-biopsy blood test rather than a tissue biopsy.
Why it matters This is the first cancer drug approved based on a blood test rather than a tissue biopsy, which could make it faster for patients with this drug-resistant breast cancer subtype to start treatment. Watch for pricing news and whether liquid-biopsy testing spreads to other cancer approvals.
Approval Sep 6, 2026
The FDA approved Ionis Pharmaceuticals' zilganersen, an intrathecal injection given every three months, as the first drug ever cleared for Alexander disease, a rare and often fatal neurological disorder mostly striking infants and young children.
Why it matters This is the first-ever approved treatment for Alexander disease, an ultra-rare and often fatal childhood neurological disorder, giving affected families a treatment option where none existed before. Watch for pricing, which hasn't been disclosed yet.
Deal Sep 6, 2026
Norman Regional Health System missed a September 1 bond payment, secured a bondholder waiver, and is seeking about 40 million dollars in interim financing by September 15 after S&P downgraded it to CC.
Why it matters A financially distressed Oklahoma hospital system narrowly avoided bond default and is now racing to secure emergency financing, a warning sign for other stretched rural and safety-net hospitals. Watch whether it closes financing by September 15 or slides toward a sale.
Rule · now Sep 6, 2026
New York approved 2027 individual and small-group ACA rates well below what insurers requested, saving an estimated $1.6 billion, while Delaware approved smaller-than-requested increases for Highmark and AmeriHealth Caritas the same day.
Why it matters If you buy your own health insurance in New York or Delaware, this is why your 2027 premium won't rise as much as insurers wanted, though regulators still approved real increases tied to expiring federal subsidies. Watch whether other states follow the same pattern before November 1 open enrollment.
Deal Sep 6, 2026
Sanford Health finalized its merger with North Memorial on September 1, 2026, forming a 61,000-employee, 60-hospital system and committing more than 600 million dollars to Minnesota facilities under a 10-year state oversight agreement.
Why it matters A major nonprofit hospital system just entered the Twin Cities market for the first time, backed by a large capital commitment and a decade of state oversight designed to protect jobs and services. Watch how Sanford executes on its Robbinsdale and Maple Grove investment promises.
Rule Sep 6, 2026
Texas hospitals began losing an estimated 27 million dollars a day in Medicaid funding after CMS withheld approval of three directed payment programs, including CHIRP, for the state's 2027 fiscal year.
Why it matters This is a funding standoff between Texas and the federal government that could force real cuts to hospital services if it drags on, especially at safety-net hospitals. Watch whether CMS approves the programs before hospitals start cutting services.
Rule Sep 6, 2026
Wisconsin began issuing new APRN licenses on September 1 that let nurse practitioners with 7,680 supervised clinical hours practice independently without a physician collaborative agreement.
Why it matters If you live in Wisconsin, this means nurse practitioners with enough clinical experience can now treat you without a supervising physician's sign-off, part of a broader trend of states easing scope-of-practice rules to fight provider shortages.
Funding Sep 5, 2026
Between September 1 and 4, 2026, CMS's Rural Health Transformation Program awarded $76 million to New York, $120 million to Indiana, $149.3 million to Arkansas, $25 million to Michigan, and $5.48 million to Rhode Island for rural care coordination, maternal health, telehealth, and workforce projects.
Why it matters This is real money starting to flow from last year's $50 billion rural health law, and it shows CMS prioritizing maternal health and telehealth access in the first wave. Watch which states get funded next and how transparently they report use of funds.
Rule Sep 5, 2026
The comment period on the CY2027 Hospital Outpatient Prospective Payment System and ASC proposed rule closed August 31, 2026, with HFMA flagging nine provisions including elimination of the alternative device pass-through pathway and ongoing Inpatient-Only list phase-out as potentially disruptive; CMS is expected to finalize the rule around November.
Why it matters The comment window on Medicare's 2027 outpatient payment rule has closed, and a major hospital finance trade group is warning the combined proposals could disrupt providers without demonstrated benefit. Watch how CMS responds in the final rule, expected around November, especially on the device pass-through elimination and site-neutral payment proposals.
Enforcement Sep 5, 2026
A federal grand jury indicted Erekle Gugava on one count of money laundering conspiracy for allegedly using a Pennsylvania durable medical equipment company to move insurer payouts from Operation Gold Rush, a scheme that billed roughly $1.3 billion in fraudulent claims using stolen identities of elderly and disabled Americans.
Why it matters This is the largest health care fraud case DOJ has ever prosecuted, and it shows how fraud networks use shell companies to launder proceeds even when insurers ultimately pay out a small fraction of what's billed. Watch for additional indictments as DOJ works through the network.
Alert · now Sep 5, 2026
FDA posted warning letters dated August 24 to five companies selling unapproved compounded semaglutide, tirzepatide, and other peptide products online, as agency data shows 990 adverse-event reports tied to compounded semaglutide alone and more than 730 for compounded tirzepatide.
Why it matters This shows the scale of harm from unregulated online peptide sellers, nearly 1,000 adverse-event reports tied to one drug alone, and that FDA considers these products illegal to sell regardless of how they're advertised. Watch for state actions or further FDA enforcement following these letters.
Deal Sep 5, 2026
The FTC's Bureau of Competition found OhioHealth's bid for Fairfield Medical Center risked raising costs and cutting care quality, prompting Fairfield to run a wider sale process that ended with Adena Health acquiring the hospital around September 1, 2026.
Why it matters This shows federal regulators actively blocking hospital mergers even without formal enforcement action, just by pressuring a target to find another buyer. Watch whether this signals more aggressive FTC involvement in rural hospital deals.
Deal Sep 5, 2026
Morgan Stanley Real Estate Investing acquired the 193-unit Sonata Lake Mary for about $60 million and the 106-unit Preserve at Dunedin for $31.1 million, pricing the combined 299 units at roughly $305,000 per unit, nearly double Florida's average.
Why it matters Institutional capital is paying well above the state average for senior housing, a sign investors see steady demand in Sun Belt markets even as broader real estate cools.
Report Sep 5, 2026
PitchBook's Q2 2026 Healthcare Services Report found overall healthcare services deal count down 18.5 percent year over year, with physician practice management deal volume at 71 in Q2 and on pace to decline 46 percent for the full year, while ancillary and outsourced services including ASCs proved comparatively resilient.
Why it matters Private equity is concentrating healthcare services investment in surgery centers while pulling hard out of physician practices in 2026. If you operate or own a stake in either type of organization, this divergence is reshaping who is acquiring assets and at what price.
Record Sep 5, 2026
Regional One Health filed a WARN notice closing its 30-bed Extended Care Hospital effective September 1, 2026 and laying off 103 workers, while financing for the rest of its $1.2 to $1.5 billion replacement campus, beyond Shelby County's $500 million commitment, remains unresolved.
Why it matters A safety-net hospital system is cutting services now while betting its future on a billion-dollar campus it hasn't fully financed; watch whether the funding gap closes or forces further cuts.
Record Sep 5, 2026
Bradley Radoff and Michael Torok, who own about 7.7 percent of Seer, called on director Meeta Gulyani to resign after the company's stock fell more than 90 percent and the board rejected three take-private offers, most recently a $2.40 per share bid plus a contingent value right.
Why it matters This is a fight over whether a struggling diagnostics company gets sold or keeps operating independently; watch whether the board caves to the activists or the proxy fight goes to a vote.
Earnings Sep 5, 2026
Surgery Partners reported a Q2 net loss of $15 million, up from $2.5 million a year earlier, walked back its $200 million annual M&A target for 2026, and signed escrow documents to sell its last two Idaho hospital stakes to Intermountain Health for roughly $795 million as part of its ASC-only pivot.
Why it matters Surgery Partners' widening net loss and shelved acquisition target signal that ASC-sector consolidation is getting more expensive even for the market leader. Watch whether additional deals close before year-end and whether the Idaho hospital sale to Intermountain closes on the disclosed terms.
Earnings Sep 5, 2026
Surgery Partners disclosed same-facility net revenue per surgical case of $5,057 in Q2 2026, a 5.8 percent year-over-year increase, while same-facility case volume grew only 0.3 percent quarter over quarter, indicating that almost all revenue growth came from higher pricing and a richer procedure mix rather than more cases.
Why it matters Surgery Partners' $5,057 per-case figure is now the clearest public benchmark for ASC pricing and case-mix performance in 2026. If your surgery center's per-case revenue is growing more slowly, the gap is likely coming from payer mix, acuity, or contract rates rather than case volume.
Enforcement Sep 5, 2026
The FTC's antitrust lawsuit against Welsh Carson-backed U.S. Anesthesia Partners, filed in September 2023 for allegedly consolidating nearly every large Texas anesthesia practice to demand higher prices, has no entered consent order four months after the parties announced an agreement in principle on April 23, 2026.
Why it matters The FTC's unresolved antitrust case against a Texas anesthesia roll-up is the first time the agency has pursued a completed practice consolidation after the fact rather than blocking it beforehand. Watch for the consent order, which will set the precedent for how aggressively regulators can unwind completed PE-backed healthcare roll-ups.
Rule Sep 5, 2026
The Wasteful and Inappropriate Service Reduction Model, a CMMI demonstration using AI to screen prior-authorization requests for epidural steroid injections, knee arthroscopy for osteoarthritis, and nerve-stimulation procedures, launched January 1, 2026 in six states and survived a 46-to-50 Senate vote to block it on July 16, 2026, clearing it to run through December 31, 2031.
Why it matters A Medicare AI prior-authorization pilot covering common pain and orthopedic ASC procedures is now active in six states and survived a Senate vote to repeal it. If you operate or refer patients in Arizona, New Jersey, Ohio, Oklahoma, Texas, or Washington, the authorization workflow requirement is already in effect and runs through 2031.
Deal Sep 4, 2026
The FTC found OhioHealth's proposed purchase of financially distressed Fairfield Medical Center risked raising costs and reducing care quality, prompting a broader sale process that closed with Adena Health on September 1, 2026.
Why it matters FTC intervention rerouted a struggling hospital's sale, showing regulators actively steering hospital deals rather than just blocking them. Watch whether the FTC repeats this playbook nationally.
Deal Sep 4, 2026
The 867-unit portfolio spans six Northeastern states and is the REIT's second nine-figure senior housing purchase in three days, pushing 2026 investment past $2 billion.
Why it matters A REIT just spent over 1.2 billion dollars in three days buying senior housing, a sign investors see supply-constrained Northeast markets as a durable opportunity. Watch whether the pace of senior housing consolidation continues.
Rule Sep 4, 2026
A federal judge dismissed AstraZeneca's lawsuit against Colorado's law requiring manufacturers to honor 340B discounts at contract pharmacies, and AstraZeneca said it will appeal.
Why it matters Courts keep siding with states on 340B contract pharmacy laws, so drugmakers are running out of legal room to resist state-level discount pricing rules.
Funding Sep 4, 2026
CMS's Innovation Center began funding up to 30 cooperative agreements worth as much as $3.3 million each over three years for organizations building nutrition, exercise, and sleep coaching programs for traditional Medicare beneficiaries.
Why it matters Medicare is now funding lifestyle and functional-medicine programs, nutrition, exercise, sleep, alongside standard medical care, a notable shift for a program historically focused on treating illness rather than preventing it.
Rule Sep 4, 2026
The DEA's temporary order placing three synthetic kratom-derived chemicals into Schedule I took effect August 26, 2026 and can run up to two years, while a separate comment period on scheduling concentrated 7-hydroxymitragynine itself closes September 10.
Why it matters The DEA has locked three synthetic kratom-derived chemicals into its strictest drug category, and a decision on the compound found in over-the-counter kratom shots sold nationwide is due within days.
Deal Sep 4, 2026
The oversubscribed round, which drew a fourth publicly traded medtech strategic investor, brings Elucid's total funding to about $185 million to commercialize Plaque-IQ and advance FFR-CT through FDA review.
Why it matters A cardiovascular AI diagnostics company raised 55 million dollars from its fourth publicly traded medtech strategic investor, signaling device makers are betting on AI plaque-detection software. Watch whether BioIntegrated FFR-CT clears FDA review.
Record Sep 4, 2026
Louisiana's Medicaid agency said Healthy Blue's managed care contract ends December 31, 2026, moving 290,000 members to one of four remaining plans on January 1, 2027.
Why it matters A major insurer is walking away from a state Medicaid program entirely, and it says more state exits are coming within the next year and a half.
Report Sep 4, 2026
The steepest projected increase since 2003 comes even after planned cost-cutting steps like higher deductibles, more premium cost-shifting, and tighter GLP-1 coverage.
Why it matters Employers expect the steepest jump in health benefit costs since 2003 and plan to push more of that cost onto workers through higher deductibles and premium shifts. Watch what employers finalize during 2027 open enrollment.
Record Sep 4, 2026
A bankruptcy court hearing put administrative and professional costs for North Star Health Alliance's Chapter 11 case at $6 million since its February 2026 filing, with New York providing bridge financing as the system cuts jobs and moves to close a maternity unit.
Why it matters A rural hospital system's bankruptcy is burning through millions in legal and administrative costs, money that isn't going to patient care, while the state props it up and services get cut.
Rule Sep 3, 2026
Wyoming went live August 31 and Tennessee went live September 1, letting licensed counselors in either state practice across all nine compact states, in person or by telehealth, without a second license.
Why it matters Licensed counselors in nine states can now cross state lines to see patients without extra licensing paperwork, part of a broader trend of interstate compacts easing workforce shortages. Watch which states join next.
Rule Sep 3, 2026
The court reversed a 2024 ruling that had declared the False Claims Act's whistleblower mechanism unconstitutional, reviving a fraud suit against three Florida Medicare Advantage companies.
Why it matters A federal appeals court kept alive the legal tool that drives billions of dollars in Medicare and Medicaid fraud recoveries each year. Watch whether the Supreme Court takes up the underlying constitutional question.
Funding Sep 3, 2026
The award splits $45 million for a University of Hawaii rural physician workforce program and $13 million for new ambulances and emergency communications upgrades in every county, under the federal Rural Health Transformation Program.
Why it matters Hawaii is getting a real infusion of federal money aimed at rural ambulance coverage and physician training, part of a much larger $50 billion national program other states are also drawing on. Watch which other states get funded next and how the money is spent.
Deadline Sep 3, 2026
The state Medicaid agency began mailing, emailing and texting notices this week that a new federal work requirement takes effect January 1, 2027, and it is also shortening recertification from annual to every six months.
Why it matters Hundreds of thousands of Colorado Medicaid enrollees now have a hard deadline to prove they meet new work requirements or lose coverage. Watch for confusion and coverage gaps as recertification also moves to twice a year.
Enforcement Sep 3, 2026
Poul Thorsen admitted to diverting more than $1 million from an $11 million-plus CDC grant using forged invoices, ending 14 years as a fugitive, and faces sentencing December 1 plus full restitution.
Why it matters A 14-year fugitive case tied to research long cited in vaccine misinformation has ended in a guilty plea, closing a chapter that fueled public distrust. Watch the December 1 sentencing for the restitution outcome.
Deal Sep 2, 2026
American Healthcare REIT closed the first six of an eight-community, 745-unit Kensington Senior Living portfolio worth roughly 873 million dollars total, with Kensington staying on as manager and the remaining two properties expected to close in Q4 2026.
Why it matters A large healthcare REIT just paid over half a billion dollars for senior living communities, a sign investors still see steady demand in senior housing even as some hospital real estate lags.
Rule Sep 2, 2026
The House passed a continuing resolution 370-48 funding the government through December 11 while blocking OMB from finalizing a rewrite of the Uniform Guidance rules that govern federal grant administration.
Why it matters This averts an imminent government shutdown and buys time before a grants-rule rewrite that worried grant recipients. Watch for the rule to resurface after the December 11 funding deadline.
Funding Sep 2, 2026
SAMHSA distributed the funds across community and tribal prevention partnerships, state-level partnerships, and long-term recovery support, timed to Overdose Awareness Day.
Why it matters This signals continued federal investment in addiction and mental health services. Watch which states and organizations receive the awards.
Deadline Sep 2, 2026
42 states plus DC had to warn ACA expansion enrollees by August 31 about new 80-hour-a-month work requirements taking effect January 1, 2027, with Washington state alone projecting 250,000 could lose coverage.
Why it matters This signals a major coverage disruption coming in 2027 as work requirements take effect. Watch state-by-state enrollment and disenrollment data as implementation proceeds.
Rule Sep 2, 2026
First Coast Service Options and Novitas Solutions finalized updated local coverage rules effective September 6 limiting billing to one code per patient per day and requiring stricter medical-necessity documentation across Florida, Texas, and more than a dozen other jurisdictions.
Why it matters This signals CMS scrutiny of a commonly billed pain procedure. Watch for denial rates in the affected states after the effective date.
Earnings Sep 2, 2026
Medtronic reported 9.8 billion dollars in fiscal first-quarter revenue, up 13.7 percent, beat Wall Street's EPS estimate, and raised its fiscal 2027 organic revenue and EPS guidance.
Why it matters Medtronic's device sales are booming, meaning the products in your hospital's cath lab and pharmacy are increasingly likely to be Medtronic's, and their prices probably are not falling.
Record Sep 2, 2026
Prime Healthcare is ending labor and delivery at Saint Joseph, Mercy, and Resurrection Medical Centers, three of the eight Ascension Illinois hospitals it bought for more than 370 million dollars in 2025, affecting about 75 nurses.
Why it matters Three Chicago-area hospitals bought in a 2025 acquisition are now cutting labor and delivery, a reminder that hospital deals can be followed by service closures once the ink dries.
Rule Sep 2, 2026
The manufacturers pledged $19.6 billion in US manufacturing investment and extended most-favored-nation pricing to every state Medicaid program, bringing the total to 26 companies covering 89 percent of the branded drug market.
Why it matters This significantly widens a federal drug pricing program tying US prices to the lowest price paid in other wealthy countries. Watch whether the projected $600 billion in savings, an administration estimate rather than an independent one, actually materializes.
Rule Sep 2, 2026
UnitedHealthcare will remove prior authorization requirements from 1,700 outpatient procedure codes across commercial, Medicare Advantage, exchange, and Medicaid plans starting October 1, 2026, alongside a new Gold Card notification program.
Why it matters The country's largest insurer is dropping prior authorization on 1,700 procedure codes starting October 1, cutting paperwork for common outpatient procedures like colonoscopies and hernia repairs, though most imaging and specialty drugs are untouched.
Rule Sep 1, 2026
The American College of Cardiology filed comments on CMS's CY2027 OPPS/ASC proposed rule ahead of the August 31 deadline, backing higher cardiac PET/CT reimbursement and opposing a proposed site-neutral cut to off-campus cardiac imaging.
Why it matters This is a comment letter, not a final rule, so nothing changes yet, but it shows what cardiology's largest physician group is fighting for as CMS finalizes 2027 outpatient payment rates by November.
Rule Sep 1, 2026
CMS published its final list of 2,600 general cardiologists required to join the mandatory Ambulatory Specialty Model for heart failure launching January 1, 2027, and the American College of Cardiology says about 500 were added in error.
Why it matters This is a mandatory Medicare payment model, not optional, so the roster determines who is on the hook for future performance-based pay swings. Watch whether CMS corrects the misclassified names before the list locks.
Deal Sep 1, 2026
Aon plc agreed August 31, 2026 to buy USI Insurance Services from KKR and other shareholders for 17 billion dollars in cash, its second major brokerage acquisition after the 2024 purchase of NFP.
Why it matters Two of the largest U.S. insurance brokers are combining, concentrating employer health benefits shopping into fewer, larger platforms. Watch the regulatory review process ahead of the expected fourth-quarter close.
Record Sep 1, 2026
Once performance-based scoring begins in 2029, cardiologists correctly included in CMS's mandatory heart-failure Ambulatory Specialty Model face a payment adjustment ranging from negative 9 percent to positive 9 percent on all their Medicare Part B claims, not just heart-failure care.
Why it matters This single number, a swing of up to 9 percent on all Medicare Part B billing, turns a reporting requirement into a practice-economics question for roughly 2,100 cardiologists once corrections are made. Watch how practices use 2026 to build the quality-reporting workflow before scoring starts.
Enforcement Sep 1, 2026
Aymancare PLLC agreed to pay $7.5 million to resolve allegations that its pop-up COVID-19 testing sites billed separate evaluation and management visit codes alongside testing codes even though patients were only seen by a technician administering a nasal swab, with claims paid through the HRSA COVID-19 Uninsured Program.
Why it matters A Dallas clinic will pay $7.5 million for billing the government for doctor visits that never happened during COVID-19 testing. This settlement confirms that DOJ is still actively closing pandemic-era fraud cases against providers that exploited the HRSA Uninsured Program.
Rule Sep 1, 2026
Buried inside proposed rule CMS-1844-P, which sets 2027 home health payment rates, CMS would gain authority to revoke or deny Medicare enrollment and claw back payments retroactively from any noncompliant provider or supplier nationwide, with estimated savings of $82 million annually, and the public comment period closed August 31, 2026.
Why it matters CMS inserted a broad Medicare enrollment crackdown into a routine home health payment update. If finalized, the agency could retroactively revoke any provider's enrollment and recoup payments already made, reaching well beyond home health agencies to every Medicare provider and supplier type.
Deal Sep 1, 2026
EIT Pharma closed an oversubscribed 35 million dollar Series A round led by Propel Bio Partners on August 31, 2026 to fund FDA review and commercial readiness for lonafarnib, an oral treatment for hepatitis delta virus.
Why it matters Early-stage funding is going toward a rare, aggressive liver co-infection with no approved cure today. Watch the FDA review, which the company itself flags as still uncertain.
Alert · now Sep 1, 2026
Inspectors found microbial contamination 47 times in 27 months at Simtra Deutschland GmbH's Halle facility, prompting an FDA warning letter and halting production of ifosfamide, a chemotherapy drug for bone, soft tissue, and lymphoma cancers, with the shortage expected to persist until at least October 2026.
Why it matters A contaminated German manufacturing plant has taken a key chemotherapy drug off the market. Pediatric oncologists are already rationing doses mid-treatment, emergency imports are authorized but cannot fully cover demand, and the shortage is expected to last into October.
Deal Sep 1, 2026
Medtronic completed its purchase of CathWorks, maker of the FFRangio system that computes fractional flow reserve from standard angiogram images instead of a pressure wire, folding it into its coronary and renal denervation business.
Why it matters This shows device makers now buying the software that interprets cath lab images, a fourth consolidation path in cardiology alongside private equity practice roll-ups, hospital employment, and payer partnerships. Watch whether other device makers follow with similar AI acquisitions.
Rule Sep 1, 2026
The White House announced August 31, 2026 that Alcon, Astellas, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva, and UCB signed most favored nation pricing deals, bringing the program to 26 manufacturers covering 89 percent of the branded drug market.
Why it matters This expands a voluntary drug pricing program that now touches most branded drugs sold to Medicaid. Watch whether the administration's self-reported savings figures hold up to independent scrutiny.
Report Sep 1, 2026
In a 262-patient randomized trial presented at ESC Congress and published in The Lancet, ablation cut AFib recurrence to 73 percent versus 52 percent for a sham procedure but produced nearly identical quality-of-life gains in both arms.
Why it matters This is the first sham-controlled trial to test whether AFib ablation's benefits go beyond keeping the heart rhythm steady, and it suggests some of what patients feel better from may be placebo. Watch whether the finding changes how doctors talk about the procedure, not whether it's still offered.
Rule Sep 1, 2026
Attorney General Peter Neronha filed formal objections on August 25, 2026 with Rhode Island's Office of the Health Insurance Commissioner against proposed 2027 rate increases from Neighborhood Health Plan of Rhode Island (22%) and Blue Cross Blue Shield of Rhode Island (9.8%), citing failure to fund primary care spending obligations and arguing that Blue Cross RI is on pace for $50 million in profit without improving affordability.
Why it matters Rhode Island's top consumer watchdog is formally opposing rate increases that would push a benchmark individual health plan past $7,000 a year. OHIC will weigh the objections before setting final 2027 rates, making this a live regulatory proceeding affecting more than 50,000 Rhode Islanders.
Deal Sep 1, 2026
The merger took effect September 1, 2026 after Minnesota's Attorney General secured a 10-year binding oversight agreement requiring Sanford to invest 600 million dollars and preserve Robbinsdale Hospital's trauma center, union contracts, and reproductive and gender-affirming care.
Why it matters A hospital merger closed alongside an unusually binding decade-long state oversight agreement, a model other states may look to replicate. Watch the required quarterly meetings and annual compliance reports over the next 10 years.
Rule Sep 1, 2026
New York's Attorney General, co-leading with Maryland and Massachusetts, filed suit in federal court on August 27, 2026, arguing HHS added conditions to Title X grants this summer requiring clinics to exclude transgender patients, discourage contraception, and counsel patients toward marriage and parenthood, without the legally required public notice and comment process.
Why it matters Twenty-three states are fighting new federal conditions on Title X grants that would reshape which patients get care and what counseling clinics may provide. The court's decision on the injunction request will determine whether the new conditions take effect before the April 2027 deadline.
Deal Aug 31, 2026
Arintra, whose AI platform audits hospital and clinic billing and now drives 5 billion dollars in annual claim value, raised a Series B led by Define Ventures to expand into more health systems.
Why it matters An AI platform that catches missed hospital billing revenue raised new funding, part of a broader wave of AI tools aimed at revenue-cycle efficiency in health systems.
Deal Aug 31, 2026
BioXcel entered a stalking horse asset purchase agreement for Teva to buy its assets for up to 145 million dollars while the company proceeds through bankruptcy court in Delaware.
Why it matters A once-promising drugmaker ran out of cash and its only approved product is now headed to Teva; watch the November 14 FDA decision on expanded at-home use for the deal's final size.
Deal Aug 31, 2026
Bloom Healthcare acquired Christian Care House Calls on August 31, with undisclosed terms, even as broader private equity investment in physician practices contracts sharply.
Why it matters One in-home primary care organization for homebound seniors kept acquiring practices even as the broader physician-practice deal market froze. Watch whether more home-based primary care consolidation follows.
Enforcement Aug 31, 2026
CMS credits AI-driven program integrity analytics with revoking 157 fraudulent lab providers, suspending 185 more among roughly 600 flagged, and blocking or identifying $1.6 billion in payments since January 2025.
Why it matters This is CMS touting its ability to catch fraud before it drains Medicare, and it's worth watching whether the AI tools flag legitimate labs by mistake.
Rule Aug 31, 2026
Attorney General William Tong filed objections to proposed 2027 rate increases from Anthem, ConnectiCare, and UnitedHealthcare covering about 220,000 Connecticut residents, ahead of a final Insurance Department decision.
Why it matters If regulators side with the insurers, 220,000 Connecticut residents could see premiums jump by double digits next year; watch the Insurance Department's decision in the coming weeks.
Rule Aug 31, 2026
Acting CPSC Chairman Peter Feldman said hospital participation in the NEISS-R emergency department data collection effort with contractor Konza Health remains voluntary, walking back outreach materials that told hospitals it was required.
Why it matters A federal agency told hospitals nationwide their ER records were mandatory to hand over, then admitted that was wrong, worth watching for how much identifiable patient data ends up flowing to a private contractor anyway.
Rule Aug 31, 2026
CMS's proposed CY2027 physician fee schedule sets a 1.19 percent cut for clinicians in advanced alternative payment models versus a 1.68 percent cut for everyone else, with comments due September 14, 2026.
Why it matters Medicare's proposed 2027 payment rates cut fee-for-service doctors more than doctors in value-based arrangements, a financial nudge toward joining an ACO. Watch the September 14, 2026 comment deadline and whether the final rule keeps the gap.
Deal Aug 31, 2026
Faro AI, whose platform is used by six of the world's ten largest pharmaceutical companies, closed a Series B round co-led by Merck's venture arm and S32 to expand its agentic AI tools for clinical development.
Why it matters A clinical-trials AI vendor already used by major pharma companies raised fresh capital, a sign investors see room to expand AI's role in running drug trials.
Approval Aug 31, 2026
The FDA approved Takeda's Mimrylo (rusfertide) for adults with polycythemia vera after a pivotal trial found 76.9 percent of patients avoided therapeutic phlebotomy versus 32.9 percent on placebo.
Why it matters This is a new treatment option for a rare blood cancer that could reduce the need for frequent therapeutic blood draws; watch for uptake and pricing once it reaches the market.
Rule Aug 31, 2026
A unanimous three-judge panel affirmed a Texas district court ruling against PhRMA, the National Infusion Center Association, and the Global Colon Cancer Association, holding that manufacturers have no protected property interest in Medicare drug pricing because program participation is voluntary.
Why it matters This is the 25th consecutive court loss for the drug industry's legal campaign against Medicare price negotiation, reinforcing that the program is likely here to stay.
Record Aug 31, 2026
HMSA is shifting independent primary care doctors off fixed monthly transformation payments back to fee-for-service starting September 1, 2026, with a final deadline of January 1, 2027, alongside new patient-attribution rules.
Why it matters A major insurer's payment model reversal is already forcing at least one independent practice to close, showing how a single payer's policy can determine whether a local doctor's office stays open.
Enforcement Aug 31, 2026
The Department of Justice said Monogram Health agreed to pay $2.4 million to resolve False Claims Act allegations that it submitted unsupported diagnosis codes to Medicare Advantage plans from 2021 through 2023, based on a former staff physician's whistleblower complaint.
Why it matters This is another Medicare Advantage upcoding settlement driven by a physician whistleblower, a reminder that inflated diagnosis codes carry real financial and legal risk.
Rule Aug 31, 2026
NAACOS wants CMS to extend ACO REACH through 2027 because the LEAD Model's January 1, 2027 start does not give the program's roughly 115 current participants enough time to plan their transition.
Why it matters Medicare's accountable care system is mid-transition, and the trade group representing most ACOs says the timeline is too tight. Watch for a CMS response before the September 15 Implementation Period begins.
Report Aug 31, 2026
Physician practice management deal volume dropped from 851 transactions in 2021 to 105 in the first half of 2026 as at least 25 states restrict private equity control of medical practices.
Why it matters Fewer private equity buyers are competing to acquire physician practices, which affects who owns your doctor's practice and how it's run. Watch whether state restrictions expand to more specialties and states.
Report Aug 31, 2026
Federally designated primary care shortage areas covering more than 92 million Americans meet only about 48 percent of documented need, and just 9.3 percent of physicians practice in rural areas.
Why it matters The government has mapped where primary care doctors are most scarce, and the shortfall is large and getting worse in rural areas even as policy tries to steer more care toward primary care and value-based models. Watch whether this workforce gap becomes a policy priority alongside payment reform.
Deal Aug 31, 2026
Radiology Partners agreed to buy Everlight Radiology, adding more than 800 radiologists across over 40 countries in a deal trade press estimates near 1 billion dollars though neither company confirmed a price.
Why it matters The deal consolidates teleradiology capacity across multiple countries under one US-based physician group, a sign of continuing scale consolidation in radiology reading services.
Rule Aug 31, 2026
CMS is proceeding with quarterly risk-adjustment audits across all 550-plus eligible Medicare Advantage contracts while its Fifth Circuit appeal of a ruling that vacated its extrapolation authority remains unresolved.
Why it matters The government is auditing Medicare Advantage plans for billing accuracy while a court fight over how those audits are calculated remains unresolved. Watch the Fifth Circuit's ruling in case 25-11293.
Deal Aug 28, 2026
AusperBio Therapeutics closed a $120 million Series C round to push its antisense drug AHB-137 into a Phase 3 program for chronic hepatitis B.
Why it matters A biotech just raised $120 million to push an experimental hepatitis B drug toward a pivotal trial, a reminder of how much capital it now takes to reach late-stage testing for a disease with no approved cure.
Record Aug 28, 2026
DaVita and Humana struck a partnership to pay DaVita for delaying or preventing dialysis among more than 10,000 Humana Medicare Advantage members with chronic kidney disease.
Why it matters DaVita, which normally gets paid every time a patient goes on dialysis, just agreed to get paid instead for keeping over 10,000 Humana Medicare Advantage members with kidney disease off dialysis altogether, a bet that managing the disease upstream can be more profitable than treating it.
Report Aug 28, 2026
The Florida Policy Institute estimated that expanding the state's homestead tax exemption through Amendment 3 would cut public hospital districts' property tax revenue by $323 million over three years, with Jackson Health System alone losing $63.7 million.
Why it matters This is a ballot-measure story with direct stakes for anyone who relies on Florida's public safety-net hospitals; a November vote could cut hundreds of millions from the property tax revenue that funds care for uninsured and low-income residents.
Funding Aug 28, 2026
CMS announced August 27, 2026 that 87 rural Georgia hospitals will split $93.3 million in Rural Health Transformation Program funding for surgical robots, telehealth, cybersecurity, and paramedic training, bringing Georgia's first-year program total to more than $218 million.
Why it matters This is new federal money flowing to rural hospitals under a $50 billion, five-year program, worth watching for whether it stabilizes struggling rural facilities or just funds equipment purchases without addressing underlying financial pressure.
Report Aug 28, 2026
STAT News found that reviewers flagged 66 percent, or $5.4 million, of the $8.1 million in Louisiana sheriff's office opioid settlement spending they could assess as inappropriate under the settlements' allowable use guidelines, while $10.7 million more went undisclosed.
Why it matters This is a public-accountability story about whether opioid settlement money, meant to fund addiction treatment, is instead going to law enforcement equipment like license-plate readers and body cameras. Watch whether other states with sheriff carve-outs face similar scrutiny.
Deal Aug 28, 2026
Sword Health agreed to buy Headspace in an all-cash deal disclosed in a Massachusetts regulatory filing, expected to close September 14, 2026.
Why it matters A virtual care company just agreed to pay up to $300 million for a mental-health app once valued near $3 billion, a steep markdown that shows how far 2021-era digital health valuations have fallen and how the sector is consolidating around fewer, broader platforms.
Enforcement Aug 28, 2026
The Villages Health System LLC agreed to pay $541.5 million to resolve False Claims Act allegations that it submitted invalid Medicare Advantage diagnosis codes from 2020 through 2024, with Humana, UnitedHealthcare and GuideWell (Florida Blue) separately returning the resulting overpayments to CMS.
Why it matters This is the largest healthcare fraud settlement in Florida history and shows federal enforcers can still recover big money from Medicare Advantage coding schemes even after a company files for bankruptcy. Watch whether other physician groups facing similar coding scrutiny follow TVH's self-disclosure playbook.
Deal Aug 28, 2026
Yardstik raised a $30 million Series B to expand continuous post-hire monitoring, including checks against the federal Medicare and Medicaid exclusion list.
Why it matters A workforce-screening startup raised $30 million to build tools that keep monitoring employees after they're hired, not just before, a category of demand fueled by employers, including healthcare organizations, that got burned by staff who went wrong post-hire.
Funding Aug 27, 2026
CMS awarded Alaska $160 million across 142 projects under the Rural Health Transformation Program, funding drone pharmacy delivery, AI stroke detection, robotic surgery, and addiction treatment infrastructure.
Why it matters It shows how a federal rural health fund is translating into concrete, often unusual tech, like prescription delivery drones, in a state where distance itself is the biggest barrier to care.
Report Aug 27, 2026
Two of three Arizona Medicaid managed care insurers reviewed could not produce reliable data showing they apply the same prior authorization rules to mental health and substance use claims as medical ones, making Arizona the third state to fail this federal audit.
Why it matters It shows that mental health parity, a law on the books for over a decade, is still not verifiably enforced in some of the biggest state Medicaid programs.
Alert · now Aug 27, 2026
Baxter International recalled two lots of 500 milliliter Viaflex saline bags shipped between July 31 and August 3, 2026 after finding fiberglass particulate matter, though it has not received any reports of patient harm.
Why it matters Contaminated IV fluid is a basic hospital supply used constantly, so a recall like this forces facilities to check inventory fast even without confirmed injuries yet.
Enforcement Aug 27, 2026
CMS has withheld the funding while more than 1,000 California hospices have lost Medicare billing privileges since early 2025 amid an escalating federal-state fraud fight.
Why it matters This shows how deep hospice fraud has spread in California and why patients caught up in it can lose access to normal medical care for months while providers get sorted out.
Record Aug 27, 2026
The fund, targeting a $125 million total, will back Series A and B device, diagnostics, and AI-enabled digital health companies addressing conditions that disproportionately affect women and children, with a final close expected in 2027.
Why it matters This is a signal of where specialist venture capital is positioning in women's and children's health technology, not a transaction that changes care delivery yet.
Report Aug 27, 2026
A June 2026 report from the Center for Healthcare Quality and Payment Reform found only 41 percent of rural hospitals still offer labor and delivery, with fewer than a third doing so in 12 states.
Why it matters This is the sector's most-cited tracker on rural maternity access, and the standby-payment fix it proposes is the policy idea to watch if Congress or CMS moves on rural OB funding.
Rule Aug 27, 2026
CMS's CY2027 Physician Fee Schedule proposed rule would let insurers keep using bundled global maternity G-codes alongside new unbundled per-visit codes, and ACOG warns that would split patients into two billing tracks.
Why it matters The choice CMS makes by early November decides whether obstetric billing gets simpler or more fragmented starting in 2027, and the comment window to weigh in closes September 14.
Enforcement Aug 27, 2026
The Justice Department said DermTech, now in bankruptcy liquidation as DTech Liquidating, billed Medicare for melanoma tests run on an unvalidated marker range from October 2022 through March 2023 without disclosing or refunding the results.
Why it matters It's a reminder that a lab's internal quality control failure, if hidden rather than disclosed, can turn into a federal fraud case even after the company is gone.
Approval Aug 27, 2026
The FDA approved daraxonrasib (Rasonque) for adults with metastatic pancreatic adenocarcinoma after one prior treatment, based on a trial showing median survival of 13 months versus 6.7 months on standard chemotherapy.
Why it matters This is the first clinical proof that directly blocking the RAS protein family, a mutation behind 90 percent of pancreatic cancers, meaningfully extends life in one of the deadliest common cancers.
Deal Aug 27, 2026
The FTC approved a final consent order letting Ascension Health Alliance close its purchase of AmSurg LLC only after Ascension agreed to divest seven ambulatory surgery centers in five metro areas to rival operators.
Why it matters This is a case study in how antitrust regulators police hospital consolidation of outpatient surgery, requiring specific market fixes rather than blocking a deal outright. Watch whether the divested centers keep prices and access stable under new owners.
Record Aug 27, 2026
Henderson Hospital in suburban Las Vegas will stop delivering babies and close its NICU around September 30, 2026, converting the space into 64 medical-surgical beds by the end of 2027.
Why it matters Watch whether other suburban, well-resourced hospitals start making the same maternity-to-medsurg trade UHS just made in Henderson, since it signals volume and geography are no longer the only variables driving closures.
Deal Aug 27, 2026
Hike Medical raised a combined $22.5 million seed and Series A round led by Saga Ventures to expand an AI platform that handles insurance prior authorization, digitizes clinical evaluations and 3D-prints custom orthotics, prosthetics and durable medical equipment.
Why it matters This funding targets a real friction point, the long wait for custom orthotic and prosthetic devices, though the company's claimed reductions in wait times and remake rates are not independently quantified.
Deal Aug 27, 2026
MiiHealth AI closed a seed funding round led by former Headspace CEO Russell Glass for its AI assistant DAINA, which calls patients before appointments and writes clinical intake notes into the electronic health record, though reported funding amounts conflict across outlets.
Why it matters The core claim, that this tool gives doctors back two hours a day, rests on a single reported clinical validation at Mayo Clinic that was not independently reviewed this run, and even the round's size is disputed between sources.
Enforcement Aug 27, 2026
Minnesota's Attorney General settled with Stevens Community Medical Center after finding it overbilled uninsured patients by up to 20.5 percent above the state-mandated discount, making roughly 3,500 patients eligible for refunds or debt cancellation totaling up to $1,412,776.25.
Why it matters It's a concrete example of a state enforcing its own uninsured-discount law against a hospital, with real refunds going to thousands of specific patients rather than just a policy change.
Report Aug 27, 2026
The same national survey found neuraxial labor analgesia use rose from 61 percent of deliveries in 2015 to 84 percent in 2025, but smaller hospitals still lean more on general anesthesia, a gap tracking with race, insurance status, and geography.
Why it matters US hospitals offering obstetric services have been cut in half over four decades even as pain-relief access improved on average, and the gap that remains tracks with race, insurance status, and geography.
Report Aug 27, 2026
A national survey of 1,180 hospitals found that just 27 percent provide a financial stipend for continuous in-house obstetric anesthesia coverage, leaving most hospitals to expect the coverage without funding it as a distinct cost center.
Why it matters The staffing cost nobody's pricing into 2027 maternity budgets is anesthesia call coverage, since only 27 percent of hospitals actually pay for it.
Report Aug 27, 2026
An HHS OIG audit of Centene, Elevance, and UnitedHealthcare Medicaid plans covering over 29 million enrollees found about 25 percent of listed maternal health providers were not actually in-network and nearly half were missing from the plans' own directories.
Why it matters A federal audit found that a quarter of the maternity providers Medicaid plans claim are in-network aren't, which matters directly if you or someone you know is trying to find a Medicaid OB provider.
Deal Aug 27, 2026
Onos Health, whose AI platform analyzes claims and clinical data to flag gaps in behavioral health care for insurers, closed a $17 million Series A led by Costanoa Ventures with CVS Health Ventures and Flare Capital Partners participating.
Why it matters This is a bet by a major insurer's venture arm that AI can catch bad behavioral health care before it becomes expensive, and the outcome metrics cited come from the company's own customers rather than an independent study.
Deal Aug 27, 2026
Oregon's attorney general approved Salem Health's merger with financially strained Santiam Hospital, under which Salem Health commits at least $61 million including $35 million in capital investment over 10 years and assumes about $22 million of Santiam's debt, with closing expected by August 31, 2026.
Why it matters This is a case of a larger nonprofit system stepping in to keep a financially strained rural hospital open, a pattern worth watching as more small community hospitals face closure pressure.
Record Aug 27, 2026
Vandalia Health will permanently close SurgiCare, a three-suite outpatient surgery center at CAMC Memorial Hospital in Charleston, West Virginia, effective August 28, 2026, citing operating room utilization and efficiency.
Why it matters This is the sixth service line Vandalia Health has closed in 2026, a pattern worth watching for what it signals about financial pressure on West Virginia's largest hospital system.
Funding Aug 25, 2026
The state distributed the first round of ARHTP funding to 138 projects in every county, covering rural workforce, mental health, and digital obstetric care initiatives.
Why it matters This is the first real money moving from a new $50 billion federal program meant to shore up rural health care access, so watch how the money actually gets spent and whether it improves care where you live.
Deal Aug 25, 2026
ArtesRx, a specialty pharmacy platform serving patients with serious mental illness and substance use disorders, grew from 3 pharmacies in one state to 16 across 15 states since 2023 before Flexpoint Ford sold it to Linden Capital Partners for an undisclosed price.
Why it matters A private-equity backed pharmacy chain serving people with serious mental illness and substance use disorders just changed owners, a sign investors see steady demand in complex-medication management for vulnerable populations.
Deal Aug 25, 2026
Union Community Care's board approved a merger with three-site Berks Community Health Center by August 24, 2026, extending the Lancaster County nonprofit's federally qualified health center network into a fourth Pennsylvania county pending regulatory approval.
Why it matters Two Pennsylvania nonprofit clinics serving low-income patients are combining to share resources and administrative capacity, a common survival strategy for small community health centers facing rising costs.
Deal Aug 25, 2026
Cityblock Health signed an all-stock deal to acquire rural Medicare Advantage company Homeward Health and closed a $116 million Series E led by General Catalyst, combining to serve nearly 250,000 Medicaid, dual-eligible and Medicare Advantage members.
Why it matters Two value-based care companies are combining to chase government health spending across both urban Medicaid and rural Medicare populations, a bet that scale and capability, not cuts, is the way to manage cost pressure in government programs.
Deal Aug 25, 2026
Concentra completed its acquisition of four independently owned Minnesota Occupational Health medical centers in the Twin Cities on August 17, 2026, doubling its state footprint to eight centers since entering Minnesota in 2018.
Why it matters A national occupational health chain absorbed four independent Twin Cities clinics, continuing steady consolidation in workplace injury and employer health services.
Enforcement Aug 25, 2026
The center is a prosecutor-led, multi-agency data-analytics team under DOJ's National Fraud Enforcement Division, which has grown to about 500 attorneys and staff since its April 2026 creation.
Why it matters This signals faster, data-driven detection of suspicious healthcare billing before losses pile up, so providers should expect scrutiny to move earlier in the billing cycle rather than after the fact.
Report Aug 25, 2026
OASAS's new report details how New York has allocated its multi-billion-dollar opioid litigation settlement funds as oversight of settlement spending remains inconsistent nationally.
Why it matters This shows how much of a multi-year opioid settlement windfall is actually reaching communities versus sitting unspent, a question watchdogs are raising in multiple states.
Enforcement Aug 25, 2026
Stephanie Mobley was sentenced to 17 months to 10 years in prison and ordered to pay $1.76 million in restitution for billing Medicaid for caregivers who never existed at ComfortZone Home Health Care LLC.
Why it matters This is a reminder that Medicaid home care fraud enforcement is active and can result in real prison time, not just fines.
Deal Aug 25, 2026
R1 agreed to acquire Humata Health, whose AI prior-authorization technology drives up to a 96 percent first-pass approval rate, folding it into R1's Phare OS platform with a close expected by the end of the third quarter of 2026.
Why it matters A major hospital revenue-cycle company is betting AI can meaningfully cut the friction and delay of prior authorization, a process patients and providers have long complained about.
Deal Aug 25, 2026
Radial, a General Catalyst-backed neuromodulation psychiatry platform, acquired TMS Health Partners, the MSO behind 21-clinic Spravato provider Mindful Health Solutions, expanding its combined network to 27 clinics with more than 100 clinicians.
Why it matters A psychiatry platform focused on TMS, Spravato and ketamine treatments just roughly doubled its footprint, reflecting investor appetite for scaling access to newer depression and treatment-resistant mental illness therapies.
Deal Aug 24, 2026
Bon Secours Mercy Health signed an asset purchase agreement to acquire the 97-bed Fauquier Health hospital in Warrenton, Virginia from LifePoint Health, converting it from for-profit to nonprofit in a deal expected to close this fall.
Why it matters This is another example of a financially stretched or non-core hospital moving from a private equity-backed chain to a larger nonprofit system; watch how the conversion affects local services and pricing.
Rule Aug 24, 2026
CMS's CY2027 ESRD PPS proposed rule would raise the per treatment dialysis base rate to $299.55, of which $15.96 reflects folding phosphate binder drug costs into the bundled payment for the first time, with the public comment period closing August 24, 2026.
Why it matters This determines how much Medicare pays dialysis facilities per treatment next year, and a chunk of the increase is really a drug cost accounting shift rather than new money. Watch whether the $15.96 phosphate binder add on survives to the final rule expected around late October or November.
Rule Aug 24, 2026
CMS's CY2027 Physician Fee Schedule proposed rule would require RPM and RTM monitoring staff to be direct employees of the billing practice, add a face to face initiation visit requirement, and cut several code payments, with comments due September 14, 2026.
Why it matters This could reshape how conditions like chronic kidney disease are remotely monitored, since programs built on outsourced monitoring vendors may have to restructure or shut down. Watch whether the direct employment mandate survives to the final rule.
Earnings Aug 24, 2026
DaVita reported that its Integrated Kidney Care division generated $40 million in adjusted operating income in Q2 2026, up from a $19 million loss in Q1, while managing about $5.8 billion in annualized risk-based medical spend across roughly 64,900 patients as of June 30, 2026.
Why it matters The country's largest dialysis chain is turning a profit on managing kidney patients under risk based contracts, meaning it is now competing more directly with outside companies for the same value based kidney care deals.
Report Aug 24, 2026
On its Q2 2026 earnings call, DaVita said full year treatment volume growth is tracking to the high end of guidance mainly because of lower patient mortality after moving phosphate binders into the Medicare payment bundle, even as revenue per treatment fell about $2 sequentially.
Why it matters A dialysis chain is crediting a drug bundling change with keeping more patients alive and in treatment, which is a nearer term volume driver than the open question of whether GLP-1 drugs will eventually shrink the dialysis population.
Rule Aug 24, 2026
A federal appeals court upheld the core of Medicare's drug price negotiation program against Teva's challenge, rejecting its constitutional claims while reviving a narrower fight over how generics count against a brand drug's eligibility.
Why it matters The ruling keeps the second round of Medicare's Inflation Reduction Act drug price negotiations intact while manufacturers keep fighting the program in multiple circuits.
Record Aug 24, 2026
President Trump will nominate Dr. Heidi Overton, a White House Domestic Policy Council deputy director, to lead the FDA, the agency that decides which drugs, vaccines and devices reach the market and when.
Why it matters The FDA has been without a permanent commissioner since May, and Overton is the third physician approached for the job after two others declined.
Deal Aug 24, 2026
Genentech agreed to pay Hanmi Pharmaceutical 190 million dollars upfront and up to 2.3 billion dollars total in milestones and royalties to license HM17321, an obesity drug that has not yet entered Phase 2 trials.
Why it matters This is a record-setting bet on an obesity drug candidate that has not started Phase 2 testing; watch whether it can actually avoid the muscle-loss side effect drawing scrutiny to current GLP-1 drugs.
Enforcement Aug 24, 2026
Federal prosecutors charged Rodney Greer in a four-count indictment, alleging he called about 261 pharmacies roughly 3,329 times using real physicians' identities to fraudulently authorize GLP-1 and other prescriptions for paying customers.
Why it matters A case that exposes a pharmacy-verification gap driving GLP-1 fraud, as demand and prices for the weight-loss drugs climb.
Record Aug 24, 2026
Mount Carmel Health System permanently closed its freestanding Franklinton emergency department in Columbus, Ohio on August 22, 2026 and opened a walk-in care center without emergency-level acuity in its place two days later.
Why it matters A hospital permanently closing an ED in a low-income neighborhood signals ongoing consolidation of emergency capacity into fewer facilities, worth watching for similar closures elsewhere.
Report Aug 24, 2026
The American Society of Nephrology's first look at the AY2026 fellowship Match found only 333 candidates matched, down 8 percent year over year, with just 89 of 186 training tracks, or 48 percent, filling completely and 66 percent of the 501 offered positions claimed.
Why it matters The pipeline of new nephrologists is shrinking even as positions offered rose slightly, meaning the competition for existing kidney specialists across practices, MSOs, and value based care companies will keep intensifying.
Enforcement Aug 24, 2026
Three Buffalo-area skilled nursing facilities agreed to pay $9 million over two separate schemes, billing for rehab therapy that was not medically necessary or never provided, and submitting false data to inflate Medicaid reimbursement rates.
Why it matters A rare double settlement resolving two distinct fraud schemes at once, phantom therapy billing and inflated Medicaid rate data, across three Erie County facilities.
Rule Aug 24, 2026
Oregon regulators finalized 2027 health insurance rates with a 21.6 percent average increase in the individual market and 15.5 percent in small group, blaming the loss of enhanced ACA subsidies and rising costs.
Why it matters One of the first states to finalize 2027 rates, Oregon shows what premium season looks like as enhanced federal ACA subsidies lapse.
Report Aug 24, 2026
Premier Medical Distribution LLC filed for Chapter 11 bankruptcy protection on August 21, 2026 with 10 million to 50 million dollars in liabilities against 1 million to 10 million dollars in assets, and the filing states unsecured creditors will receive nothing.
Why it matters This shows how thin margins have gotten for mid-sized medical-supply distributors squeezed between manufacturer pricing and health-system purchasing power, and it could disrupt supply relationships for facilities that used this vendor.
Report Aug 24, 2026
KFF analyzed the first federal data set that lets patients compare prior authorization denial rates insurer by insurer, covering 14 major insurers and roughly 71 million enrollees, and found denial rates ranging from 2 percent to 25 percent.
Why it matters The first federal data set that lets patients compare prior authorization denial rates insurer by insurer, forced into the open by a 2024 CMS transparency rule.
Deal Aug 24, 2026
SuperiorMed Holdings Limited, a Cayman Islands holding company for a Dubai-based longevity medicine and health-tourism platform, signed a merger agreement with Nasdaq-listed Starry Sea Acquisition Corp without disclosing a deal valuation.
Why it matters A Dubai-based health-tourism and longevity-medicine company going public in the U.S. through a SPAC signals investor interest in cross-border wellness business models, though the deal still needs shareholder approval and no valuation was disclosed.
Deal Aug 23, 2026
BioMarin will pay $275 million upfront plus up to $215 million in milestones for Alesta's early-stage oral candidate ALE1, a potential first oral therapy for the rare bone disease hypophosphatasia.
Why it matters This is a bet on a still-unproven pill years from approval; watch Phase 1/2a data before assuming hypophosphatasia patients will have an oral option anytime soon.
Alert · now Aug 23, 2026
FDA classified its highest-risk recall for more than 165,000 Enroute Transcarotid Neuroprotection System units after reports that the device's arterial sheath tip can separate inside a patient's artery during the procedure meant to prevent stroke.
Why it matters This is FDA's most serious recall category for a device meant to prevent stroke during carotid artery procedures, worth watching for how many of the 165,000 distributed units are still in active use.
Record Aug 23, 2026
Glenview Capital CEO Larry Robbins departed CVS's board effective August 13, 2026, two years after his fund's roughly $700 million stake won him a seat, and will be replaced in November by JPMorgan's chief data and analytics officer Teresa Heitsenrether.
Why it matters This is a signal on how CVS's activist-driven shakeup, which already replaced the CEO and launched a $2 billion cost-cutting plan, may be entering a new phase; watch whether Glenview keeps pushing or has moved on.
Enforcement Aug 23, 2026
Federal prosecutors unsealed a nine-count indictment alleging the men used GPS spoofing to fake non-emergency medical transportation rides, paid patient kickbacks, laundered proceeds through a sham charity, and carried out an armed home invasion against a rival fraud ring.
Why it matters This shows Medicaid fraud enforcement now reaching into RICO and violent-crime territory, not just billing audits, a sign prosecutors are treating organized fraud rings more aggressively.
Deadline Aug 23, 2026
Commissioners are set to adopt a 23.7-cent no-new-revenue tax rate and FY2027 budget for University Medical Center of El Paso on August 24 even as the CEO projects $277 million in uninsured patient care costs next year.
Why it matters This is a local funding story, not a federal policy shift; watch whether UMC has to return for a tax increase if uninsured costs keep rising.
Report Aug 23, 2026
Fitch Ratings found the median operating margin for 222 rated nonprofit hospitals rose to 1.5 percent in 2025 from 1.1 percent in 2024, but warned Medicaid cuts starting in 2027 could end the recovery.
Why it matters Hospital finances just had their best year in decades, but Fitch itself says 2025 could be the peak before Medicaid funding cuts squeeze providers starting in 2027; watch 2026 margin trends as an early signal.
Rule Aug 23, 2026
HHS posted a Request for Information asking whether the Routine, Risk-Based, and Shared Clinical Decision-Making vaccine categories should change, with comments due September 20, 2026.
Why it matters The category a vaccine sits in determines whether your insurer must cover it free; watch whether HHS narrows the Routine label since that could shift shots from free to cost-sharing.
Deadline Aug 23, 2026
HRSA's revived 340B Rebate Model Pilot Program requires manufacturers of drugs in the Medicare Drug Price Negotiation Program to submit participation plans by August 24, with approved switches to after-sale rebates taking effect January 1, 2027.
Why it matters This changes how safety-net hospitals get paid for discounted drugs, from an upfront price cut to a rebate paid after the fact, which can strain their cash flow.
Record Aug 23, 2026
The insurer will wind down all Medicare Advantage, Medicaid, and commercial coverage by the end of 2026 after talks to hand its Medicare Advantage business to a national insurer fell through.
Why it matters If you're a Providence Health Plan member, you'll need to find new coverage before the end of 2026; watch for your enrollment window and any state guidance on your options.
Enforcement Aug 23, 2026
Steven Richardson was sentenced to two years in prison after his companies paid telemarketers to generate leads and doctors to sign unexamined orders for durable medical equipment like back and knee braces from 2016 to 2023, with $15.7 million subject to forfeiture.
Why it matters This is a real-world example of the telemarketing-to-DME fraud pattern regulators have been warning is still outrunning Medicare's safeguards, worth watching for further prosecutions of the same playbook.
Deal Aug 23, 2026
Universal Health Services paid $5.25 per share in debt-financed cash to acquire the virtual therapy platform, aiming to link it with its inpatient and outpatient behavioral health facilities.
Why it matters A hospital operator now owns a virtual therapy network reaching 200 million-plus Americans; watch whether UHS actually integrates referrals between virtual and in-person care or keeps Talkspace as a standalone unit.
Deal Aug 21, 2026
The round, led by InnovaHealth Partners, follows what the company calls a successful commercial relaunch of Cerene, its cryotherapy device for heavy menstrual bleeding.
Why it matters A women's health device that struggled commercially has found its footing enough to raise a fresh round, worth watching for whether non-surgical alternatives to endometrial ablation are gaining real traction.
Deal Aug 21, 2026
CHG did not disclose the purchase price for KREWE, a firm founded in 2022 that provides locum tenens staffing and coverage solutions for certified registered nurse anesthetists.
Why it matters A major staffing company buying a firm dedicated to anesthesia providers is a direct response to how hard it has become for hospitals and surgery centers to keep that specialty staffed.
Alert · now Aug 21, 2026
The agencies raised Medusa's confirmed victim count to more than 500 organizations and added HHS as a co-sealing agency for the first time to detail healthcare-sector impact.
Why it matters This is a reminder that ransomware groups continue to target hospitals specifically; watch whether your own health system or provider has applied the recommended patching and MFA controls.
Deadline Aug 21, 2026
The FDA's PDUFA target action date on Capricor Therapeutics' deramiocel arrives August 22, three weeks after the agency's advisory committee voted 9 to 3 that the evidence did not support approval.
Why it matters Watch whether the FDA follows its advisory committee's negative vote; a rejection would delay the first approved treatment for a fatal complication of Duchenne muscular dystrophy.
Deal Aug 21, 2026
The Sunnyvale startup is developing a single-procedure platform that combines ultrasound imaging with tissue-selective therapy to treat the prostate through the urethra.
Why it matters A well-funded new device platform for a common condition is being built by a startup you'll likely not interact with directly yet, but watch whether it reaches later-stage trials and eventual market entry, since a major device maker rarely backs a company without confidence in the science.
Report Aug 21, 2026
HHS's inspector general published a white paper flagging that fraud schemes exploiting supplier enrollment, physician orders, and beneficiary ID numbers continue to outpace CMS's efforts to stop them, even as CMS stands up a new Fraud Defense Operations Center.
Why it matters This is a reminder that a chunk of Medicare spending on wheelchairs, braces, and similar equipment still leaks to fraud; watch whether CMS's new fraud center actually slows the schemes down.
Deadline Aug 21, 2026
Pennsylvania's public comment period on proposed 2027 individual and small-group health insurance rates, including a 40.9 percent increase requested by Ambetter Health, closes August 22.
Why it matters These filings hint at what individual and small-group premiums could look like in Pennsylvania next year; watch the state's final decisions this fall.
Deal Aug 21, 2026
Rockbridge Growth Equity is exiting its stake in the waiting-room health education and pharma advertising platform on undisclosed terms, with the deal expected to close in the third quarter of 2026.
Why it matters A private equity firm buying majority control of a point-of-care advertising and education platform is a reminder of how much healthcare marketing infrastructure sits inside waiting rooms and exam rooms, largely invisible to patients.
Alert · now Aug 21, 2026
The FDA classified the July 29 recall of GreenWise Organic frozen blueberries and mixed berries as its most serious risk category after confirming Escherichia coli O145:H28 contamination tied to 12 illnesses and 4 hospitalizations in Florida and Georgia.
Why it matters If you bought GreenWise Organic frozen blueberries or mixed berries from Publix, discard them or return them for a refund; watch for updates if the illness count grows.
Rule Aug 20, 2026
CMS published a new Privacy Act System of Records Notice for its Nurses for Nursing Homes Program, the records backend for an $80 million initiative paying nurses' loan repayment and stipends to work in nursing homes, with public comment open through September 21, 2026.
Why it matters This is the administrative paperwork behind an $80 million push to draw nurses into nursing home jobs, worth watching if you want a say in how CMS handles nurses' personal data under the program.
Rule Aug 20, 2026
HRSA republished its 340B Rebate Model Pilot Program in the Federal Register, giving drug manufacturers until August 24, 2026 to opt in ahead of a January 1, 2027 launch, with no exemption this time for critical access or children's hospitals.
Why it matters This revives a rebate scheme a federal court already blocked once, and this version removes exemptions that protected the most financially vulnerable hospitals, so watch whether Congress's SUSTAIN 340B Act overtakes it before launch.
Enforcement Aug 20, 2026
Federal and Illinois prosecutors allege Foot & Ankle Health Care Center and related entities kept billing Medicaid and Medicare for podiatry services performed by Dr. Vadim Goshko after Illinois Medicaid had already terminated him, by listing other physicians as the treating provider.
Why it matters This case shows how a terminated provider allegedly kept billing government programs by hiding behind other physicians' names, and it started from a whistleblower tip, so watch for the case's outcome under the False Claims Act.
Enforcement Aug 20, 2026
David Morens pleaded guilty August 18, 2026 to conspiring to evade FOIA requests and violate federal records law regarding COVID-19 research grant communications, and faces sentencing November 12, 2026.
Why it matters This is a criminal accountability case over how a top federal science official handled records tied to pandemic origins research, not a new rule, so watch the November 12 sentencing for how seriously courts treat records violations.
Report Aug 20, 2026
New CMS data shows nearly 1.4 million No Surprises Act arbitration disputes were initiated in the second half of 2025 alone, with providers winning about 85 percent of decided cases and 87 percent of awards exceeding insurers' benchmark rate.
Why it matters This shows the arbitration system meant to protect patients from surprise bills is increasingly a provider-favorable revenue fight behind the scenes, with disputes still growing 16 percent, so watch whether Congress or courts move to recalibrate the benchmark rate.
Funding Aug 20, 2026
CMS is distributing $90 million of its Rural Health Transformation Program allocation to 82 rural hospitals and clinics in South Dakota, though 144 organizations applied for a combined $336 million.
Why it matters This funding round shows how a $50 billion federal rural health fund is starting to reach providers, but most applicants in this state went unfunded, so watch how other states ration their own allocations this fall.
Deal Aug 19, 2026
The dental support organization behind Affordable Dentures & Implants completed an August 13, 2026 recapitalization that cut its debt by roughly 65 percent and handed ownership to lenders led by Blackstone and KKR, effectively wiping out Harvest Partners' 2021 equity stake.
Why it matters This shows private credit lenders increasingly taking ownership of healthcare roll-ups when leveraged buyouts sour, converting paper losses into real control changes. Watch whether other heavily levered PE-backed dental and physician groups follow the same path.
Rule Aug 19, 2026
CMS's CY2027 Home Health PPS proposed rule pairs a net 2.4 percent, $420 million payment increase with a temporary 3.0 percent clawback of PDGM overpayments and $82 million in annual program-integrity savings, with comments due August 31.
Why it matters This is the annual Medicare payment update for home health agencies, and it keeps clawing back billions in prior overpayments while raising base rates; watch the August 31 comment deadline and the final rule this fall.
Rule Aug 19, 2026
CMS finalized a rule barring federal Medicaid and CHIP dollars from paying for puberty blockers, hormones, or surgery for gender dysphoria in minors starting October 13, with a six-month taper for patients already on hormone therapy.
Why it matters This cuts off federal funding for a category of care in roughly 17 states that currently cover it, though states can still pay with state-only dollars; watch for expected legal challenges.
Deal Aug 19, 2026
The deal gives Curium global rights to develop and commercialize ABS-011, an investigational gallium-68 PET tracer targeting HER2, a marker found in some breast and gastric cancers, with no purchase price disclosed.
Why it matters A global radiopharmaceutical maker is expanding its oncology imaging pipeline with an investigational HER2-targeted PET tracer, part of a broader wave of radiopharmaceutical dealmaking this month. Watch for clinical trial progress on ABS-011 and further consolidation in the radiopharma space.
Rule Aug 19, 2026
DEA issued a two-year temporary order placing O-desmethyltramadol, a potent opioid metabolite of tramadol increasingly sold on its own, into Schedule I effective August 12, 2026, despite only 148 documented law enforcement encounters since 2011.
Why it matters This restricts a little-encountered but potent opioid substance for two years while DEA considers permanent scheduling; watch for harm-reduction pushback on the sparse data behind the imminent-threat designation.
Deal Aug 19, 2026
The merged organization will treat about 3 million patients annually across 12 states, with DermCare's Jeffrey Schillinger becoming executive chair and USDP's Paul Singh becoming president and CEO of the combined company.
Why it matters Two of the largest dermatology practice platforms are merging into a single group treating roughly 3 million patients a year, continuing the trend of physician-specialty consolidation. Watch whether the combined scale changes payer negotiating leverage or referral patterns in dermatology markets.
Deal Aug 19, 2026
DocGo will pay Hicuity's Series F preferred stockholder in DocGo stock plus a market-cap-linked earnout and assume approximately $52 million of Hicuity's term loans, while Perceptive Credit separately commits up to $50 million in new financing to DocGo.
Why it matters A mobile health and ambulance operator is expanding into tele-ICU and virtual nursing, another sign that ambulance and urgent-care companies are building toward integrated virtual-to-in-home care platforms. Watch whether DocGo can integrate Hicuity's hospital and health-system contracts profitably.
Rule Aug 19, 2026
The full Fifth Circuit ruled en banc that HHS, Labor, and Treasury violated the No Surprises Act by letting insurers use ghost rates and exclude bonus payments when calculating the qualifying payment amount that anchors out-of-network arbitration.
Why it matters This forces federal agencies to rewrite the pricing benchmark behind surprise medical bill arbitration, though the current formula stays in place until a replacement is issued.
Report Aug 19, 2026
HHS's Inspector General reviewed 100 denied prior-authorization requests from Health Share of Oregon and found 21 violated federal or state rules, extrapolating to roughly 5,677 improper denials in 2023.
Why it matters This shows how little routine scrutiny Medicaid managed-care denials get nationwide; watch whether other coordinated care organizations face similar audits.
Funding Aug 19, 2026
HRSA awarded $102 million in New Access Points grants to 158 community health centers to open 415 new sites, extending primary care to nearly 1 million more Americans in the program's largest expansion since 2019.
Why it matters This expands access to primary care through the federal health center program's biggest growth since 2019, reaching nearly 1 million more people; watch for the new sites standing up over the coming months.
Deal Aug 19, 2026
The private equity firm will pay $7.40 per share in cash, a roughly 34 percent premium to Weave's unaffected price, in a deal the board approved unanimously and expects to close in the fourth quarter of 2026.
Why it matters A private equity firm is paying a 34 percent premium to take a healthcare patient-engagement software vendor private, signaling continued PE appetite for healthcare-adjacent software with recurring revenue. Watch for how the ownership change affects product pricing and roadmap for practices that rely on Weave.
Deal Aug 18, 2026
The unit, which generated 645 million dollars in 2025 revenue making antimicrobial susceptibility testing and culture media products, now operates independently under chief executive Dirk Bontridder and will launch under a new brand later in 2026.
Why it matters A diagnostics maker's antimicrobial-resistance testing unit changing owners does not change how tests are run, but it is worth watching whether new ownership shifts pricing or investment in the space.
Rule Aug 18, 2026
Public comments closed August 17 on CMS's proposal to make the Medicare Drug Price Negotiation Program permanent, aggregate reformulated drugs with their originals for pricing, and end the small-biotech exception after 2028, with CMS aiming to finalize the rule this fall.
Why it matters A rule meant to stop drugmakers from dodging Medicare's drug price negotiation program through reformulation is headed toward finalization this fall.
Alert · now Aug 18, 2026
CDC has tracked more than 24,000 domestically acquired cyclosporiasis illnesses since May 1 across at least 17 states, with Michigan alone logging nearly 14,000 cases and both US deaths, after FDA traced the outbreak to recalled Taylor Farms de Mexico iceberg lettuce.
Why it matters A lettuce-linked parasite outbreak has become the largest cyclosporiasis event in US surveillance history, concentrated heavily in Michigan, with two deaths reported so far.
Earnings Aug 18, 2026
Second quarter revenue fell to 55.2 million dollars with a 7.5 million dollar GAAP net loss, while adjusted EBITDA of 14.6 million dollars topped guidance and the company raised its adjusted EPS outlook, pointing to its new Turbo AI platform as a stabilizing factor.
Why it matters A healthcare data analytics company beating its own profit guidance while revenue keeps shrinking shows the difference between cost discipline and growth; watch whether the new Turbo AI product actually reverses the revenue decline.
Rule Aug 18, 2026
U.S. District Judge Amit Mehta was assigned August 17 to a proposed class action five federal employees filed against OPM director Scott Kupor challenging a directive that excluded gender-affirming care from FEHB and PSHB plans starting January 1, 2026.
Why it matters A federal court will now decide whether excluding gender-affirming care from federal employee health plans violates civil rights law, a case that could affect tens of thousands of transgender workers and retirees.
Rule Aug 18, 2026
A final rule effective August 24 strips health care fraud jurisdiction from DOJ's Criminal Division and hands it to the new National Fraud Enforcement Division, which can also prosecute any other crime it uncovers and convene special grand juries nationwide.
Why it matters A new DOJ unit built specifically to chase health care fraud is now law, effective August 24, and it can pursue any crime it finds along the way, not just fraud.
Deal Aug 18, 2026
Under an all-stock deal, pre-merger Fulcrum shareholders will hold about 5 percent of the combined company while Slate's investors hold roughly 95 percent, with Slate simultaneously closing a 245 million dollar private placement to fund migraine drug SLTE-1009 through 2029.
Why it matters A struggling biotech merging with a private company to survive is a sign of how thin the margin is in clinical trials; watch whether Slate's migraine drug clears trials that Fulcrum's own drug failed.
Rule Aug 18, 2026
OPTN's emergency policy, effective August 17, cuts HIV testing from 28 days to 7 and West Nile virus testing from 14 days to 7 for all living kidney and liver donors, across all 17 required serology and crossmatch tests.
Why it matters Living kidney and liver donors will now be tested for HIV and West Nile virus much closer to their surgery date, closing a gap that could let an infection go undetected.
Deal Aug 18, 2026
PTC's winning bid of up to 211 million dollars beat Astellas Pharma's original 25 million dollar stalking-horse offer and TerSera Therapeutics after Sangamo filed Chapter 11 in June 2026 following the loss of its Pfizer partnership.
Why it matters A four-times bidding war for a bankrupt biotech's only drug shows how much value gene therapies for rare diseases still command even in distress; watch PTC's FDA filing timeline this quarter.
Deal Aug 18, 2026
Teledyne will pay 18.90 dollars per share in an all-cash deal valued at approximately 1.1 billion dollars for the maker of X-ray detectors used in CT scanners, with both boards approving unanimously and closing expected in early 2027.
Why it matters An 88 percent premium for a company that makes parts inside a huge share of the world's CT scanners signals real appetite for imaging-hardware consolidation; watch whether the deal clears regulatory review given Varex's market position.
Rule Aug 17, 2026
CMS rejected Arkansas's request to renew its 13 year old ARHOME Medicaid expansion waiver under a new prospective budget neutrality policy, putting coverage for roughly 200,000 low income residents at risk when the waiver expires December 31, 2026.
Why it matters This is an early test of a new federal rule that could let Medicaid officials pull back coverage in other expansion states, not just Arkansas. Watch whether Arkansas gets its requested two year bridge or loses coverage outright at year end.
Rule Aug 17, 2026
CMS and FDA jointly proposed the RAPID Coverage Pathway, under which eligible Breakthrough-designated devices could get a final national Medicare coverage determination roughly 60 to 90 days after FDA authorization instead of the multi-year gap that exists today, with comments due October 13, 2026.
Why it matters This could meaningfully shorten how long it takes new medical technology to reach Medicare patients, though its real world impact is untested since no device has gone through it yet.
Rule Aug 17, 2026
The DEA proposed reclassifying suvorexant, lemborexant, and daridorexant from Schedule IV to Schedule V after an HHS review found low abuse and dependence potential, with public comment open through September 10, 2026.
Why it matters Easier scheduling could make these newer insomnia drugs simpler to prescribe and fill, an incremental access improvement to watch through the comment period ending September 10.
Alert · now Aug 17, 2026
A federal verification committee is assessing whether ongoing transmission chains, including a Utah outbreak running since June 2025, mean the US has lost the elimination status it has held since 2000, as national case counts reach 2,465, the highest since 1991.
Why it matters Losing elimination status would be a symbolic and public health setback showing sustained domestic measles spread; watch for the WHO regional body's determination in November.
Rule Aug 17, 2026
Three Republican and three Democratic senators introduced the SUSTAIN 340B Act on August 5, 2026, which would codify contract pharmacy use, create a duplicate discount clearinghouse, require patient financial assistance policies, and give HHS new audit and removal authority over covered entities.
Why it matters This is a rare bipartisan attempt to settle the years long fight between drugmakers and hospitals over 340B contract pharmacies; watch whether it gains traction as a standalone bill or gets folded into other legislation.
Enforcement Aug 17, 2026
Maryam Qayum was sentenced to 150 months in federal prison for running a cash-only Kingwood, Texas clinic that prosecutors say issued prescriptions for more than 3 million opioid pills to street-level dealers from 2022 to 2025.
Why it matters This is another example of DOJ and DEA prioritizing pill mill prosecutions; watch for continued enforcement against cash only prescribing operations nationally.
Enforcement Aug 16, 2026
Eldar Zarbavel of Pepper Pike, Ohio pleaded guilty August 14, 2026 to money laundering for laundering about $3.4 million in proceeds from Operation Gold Rush, a $1.42 billion Medicare fraud scheme run through a Florida durable medical equipment company, and faces up to 20 years at sentencing December 16, 2026.
Why it matters This is an update in the largest health care fraud case DOJ has ever prosecuted, a reminder that federal prosecutors are actively working through a 35-person Medicare fraud network with more guilty pleas likely.
Alert · now Aug 16, 2026
HHS Secretary Robert F. Kennedy Jr. declared a public health emergency for six Washington counties on August 7, 2026, and CMS followed August 10 with Medicare and Medicaid flexibilities retroactive to August 1 that speed prescription refills, ease prior authorization and allow alternative care settings, amid wildfires that have burned more than 425,000 acres and destroyed over 800 structures.
Why it matters Washington wildfires triggered a federal public health emergency, which unlocks Medicare and Medicaid flexibilities that let displaced patients keep getting care and medications without normal red tape.
Enforcement Aug 16, 2026
The Justice Department's National Fraud Enforcement Division issued an August 13, 2026 memo naming home health, hospice, telemedicine and Medicare/Medicaid billing schemes top targets and said it will staff up to roughly 500 attorneys and support staff by August 24, 2026.
Why it matters This signals the federal government is putting more investigators and money behind healthcare fraud cases, so expect more audits, subpoenas and prosecutions touching home health, hospice and telehealth billing over the next two years.
Rule Aug 16, 2026
FDA finalized a rule moving in situ hybridization test systems used alongside approved oncology drugs from Class III premarket approval to Class II 510(k) clearance, publishing August 17, 2026 and taking effect September 16, 2026, while also proposing related device-classification changes with comments due October 16, 2026.
Why it matters This makes it cheaper and faster for diagnostic makers to bring cancer companion tests to market, which could speed availability of tests that determine which patients qualify for targeted cancer drugs.
Report Aug 16, 2026
HHS released a report August 13, 2026 finding more than 225 hospitals and health systems filed close to $120 million in claims for pediatric gender-transition care using diagnosis codes, including a generic endocrine-disorder code that did not reference gender dysphoria, and referred providers to the Justice Department and its own Inspector General.
Why it matters A federal report accuses hundreds of hospitals of miscoding pediatric gender-care claims and has now been referred for potential investigation, though a referral is not a finding of guilt and the named hospitals have not yet responded in detail.
Deal Aug 15, 2026
American Healthcare REIT agreed to acquire eight Kensington Senior Living communities totaling 745 units across California, Maryland, New York and Virginia for approximately 873 million dollars, including about 56.46 million dollars in assumed debt.
Why it matters This is one of the largest senior living deals of the year so far, a sign of how much investor money is flowing back into senior housing real estate.
Enforcement Aug 15, 2026
Renat Abramov, a former Brooklyn bank branch manager, was sentenced to 18 months in prison for laundering more than 8 million dollars for a Russia based criminal organization that used shell durable medical equipment companies to bill Medicare and private insurers.
Why it matters A bank employee helped a Russia based crime ring launder more than 8 million dollars in stolen Medicare money, showing how fraud proceeds move through ordinary financial institutions.
Deal Aug 15, 2026
Cardinal Health signed two definitive agreements to acquire AdaptHealth Corp's Diabetes Health mail order business for 235 million dollars and Strive Medical, a urology and wound care supply company, for an implied 125 million dollars, together about 360 million dollars in cash.
Why it matters This shows a major drug distributor betting that shipping diabetes and urology supplies straight to patients' homes is a growing business worth paying for.
Report Aug 15, 2026
KFF's analysis of newly mandatory CMS disclosures found 2025 standard-request denial rates averaging 12 percent in Medicare Advantage, 14 percent in Medicaid managed care and 18 percent in ACA marketplace plans, with 67 percent of appealed Medicare Advantage denials overturned.
Why it matters This is the first time you can see how often insurers deny care requests and how often those denials are wrong on appeal, since most denied patients never actually file that appeal.
Report Aug 15, 2026
The International Foundation of Employee Benefit Plans found employers expect a median 10 percent increase in health plan costs next year, with GLP-1 weight loss and diabetes drugs cited by 67 percent as the top specialty drug cost driver.
Why it matters This is the clearest early signal of how much your health premiums or plan costs could rise next year, and weight loss drugs are now the single biggest reason costs are climbing.
Rule Aug 15, 2026
The en banc Fifth Circuit held HHS unlawfully let insurers pad the qualifying payment amount with rates for services never delivered while excluding real bonus pay, vacating those provisions and ordering a new methodology.
Why it matters A federal appeals court just said the benchmark used to settle millions of surprise medical bills was rigged in insurers' favor, which could raise what insurers pay doctors and hospitals for out of network care.
Rule Aug 15, 2026
CMS's proposed rule implementing the 2025 reconciliation law would cap state directed Medicaid managed care payments to hospitals at 100 to 110 percent of Medicare rates, with KFF estimating California, Illinois and Kentucky face the largest losses.
Why it matters A proposed federal rule could cut 60 billion dollars in Medicaid payments that states currently direct to hospitals, with California facing the single largest loss at 7.4 billion dollars.
Enforcement Aug 15, 2026
A Franklin County grand jury indicted six Ohio Medicaid providers, including behavioral health and home care operators, accused of billing a combined 558,383 dollars for services never delivered, marking the state's fourth fraud indictment round since early summer.
Why it matters Ohio charged six more Medicaid providers with stealing over half a million dollars combined by billing for behavioral health and home care services that were never actually provided.
Deadline Aug 15, 2026
Texas regulators confirmed that Baylor Scott & White Health Plan and sister insurer FirstCare will stop accepting Texas Medicaid, STAR and CHIP claims after August 31, 2026, with contracts ending September 1 and 321 jobs cut as the companies also exit ACA marketplace plans.
Why it matters If you or someone you know is on Texas Medicaid, STAR, CHIP or an ACA marketplace plan through Baylor Scott & White or FirstCare, you will need to find new coverage before September 1, 2026.
Report Aug 13, 2026
The American College of Nurse-Midwives' Midwifery Workforce Study finds the U.S. is short 8,200 certified nurse-midwives against the World Health Organization's minimum staffing benchmark, with 56 percent of counties having none.
Why it matters Staffing, not bed capacity, is now the binding constraint on keeping a labor and delivery unit open, and this is the number that quantifies it.
Rule Aug 13, 2026
CMS's proposed CY2027 Medicare Physician Fee Schedule rule would let payers run legacy bundled global maternity codes alongside 15 new unbundled G-codes, with public comments on CMS-1848-P closing September 14, 2026.
Why it matters The rule decides whether OB billing splits into two competing systems in 2027; watch whether CMS finalizes one code set or lets the dual system stand once comments close September 14.
Enforcement Aug 13, 2026
The U.S. Attorney's Office for the District of Colorado announced August 10, 2026 that the federal government intervened in a False Claims Act whistleblower suit alleging Front Range Urgent Care, Comfort Care Family Practice, QwikCareMD and two individuals billed Medicare and Tricare for nearly a decade under one physician's provider number for services he didn't provide or supervise.
Why it matters This is an allegation, not a finding of liability, but government intervention signals prosecutors found the whistleblower's claims credible enough to take over the case.
Report Aug 13, 2026
As of March 2026, 26 states and Washington, D.C. reimburse doula services through Medicaid, but a peer-reviewed study found fewer than 1 percent of Virginia's Medicaid-covered pregnant patients used a covered doula visit from 2022 through 2024.
Why it matters Coverage on paper is not the same as access; provider enrollment and patient awareness, not the coverage decision itself, determine whether a doula benefit does anything.
Alert · now Aug 13, 2026
FDA and CDC are investigating a multistate Salmonella Javiana outbreak traced to Mexican-grown jalapenos distributed by Coast Citrus Distributors, with 345 confirmed cases, 36 hospitalizations and no deaths as of the latest update, and most patients reporting eating at Chipotle or QDOBA beforehand.
Why it matters If you've eaten at Chipotle or QDOBA recently and have gastrointestinal symptoms, this outbreak is worth knowing about; watch for updated case counts and any expansion of the recall.
Enforcement Aug 13, 2026
Herbert Kimble, who fled to the Philippines to dodge sentencing on a $1.2 billion telemedicine and DME fraud scheme, pleaded guilty August 11, 2026 and stipulated to 15 to 20 years in prison plus $208 million in restitution.
Why it matters This closes out one of the largest telehealth and DME fraud cases in recent years and shows federal agencies actively hunting fugitives who flee overseas. Watch whether Kimble actually pays any of the $208 million.
Record Aug 13, 2026
MaineHealth's board voted August 6, 2026 to close Labor and Delivery at Lincoln Hospital's Miles campus in Damariscotta effective December 18, 2026, Maine's 12th maternity unit closure in about a decade.
Why it matters A hospital board closed a unit despite rising birth volume, showing that overall hospital margin, not unit demand, drives closure decisions; watch whether other high-volume-but-losing units follow.
Report Aug 13, 2026
March of Dimes reported on August 11, 2026 that at least 96 U.S. labor and delivery units have closed since January 2024, pushing roughly one in three U.S. counties into maternity care desert status.
Why it matters This is the national pattern behind the Maine closure above; the number to watch is your own county's labor and delivery access as more units close.
Enforcement Aug 13, 2026
Dr. Sanjeev Kumar was sentenced July 8, 2026 to 240 months in federal prison after reusing adulterated single-use surgical devices on more than 15,000 Medicare and Medicaid patients and billing more than 41 million dollars.
Why it matters A single high-volume operator generated criminal exposure on both fraud and patient-safety grounds at once, a reminder that device-reuse schemes reach gynecologic procedure volume, not just general surgery or endoscopy.
Report Aug 13, 2026
Pennsylvania's Department of Human Services said it expects roughly 310,000 residents, including 26,000 in Allegheny County, to lose Medicaid coverage as the state shifts to six-month renewals and adds federal work-documentation requirements, and it is spending $7.8 million on IT to process the change.
Why it matters If you or someone you know is on Pennsylvania Medicaid, expect more frequent renewal paperwork starting late August 2026; watch for a notice and respond promptly since many losses are expected to hit people who remain eligible but miss paperwork.
Enforcement Aug 13, 2026
Aditya Humad, former CFO of Massachusetts spinal implant maker SpineFrontier, was sentenced August 6, 2026 to four months in prison and a $9,500 fine for conspiring to pay surgeons more than $540,000 in sham consulting fees to use the company's implants.
Why it matters This is a reminder that device-company consulting arrangements with prescribing physicians remain a top federal enforcement target, and executives, not just companies, are going to prison over them.
Earnings Aug 12, 2026
American Healthcare REIT reported Q2 2026 revenue of $674.3 million and net operating income of $137.2 million, and raised its full-year FFO and same-store NOI growth guidance on the strength of $1.4 billion in completed 2026 acquisitions.
Why it matters Signals continued institutional capital flowing into senior housing on demographic demand; watch whether the more than $800 million pipeline closes as planned by year end.
Rule Aug 12, 2026
The rule bars federal Medicaid dollars for puberty blockers, hormone therapy and surgeries for children under 18 and CHIP funding for the same care for people under 19, projecting $235 million in savings over ten years.
Why it matters This cuts off federal Medicaid and CHIP payment for gender-transition care in kids, a shift that will change what's available to families who rely on public coverage. Watch whether states backfill the funding with their own dollars.
Rule Aug 12, 2026
HB 26-1195 bars AI systems from independently delivering therapy or generating treatment plans without licensed review, exposing violators to civil penalties up to $20,000 per violation.
Why it matters Colorado now fines AI chatbots that pose as therapists, joining four other states that have moved to restrict this technology this year. Watch whether more states follow with their own laws.
Earnings Aug 12, 2026
CVS Health will offer $29 virtual weight-loss visits and transparent Eli Lilly app pricing for Zepbound and Foundayo across roughly 9,000 pharmacies starting early Q4 2026, alongside a Q2 earnings beat that still sent shares down about 9 percent on 2027 concerns.
Why it matters A major retail pharmacy is pushing GLP-1 access and price transparency; watch adoption once app-based Eli Lilly pricing goes live in the fourth quarter.
Alert · now Aug 12, 2026
Hackers accessed DentaQuest's network in May and stole Social Security numbers, Medicaid and Medicare ID numbers, and treatment records, with an independent researcher estimating the true toll could exceed 23 million.
Why it matters A dental benefits administrator with Medicaid contracts in multiple states is notifying 15 million people their personal and health data was stolen, the largest health breach reported to regulators this year. If you or your dependents have dental coverage through a state Medicaid program, watch for a notification letter.
Deal Aug 12, 2026
Park Dental Partners agreed to acquire the 12-location, 48-doctor Village Family Dental Services Organization in Fayetteville, North Carolina, expanding Park beyond its existing three-state, 87-location footprint on undisclosed terms.
Why it matters Another data point in the ongoing private-equity-backed dental roll-up wave; watch how many more states Park adds this year.
Deal Aug 12, 2026
Sentynl Therapeutics, a Zydus Lifesciences subsidiary, gained an option for U.S. commercial and global manufacturing rights to Mereo's pre-Phase 3 lung disease drug alvelestat in a deal worth up to roughly $475 million plus royalties.
Why it matters A large sum is being paid for a rare-disease drug that has not finished Phase 3 trials yet; watch whether the global Phase 3 study starting as early as 2027 succeeds.
Rule Aug 12, 2026
The executive order directs CDC and ACIP to drop flu, COVID-19, rotavirus, meningococcal, hepatitis A and hepatitis B from the recommended childhood schedule, and insurers have pledged free coverage of those shots only through the end of 2026.
Why it matters Six vaccines are dropping off the government's recommended list for kids, and because free coverage is tied to that list, insurers' pledge to keep covering them at no cost only runs through the end of this year. Watch what happens to coverage in 2027.
Enforcement Aug 12, 2026
Minnesota regulators confirmed UCare will lay off 102 additional remote employees between October 2 and November 2026 as its state Medicaid contracts formally end October 1, with nearly 300,000 members moving to Medica.
Why it matters A 40-year-old nonprofit insurer's collapse is displacing workers and nearly 300,000 Medicaid members; watch whether outstanding hospital bills get paid before 2027 as officials warned they might not.
Enforcement Aug 12, 2026
The Justice Department says Veloxis bribed doctors and pharmacies with resort trips, meals and disguised fees from 2016 through 2023 to boost prescriptions of its kidney transplant drug Envarsus XR.
Why it matters A drugmaker admitted bribing doctors and pharmacies for years to push a transplant drug, a reminder that kickback enforcement remains active even for niche specialty drugs. Watch whether other immunosuppressant makers face similar scrutiny.
Deal Aug 11, 2026
Anthem Blue Cross Blue Shield of Georgia and Northside Radiology Associates, a Georgia affiliate of Radiology Partners, announced a multi-year in-network agreement August 3, 2026, with financial terms undisclosed.
Why it matters A large insurer and a large private-equity-backed radiology group chose to stay in-network rather than fight over rates, a small sign of stability in a market otherwise defined by insurer-radiology billing disputes.
Deal Aug 11, 2026
BWX Technologies agreed to sell its BWXT Medical and Kinectrics stable isotopes units to private equity firm Nordic Capital for up to 800 million dollars while retaining a minority stake and continuing to supply isotope expertise.
Why it matters Private equity is now buying into the fragile supply chain that keeps nuclear medicine scans and new radioactive cancer therapies stocked with isotopes, a niche most people never think about until a shortage delays a scan or treatment. Watch whether Nordic Capital's investment expands isotope production capacity or just extracts returns.
Alert · now Aug 11, 2026
Six U.S. and South Korean agencies jointly warned that the Gunra ransomware group is breaking into healthcare networks through exposed VPNs, firewalls and remote desktop systems to steal and encrypt data for extortion.
Why it matters This is a direct warning that hospitals are an active target for a specific ransomware gang right now, so if you or a family member rely on a local hospital system, it's worth knowing their IT team should be patching this week.
Rule Aug 11, 2026
CMS's procedural notice for the RAPID coverage pathway, which commits the agency to issuing a proposed national coverage determination the same day an FDA-designated breakthrough device wins market authorization, published in the Federal Register today and opened public comment.
Why it matters This is the formal starting gun on a policy that could get breakthrough medical devices covered by Medicare in months instead of a year or more, worth watching if you or a family member might need a new device technology.
Rule Aug 11, 2026
CMS's proposed CY2027 rule cuts the physician conversion factor about 1.68 percent while individual radiology codes move far more, with CT angiography of the chest proposed up 149 percent and CT of the upper extremity down 15 percent, and comments close September 14, 2026.
Why it matters The headline "Medicare cut doctor pay again" hides big winners and losers underneath; if you get imaging done, access to certain scans may shift as practices adjust to code-level reimbursement changes.
Rule · now Aug 11, 2026
The FDA proposed a rule that would end the voluntary Generally Recognized as Safe self-affirmation system and require food and animal-food makers to notify the agency of the safety basis for new ingredients, opening a 120-day comment period.
Why it matters If finalized, this would end the decades-old practice of food companies quietly deciding on their own that a new ingredient is safe, giving FDA visibility it currently lacks into what's actually in the food supply.
Approval Aug 11, 2026
GE HealthCare announced August 3, 2026 that its Invenia ABUS Prime scanner and ABUS StreamVue viewer received FDA clearance and CE marking, with the company citing up to 40 percent faster scans and up to 93 percent sensitivity for dense-breast lesion detection when paired with AI-assisted reading.
Why it matters If you have dense breast tissue, this adds another supplemental-screening option your imaging center may offer alongside or instead of contrast-enhanced mammography or MRI.
Deal Aug 11, 2026
Health Catalyst completed the sale of its Vitalware revenue cycle software unit to Med-Metrix for 147 million dollars in cash and used the proceeds to fully repay roughly 160 million dollars in outstanding debt.
Why it matters A healthcare data analytics company sold off a software unit to pay down debt and refocus on artificial intelligence and analytics, a sign of continued portfolio trimming across health tech as companies prioritize balance sheet health over diversification. Watch whether Med-Metrix integrates Vitalware smoothly into its revenue cycle management offerings.
Deadline Aug 11, 2026
Indiana's Family and Social Services Administration launched text alerts, an online exemption screener and town halls this week to help Healthy Indiana Plan members determine before January 1, 2027 whether they are exempt from new 80-hour monthly work requirements.
Why it matters If you're on Indiana's Medicaid expansion plan, this is your heads-up to check the new online screener now so you're not caught off guard when the 80-hour work requirement starts in 2027.
Deal Aug 11, 2026
Jazz Pharmaceuticals agreed to pay 820 million dollars upfront plus up to 500 million dollars in milestones for Actio Biosciences and its experimental KCNT1 epilepsy drug ABS-1230, which has FDA Fast Track and Orphan Drug status but no approved competitor.
Why it matters A large drugmaker is betting hundreds of millions on a rare seizure disorder that affects only about 2,500 Americans and currently has no approved treatment. Watch whether ABS-1230 clears FDA trials, since approval would create the first therapy for KCNT1-related epilepsy.
Deal Aug 11, 2026
KKR agreed to acquire medical device contract manufacturer Integer Holdings for 127 dollars per share in an all-cash deal, its largest healthcare transaction since the 9.9 billion dollar Envision Healthcare buyout in 2018.
Why it matters One of the largest private equity firms is taking a major device-component maker private, a sign private equity remains willing to write big checks for the medical device supply chain. Watch whether KKR pursues further consolidation or cost cuts across cardiovascular and surgical device manufacturing.
Enforcement Aug 11, 2026
A federal jury trial began today in Los Angeles for hospice operator Oren Shachar and marketer Abraham Shin, accused of billing Medicare $27.7 million by enrolling deceased people as hospice patients using identities bought from a mortuary worker.
Why it matters This trial shows how far Medicare fraud schemes can go, using dead people's identities to fake hospice enrollments, and it's a reminder that program integrity enforcement is active and public.
Enforcement Aug 11, 2026
Class members affected by the January 2025 ransomware attack on Mt. Baker Imaging and Northwest Radiologists have until August 19, 2026 to file a claim in the $3.3 million settlement, with final court approval scheduled August 21, 2026.
Why it matters If you were a patient at these two Washington imaging practices, this is your deadline to file for compensation; more broadly it's a real-dollar benchmark for what a mid-size imaging data breach costs.
Report Aug 11, 2026
The Harvey L. Neiman Health Policy Institute reported August 4, 2026 that median time from outpatient imaging study to final interpretation rose 27 percent between 2023 and 2024, with ultrasound turnaround worsening the most at 49.1 percent, based on 2.9 million Medicare claims.
Why it matters If your imaging report is taking longer to come back, this data confirms it's a real, measurable trend, not just anecdote, and ultrasound and X-ray are degrading fastest right now.
Earnings Aug 11, 2026
RadNet's Q2 2026 SEC filing showed revenue up 25 percent to $622.7 million and a new $250 million credit facility earmarked for imaging center and AI acquisitions.
Why it matters Bigger picture: the largest imaging chain in the country now has more cash and cheaper debt to buy up competitors, a sign of consolidation ahead in local imaging markets. Watch whether more independent groups get bought in your area.
Deal Aug 11, 2026
Supernus Pharmaceuticals and Indivior agreed to combine in an all-stock merger of equals that will trade as Supernus, Inc. on Nasdaq, with Indivior shareholders owning 56.5 percent and receiving a 1 billion dollar special dividend before close.
Why it matters Two mid-size drugmakers are combining to build a bigger central nervous system portfolio anchored by an opioid addiction treatment nearing 1 billion dollars in annual sales. Watch whether the combined company uses its larger scale to expand access to opioid use disorder treatment or simply consolidates costs.
Rule Aug 11, 2026
HHS declared a public health emergency for six Washington counties hit by wildfires and CMS followed with Section 1135 waivers relaxing Medicare, Medicaid and CHIP enrollment, documentation and telehealth rules retroactive to August 1, 2026.
Why it matters If you live in or near Spokane, Stevens, Okanogan, Ferry, Chelan or Yakima counties, this waiver means local hospitals and providers have more flexibility to keep treating patients without normal paperwork getting in the way during the wildfires.
Record Aug 10, 2026
The South Carolina nonprofit system's tenth public update on August 5 gave no restoration date or cost estimate after malware knocked out email, phones, and MyChart starting July 26.
Why it matters Two weeks after a malware attack, a 106-facility hospital system still cannot say when it will be fully restored or what the outage has cost, a real-time look at how long ransomware recovery actually takes. Watch for the eventual cost disclosure.
Deal Aug 10, 2026
The claims-repricing platform bought the dialysis cost-management program, which says it has saved health plans 325 million dollars since 2006, in an undisclosed-terms deal announced August 6, 2026.
Why it matters A dialysis cost-management program with a 325 million dollar savings track record for health plans just found a buyer backed by private equity, a sign consolidation continues in the claims cost-management space. Terms were not disclosed.
Rule Aug 10, 2026
CMS released a procedural notice on August 7, 2026 for its RAPID pathway, committing to issue a proposed national coverage determination the same day an eligible breakthrough device receives FDA market authorization, with the notice publishing in the Federal Register on August 11 and opening a 60-day comment period.
Why it matters This could cut the time between FDA approval and Medicare coverage for breakthrough devices from a year or more down to about two months, a significant change for patient access to new technology.
Enforcement Aug 10, 2026
The Department of Justice announced August 3, 2026 that Complete Health Partners Holdings will pay $14.1 million to settle allegations it pressured coders to submit invalid mental health and substance abuse diagnoses between 2020 and 2023 to inflate Medicare Advantage risk scores.
Why it matters This is another case showing federal prosecutors are actively pursuing Medicare Advantage upcoding, so watch for similar False Claims Act suits against other MA-focused providers.
Rule Aug 10, 2026
The FDA published a proposed rule on August 10, 2026 to move digital breast tomosynthesis systems from Class III to Class II, with public comment open through October 9, 2026.
Why it matters If finalized, this could make new 3D mammography technology reach the market faster and cheaper, similar to what happened with 2D digital mammography systems in the 2010s.
Earnings Aug 10, 2026
The musculoskeletal digital health company reported 213 million dollars in Q2 revenue, turned GAAP operating income positive, raised full year guidance, and confirmed its 105 million dollar Cylinder Health acquisition remains on track to close in Q3.
Why it matters A digital health company's swing to positive operating income and raised guidance shows demand for musculoskeletal virtual care is scaling profitably, not just growing revenue. Watch whether the Cylinder Health deal closes on schedule in Q3.
Enforcement Aug 10, 2026
Texas Attorney General Ken Paxton finalized a settlement in early August 2026 requiring Texas Children's Hospital to pay $10 million, permanently revoke five physicians' privileges, and open the nation's first hospital-run detransition clinic by late October.
Why it matters This settlement shows a state Medicaid billing law can force major operational changes at a hospital years after the underlying law passed, so watch how other states with similar bans pursue their own enforcement.
Record Aug 10, 2026
Board pushed out CEO Mike Dandorph and CFO Andrew DeVoe even after the four-hospital system cut its operating loss from 214 million dollars to 51.6 million dollars in fiscal year 2026, with COO Phil Okala elevated to CEO effective end of September.
Why it matters A hospital system's board pushed out its top two executives even as losses shrank sharply, showing boards now want a faster path to breakeven, not just a smaller loss. Watch who leads the next phase of the turnaround.
Report Aug 10, 2026
The White House Task Force to Eliminate Fraud launched a public dashboard on August 6, 2026 crediting HHS programs with $96 billion of the $230 billion in fraud, waste and improper payments identified across federal programs since January 2025.
Why it matters This is a political claim more than an audited number, so watch whether independent auditors like GAO ever confirm the figures rather than taking the tally at face value.
Earnings Aug 9, 2026
agilon health reported second quarter 2026 net income of 18 million dollars, reversing a 104 million dollar loss a year earlier, even as total platform membership fell to 549,000 from 614,000.
Why it matters A company that helps independent doctors take on financial risk for Medicare patients turned profitable by shedding unprofitable membership rather than growing it, a shift worth watching if your doctor participates in one of its risk contracts.
Earnings Aug 9, 2026
AMN Healthcare reported second quarter 2026 adjusted EBITDA of 73.4 million dollars, up 26 percent, as travel nursing volume grew for a second straight quarter.
Why it matters The largest US healthcare staffing firm says hospital reliance on travel nurses is stabilizing after a two year slide, a signal the post-pandemic staffing crunch is easing.
Record Aug 9, 2026
Registered nurses at Sierra Nevada Memorial Hospital in Grass Valley picketed August 6 against CommonSpirit's plan to cut five Family Birth Center and two cancer infusion positions as the nonprofit system posted a 578 million dollar quarterly operating loss.
Why it matters A major nonprofit hospital system is cutting maternity and cancer infusion staff while posting steep quarterly losses, a pattern worth watching if you or a family member relies on one of its hospitals for these services.
Approval Aug 9, 2026
The FDA granted accelerated approval to Replimune's Tudriqev in combination with nivolumab for advanced melanoma after progression on anti-PD-1 therapy, following two prior rejections, based on a 24.2 percent response rate in a 91-patient trial.
Why it matters This is the first cancer therapy of its kind, a genetically modified virus that attacks tumors directly, cleared for use, and it gives melanoma patients who've run out of standard options a new tool. Watch confirmatory trial data since this is an accelerated approval.
Deal Aug 9, 2026
HealthSnap secured a 25 million dollar senior secured growth financing facility led by Eastward Capital Partners, with health system investors Sentara Health, Tampa General Hospital and UnityPoint Health participating.
Why it matters A vendor running AI-powered remote monitoring programs for chronically ill patients inside 200 health systems, including AdventHealth and Ascension, raised new financing to expand, a sign hospitals are investing further in remote chronic care monitoring.
Enforcement Aug 9, 2026
Federal reviewers found 28 of 351 examined donation cases where the patient may not yet have been deceased when Network for Hope began preparing them for organ donation, making it only the second OPO decertification in program history.
Why it matters This is only the second time the federal government has ever pulled an organ procurement group's certification, and it centers on whether patients were treated as deceased before they actually were. Watch whether Network for Hope's appeal succeeds and whether other OPOs face similar scrutiny.
Rule Aug 9, 2026
Six senators introduced the SUSTAIN 340B Act on August 5, 2026, which would kill HRSA's rebate-based 340B overhaul within one year of enactment and replace it with an independent data clearinghouse, threatening the pilot's August 24 manufacturer opt-in deadline.
Why it matters This bill would unwind a major change to how the 340B drug discount program works before it fully takes effect, adding uncertainty for safety-net hospitals and drug manufacturers already gearing up for an August 24 opt-in deadline. Watch whether the bill gains momentum before that deadline arrives.
Enforcement Aug 9, 2026
A federal jury in Massachusetts awarded Larry and Tammy Patterson $88 million after finding Medtronic's Covidien unit failed to warn that its Symbotex hernia mesh coating could dissolve faster than expected, in the first of more than 2,400 pending cases to reach trial.
Why it matters This is the largest compensatory verdict in 15 years of hernia mesh litigation and the first of thousands of pending cases to go to trial, so it will shape how the remaining 2,400-plus cases are valued and whether Medtronic settles going forward. Watch Medtronic's post-trial motions and appeal.
Rule · now Aug 9, 2026
The Senate voted 90 to 6 to pass H.R. 6500, a continuing resolution funding federal agencies including WIC through December 11 and delaying a hemp-derived THC product ban, sending it to the House for reconciliation with its own stopgap bill.
Why it matters This averts a government shutdown before the midterms and keeps WIC and other programs funded through December 11, but it still needs House agreement on a bill that differs from what the House already passed. Watch whether the House accepts the Senate version or a standoff develops closer to the new deadline.
Report Aug 8, 2026
VMG Health's survey of 97 ASC leaders found 44 percent expect to pay an anesthesia stipend in 2026, up from 28 percent two years earlier, with 67 percent now ranking anesthesia coverage among their top three financial challenges.
Why it matters Anesthesia has shifted from a negotiable line item to a fixed cost most ASCs now budget for. Watch your own anesthesia contract renewal for stipend demands if you haven't seen one yet.
Enforcement Aug 8, 2026
The Department of Justice's Fraud Section declined to prosecute Campus Eye Management after the company self-disclosed a kickback and unnecessary-testing scheme, marking the first declination for a health care company under the March 2026 Corporate Enforcement and Voluntary Self-Disclosure Policy.
Why it matters This is the first real-world test of DOJ's new corporate leniency policy in health care, showing that self-disclosure and cooperation can spare a company prosecution even as its founder faces criminal charges. Watch whether other companies start self-reporting sooner.
Enforcement Aug 8, 2026
EyePoint Pharmaceuticals agreed to pay the United States $4,657,463.18 to resolve False Claims Act allegations it ran an 'Assurance Program' reimbursing ASCs when insurers paid less than cost for its cataract-surgery drug DEXYCU, and entered a five-year Corporate Integrity Agreement with HHS OIG.
Why it matters This is a reminder that drugmakers offering financial cushions to providers to stock a product carries kickback risk on both sides of the transaction. Watch for more ASC-directed pharma settlements as DOJ works through this cluster of ophthalmology cases.
Deadline Aug 8, 2026
CMS's temporary use of the hospital market-basket index to set ASCs' annual Medicare payment update expires after 2026, and companion bills to make it permanent, H.R.8091 and S.4963, remain stuck in committee.
Why it matters If Congress does nothing, ASCs get a smaller inflation-based raise starting in 2027, a real-dollar cut from what they'd get under the current formula. Watch whether H.R.8091/S.4963 move before the trial lapses.
Deal Aug 8, 2026
Surgery Partners signed binding agreements to sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for roughly $795 million, sharpening its focus on its ASC portfolio a year after its board rejected Bain Capital's take-private offer.
Why it matters Surgery Partners is signaling it wants to grow as a standalone, ASC-focused public company rather than sell out, a year after turning down a $3.2 billion take-private bid. Watch the Hart-Scott-Rodino review and physician/board approvals for close timing.
Rule Aug 8, 2026
CMS's FY2027 Hospital IPPS final rule adds three new severity-based DRGs for spinal fusion and refines episode attribution under the mandatory TEAM bundled-payment model, while leaving open, via an earlier RFI, whether to bring ASCs directly into TEAM's financial accountability.
Why it matters About 740 hospitals move to downside financial risk under TEAM starting January 1, 2027, which sharpens their incentive to push joint and spine cases into ASCs, procedures ASCs today capture without sharing that risk. Watch whether CMS acts on ASC inclusion in a future rule.
Deal Aug 7, 2026
Addus HomeCare said its May 2026 acquisition of HomeCourt Home Care, its entry into Indiana, has slightly outperformed expectations and a second Indiana acquisition is already lined up.
Why it matters A consolidator's first deal in a new state beating projections is a signal other operators watch when deciding whether to expand into that market.
Enforcement Aug 7, 2026
California's attorney general settled with Carbon Health Technologies for a 4.4 million dollar corporate penalty plus a first of its kind 100,000 dollar personal penalty against co-founder Eren Bali, following a similar settlement with Aspen Dental, both under a law effective January 1, 2026.
Why it matters California is actively enforcing a new law against management companies that control physician and dentist clinical decisions, including the state's first ever personal fine against a company executive.
Rule Aug 7, 2026
The DEA's July 6 Federal Register notice said it would not issue its order temporarily placing concentrated 7-hydroxymitragynine into Schedule I before August 5, and that date has now passed, meaning a nationwide ban on products above 0.05 percent concentration could take effect any day.
Why it matters A concentrated kratom compound sold in some gas-station and vape-shop products could become a federal Schedule I substance any day now, while ordinary kratom leaf stays legal.
Earnings Aug 7, 2026
Doximity reported fiscal first quarter 2027 revenue of 156.6 million dollars and raised full year guidance to 671 to 681 million dollars, driven largely by new AI Search advertising contracts that recognized zero revenue this quarter.
Why it matters A digital health company's stock jumped sharply on earnings, but the guidance raise leans on a new AI advertising product that has not yet booked revenue, so watch whether it delivers.
Rule Aug 7, 2026
The FCC adopted an order August 6 letting Rural Health Care Program participants reuse a prior approved rural rate for funding year 2027 instead of redoing a cost-justification, and opened a Third Further Notice of Proposed Rulemaking seeking comment on cutting administrative burden for roughly 14,000 rural providers.
Why it matters A federal subsidy fund that keeps rural clinics connected to broadband just got a little easier to use, and more paperwork cuts could follow.
Rule Aug 7, 2026
CMS published the FY2027 Hospice Wage Index final rule raising payments 2.3 percent and locking in the Service and Spending Variation Index fraud score for nearly every hospice.
Why it matters CMS just gave itself a systematic way to flag hospices for fraud risk, using the same rule that sets next year's payment rates. Watch how fast these scores turn into audits.
Earnings Aug 7, 2026
GoodRx's core prescription transaction revenue fell 26 percent to 106.4 million dollars while its manufacturer funded Pharma Direct channel grew 76 percent to 61.6 million dollars, prompting a full year guidance raise to 790 to 805 million dollars.
Why it matters A consumer drug discount app's original business is shrinking while a pharma funded channel takes over as its growth engine.
Record Aug 7, 2026
A Supreme Court ruling has cleared the way for Haiti's Temporary Protected Status to expire, putting an estimated 21,000 Haitian nursing assistants and caregivers who work in home health, home care, and PACE at risk of losing work authorization while a House-passed extension bill awaits Senate action.
Why it matters Thousands of caregivers could lose work authorization just as agencies are already reporting staffing gaps, a workforce risk driven by immigration law rather than payment policy.
Deadline Aug 7, 2026
Starting October 1, 2026, hospices must give patients a written addendum within five days of election spelling out uncovered services, while telehealth face-to-face recertification is extended through December 31, 2027.
Why it matters Every hospice patient gets new paperwork explaining exactly what will not be covered, while operators keep a telehealth option they had been bracing to lose.
Enforcement Aug 7, 2026
The Department of Justice's Northeast Health Care Fraud Strike Force expansion into Philadelphia signals that the enrollment-moratorium-era hospice and home care fraud enforcement model built in California, Nevada, Arizona, and Texas is exporting itself to new markets.
Why it matters The enforcement model that has targeted hospice and home care fraud in a handful of Sun Belt states just showed up in the Northeast, meaning operators everywhere should expect a standing task force, not just periodic sweeps.
Deal Aug 7, 2026
iRhythm Technologies agreed to pay 237.5 million dollars in cash plus 50 million dollars in stock for VitalConnect, a maker of cardiac and vital sign monitoring patches running at roughly 65 million dollars in annual revenue.
Why it matters Two makers of wearable heart and vital sign monitors are consolidating into one company.
Record Aug 7, 2026
Lane Regional Medical Center in Zachary, Louisiana eliminated 18 positions and is closing its Allergy, Asthma and Immunology Clinic, citing low patient volume, rising operating costs and lagging reimbursement rates.
Why it matters A small independent community hospital is cutting staff and closing a specialty clinic rather than continuing to subsidize it.
Rule Aug 7, 2026
Minnesota's Medical Assistance Protection Act took effect August 1, creating a Severity Level 8 felony tier with a presumptive 48-month prison sentence for Medicaid theft over $1 million, and Attorney General Keith Ellison says it funded growing the state's Medicaid Fraud Control Unit from 32 to 50 staff.
Why it matters Minnesota just made large-scale Medicaid theft carry real, tiered prison time instead of treating all fraud above $35,000 the same, and added investigators to pursue it.
Report Aug 7, 2026
HHS OIG sampled 100 Medicare sacroiliac joint injection sessions and found 72 violated program rules, extrapolating to an estimated $15.2 million improperly paid across 134,526 sessions nationwide, while CMS rejected the recommendation to fix the underlying billing error.
Why it matters This shows a specific pain-procedure billing pattern that federal auditors flagged but the agency in charge chose not to fully fix, so the error will likely keep recurring.
Rule Aug 7, 2026
Led by Oklahoma's Gentner Drummond, 17 state attorneys general sent an August 4 letter to House and Senate committees backing the STOP FRAUD in Medicaid Act, which would expand state Medicaid Fraud Control Units' authority to investigate recipients as well as providers, citing $4.64 recovered per dollar spent and nearly $2 billion recovered in 2025.
Why it matters State fraud investigators want new legal authority to go after Medicaid recipients directly, not just doctors and hospitals, though neither congressional committee has scheduled a markup yet.
Enforcement Aug 7, 2026
The Department of Justice charged 19 defendants on August 4, 2026 in a roughly $4 million Medicaid and Medicare home care fraud scheme and expanded its Northeast Health Care Fraud Strike Force into Philadelphia.
Why it matters A large fraud case just landed in a city that had not previously had a standing federal fraud task force, a sign enforcement is spreading to new markets.
Report Aug 7, 2026
CMS data show non-hospice Medicare spending on hospice patients reached $2.8 billion in FY2024, with for-profit hospices running about 167 percent higher per-day spending than nonprofits, up from roughly 60 percent in FY2022.
Why it matters This is the exact data gap CMS used to build its new hospice fraud score, so it is now a benchmark every hospice, not just the ones under investigation, will be measured against.
Record Aug 7, 2026
The U.S. Preventive Services Task Force has not convened since March 2025 or issued a new recommendation since August 2025, and HHS pushed its July 2026 meeting to late August to onboard new members, freezing any new no-cost preventive coverage mandates in the meantime.
Why it matters The panel whose ratings decide which preventive screenings and shots insurers must cover for free hasn't met in over a year, so no new services can get that no-cost guarantee until it resumes.
Deal Aug 7, 2026
UMass Memorial Health, an existing clinical partner, co-led the first close of a 10 million dollar Series B for Wellinks, whose FDA cleared COPD remote monitoring program is tied to more than 60 percent lower odds of 30 day readmission.
Why it matters A hospital system is putting its own money behind a remote monitoring vendor it already uses clinically, betting on reduced COPD readmissions.
Report Aug 6, 2026
CMS's new toolkit shows national Medicaid and CHIP ABA spending rose 400 percent from 2021 to 2025 while diagnosed children receiving services grew only 67 percent, with median per-child spending climbing from $8,903 to $21,203 and treatment plans above 16 hours a week now flagged for review.
Why it matters Two numbers to know: Medicaid's autism therapy spending grew 400 percent in four years while the population receiving it grew just 67 percent, a gap regulators are now built to spot.
Enforcement Aug 6, 2026
A federal judge approved the $16,205,774.05 civil judgment against ARC and affiliates Pioneer Health Group and Science Hill Family Care after a whistleblower suit alleged therapy sessions were billed under higher-licensed clinicians than the staff who actually performed them and individual therapy codes were used for group sessions.
Why it matters A whistleblower suit over who actually delivered therapy sessions just cost Kentucky's largest addiction treatment network $16.2 million; watch for similar credential-mismatch claims elsewhere.
Deal Aug 6, 2026
The private equity firm is selling the 30-plus facility, eight-state mental health and sober-living network to nonprofit QCF/I through a non-rated municipal bond issuance underwritten by KeyBanc, delivering about $415 million upfront plus up to $100 million in earnout tied to 2026 EBITDA targets.
Why it matters A private equity firm just found a new way to cash out of a behavioral health platform, tax-exempt municipal bonds instead of a sale to another buyer, and advisors say a dozen similar deals worth $3 billion are in the pipeline.
Earnings Aug 6, 2026
Clover Health reported 743.2 million dollars in second-quarter revenue, 28.0 million dollars in net income versus a 10.6 million dollar loss a year earlier, and raised full-year guidance across revenue, profit and membership.
Why it matters Clover Health's swing to profitability, with membership up 48 percent, is a sign that at least one AI-driven Medicare Advantage insurer is finding a working formula after years of losses.
Report Aug 6, 2026
The toolkit responds to national Medicaid and CHIP ABA spending rising from about $2 billion in 2021 to $10 billion in 2025 while the number of children served grew just 67 percent, and recommends prior authorization thresholds, breaks before extended billing, and flags 40-hour weekly treatment plans as not best practice.
Why it matters CMS wants states to tighten oversight of a Medicaid autism therapy benefit whose cost grew far faster than the number of children it serves; watch which states adopt prior authorization and hour caps first.
Rule Aug 6, 2026
The proposed CY2027 OPPS rule would pay 340B-acquired drugs at average sales price minus 33.4 percent starting January 1, 2027, require new JG, TB, and XX billing modifiers, and remove 637 more procedures from the inpatient-only list, with comments closing August 31, 2026.
Why it matters This CMS rule would cut Medicare payments for hospital-administered outpatient drugs by 4.55 billion dollars next year, with most of the change tied to how the program prices drugs bought through the 340B discount program.
Rule Aug 6, 2026
The FY 2027 IPPS/LTCH final rule raises hospital payments by a net 2.3 percent while embedding the CJR-X model, which puts most acute care hospitals on the hook for the full cost of hip, knee and ankle replacement episodes starting January 1, 2028.
Why it matters This raises what Medicare pays hospitals next year and quietly makes joint replacement surgery a test case for mandatory bundled payment nationwide, a model CMS could extend to other procedures. Watch whether CJR-X becomes the template for future mandatory bundles.
Rule Aug 6, 2026
CMS's final IPF PPS rule lifts the federal per diem base rate from $892.87 to $912.40 and caps outlier payments at 20 percent of total IPF payments, while Colorado cut most Medicaid provider rates 2 percent effective July 1, 2026 and moved its Comprehensive Safety Net Providers to a bundled nine-service payment model.
Why it matters Medicare is paying psychiatric hospitals a bit more next year while Colorado is paying its Medicaid behavioral health clinics a bit less right now; watch how the two systems' funding trajectories diverge.
Deadline Aug 6, 2026
While the January 2025 rule permanently allowing telehealth buprenorphine prescribing for opioid use disorder stands, DEA's broader Schedule II through V telemedicine prescribing extension, last renewed December 31, 2025, runs out at year-end 2026 with no permanent rule yet published.
Why it matters The rule letting doctors prescribe buprenorphine for opioid addiction by video visit is now permanent, but the broader rule covering other controlled substances by telehealth expires again at the end of 2026 unless DEA acts.
Approval Aug 6, 2026
The FDA approved Takeda's Orzeyful (oveporexton) on August 5, 2026 as an oral orexin receptor 2 agonist that restores signaling lost in narcolepsy type 1, though the DEA's controlled substance scheduling decision, expected within 90 days, must come before patients can access it through specialty pharmacy.
Why it matters The FDA approved the first drug that treats narcolepsy type 1 at its underlying cause rather than symptom by symptom, but patients still cannot get it until the DEA decides how tightly to control it, a decision expected within 90 days.
Record Aug 6, 2026
Gateway Regional Medical Center in Granite City, Illinois missed payroll again in early August 2026, the fourth such disruption since January, until founder Mike Sarian personally loaned the hospital 1 million dollars to pay hundreds of employees.
Why it matters A hospital's own founder having to personally loan it a million dollars just to make payroll, for the fourth time since January, is a stark sign of financial distress at a single facility that's worth watching for whether it stabilizes or heads toward closure or sale.
Deal Aug 6, 2026
HCA Healthcare closed its acquisition of the 40-location Texas MedClinic chain and split it among three regional HCA affiliates, rebranding all locations under its CareNow urgent care division, which now runs more than 430 clinics nationwide.
Why it matters HCA Healthcare absorbing 40 Texas urgent care clinics into its own hospital network is part of a broader pattern of hospital systems buying urgent care chains to capture patients and referrals before they reach a competitor's emergency room.
Rule Aug 6, 2026
HRSA's second attempt at a 340B rebate model, after a 2025 version was withdrawn following a hospital lawsuit, requires manufacturers of drugs in Medicare's price negotiation program to file rebate plans by August 24 for approvals expected by September 24 and an effective date of January 1, 2027.
Why it matters Drugmakers now have a firm deadline to decide whether to shift how the 340B discount reaches safety net hospitals, from an upfront price cut to an after-the-sale rebate, reviving a fight hospitals already won once in court.
Enforcement Aug 6, 2026
Federal prosecutors allege Stephen Dubin, M.D. billed Medicare more than $95 million for unnecessary amniotic wound allografts on elderly and hospice patients while taking kickbacks through inflated distributor invoices, with Medicare having paid out more than $54 million before the scheme was stopped.
Why it matters A single Nevada doctor's alleged $95 million wound care fraud scheme, targeting elderly and hospice patients, shows how expensive skin substitute billing schemes have become a top enforcement target. Watch for more indictments in this product category.
Deal Aug 6, 2026
Santiam Hospital and Clinics withdrew its Health Care Market Oversight review and obtained an emergency exemption on July 31, 2026 citing imminent insolvency, leaving only the Oregon Department of Justice's public comment period, open through August 7, as a checkpoint before its affiliation with Salem Health closes.
Why it matters A financially failing rural Oregon hospital's takeover is closing without the state's usual competition review, after regulators found it too close to insolvency to wait, leaving the state attorney general as the only remaining checkpoint before a public comment deadline of August 7.
Earnings Aug 6, 2026
Oscar Health reported 4.88 billion dollars in second-quarter revenue and 361.8 million dollars in net income, but its first-half operating income already exceeds its raised full-year guidance of 500 million to 700 million dollars, implying an operating loss of roughly 393 million to 593 million dollars in the second half.
Why it matters Oscar Health's earnings beat masks a warning sign worth watching: the company's own numbers imply a swing back to a loss in the second half of the year, so the headline growth story is not the full picture.
Earnings Aug 6, 2026
Privia Health, which helps independent physician practices adopt value-based care, reported 632.6 million dollars in second-quarter revenue, 9.0 million dollars in net income up 236.7 percent, and raised full-year guidance to the high end of its prior range.
Why it matters Privia Health's strong quarter shows independent physician practices continuing to move into value-based care arrangements at a steady pace, with revenue up 21 percent and profit more than tripling.
Record Aug 6, 2026
The August 4, 2026 hearing pitted Paragon Health Institute and Foundation for Government Accountability witnesses arguing Medicaid spending is unsustainable and fraud-prone against Georgetown's Andy Schneider defending home and community based services growth, with no bill or markup resulting.
Why it matters Dueling Senate testimony previewed the next fight over Medicaid, the program covering roughly 72 million Americans, with no bill or markup resulting yet.
Record Aug 5, 2026
AON announced July 23, 2026 that it now operates nine active radioligand therapy centers nationwide, up from one in 2023, with five more in development and two new physician leaders.
Why it matters Shows community oncology building out capacity for targeted radiation cancer treatment fast enough to match a consolidating manufacturing supply chain.
Report Aug 5, 2026
CareCloud disclosed that hackers accessed one of its Amazon Web Services environments between March 10 and March 16, 2026, exposing Social Security numbers and, for some patients, full credit card numbers, with at least 270,197 of those affected located in Texas.
Why it matters A cloud EHR vendor spent six days compromised before catching it, exposing Social Security numbers and, for some patients, full credit card data. Watch how many more state attorney general filings raise the disclosed total.
Rule Aug 5, 2026
CMS issued a State Medicaid and CHIP Applied Behavior Analysis Toolkit directing states to tighten billing oversight after ABA therapy spending grew 421 percent from 2021 to 2025.
Why it matters CMS is pushing states to tighten oversight of a fast-growing Medicaid benefit category; watch which states adopt the toolkit's recommendations.
Deal Aug 5, 2026
Curium agreed August 3, 2026 to buy Lantheus Holdings for 102.50 dollars per share cash plus a contingent value right worth up to 12.00 dollars per share, up to 114.50 dollars per share total, in the largest radiopharmaceutical deal ever.
Why it matters Signals that the isotope and imaging-agent supply layer behind targeted cancer treatment is consolidating into fewer large companies, even as clinical use of radiopharmaceuticals grows quickly.
Earnings Aug 5, 2026
CVS Health posted 106.1 billion dollars in second quarter revenue and raised full year 2026 guidance, yet its stock fell more than 6 percent after executives warned of 2027 headwinds from the 340B drug discount program and expected Caremark membership losses.
Why it matters CVS Health's Aetna insurance costs are stabilizing, but Wall Street is more worried about 2027 drug discount and pharmacy benefit headwinds than pleased with this quarter's beat. Watch whether that caution proves right.
Rule Aug 5, 2026
CMS's CY2027 Medicare Physician Fee Schedule proposed rule, released July 14, 2026, would require 340B covered entities to report quarterly Part D claims data starting January 1, 2027 and would raise the G2211 complexity bonus for oncologists in MSSP Advanced or LEAD-track ACOs to 32 percent versus 16 percent for others, with comments closing September 14, 2026.
Why it matters A single Medicare rule combines a new federal 340B reporting requirement with a real financial incentive pushing oncologists toward ACO participation; comments close September 14, 2026.
Enforcement Aug 5, 2026
Federal and state prosecutors charged 19 defendants with billing Pennsylvania Medicaid $5.76 million for home care fraud, including an aide who billed while incarcerated, as DOJ unveiled a new embedded anti-fraud unit.
Why it matters DOJ permanently embedding fraud investigators inside a U.S. Attorney's office signals sustained scrutiny on home health billing; watch whether similar offices open in other cities.
Earnings Aug 5, 2026
Eli Lilly raised its full year 2026 revenue guidance to 85 to 87 billion dollars after Mounjaro sales climbed 91 percent to 9.9 billion dollars and Zepbound sales rose 46 percent to 4.9 billion dollars in the quarter.
Why it matters Eli Lilly's weight loss and diabetes drugs are driving explosive growth, and the company just raised its full year guidance for the second time this year. Watch how long that growth rate holds as competition from Novo Nordisk intensifies.
Alert · now Aug 5, 2026
Medline and Arrow International corrected surgical and spinal-anesthesia convenience kits on August 3, 2026 after a Class I recall of Huons bupivacaine tied to infection and meningitis risk.
Why it matters A supply-chain quality problem is prompting removal of specific anesthetic vials from surgical kits; watch for the FDA's evolving list of affected lot numbers.
Approval Aug 5, 2026
The FDA approved zidesamtinib (Jideytro) July 22, 2026 for previously treated ROS1-positive non-small cell lung cancer, one week after GSK closed its acquisition of Nuvalent, the drug's originator.
Why it matters A new oral option arrives for a genetic subtype of lung cancer, just one week after GSK finished buying the small biotech that invented it.
Record Aug 5, 2026
Henry Ford Health System priced 1.317 billion dollars and Intermountain Health priced 1.118 billion dollars in municipal bonds on August 3, 2026, both moving early to beat a crowded municipal supply calendar and falling Treasury yields.
Why it matters Two major nonprofit hospital systems moved fast to lock in lower borrowing costs this week, a signal of how sensitive health system finances are to interest rate swings and bond market timing.
Report Aug 5, 2026
Missouri lawmakers are debating the value of the state's three private Medicaid managed-care insurers, whose 8.17 percent administrative overhead exceeds the 1 to 3 percent Missouri spends managing complex populations directly, as a 2029 deadline to cut the state's error rate below 3 percent looms.
Why it matters A looming $1 billion federal penalty is fueling a state debate over whether to keep paying private insurers to run Medicaid; watch for legislative action ahead of the 2029 deadline.
Rule Aug 5, 2026
A final rule that took general effect August 3, 2026 cut the per-party fee to file a No Surprises Act billing dispute and revised batching and eligibility rules for the federal arbitration system.
Why it matters Arbitration got cheaper and faster to use; watch whether dispute volume, already over 5.1 million since 2022, rises further now that filing costs less.
Earnings Aug 5, 2026
Novo Nordisk raised its full year 2026 sales outlook after second quarter results, but its oral Wegovy pill sales came in slightly below analyst estimates and its ziltivekimab heart drug trial failed to meet its primary endpoint the same week.
Why it matters Novo Nordisk raised its outlook and still got punished by investors, a sign the market is now judging GLP-1 makers on execution details like pill uptake and pipeline results, not just headline growth.
Approval Aug 4, 2026
Biocon launched Yesafili, an FDA interchangeable biosimilar to Regeneron's Eylea 2 mg, in the United States on August 3, 2026, targeting a US aflibercept market Biocon estimates at roughly $5.89 billion.
Why it matters An interchangeable biosimilar lets pharmacists substitute it for the brand drug without a new prescription, which could speed price competition in a nearly $6 billion eye drug market.
Rule Aug 4, 2026
The CY2027 Medicare Physician Fee Schedule proposed rule projects roughly 1 percent higher overall cardiovascular payment while continuing a 2.5 percent efficiency adjustment and reducing tricuspid valve, coronary IVUS, and left atrial appendage closure values.
Why it matters The 2027 cardiology pay picture is a modest headline gain over a broad efficiency cut, so your exposure depends entirely on service mix. Watch the final rule this fall.
Rule Aug 4, 2026
The CY2027 MPFS proposes a 50 percent reduction to an evaluation and management visit billed the same day as a 0, 10, or 90 day global procedure by the same practice, and replaces 17 remote physiologic and therapeutic monitoring codes with four new G codes.
Why it matters A proposed cut to same-day office visits would touch nearly every cardiology practice that pairs a visit with a device check or echo. Watch whether it survives to the final rule.
Report Aug 4, 2026
MedAxiom's most recent compensation survey put private-equity ownership of cardiology groups at about 50 percent, with integrated median cardiologist compensation crossing 700,000 dollars versus 588,479 dollars in private practice, the widest gap in years.
Why it matters Consolidation has reshaped cardiology ownership, and the buyers have not slowed. For an independent group the question is which of four bids to weigh, not whether to align.
Rule Aug 4, 2026
CMS finalized a 2.3 percent net inpatient payment rate increase worth about $2.1 billion and expanded the Comprehensive Care for Joint Replacement model into a mandatory nationwide bundle called CJR-X starting January 1, 2028.
Why it matters This is the first time Medicare has made a bundled payment model mandatory for every eligible hospital nationwide rather than a voluntary subset, changing how hip, knee and ankle replacements get paid starting in 2028.
Enforcement Aug 4, 2026
Complete Health Partners Holdings, a Jacksonville physician management company, agreed to pay $14.1 million to resolve False Claims Act allegations that it pressured coders and physicians to add unsupported mental health and substance use diagnoses from 2020 to 2023 to inflate Medicare Advantage risk-adjustment scores.
Why it matters A physician management company that directed coders to add unsupported behavioral health diagnoses is paying $14.1 million under the False Claims Act. Federal prosecutors are targeting management-level coding pressure, not just individual coders, which widens the enforcement footprint for anyone overseeing risk-adjustment programs.
Deadline Aug 4, 2026
The CY2027 Hospital Outpatient and Ambulatory Surgical Center proposed rule again defers cardiovascular inpatient-only list removals to 2028 while removing about half of the remaining inpatient-only services in other specialties; public comments are due August 31, 2026.
Why it matters Cardiac procedures keep inpatient-only protection one more year, but the site-of-service migration is scheduled to reach more cardiac codes in 2028. Comments are due August 31.
Record Aug 4, 2026
Dignity Health confirmed 57 permanent layoffs at Bakersfield Memorial Hospital and a notice of 82 proposed layoffs at California Hospital Medical Center in Los Angeles, including that facility's entire pediatric nursing staff.
Why it matters A major nonprofit hospital system is cutting frontline clinical staff, including an entire pediatric nursing unit, even as its parent company markets itself as mid-turnaround, a sign of financial pressure worth watching across the nonprofit hospital sector.
Rule Aug 4, 2026
The FCC will vote at its August 6 open meeting on a Third Further Notice of Proposed Rulemaking to reduce paperwork for roughly 14,000 rural health providers and extend a companion waiver letting clinics reuse previously approved rural broadband rates for funding year 2027 instead of redoing annual cost justifications.
Why it matters The FCC is voting Thursday on proposed rules to cut paperwork and extend a rate-justification waiver for the federal program that subsidizes broadband and phone service for roughly 14,000 rural health clinics. If the proposed rule is finalized after comment, rural providers would face less administrative burden to maintain their connectivity subsidies.
Report Aug 4, 2026
A cross-sectional study in JAMA Network Open of 32 cardiology services across four major insurers found the facility fee for an implantable cardioverter-defibrillator ranged from 6,674 dollars at one insurer to 36,269 dollars at another, a greater than five-fold spread for the same procedure.
Why it matters A more than five-fold spread in facility fees for the same defibrillator implant is the evidence base behind site-neutral payment pressure. Track the facility-fee share of your highest-volume implant.
Deal Aug 4, 2026
KKR agreed to acquire Integer Holdings, the world's largest pure-play medical device contract manufacturer, for $127 per share in cash, a 52 percent premium, with the deal expected to close by year end 2026.
Why it matters A major private equity buyout of a device supply chain company signals PE appetite for medtech manufacturing; watch how new ownership affects device pricing and supply reliability.
Enforcement Aug 4, 2026
Michigan Attorney General Dana Nessel sued Pioneer Health Care Management and nine southeast Michigan nursing homes alleging the operator collected more than $111 million in Medicaid reimbursement over a two-year investigation period while failing to meet acuity-based staffing requirements roughly 96 percent of the time, and seeks full repayment plus treble damages.
Why it matters Michigan's attorney general is suing a nursing home operator for allegedly collecting $111 million in Medicaid payments across nine facilities while missing required staffing levels 96 percent of the time. The state wants the money back, tripled, plus civil penalties up to $10,000 per violation.
Earnings Aug 4, 2026
Pfizer reported second quarter 2026 revenue of $15.03 billion, ahead of the $14.45 billion consensus estimate, and raised full year revenue guidance by $500 million at the midpoint.
Why it matters Pfizer's beat and second guidance raise this year signals its non-COVID product portfolio is offsetting the decline in Comirnaty and Paxlovid sales, a trend worth watching for the broader pharma sector.
Record Aug 4, 2026
The Senate Finance Subcommittee on Health Care heard testimony on August 4, 2026 from officials including the CARB-X director on whether the United States can sustain domestic biomanufacturing capacity and funding for the antimicrobial-resistance drug pipeline, with no bill yet introduced.
Why it matters The Senate Finance Subcommittee on Health Care is hearing testimony today on domestic biomanufacturing and antibiotic pipeline funding. No bill has been introduced, so this is early-stage congressional signaling rather than imminent policy change, but the witnesses include the officials who control early-stage antibiotic funding.
Rule Aug 4, 2026
The proposed national coverage determination for transcatheter aortic valve replacement would keep procedural volume expectations for established programs, ease requirements for new centers, end coverage with evidence development for symptomatic severe aortic stenosis, and extend it to asymptomatic severe disease, with a final decision expected around September 13, 2026.
Why it matters The proposed rewrite protects incumbent heart-valve programs while making it easier for new ones to open. A final decision is expected in mid September.
Enforcement Aug 4, 2026
Two New York eye practices settled False Claims Act allegations that they billed Medicare and Medicaid for medically unnecessary trans-cranial doppler ultrasounds through a kickback arrangement with a third-party testing company, with cooperation deals pointing at more defendants in a multistate sweep that began with five Florida practices in January 2026.
Why it matters A federal kickback sweep over unnecessary brain-blood-flow scans billed through ophthalmology practices has expanded from five Florida practices to two New York practices, with cooperation deals in place that signal more defendants are coming.
Deadline Aug 4, 2026
Two insurers covering roughly 3.5 percent of Texas Medicaid managed-care enrollment are ending participation August 31, triggering automatic member reassignment and requiring all home-care providers to obtain new EVV authorizations under new payer codes before September 1 or face denied claims.
Why it matters Two health insurers are dropping out of Texas Medicaid managed care August 31, forcing automatic plan reassignment for enrolled members and a same-day billing system cutover that home-care providers must complete before September 1 or face denied claims.
Enforcement Aug 4, 2026
The Department of Justice resolved allegations that a vascular physician and practice performed medically unnecessary dialysis-access and peripheral artery disease interventions, including angioplasty, stenting, and atherectomy, and repeated them every few days or weeks without clinical benefit.
Why it matters Peripheral vascular remains the specialty's top enforcement magnet. The theory is repeat interventions without documented clinical benefit.
Report Aug 3, 2026
CMS's July 9 settlement results credit ACO REACH with $988.3 million in net savings for 2024, while the agency's own third independent evaluation found Medicare's net spending under the model still rose, 0.2 percent in 2024, and CMS has not published which ACOs were accepted into the LEAD Model's 2027 start.
Why it matters CMS's own numbers on its flagship accountable care model contradict each other right as ACOs decide whether to sign a ten-year commitment to its successor; watch for whether CMS ever reconciles the two methodologies.
Earnings Aug 3, 2026
The Medicare Advantage insurer reported adjusted EPS of $0.17 versus a $0.13 consensus, membership of 294,100 up 31 percent year over year, and raised its 2026 membership forecast, yet its stock still fell in after-hours trading.
Why it matters A Medicare Advantage insurer beat every number it promised Wall Street and grew membership fast, yet investors sold the stock anyway, a sign the market is watching profit timing and spending plans, not just top-line growth. Watch whether the company's 2027 growth-over-profit stance changes.
Enforcement Aug 3, 2026
The settlement requires Carbon Health to restructure its management services organization so licensed physicians, not the MSO, control the medical group, and holds co-founder Eren Bali personally liable.
Why it matters California just made an example of a common private-equity-style MSO structure, fining a primary care platform $4.5 million and forcing it to hand clinical control back to its doctors.
Rule Aug 3, 2026
The rule raises Inpatient Rehabilitation Facility Prospective Payment System rates by a net 2.3 percent for fiscal year 2027, effective October 1, 2026, and holds the outlier payment threshold at 3 percent of total payments.
Why it matters Medicare is paying inpatient rehab hospitals more starting in October, a modest rate bump that keeps pace with cost growth but doesn't reshape the sector.
Enforcement Aug 3, 2026
The Medicaid Fraud War Room, launched April 23, 2026, used billing-pattern analytics to identify 50 high-risk providers linked to more than $203 million in Medicaid payments in its first 88 days, per a CMS press release issued July 28, 2026.
Why it matters CMS is using data analytics instead of traditional audits to catch Medicaid fraud faster, and 50 providers have already been flagged in under three months.
Rule Aug 3, 2026
CMS's new risk-based survey process, announced via memo QSO-26-14-NH, gives nursing homes with 5-star ratings, adequate staffing scores, and no recent harm citations a streamlined inspection using fewer surveyors in roughly half the time, starting September 2026.
Why it matters About 12 percent of nursing homes will get faster, lighter federal inspections starting in September, a change patient advocates say could let problems go undetected between visits.
Deal Aug 3, 2026
Curium agreed to pay Lantheus shareholders up to $114.50 a share, $102.50 in cash plus up to $12 in contingent value rights tied to sales milestones through 2030, in a deal expected to close in the first half of 2027.
Why it matters Two of the world's largest makers of radioactive imaging and treatment drugs are combining, a bet that pairing diagnosis and treatment in one company, called theranostics, is the future of nuclear medicine. Watch whether the combined company changes access or pricing for scans used in prostate cancer and heart disease.
Report Aug 3, 2026
Hint Health's 2026 report found DPC membership growth of 837 percent from 2017 to 2025 and projects the market growing from $70.2 billion in 2025 to $75.1 billion in 2026.
Why it matters Direct primary care has quietly shifted from a niche cash-pay option to something employers now buy at scale, funding 60 percent of memberships for the first time.
Earnings Aug 3, 2026
The nation's largest medical-office-building landlord reported total revenue fell to $281.8 million on completed asset sales, posted a wider than expected GAAP loss, but raised its full-year 2026 same-store cash NOI growth guidance to 4.25-5 percent.
Why it matters The country's largest owner of medical office buildings, the outpatient clinics and imaging centers next to hospitals, is shrinking its portfolio through asset sales while the space it keeps is generating more income and staying more occupied. Watch whether this signals durable demand for outpatient care sites even as the REIT trims its footprint.
Enforcement Aug 3, 2026
CMS deferred $867.5 million of California's and $199 million of Minnesota's Medicaid spending on July 21, 2026, pending review of claims tied to high-risk providers, bringing cumulative deferrals to $2.76 billion since February.
Why it matters The federal government is withholding billions in Medicaid funding from two states pending fraud reviews, a dispute over whether delay-first enforcement is fair to states and providers.
Enforcement Aug 3, 2026
HHS's Office for Civil Rights found OSF Healthcare System failed to conduct an accurate risk analysis and did not notify 53,907 affected individuals on time after a 2021 Nephilim ransomware attack, making it OCR's 21st settlement from its ransomware enforcement initiative.
Why it matters A hospital system is paying over half a million dollars because it was slow to report a ransomware breach that exposed nearly 54,000 people's health data.
Rule Aug 3, 2026
ACOs choosing LEAD's Global Risk Option can convert all attributed beneficiaries' Medicare Parts A and B spending into a monthly capitated payment and take on 100 percent of savings or losses for a ten year term, twice MSSP's five year agreement period.
Why it matters Medicare is replacing an annual savings check with monthly capitated payments for accountable care organizations, a structural shift that locks participants in for twice as long as the current model.
Report Aug 3, 2026
Federal auditors found Georgia's Medicaid program overpaid clinical diagnostic laboratories $26.1 million on 648,412 of 13.6 million lab services from 2019 through 2023 and recommended the state refund the $18.5 million federal share.
Why it matters Federal auditors caught a state Medicaid program overpaying lab companies for years, and now want $18.5 million back.
Deal Aug 3, 2026
The $110 million round, $50 million in equity led by Andreessen Horowitz plus a $60 million debt facility led by Trinity Capital, will fund expansion of Pearl Health's AI risk-modeling platform into Medicare Advantage.
Why it matters A software platform that helps ACOs manage Medicare risk just raised the largest venture round in that niche since December, a sign investors still see opportunity even as the REACH-to-LEAD transition adds uncertainty to the payment model itself.
Deal Aug 3, 2026
Indivior shareholders will hold about 56.5 percent of the combined company, named Supernus, Inc., and receive a $1.0 billion cash dividend before closing, in an all-stock deal expected to close in the fourth quarter of 2026.
Why it matters Two central-nervous-system drugmakers, one known for ADHD and epilepsy medicines and the other for opioid-addiction treatment, are combining into an 11-medicine company. Watch whether the combined company changes access, marketing, or pricing for these drugs.
Rule Aug 2, 2026
California, Colorado and 20 other states, joined by Pennsylvania's governor, filed suit July 31, 2026 in federal court in California to block CMS's 2027 Notice of Benefit and Payment Parameters rule, citing HHS's own estimate of 5 million lost marketplace enrollees by 2030.
Why it matters A rule expanding cheaper, skimpier catastrophic plans is now in court, and the government's own numbers say millions could lose standard marketplace coverage if it survives. Watch whether the court blocks the rule before its provisions take effect.
Rule Aug 2, 2026
CMS's CMS-1851-F raises FY2027 hospice payments a net 2.3 percent for an estimated $755 million increase and makes the hospice election-statement addendum, disclosing care Medicare won't cover, mandatory for every patient starting October 1, 2026.
Why it matters Hospices get more money next year, but starting in October every hospice patient's family must get a written list of care Medicare won't pay for, a transparency requirement that used to be available only on request. Watch how hospices handle patient and family reactions to that disclosure.
Rule Aug 2, 2026
CMS's CMS-1849-F raises FY2027 inpatient hospital rates 2.3 percent for an estimated $2.1 billion increase and finalizes CJR-X, a mandatory bundled-payment model for hip, knee and ankle replacements starting January 1, 2028 at nearly every acute-care hospital.
Why it matters Medicare is paying hospitals more next year, but nearly every acute-care hospital will also be required to take on financial risk for hip and knee replacement outcomes starting in 2028. Watch how your hospital's readmission and complication rates translate into bundled-payment risk.
Enforcement Aug 2, 2026
CMS's published audit schedule opens Risk Adjustment Data Validation audits of Medicare Advantage insurers' 2024 payment records this month, ahead of Payment Year 2023 in November 2026 and the still-unaudited Payment Year 2022 in January 2027.
Why it matters Federal auditors are checking whether Medicare Advantage insurers got paid the right amount in 2024, and they're doing it before finishing an older, unaudited 2022 backlog. Watch for expanded audit findings as this rolls out under CMS's 2025 audit-acceleration push.
Deal Aug 2, 2026
Guardian Dentistry Partners announced July 15, 2026 a definitive agreement for a strategic majority acquisition of Select Dental Management, a dental support organization operating 38 locations across eight states and Washington, D.C., with closing targeted before the end of Q3 2026.
Why it matters Dental care consolidation keeps accelerating as private-equity-backed dental support organizations buy up regional networks. Watch whether financial terms surface and whether the deal closes on schedule in Q3.
Deal Aug 2, 2026
Private equity firm Knox Lane closed its all-cash acquisition of travel-nurse staffing company Cross Country Healthcare on July 21, 2026 at $13.25 a share, and carved out the company's locum tenens division to sister portfolio company All Star Healthcare Solutions.
Why it matters One private equity firm now controls two of the largest platforms in healthcare staffing, a sign of accelerating consolidation in the labor-cost side of healthcare. Watch for further roll-ups combining travel nursing, allied health and locum tenens platforms.
Enforcement Aug 2, 2026
HHS's Office of Inspector General updated its Heightened Scrutiny list July 29, 2026, naming 13 companies, including Aetna Inc. and CVS Pharmacy Inc., that settled federal fraud investigations but declined to sign a Corporate Integrity Agreement.
Why it matters Two of the biggest names in health insurance and pharmacy are now flagged on a public federal list for refusing the compliance-monitoring deal regulators normally require after a fraud settlement. Watch whether OIG escalates scrutiny of these companies further.
Report Aug 2, 2026
HHS's Office of Inspector General audited 100 claims from Hospice of the Valley, West covering July 2020 to June 2022, found 15 errors worth $69,184, and extrapolated at least $8.6 million in Medicare overpayments, which the hospice disputes.
Why it matters A federal audit sampled just 100 claims, found errors in 15 of them, and extrapolated that into an $8.6 million overpayment estimate, a reminder of how much weight small samples carry in Medicare audits. Watch whether OIG or CMS pursues collection given the hospice's refusal to concur.
Earnings Aug 2, 2026
Regeneron reported second quarter 2026 revenue of $4.291 billion, up 17 percent year over year, and non-GAAP EPS of $14.29 that beat consensus by more than $4, as Dupixent's global sales rose 38 percent to a record $6.0 billion.
Why it matters Regeneron's blowout quarter shows demand for its immunology and eye drugs keeps climbing, a sign biotech innovation is still commanding premium pricing. Watch whether Dupixent's growth holds as competitors enter the eczema and asthma space.
Record Aug 2, 2026
Wellstar notified employees July 28, 2026 that it is eliminating 761 positions, about 2 percent of its more than 35,000-person workforce, concentrated in corporate, shared-services and select administrative roles while leaving frontline clinical staff untouched.
Why it matters A major nonprofit hospital system trimming corporate staff signals financial pressure even at large, established health systems. Watch whether other Georgia or regional systems follow with similar restructuring.
Report Aug 1, 2026
Congress appropriated $345 million for AHRQ this fiscal year but the agency has spent under $15 million, halted at least 104 grants, and cut staff from about 300 to 74 amid a lawsuit by the Society for General Internal Medicine.
Why it matters This is about whether the federal government keeps funding the research that identifies unsafe hospital practices before more patients get hurt. Watch whether the lawsuit forces AHRQ to resume grant-making.
Deal Aug 1, 2026
The Belgian immunology drugmaker will pay 77 dollars a share in cash, an 86 percent premium, to gain full control of Forte's anti-CD122 antibody FB102 after it posted positive Phase 1b vitiligo data on July 9.
Why it matters A single positive early-stage trial readout turned a strategic minority stake into a full 2.2 billion dollar buyout, illustrating how fast biotech valuations move on clinical data. Watch FB102's progress toward pivotal trials in vitiligo and celiac disease.
Earnings Aug 1, 2026
The company reported 13.0 billion dollars in second-quarter 2026 revenue, up 6 percent and more than a billion dollars ahead of consensus, and raised full-year revenue guidance to 49.0 to 50.0 billion dollars.
Why it matters One of the largest US drugmakers is outgrowing patent losses on older products, a sign the broader branded-pharma sector's newer drug launches are gaining traction. Watch whether the Growth Portfolio keeps outpacing legacy drug declines.
Enforcement Aug 1, 2026
CVS Health's Omnicare unit faces an August 12 bankruptcy court hearing on its July 1 settlement resolving a decade old False Claims Act case in which a jury found more than 3.3 million false claims for prescriptions dispensed without valid orders.
Why it matters This is the closing chapter of a decade old fraud case that tests how the government prices and prosecutes dispensing without a valid prescription claims in long term care pharmacy. Watch the August 12 hearing for final court approval.
Rule Aug 1, 2026
The public comment period on excluding semaglutide, tirzepatide, and liraglutide from the section 503B Bulks List closed July 30, 2026 at 11:59pm ET, with no timeline yet announced for a final rule.
Why it matters The public's last chance to weigh in on permanently banning bulk compounded GLP-1s has passed. Watch for FDA's final rule, which has no announced timeline.
Enforcement Aug 1, 2026
The FTC's July 14, 2026 order bars Caremark from disadvantaging low list price insulin, requires a rebate pass through option, and projects up to 8.5 billion dollars in patient savings over 10 years, leaving Optum Rx as the only Big Three PBM without a final order.
Why it matters This closes one of the biggest PBM antitrust cases in years and signals that low cost insulin access terms are becoming standard practice at major pharmacy benefit managers. Watch whether Optum Rx follows with a final order.
Rule Aug 1, 2026
HRSA's revised 340B Rebate Model Pilot Program grew from about 10 drugs and eight manufacturers to as many as 25 products from 13 companies, days after a federal appeals court ruled Novartis, Johnson and Johnson Health Care Systems, Bristol Myers Squibb and Eli Lilly cannot run their own rebate models without HHS approval.
Why it matters This is about who fronts the cash for a drug discount meant for safety-net providers, the government's own program or drugmakers acting unilaterally; watch whether more manufacturers join HRSA's voluntary pilot.
Report Aug 1, 2026
NCPA's member survey found 96.5 percent of independent pharmacists say Medicare Part D reimbursement threatens their business's viability and 30.3 percent are considering closing within the year, as the industry loses roughly one independent pharmacy a day.
Why it matters Nearly every independent pharmacist says their business is at risk under current Part D reimbursement, and the industry is losing roughly one pharmacy a day. Watch whether this accelerates network consolidation in your area.
Deal Aug 1, 2026
The companies will expand KwikPen injectable-device capacity at Resilience's Cincinnati-region facilities, adding at least 400 jobs, while Resilience relocates its headquarters from San Diego to Blue Ash, Ohio.
Why it matters More US-based manufacturing capacity for GLP-1 injector pens could help ease the supply shortages that have dogged Lilly's diabetes and obesity drugs. Watch whether the early 2027 timeline holds amid continued high demand.
Rule Aug 1, 2026
CMS's interim final rule requiring most Medicaid expansion enrollees to document 80 hours a month of work, school or volunteering took legal effect July 31, 2026, two days after a federal judge denied a preliminary injunction sought by Massachusetts and 25 other states in Commonwealth of Massachusetts et al. v. Oz et al.
Why it matters This changes whether millions of Medicaid expansion enrollees keep coverage based on documenting work or school hours; watch the notification deadline and whether the underlying lawsuit over the medically-frail exemption succeeds.
Enforcement Aug 1, 2026
A report this week found Centers Health Care, a 37-facility New York nursing home chain that paid $45 million in 2024 to settle Medicaid fraud and neglect claims, still in violation of that settlement, including a March 2026 inspection that found residents at risk of hypothermia, as the state's monitoring period closes July 31, 2026.
Why it matters This is about whether a nursing home chain that already admitted to diverting Medicaid funds from resident care is actually fixing conditions, right as state oversight of it is set to end.
Deal Aug 1, 2026
The Swiss plasma-therapeutics maker will invest 1.5 billion dollars and create about 1,500 jobs at Palmetto Research Park after Rock Hill's city council voted 7 to 0 on July 24 to approve the land sale and tax incentive package.
Why it matters A major foreign drugmaker is building its first US factory, adding domestic capacity for plasma-derived medicines used in trauma and critical care. Watch whether the mid-2030s timeline holds and how the local tax fight resolves.
Deadline Aug 1, 2026
CMS's deadline for applicable clinical laboratories to report private-payer rate and volume data for January through June 2025 passed at 11pm Eastern on July 31, 2026, with penalties up to $10,000 per day for noncompliance, and the data will set Medicare lab payment rates for 2027 through 2029.
Why it matters This determines how much Medicare pays for lab tests nationally for three years starting in 2027; watch how many labs actually reported and whether CMS enforces the daily penalty.
Report Aug 1, 2026
Practice management and billing vendor Unlimited Technology Systems began notifying more than 442,000 affected patients on July 21, 2026, nine months after an October 2025 ransomware intrusion exposed health insurance, diagnosis, and Social Security data.
Why it matters A single back-office vendor's ransomware breach exposed data on hundreds of thousands of patients across unrelated practices nationwide, and the nine-month gap before notification highlights how slow breach disclosure can be. Watch whether more state attorneys general disclose additional affected totals.
Deal Aug 1, 2026
A Warburg Pincus led investor group partnered with the Abu Dhabi Investment Authority agreed on July 13, 2026 to acquire a controlling interest in PANTHERx Rare from sellers Nautic Partners, General Atlantic, and the Vistria Group, who will retain minority stakes.
Why it matters Private equity keeps paying premium prices for the infrastructure behind specialty drug distribution rather than the drugs themselves. Watch for regulatory clearance before the deal closes.
Enforcement Jul 31, 2026
Access DX Laboratory, former CEO Michael Stewart and Florida businessman Harold Shatz agreed to pay a combined $36.4 million to settle False Claims Act allegations of kickbacks for referrals, unbundled billing and medically unnecessary genetic testing from January 2018 through January 2020.
Why it matters A genetic-testing lab and two executives are paying $36.4 million after a whistleblower exposed a scheme that paid for referrals and unbundled billing codes for tests patients didn't need. It shows how one tipster can unwind a multi-year fraud scheme and trigger criminal pleas.
Report Jul 31, 2026
CMS's ACO REACH settlement results report $988.3 million in net savings for performance year 2024, while CMS's separately published independent evaluation of performance year 2023 found net Medicare spending rose 0.8 percent under a different comparison methodology.
Why it matters CMS's own numbers disagree with each other on whether its flagship Medicare ACO model actually saves the program money, depending on which measurement method is used.
Rule Jul 31, 2026
CMS finalized its FY2027 hospice rule, publishing named Service and Spending Variation Index scores for 6,673 hospices for the first time and requiring a mandatory written non-hospice-coverage addendum for elections beginning October 1, 2026.
Why it matters Medicare published, for the first time, named risk scores for individual hospices meant to flag which ones shift costs onto other parts of the program, worth watching for how aggressively CMS acts on them.
Rule Jul 31, 2026
CMS finalized CMS-1847-F on July 29, 2026, raising Inpatient Psychiatric Facility PPS rates by a net 2.3 percent for fiscal year 2027 and capping facility-level outlier payments at 20 percent of total payments starting fiscal year 2028.
Why it matters This raises what Medicare pays psychiatric hospitals for patient care next year and adds a new limit on how much a hospital can collect for its most expensive psychiatric admissions starting in 2028. Watch whether the outlier cap changes how hospitals handle high-cost patients.
Rule Jul 31, 2026
CMS finalized a 2.4 percent net FY2027 payment increase for skilled nursing facilities, an estimated $882.74 million aggregate increase, five months after MedPAC recommended a 4 percent cut citing a 24.4 percent industry profit margin.
Why it matters CMS raised Medicare payments to nursing homes even after its own advisers said industry margins were already high, a sign the agency did not follow MedPAC's rate advice this cycle.
Rule Jul 31, 2026
CMS's CY2027 OPPS proposed rule makes the Emergency Care Access and Timeliness measure, which tracks wait times, boarding over four hours, and ED stays over eight hours, voluntary for CY2027 and mandatory for CY2028 with comments due August 31, 2026.
Why it matters This sets a real deadline for hospitals to publicly report ER wait times and boarding, a measure meant to make crowding visible before it becomes tied to Medicare payment in CY2030. Watch the August 31, 2026 comment deadline if you want to weigh in.
Deadline Jul 31, 2026
The D.C. Department of Health Care Finance is automatically reassigning everyone enrolled in Elevance Health's Wellpoint DC Medicaid plan to AmeriHealth Caritas DC effective August 1, 2026, with a continuity period through October 31, 2026 and a window until January 31, 2027 to instead choose MedStar Family Choice DC.
Why it matters Elevance is walking away from its Washington D.C. Medicaid contract because the numbers don't work, and 250,000 enrollees get automatically moved to a new plan starting tomorrow. Watch for Elevance to name more state Medicaid exits over the next 12 to 18 months.
Report Jul 31, 2026
BCC Research reported that decentralized clinical trial platforms, led by Medable's $506.6 million in total funding, have raised more than $650 million as AI tools are pitched to fix low enrollment and costly trial delays in an $8.5 billion market.
Why it matters A corner of the drug-development supply chain, decentralized clinical trials, is drawing AI investment pitches aimed at fixing chronic enrollment failures and costly delays.
Enforcement Jul 31, 2026
Laurent Cassagnol, a VA Community Care Program employee, and Heriberto Rivera, CEO of Family Integrative Medicine of Orlando, pleaded guilty to conspiracy to pay and receive kickbacks after steering VA patients to the clinic for holistic services that billed the VA more than $14 million and were paid more than $11 million.
Why it matters A VA employee and a veterans' clinic CEO admitted to a scheme that billed the VA more than $14 million for holistic care services steered through kickbacks. It's a reminder that VA Community Care referrals face the same fraud scrutiny as Medicare and Medicaid.
Report Jul 31, 2026
LevinPro HC reported 459 healthcare deals in Q2 2026, down 23 percent from 503 a year earlier, while disclosed dollar volume reached $95.3 billion, more than triple the prior-year quarter, driven by 21 deals exceeding $1 billion.
Why it matters Fewer healthcare deals closed last quarter, but far more money changed hands, driven by a jump in billion-dollar-plus transactions, meaning consolidation is concentrating in fewer, larger deals.
Rule Jul 31, 2026
A finalized federal rule cut the No Surprises Act's per party filing fee from $115 to $15 effective June 11, 2026 and allows batching up to 50 line items per dispute, though emergency E/M codes 99281 through 99285 still cannot be batched across patients.
Why it matters The federal dispute process used most by emergency doctors just got cheaper to file into, and analysts expect that to pull in about 30 percent more disputes, which is a volume and staffing issue as much as a policy change. Watch your own IDR filing volume against this projection.
Enforcement Jul 31, 2026
The Maryland Insurance Administration fined Cigna $80,000 on March 13, 2026 for automatically downcoding E/M claims under Policy R49, then extended the ban on unilateral algorithmic downcoding to every insurer in the state on April 7, 2026.
Why it matters This matters because a state regulator forced an insurer to stop quietly cutting doctors' billing codes with an algorithm, and the fix now applies to every insurer in Maryland, not just Cigna. Watch whether other states follow Arkansas, Virginia, and pending New York legislation.
Record Jul 31, 2026
Mount Carmel Health System will close its freestanding Franklinton Emergency Department on August 22, 2026 and open a walk-in primary care clinic two blocks away two days later, leaving Grant Medical Center as the nearest ER about two miles away.
Why it matters This shows a large urban hospital system making the same shrink-the-ER trade that federal rural funding is pushing, on its own balance sheet, which suggests the economics apply beyond rural markets. Watch whether other urban systems follow with similar freestanding ED closures.
Funding Jul 31, 2026
CMS caps direct patient care spending at 15 percent of the $50 billion Rural Health Transformation Program, and at least 25 states are using the money to convert full service EDs into smaller facilities rather than expand emergency care.
Why it matters This affects how rural hospitals near you may change over the next few years, since federal money meant to help them is being used to shrink services like full ERs, maternity, and dialysis rather than expand them. Watch whether your local rural hospital converts to a Rural Emergency Hospital.
Record Jul 31, 2026
The agreement, reached July 31, 2026, preserves in-network access for more than 60,000 UHealth patients across commercial, individual and Florida Medicaid plans, with financial terms undisclosed.
Why it matters The deal avoided a network disruption for tens of thousands of patients, showing how public negotiation pressure can resolve a payer-provider standoff before a deadline.
Report Jul 30, 2026
An AMA Policy Research Perspective found OB/GYN liability premiums for 2025 reached $243,988 in Miami-Dade County and $159,537 in Connecticut, with career-lifetime OB/GYN malpractice claim rates near 60 percent.
Why it matters This shows OB/GYN malpractice insurance costs have now climbed for seven straight years, the longest run since the early 2000s.
Enforcement Jul 30, 2026
DOJ declined to prosecute Campus Eye Management under its self-disclosure policy in exchange for $1 million in restitution while indicting former CEO E. Bruce DiDonato on seven counts tied to about $3.4 million in fraudulent billings and kickbacks to ophthalmologists.
Why it matters A company that caught and reported its own Medicare fraud avoided criminal charges entirely, while its founder was indicted alone, showing self-disclosure can work if you act fast.
Earnings Jul 30, 2026
Cigna reported second quarter 2026 revenue of 71.7 billion dollars, up 7 percent year over year and above analyst estimates, and raised its full year adjusted earnings per share guidance to at least 30.45 dollars.
Why it matters This is the first scorecard on Cigna's new CEO, and the numbers came in strong, but watch the medical care ratio for signs of rising costs across the industry.
Rule Jul 30, 2026
CMS's CY2027 Medicare Physician Fee Schedule proposed rule adds 15 new G-codes to preserve the legacy bundled maternity payment structure alongside the AMA's new unbundled per-visit codes, both set to take effect January 1, 2027, and ACOG and OBHG have formally opposed the dual system.
Why it matters This is about how complicated OB billing will get in 2027, and whether CMS keeps both an old and new coding system running side by side.
Rule Jul 30, 2026
CMS-1843-F raises skilled nursing facility Medicare rates 2.4 percent for an estimated $882.74 million aggregate increase while requiring all SNFs to submit resident assessment data regardless of payer.
Why it matters Medicare is paying skilled nursing facilities more next year, but the tradeoff is that every nursing home, not just Medicare-billing ones, now has to report detailed patient data faster.
Enforcement Jul 30, 2026
The Justice Department's National Fraud Enforcement Division charged 17 cases totaling more than $350 million in intended losses and signed data-sharing agreements covering SNAP, SBA loan and Medicaid records with Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina and South Carolina.
Why it matters The federal government just made it easier to catch Medicaid and benefits fraud in seven Southeastern states by linking government databases together, and 17 cases are already charged.
Earnings Jul 30, 2026
Grifols reported first half 2026 revenue up 2.6 percent to 3.6 billion euros and net profit up 28.7 percent to 227 million euros, even as it absorbs restructuring costs from closing 29 US donor centers under a new dual operating model that separates its US plasma division from its global structure.
Why it matters The world's largest plasma collector is restructuring its US operations, a supply chain shift worth watching if you or someone you know depends on plasma-derived treatments for immune disorders or rare diseases.
Deal Jul 30, 2026
Included Health announced July 29, 2026 that it struck a deal to acquire virtual-first primary and specialty care practice Firefly Health, with undisclosed terms and an expected close in the third quarter of 2026.
Why it matters Two virtual care companies are combining to offer employers a lower cost alternative to traditional health insurance, a trend worth watching if your employer offers virtual-first health plans.
Deal Jul 30, 2026
Johnson & Johnson completed a 1 billion dollar cash acquisition of oncology biotech Firefly Bio and struck a 785 million dollar initial agreement with an option to acquire Sail Biomedicines for 2.58 billion dollars, cutting its 2026 adjusted earnings per share guidance by about 64 cents.
Why it matters J&J chose to absorb a near term profit hit to buy into next-generation cancer and autoimmune disease technology, a bet that the science pays off later even as this year's numbers take a hit.
Record Jul 30, 2026
MaineHealth's Lincoln Hospital in Damariscotta runs a 5.56 percent operating margin and 43 percent birth-volume growth since 2019, yet its board votes August 5, 2026 on closing Labor and Delivery, with 60 percent of deliveries billed to Medicaid and the nearest alternative 45 minutes away.
Why it matters This shows profitable rural hospitals are still closing maternity units, so watch whether the August 5 board vote confirms it and what happens to your own local options.
Rule Jul 30, 2026
Judge Richard Stearns ruled July 29, 2026 that 26 states and DC failed to show unrecoverable harm since CMS agreed to reimburse 90 percent of implementation costs, leaving the rule on track for January 1, 2027.
Why it matters This keeps Medicaid work requirements on track to start January 1, 2027, so if you or someone you know is on Medicaid, watch for a notice by August 31, 2026 explaining how to comply or claim an exemption.
Enforcement Jul 30, 2026
Dr. Valinda Nwadike agreed to a False Claims Act settlement for signing thousands of prescriptions for compounded drugs and durable medical equipment for patients she never examined between November 2014 and January 2018, claims that Medicare and TRICARE ultimately paid.
Why it matters This shows federal fraud enforcement reaching physicians who sign off on prescriptions arranged by telemarketers without examining patients.
Record Jul 30, 2026
The Senate HELP Committee voted 13 to 10 to advance Erica Schwartz's nomination as CDC director and unanimously advanced the Health Information Privacy Reform Act extending HIPAA-style rules to health apps and wearables.
Why it matters A Senate committee moved forward on both a controversial CDC director pick and a new bill that would bring HIPAA-style privacy protections to health apps and wearables for the first time.
Deal Jul 30, 2026
Organon shareholders approved Sun Pharmaceutical Industries' all-cash acquisition on July 24, 2026, the largest overseas acquisition by an Indian pharmaceutical company in history, with the deal expected to close in early 2027 pending remaining regulatory clearances.
Why it matters This is the largest pharma deal of the year and it puts one of the two dominant global contraceptive makers under new Indian ownership.
Deadline Jul 30, 2026
As of July 30, 2026, UHealth and UnitedHealthcare have not reached a new contract, and if the July 31 deadline passes, UHealth's hospitals, clinics and physicians go out of network for UnitedHealthcare's commercial, ACA exchange and Medicaid plans starting August 1.
Why it matters If you or someone you know is a UnitedHealthcare member who uses UHealth or Bascom Palmer Eye Institute, a missed deadline tomorrow could mean losing in-network access starting August 1.
Earnings Jul 30, 2026
Ventas reported second quarter 2026 results that beat Wall Street estimates, closed 2.2 billion dollars in senior housing investments during the quarter, and raised its full year 2026 senior housing investment target by 50 percent to more than 4.5 billion dollars.
Why it matters A major healthcare landlord is betting big on senior housing demand outpacing new supply, a trend worth watching if you or a family member may need senior living in the next few years.
Rule Jul 30, 2026
A bipartisan Wisconsin law extending Medicaid postpartum coverage from 60 days to 12 months took effect July 1, 2026, an estimated benefit to more than 16,000 low-income mothers, leaving Arkansas as the only state without a full postpartum year.
Why it matters This closes the gap on postpartum Medicaid coverage nationwide, leaving Arkansas as the only state that still cuts new mothers off at 60 days.
Deadline Jul 30, 2026
Senate Finance Committee Democrats led by Ron Wyden released an 86-page request for information seeking public feedback by October 2, 2026 on proposals to lower premiums and deductibles and simplify enrollment.
Why it matters Senate Democrats want to hear from the public by October 2, 2026 on ideas to lower what people pay for private health insurance, though they cannot force a vote on any resulting bill.
Earnings Jul 29, 2026
Boston Scientific reported Q2 2026 net sales of 5.442 billion dollars, up 7.5 percent, and adjusted EPS of 0.86 dollars beating its own guidance range, but full year adjusted EPS guidance of 3.28 to 3.32 dollars sits just under Wall Street's 3.36 dollar consensus.
Why it matters Boston Scientific topped Wall Street's Q2 estimates and shares rose more than 3 percent, though full-year guidance landed just under consensus. Watch whether device demand holds up in the second half.
Enforcement Jul 29, 2026
CMS said the task force, launched April 23, 2026, has taken coordinated action against 50 high-risk Medicaid providers whose billing totals more than $203 million now facing federal exclusion and state enforcement.
Why it matters A new federal-state data-sharing effort is catching suspect Medicaid billing before payment goes out rather than clawing it back later. Watch for more provider exclusions as the program matures.
Rule Jul 29, 2026
CMS confirmed July 28, 2026 it will discontinue the Part D Premium Stabilization Demonstration at the end of this year, raising the 2027 base beneficiary premium from $38.99 to $41.33.
Why it matters This raises what many Medicare drug plan enrollees pay starting in 2027, though CMS says most will see only modest increases or none at all. Watch your own plan's premium notice this fall.
Deal Jul 29, 2026
A faith coalition and a Weld County resident sued Hudson, Colorado on July 23, 2026, arguing the town let GEO Group skip zoning approval to reopen a shuttered prison as a 1,200-bed immigration detention center.
Why it matters This is a local zoning fight over a large federal detention contract, and the outcome could set precedent for whether federal contracting preempts local zoning nationwide. Watch for a hearing date.
Deal Jul 29, 2026
Doctronic, an AI-assisted telehealth startup that has raised 65 million dollars in under a year, acquired text-based pediatric telehealth service Summer Health for an undisclosed amount to expand into pediatric care.
Why it matters An AI telehealth startup is using nearly a year of rapid fundraising to expand from adult triage into pediatric care by acquiring Summer Health. Watch how AI chatbots handling patient triage scale into new clinical populations.
Rule Jul 29, 2026
The FDA's Oncology Center of Excellence finalized three guidances, announced in the Federal Register July 28, 2026, urging researchers to drop unjustified lab-value cutoffs, washout periods and fitness thresholds that currently screen out otherwise eligible cancer patients.
Why it matters Only 3 to 5 percent of cancer patients enroll in trials today, and this guidance aims to widen who qualifies without changing what's being tested. Watch whether enrollment and trial diversity actually improve, since this is a recommendation, not a mandate.
Earnings Jul 29, 2026
Humana reported Q2 2026 net income of 694 million dollars and adjusted EPS of 7.61 dollars, beating Wall Street's 7.23 dollar estimate, but cut its full year GAAP EPS guidance floor to at least 6.52 dollars from at least 8.36 dollars after its medical benefit ratio rose to 91.2 percent.
Why it matters Humana beat Wall Street's profit estimate but warned the rest of the year could be rougher by cutting its GAAP profit guidance floor. Watch whether Medicare Advantage medical costs keep climbing through the second half.
Report Jul 29, 2026
An estimated 20 million Americans owe roughly 220 billion dollars in medical debt, and market researchers project the healthcare buy now pay later financing segment will grow from 6.14 billion dollars in 2026 to 17.89 billion dollars by 2034.
Why it matters An estimated 20 million Americans carry medical debt totaling roughly 220 billion dollars, and a buy now pay later industry is growing quickly to finance it. Watch whether this financing helps patients or adds new debt burden.
Deadline Jul 29, 2026
The Senate HELP Committee rescheduled its vote on CDC director nominee Erica Schwartz to July 30, 2026, after Senator Lisa Murkowski's absence delayed the original July 23 vote, alongside a bill extending privacy rules to health apps and wearables.
Why it matters A Senate committee is set to vote on who runs the CDC and on a bill that would bring privacy rules to health apps and wearables that HIPAA does not currently cover. Watch the July 30 vote outcome.
Record Jul 29, 2026
As of July 29, 2026, UHealth and UnitedHealthcare have not reached a new contract, and hundreds of thousands of patients face going out of network for commercial, ACA exchange and Medicaid plans starting August 1 if no deal is struck by the July 31 deadline.
Why it matters Miami's academic health system and the nation's largest insurer are two days from a deadline that could push hundreds of thousands of patients out of network. Watch whether a deal is reached by July 31.
Deal Jul 28, 2026
CARPL.ai, whose platform connects radiology groups to more than 300 AI applications from over 100 vendors, closed a $10 million Series A led by the International Finance Corporation with participation from existing investor Stellaris Venture Partners to fund global expansion.
Why it matters Capital is still flowing into radiology AI infrastructure even while Medicare is still working out how to pay for the AI tools themselves. It signals investor confidence in AI adoption broadly, not in any single diagnostic product.
Earnings Jul 28, 2026
Centene's health benefits ratio fell to 89.6 percent from 93.0 percent a year earlier, driving second quarter 2026 revenue to 53.58 billion dollars and adjusted EPS of 2.51 dollars, while Marketplace enrollment under the Ambetter brand dropped to 3.5 million from 5.8 million.
Why it matters Centene is the country's largest Medicaid insurer, so its swing back to profit signals that the industry's 2025 cost spike may be easing, but its own numbers show a shrinking ACA marketplace book as subsidies lapse.
Rule Jul 28, 2026
CMS's CY2027 hospital outpatient proposed rule creates a new Software as a Medical Service billing category covering 36 codes, mostly radiology and cardiac imaging AI, and moves 21 of them onto a temporary New Technology APC track that holds payment near 2026 levels.
Why it matters Medicare is for the first time proposing to pay for AI software as its own billable service, which could reshape how hospitals adopt diagnostic AI tools. Watch whether this new category survives into the final rule this fall.
Rule Jul 28, 2026
CMS's proposed CY2027 physician fee schedule cuts the base conversion factor 1.68 percent for non-APM physicians, but ACR's analysis of the rule's practice-expense changes projects diagnostic radiology and nuclear medicine up 2 percent and interventional radiology and radiation oncology up 3 percent if finalized as proposed.
Why it matters A Medicare rule that looks like a pay cut on its face actually helps most imaging specialties once the underlying cost-allocation math is applied. It is a reminder to read past the headline conversion factor number.
Deal Jul 28, 2026
Erlanger's board has approved a non-binding letter of intent to become a wholly owned subsidiary of Prisma Health, which would invest 2 billion dollars over 15 years while Erlanger keeps a local governing board for up to nine years and two seats on Prisma's 11 member corporate board.
Why it matters A Tennessee safety-net hospital trading independence for capital is part of a broader wave of financially stretched systems seeking well-capitalized nonprofit partners; watch the 120-day due diligence period and required regulatory approvals.
Enforcement Jul 28, 2026
A federal judge sentenced the CEO to 48 months, the medical director to 60 months, and the billing manager to 24 months, and ordered 812,881 dollars in restitution for billing Medicare and Medicaid for opioid-addiction treatment that was never rendered or was billed as more complex than it was.
Why it matters This is a reminder that addiction-treatment billing fraud carries real prison time, not just fines, and that patient records can become evidence in these cases.
Rule Jul 28, 2026
25 states and DC are seeking a preliminary injunction against a June 3 interim final rule that adds a significant impairment standard to the medically frail exemption from Medicaid work requirements taking effect January 1, 2027.
Why it matters This case will decide who gets excused from proving they are working to keep Medicaid, including people in stable addiction recovery; watch for a ruling and whether it gets appealed.
Report Jul 28, 2026
Deal count fell to 51 transactions and disclosed dollar volume dropped to 272.1 million dollars across 13 priced deals, down from 927 million dollars across 34 priced deals in the first quarter, according to LevinPro HC.
Why it matters A slowdown in one of healthcare real estate's steadiest niches signals capital markets caution is spreading even to outpatient building investment, which tracks the broader shift of care away from inpatient hospital settings.
Enforcement Jul 28, 2026
Four men used their company, Brilliant Minds Services LLC, to bill Minnesota Medicaid's Housing Stabilization Services program for services roughly 350 disabled people never received, then used AI chatbots to fake records for investigators.
Why it matters This shows fraud schemes now using AI to generate fake documentation, a pattern the public and investigators should expect to see more of in Medicaid fraud cases.
Enforcement Jul 28, 2026
Mt. Baker Imaging and Northwest Radiologists agreed to a $3.3 million non-reversionary class-action settlement in Whatcom County Superior Court covering roughly 340,184 patients whose data was exposed in a January 2025 ransomware attack, with claims due August 19, 2026.
Why it matters A single ransomware attack on two small imaging practices turned into a multimillion-dollar settlement affecting hundreds of thousands of patients, showing how costly a healthcare data breach can get regardless of the practice's size. Watch the August 21 final approval hearing.
Deal Jul 28, 2026
Novanta paid 1.2 billion dollars in cash plus a 250 million dollar milestone due in early 2027 for Riverpoint Medical's surgical fiber consumables business, a deal that roughly doubles Novanta's recurring medical device revenue to about 300 million dollars.
Why it matters A device maker doubling its recurring medical revenue overnight shows continued consolidation in surgical consumables, a corner of the medical device market tied to elective procedure volume.
Rule Jul 28, 2026
Representatives John Joyce, Greg Murphy, and Kim Schrier introduced the Patients First Act on July 14, 2026, which incorporates the ROOT Act's provisions reviving Medicare's imaging appropriate-use-criteria program through clinical decision support rather than the rescinded claims-reporting requirement.
Why it matters A bill to revive Medicare's shelved imaging-guideline-checking program just got a stronger legislative vehicle, backed by physician co-chairs of both House Doctors Caucuses. Passage timing is still uncertain since the bill has not had a committee vote.
Deal Jul 28, 2026
TerraPower Isotopes is building a $450 million, 250,000-square-foot actinium-225 manufacturing facility in Philadelphia, expected to start production in 2029 and, combined with its Everett, Washington site, grow the company's isotope output twentyfold while a Bristol Myers Squibb trial has already paused enrollment for lack of supply.
Why it matters Theranostics and radiopharmaceutical treatments depend on an isotope that decays within about ten days and cannot be stockpiled, so today's cancer care growth is capped by a supply chain that will not meaningfully expand until 2029. Watch actual production ramp-up, not just the announced capacity target.
Deadline Jul 28, 2026
Without a new agreement by July 31, UHealth's hospitals, clinics and physicians go out of network August 1 for UnitedHealthcare's commercial, ACA exchange and Medicaid plans, though Medicare Advantage members are protected through August 31 under a separate carve out.
Why it matters If the deadline is missed, hundreds of thousands of Miami-area UnitedHealthcare members lose in-network access to UHealth's hospitals and specialists, including the Bascom Palmer Eye Institute, starting August 1.
Rule Jul 27, 2026
The U.S. District Court for the District of Maryland ruled July 16, 2026 to stay eight provisions of CMS's 2027 Notice of Benefit and Payment Parameters final rule, days before they were set to take effect July 20.
Why it matters This pause means the marketplace plans you might buy for 2027 will look more like today's plans for now, since expanded out-of-pocket maximums and looser network rules are on hold while the case proceeds.
Deal Jul 27, 2026
American Industrial Partners paid 25.00 dollars a share in cash to take Avanos Medical, a maker of pain management, respiratory and enteral feeding devices, off the New York Stock Exchange.
Why it matters A well known medical device maker used in hospitals and homes is now privately held, which can mean less public financial disclosure and different investment priorities going forward.
Alert · now Jul 27, 2026
CISA, the NSA, the FBI and the Defense Cyber Crime Center published advisory AA26-194A naming healthcare among the critical infrastructure sectors targeted by Russian Federal Security Service-linked actors exploiting poorly configured or unpatched routers and networking devices.
Why it matters This is a direct federal warning naming healthcare as a target for Russian state-sponsored hacking of network equipment, a different threat than the ransomware attacks hospitals usually hear about.
Rule Jul 27, 2026
The proposed CY2027 ESRD PPS rule would raise the per-treatment base rate to $299.55, a projected 1.1 percent overall payment increase, while retiring the Hypercalcemia quality measure and adding a new post-TDAPA drug payment category.
Why it matters Medicare pays for the vast majority of dialysis treatments, so this rate sets the baseline economics for the whole industry; watch whether the 1.1 percent bump survives to the final rule this fall.
Deal Jul 27, 2026
Dentalcorp, Canada's largest dental service organization, acquired 21-practice Florida group Northstar Dental Partners, marking its entry into the US market and pushing its supported network past 650 practices.
Why it matters Dental care consolidation keeps accelerating, with a major Canadian consolidator now entering the US market for the first time, a trend that affects how much choice patients have among dental providers over time.
Report Jul 27, 2026
USRDS data show the national ratio of dialysis facility openings to closures fell from 8.9 in 2018 to 0.8 in 2024, with closures concentrated among rural, smaller, and dual-eligible-heavy clinics.
Why it matters Access to dialysis care is shrinking in rural and low income areas even as larger, better capitalized facilities expand, a trend worth watching for its effect on patient travel burden and outcomes.
Enforcement Jul 27, 2026
CMS filed a notice of appeal around July 21, 2026 to the Eleventh Circuit challenging a Georgia court's May 29, 2026 ruling that it used unlawful measures in Clover Health's star rating, while Elevance Health, SCAN Health Plan and Alignment Healthcare separately sue over the same recalculation issue seeking a combined 290 million dollars.
Why it matters This is a fight over the formula that generates Medicare Advantage star ratings and bonus payments, and CMS choosing to appeal instead of pay signals a longer legal fight over how those ratings get calculated.
Deal Jul 27, 2026
First Choice Healthcare Solutions and Nasdaq listed Westin Acquisition Corp will combine into Wellgevity 360, Inc., valuing the longevity and regenerative medicine clinic chain at approximately 650 million dollars on a pro forma basis, with closing expected in the fourth quarter of 2026.
Why it matters A chain of longevity and wellness clinics is taking the public markets route through a SPAC merger, a sign of continued investor appetite for consumer facing longevity and wellness care.
Record Jul 27, 2026
CareSource is rescinding a 20 percent reimbursement cut on special-needs therapy services that had been set to take effect May 11, 2026 for some but not all providers in its network.
Why it matters This shows how a Medicaid managed-care rate cut aimed at special-needs therapy providers got partially walked back after pressure, but not evenly, leaving some clinics still facing a cut that could hurt access to care for children who depend on it.
Rule Jul 27, 2026
A meta-analysis of 19 trials found GLP-1 receptor agonists cut kidney function decline by 12 percent and mortality by 14 percent without reducing progression to kidney failure, while Medicare's IOTA model doubled hospitals' maximum transplant incentive to $15,000 in its second performance year starting July 1, 2026.
Why it matters Two separate trends are moving at once: GLP-1s are extending time on dialysis rather than preventing it, and Medicare is now paying hospitals more to do transplants while paying nephrology referral sources less.
Rule Jul 27, 2026
CMMI extended the Kidney Care Choices model through 2027 but eliminated the per-beneficiary transplant bonus, cut quarterly chronic kidney disease capitation payments by 50 percent, and added a 1 percent benchmark discount after the model posted $304 million in net losses.
Why it matters This is a real cut to a Medicare value based kidney care program that lost money; watch how many nephrology practices stay in the model through 2027 versus shifting to MSSP ACOs.
Enforcement Jul 27, 2026
Dr. Feliciano Serrano and his practice agreed to pay $6.73 million to resolve False Claims Act allegations that he performed medically unnecessary stents, atherectomies, and angioplasty on dozens of dialysis and peripheral artery disease patients from 2016 to 2024.
Why it matters This is the latest in a pattern of federal fraud enforcement targeting dialysis vascular access procedures, an area where procedure volume per patient draws close scrutiny.
Deal Jul 27, 2026
Strive Health closed a $550 million Series D round in September 2025, split between equity led by New Enterprise Associates and debt financing, pushing its valuation to $1.8 billion while it works with more than 6,500 providers covering about 145,000 kidney disease patients.
Why it matters This valuation is the reference point for how much capital is flowing into value based kidney care platforms that sit between nephrology practices and Medicare; watch how competitors' valuations compare.
Deadline Jul 27, 2026
UHealth, the University of Miami's health system, and UnitedHealthcare remain without a new contract as of July 27, with UHealth's hospitals, clinics and physicians set to go out of network August 1 for commercial, ACA exchange and Medicaid plans if the July 31 deadline is missed.
Why it matters Hundreds of thousands of Miami area patients could lose in network access to a major academic health system in days if no deal is reached, a reminder that provider payer contract fights can hit patients directly.
Earnings Jul 27, 2026
Universal Health Services cut its full year 2026 adjusted EPS and EBITDA guidance and reported a shrinking free cash flow margin, citing a 72 million dollar Florida Medicaid and reserve hit.
Why it matters This is a snapshot of hospital industry health: a big operator's revenue beat masks weaker profit expectations and cash generation, a signal investors read as a warning about margins ahead.
Record Jul 27, 2026
More than seven months after December 12, 2025 oral argument in U.S. ex rel. Zafirov v. Florida Medical Associates, the Eleventh Circuit has not issued an opinion on whether the False Claims Act's qui tam whistleblower provisions are unconstitutional.
Why it matters If the qui tam provisions are struck down, whistleblowers could lose the ability to sue over Medicare and Medicaid fraud on the government's behalf, which currently drives most federal fraud recovery dollars.
Deal Jul 26, 2026
Private-equity-backed staffing platform Care Career acquired MAS Medical Staffing, pushing combined annualized revenue above $150 million toward a stated goal of exceeding $250 million by the end of 2026.
Why it matters This is part of a broader wave of private-equity-backed consolidation in healthcare staffing as travel-nurse demand normalizes.
Rule Jul 26, 2026
CMS published a Federal Register notice on July 27, 2026 approving a six-year renewal of the National Committee for Quality Assurance's deeming authority to accredit Medicare Advantage HMOs and PPOs in place of direct federal inspection.
Why it matters A private accreditor keeps its power to certify Medicare Advantage plans, the option more than half of Medicare enrollees now choose, without a fresh government re-evaluation of that process for six years.
Enforcement Jul 26, 2026
HHS said July 21, 2026 it is deferring about $867.5 million in Medicaid matching funds from California, largely tied to in-home care programs, and about $199 million from Minnesota across 14 claims categories, pending a fraud and noncompliance review.
Why it matters If you live in California or Minnesota and rely on Medicaid, especially in-home care, watch for payment or service disruptions while the review is underway.
Record Jul 26, 2026
A House Oversight subcommittee roundtable examined why Medicare Part B spending on skin substitutes, which grew from about 200 million dollars in 2019 to more than 14.4 billion dollars in 2025, has not been curbed despite a CMS rule effective January 1, 2026 that set a single payment rate of 127.14 dollars per square centimeter.
Why it matters Medicare spending on wound-care skin substitutes grew 7,100 percent in six years, and lawmakers are questioning whether a rate cut already in effect is enough to stop the fraud; watch for any legislation coming out of this roundtable.
Record Jul 26, 2026
The House Energy and Commerce Committee voted 45-0 for H.R. 9393 and the Senate HELP Committee voted 21-1 for S. 2355, both requiring hospitals, labs, surgery centers, and pharmacy benefit managers to disclose real negotiated prices, but neither has a floor vote scheduled.
Why it matters Two bills forcing real price disclosure from hospitals and PBMs cleared committee within a day of each other, but neither is scheduled for a floor vote yet, so no new transparency rule is imminent.
Report Jul 26, 2026
A Maine jury awarded $17 million over a wrong-organ removal, the fourth verdict against Northern Light Health in 2026, as AMA data shows medical liability premiums rose for a seventh straight year in 2025 and insurers respond by consolidating.
Why it matters This is part of a broader trend of rising malpractice verdicts and insurance costs that can eventually show up in what providers charge and where they choose to practice.
Report Jul 26, 2026
The Massachusetts Division of Insurance renegotiated lower 2027 merged-market rate increases with seven insurers and rejected Fallon Community Health Plan's initial 25.7 percent increase request, saving an estimated 72 million dollars for about 670,000 residents and businesses.
Why it matters State regulators pushed back on insurer rate requests and say they saved residents and small businesses an estimated 72 million dollars, though average premiums are still rising for 2027.
Rule Jul 26, 2026
A federal district court in Massachusetts will hold a July 28, 2026 hearing on a preliminary injunction request from 25 states and D.C. challenging a June 3, 2026 interim final rule that narrows the medically frail exemption from Medicaid work requirements.
Why it matters This fight decides how easily sick or disabled Medicaid enrollees can be exempted from proving they work once new requirements start January 1, 2027. Watch the July 28 hearing outcome for whether the narrower standard survives.
Report Jul 26, 2026
The HHS Office of Inspector General reported that state Medicaid managed care contracts give insurers anywhere from 1 to 270 days, or no deadline at all, to refer suspected provider fraud, and recommended CMS require prompt referrals and specify consequences for noncompliance.
Why it matters A federal watchdog found Medicaid fraud can go unreported for months in some states with no real consequence for insurers that fail to flag it; watch whether CMS acts on the two recommendations it has not yet fully addressed.
Deal Jul 26, 2026
Tempus AI agreed to pay $16.25 per share for Personalis in a deal structured as all-stock with an option to pay up to 50 percent in cash, expanding its molecular residual disease cancer-testing platform.
Why it matters This is a bet that combining two cancer-testing companies' data will improve tests that check whether a patient's cancer has returned after treatment.
Record Jul 26, 2026
University of Miami Health System says it will leave UnitedHealthcare's network for commercial, exchange and Medicaid plans starting August 1, 2026 if no new contract is reached by July 31.
Why it matters If you or a family member is a UnitedHealthcare member in South Florida, watch for an out of network notice, though a deal could still land before July 31.
Report Jul 25, 2026
VMG Health's 2026 Healthcare M&A Report found standard control-level ASC deals cluster around 7 to 8 times EBITDA while select high-growth multi-specialty centers are commanding double-digit multiples.
Why it matters If you are weighing whether to sell or recapitalize a surgery center, this is the current market benchmark to use, not last year's number, and it reflects the same strategic buyers now dominating the sector.
Deal Jul 25, 2026
Ascension closed the acquisition June 4, 2026 after an FTC consent agreement required divesting seven overlapping-market surgery centers, giving the nonprofit system more than 300 ASCs behind only Tenet/USPI and Optum/SCA Health.
Why it matters All three of the largest surgery center platforms now sit inside strategic health systems and insurers rather than private equity, a structural shift in who controls outpatient surgery capacity nationally.
Enforcement Jul 25, 2026
HHS and CMS announced July 21, 2026 they are deferring $867.5 million in federal Medicaid matching funds from California, mostly tied to its In-Home Supportive Services program, and $199 million from Minnesota tied to providers flagged for aberrant billing, pending fraud reviews.
Why it matters Two states just lost access to over a billion dollars in Medicaid funding while the federal government reviews fraud claims, which could squeeze state budgets and the services those programs fund. Watch whether California and Minnesota get the money released or whether the deferral turns into a permanent cut.
Enforcement Jul 25, 2026
Chesapeake Regional Medical Center in Virginia was indicted January 8, 2025 for collecting an estimated $18.5 million from unnecessary and misclassified procedures performed by a former OB-GYN convicted on 52 counts in 2020.
Why it matters DOJ charging the facility itself, not only the individual doctor, is a notable escalation in how healthcare fraud cases get built, and a conviction could end this hospital's ability to operate under Medicare and Medicaid.
Rule Jul 25, 2026
The proposed rule would also strip 637 procedures off the inpatient only list, raise ASC payment rates 2.4 percent to about $9.9 billion, and eliminate the device pass-through pathway starting October 1, 2026.
Why it matters This is the biggest one-year expansion of what Medicare will pay outpatient surgery centers to do, and it also makes it harder for new medical devices to reach the market quickly. Watch whether the code counts and the device pass-through cut survive to the final rule expected in November.
Earnings Jul 25, 2026
Gentherm reported second quarter 2026 product revenue of 416.2 million dollars, up 11 percent year over year, and its board approved a new 400 million dollar stock repurchase program to take effect once its roughly 1 billion dollar combination with Modine's Performance Technologies business closes.
Why it matters This is a routine earnings beat with a bigger stock buyback, not something most patients will notice directly, but it points to steady demand in the medical device supply chain.
Report Jul 25, 2026
Comparitech counted 410 ransomware attacks against healthcare linked organizations in the first half of 2026, with attacks on healthcare businesses and vendors growing nearly 35 percent versus a 3 percent rise in attacks on hospitals and direct care providers.
Why it matters If your health data passes through a hospital's vendors, billing company or device maker, not just the hospital itself, you're increasingly exposed to a ransomware breach; this shift is where health data risk is heading.
Rule Jul 25, 2026
HHS published a final rule in the Federal Register on July 24, 2026, effective immediately, removing 45 CFR Part 80 provisions that let it pursue civil-rights enforcement based on discriminatory effect without proof of intent, skipping notice-and-comment under the grant-rule APA exemption.
Why it matters This changes how HHS enforces civil rights protections at any hospital, clinic, or state program that takes federal money, and it happened with no public input. Watch for how HHS's Office for Civil Rights actually applies the new rule in practice.
Record Jul 25, 2026
Intermountain Health confirmed changes effective July 24, 2026 that eliminate about 93 leadership and staff positions while closing several clinics in Colorado and Montana, citing long-term financial sustainability.
Why it matters If you're a patient at one of the closed clinics, you'll need to find a new care location; the cuts show even a large nonprofit system tightening its footprint.
Enforcement Jul 25, 2026
DOJ announced July 23, 2026 that Magnolia Diagnostics and owners John and Kelly Bains will pay $19.2 million and the lab's passive investors will separately pay $4.8 million, resolving allegations that senior-living communities were required to accept unnecessary respiratory pathogen panels via prepopulated test-order forms from April 2020 through September 2021.
Why it matters A Dallas lab's passive investors, not just its owners, are now on the hook for fraud proceeds even without proof they knew about the scheme, a legal theory DOJ used this way for the first time. Watch whether DOJ applies this investor-liability theory to other health care fraud cases.
Record Jul 25, 2026
Senators Bill Cassidy and Richard Blumenthal introduced S.4963 on July 14, 2026, mirroring a House bill, to switch ASC payment updates to the hospital market basket index and drop a budget-neutrality cut ASCA says has suppressed rates.
Why it matters This is a policy fight the ASC industry has waged since 2021 without success; it explains why surgery centers say their Medicare pay raises lag hospitals, but passage this Congress is unlikely given the bill's history.
Deal Jul 25, 2026
Samsung Biologics announced an all-cash tender offer of 44.31 Swiss francs per share, about 1.81 billion dollars, for 100 percent of PolyPeptide Group, a Swiss contract manufacturer of peptide APIs used in GLP-1 obesity and diabetes drugs.
Why it matters This deal is about who controls manufacturing capacity for the ingredients behind GLP-1 drugs like Ozempic and Zepbound, not something that changes your prescription directly, but it shows how much capital is chasing that supply chain.
Record Jul 25, 2026
Skagit County Public Hospital District No. 304, which operates United General Hospital in Sedro-Woolley, is asking voters in an August 2026 special election to raise its property tax levy from about 9 cents to 50 cents per $1,000 of assessed value, still under the state's 75-cent cap.
Why it matters A rural Washington hospital district wants voters to raise property taxes nearly six-fold just to keep current services running, a sign of how rural hospitals are leaning on local taxpayers as federal and state reimbursement lags. Watch the August special election result.
Record Jul 25, 2026
The Surgery Center of Hackensack became the first US ASC to use the eCential Robotics platform on March 5, 2026, and Distalmotion's compact DEXTER system is gaining commercial momentum, with a January 2026 Medicare payment change projected to push ASC robotic surgery growth to about 16 percent annually through 2031.
Why it matters Robotic surgery is moving out of hospitals and into outpatient surgery centers faster than expected, driven partly by a Medicare payment change; the open question for operators is which procedures justify the capital cost first.
Deadline Jul 25, 2026
As of July 22, 2026, UHealth and UnitedHealthcare have not reached a new contract, and UHealth's hospitals, clinics and physicians go out-of-network for UnitedHealthcare's commercial, ACA exchange and Medicaid plan members on August 1 if no deal is struck by July 31.
Why it matters If you're a UnitedHealthcare member who uses UHealth, watch for an update before August 1: without a deal, your visits there could suddenly cost far more or not be covered.
Enforcement Jul 25, 2026
A federal jury in the Southern District of Florida convicted Olushola Yusuf, 60, on July 23, 2026 of conspiracy and illegal distribution for dispensing at least 326,079 oxycodone pills, cash only and at roughly ten times normal price, through two locked-door Broward County pharmacies, with sentencing set for October 14, 2026.
Why it matters A pharmacist was convicted for running a large-scale oxycodone distribution scheme through locked-door storefronts that ignored repeated DEA and employee warnings. Watch for the October 14 sentencing, where she faces up to 20 years per count.
Report Jul 24, 2026
AM Best raised Delta Dental of California's Financial Strength Rating to A+ from A and its Long-Term Issuer Credit Rating to aa- from a+, both with a stable outlook, effective July 23, 2026.
Why it matters A credit rating upgrade for one of the country's largest nonprofit dental insurers highlights how uneven private equity's push into dental care has been, stronger on the insurance side, more disruptive on the practice ownership side.
Rule Jul 24, 2026
CMS's CY2027 Home Health Prospective Payment System proposed rule pairs a 2.4% aggregate payment increase with a temporary 3% adjustment meant to recoup an estimated 4.9 billion dollars in PDGM overpayments from CY2020 through CY2025.
Why it matters Watch whether the temporary 3% clawback survives to the final rule, since it would offset most of the headline payment increase for home health agencies.
Rule Jul 24, 2026
CMS published CMS-2452-P on July 23, 2026, implementing Section 71115 of the Working Families Tax Cut legislation by lowering the indirect hold harmless threshold for health care-related taxes, with new limits phasing in from October 2027 and stepping down annually to 3.5 percent by 2032.
Why it matters This proposed rule would reshape how states fund Medicaid programs; states that rely on provider taxes to draw extra federal matching dollars will face tighter limits starting in 2027, with thresholds stepping down each year through 2032.
Report Jul 24, 2026
The Government Accountability Office found Medicare Advantage had a 6.1 percent improper payment rate in fiscal year 2025, totaling $23.7 billion, and recommended CMS develop a plan to accelerate risk-adjustment data validation audits and conduct a comprehensive fraud risk assessment of the program.
Why it matters GAO's finding that roughly one in sixteen dollars paid to Medicare Advantage plans last year was improper highlights sustained oversight gaps; watch for CMS to announce RADV audit acceleration and new fraud controls in response.
Earnings Jul 24, 2026
HCA Healthcare reported second quarter revenue of 20.23 billion dollars and diluted EPS of 7.62 dollars, with a roughly 400 million dollar hit from ACA exchange coverage losses nearly offset by a 400 million dollar boost from Florida's Medicaid Supplemental Payment Program.
Why it matters The offsetting swing shows how directly a hospital chain's profits can hinge on two policy levers, ACA exchange enrollment and state Medicaid supplemental payment programs, both now under federal scrutiny.
Rule · now Jul 24, 2026
CMS's acting Center for Program Integrity director said operators will get 60 days notice before any decision to extend the six-month nationwide hospice and home health enrollment moratorium past its November 13, 2026 expiration.
Why it matters The freeze on new hospice and home health Medicare enrollments is scheduled to expire November 13; watch for a 60-day advance notice around mid-September if CMS plans to extend it.
Rule Jul 24, 2026
CMS began posting Hospice Annual Payment Update non-compliance notices in July 2026 warning of a 4% FY2027 payment cut for hospices that missed a 90% timely HOPE assessment submission threshold or lacked an approved CAHPS survey vendor during calendar year 2025.
Why it matters If your hospice submitted 2025 HOPE assessments, check your iQIES My Reports folder now, since a 4% payment cut for FY2027 is at stake and a reconsideration process is available.
Report Jul 24, 2026
CMS is using the 19.1% national hospice live-discharge rate, the share of patients discharged alive rather than dying in care, alongside long length-of-stay patterns as an automated screen for which hospices receive payment-suspension letters, with some suspended California hospices cited at rates in the mid-50s to 64%.
Why it matters If a hospice caring for you or a family member has an unusually high rate of patients being discharged alive, that pattern is now a documented fraud-screening trigger for CMS.
Enforcement Jul 24, 2026
Khalid Satary, 54, originally indicted in 2019 in the U.S. District Court for the Eastern District of Louisiana, was arrested July 21, 2026 in what HHS OIG calls one of the largest health care fraud schemes DOJ has ever charged, involving allegedly medically unnecessary genetic tests billed to Medicare.
Why it matters The arrest of a fugitive nearly seven years after indictment shows sustained federal pursuit of large-scale Medicare fraud; the $547 million alleged scheme illustrates how fraud at this scale can persist before detection and recovery.
Record Jul 24, 2026
AFSCME Local 3299 members struck for one day on July 22, 2026 over UC San Diego Health's plan to eliminate about 230 positions, while Novant Health separately confirmed cutting 31 revenue cycle jobs system-wide the same day.
Why it matters Hospital layoffs and labor unrest at two different systems in the same week point to continued cost pressure across the hospital sector even as some large chains post strong earnings.
Rule Jul 24, 2026
The U.S. Court of Appeals for the D.C. Circuit held on July 21, 2026 in Novartis Pharmaceuticals Corp. v. Kennedy that Eli Lilly, Bristol Myers Squibb, Sanofi, and Novartis cannot replace 340B point-of-sale discounts with a rebate model without prior HHS Secretary approval, backing HRSA's authority over the program.
Why it matters This ruling keeps the 340B drug discount structure intact for now; hospitals and safety-net clinics retain upfront discounts rather than being forced to pay full drug costs and wait for reimbursement.
Report Jul 24, 2026
The Private Equity Stakeholder Project found more than 500 US healthcare facilities now operate through joint ventures between private equity owned companies and nonprofit health systems, including 61 percent of Apollo-owned LifePoint Health's hospitals.
Why it matters The report raises the question of whether joint venture structures let private equity firms operate inside nonprofit hospitals without triggering the new state laws written specifically to screen private equity health care transactions.
Rule Jul 24, 2026
Sixteen carriers filed 2027 individual-market rate requests with the Pennsylvania Insurance Department ranging from 10.46 percent to 40.90 percent, with a statewide average of 17.1 percent, and 16 small-group carriers filed requests averaging 11.5 percent; public comment is open before the state approves final rates this fall.
Why it matters Pennsylvania residents who buy their own health coverage could face premium increases of 17 percent or more in 2027 if filed rates are approved; the public comment period is open and you can submit feedback before the state sets final rates.
Deal Jul 24, 2026
General Atlantic completed a roughly 3 billion dollar acquisition of non-medical personal care platform Team Services Group from Alpine Investors, while Kinderhook Industries separately closed a 1.1 billion dollar take-private of Medicare-certified provider Enhabit.
Why it matters The quarter's two biggest deals split between non-medical personal care, which sits outside Medicare's fraud crackdown, and Medicare-certified home health and hospice, which sits directly in its path.
Report Jul 24, 2026
Home health, hospice, and personal care M&A fell to just 16 closed deals in Q2 2026, down from 27 in Q1 2026 and 29 in Q2 2025, according to Mertz Taggart deal data.
Why it matters Fewer deals closing means less consolidation and slower change in who owns your local home health or hospice agency right now.
Earnings Jul 24, 2026
Quest Diagnostics grew adjusted EPS 19.1 percent to 3.12 dollars and revenue 10.2 percent to 3.04 billion dollars in the second quarter, and raised full year 2026 revenue guidance to 11.95 to 12.05 billion dollars.
Why it matters Continued growth at the country's largest independent lab shows outside diagnostic testing volume keeps expanding even as some hospital systems report softer surgical volumes.
Deadline Jul 24, 2026
Chairman Bill Cassidy delayed the July 23, 2026 committee vote on CDC director nominee Dr. Erica Schwartz after Senator Lisa Murkowski was absent for a family emergency; Cassidy said he has the votes to confirm Schwartz after CDC updated vaccine-autism website language, and the next vote opportunity is July 30, 2026.
Why it matters The CDC director confirmation moves to a July 30 vote; the outcome affects agency leadership at a time of significant public health policy shifts, including evolving vaccine guidance and chronic disease programs.
Earnings Jul 24, 2026
Tenet posted adjusted EPS of 6.12 dollars versus a 4.26 dollar estimate on revenue of 5.63 billion dollars and raised full year 2026 EPS guidance to 20.30 to 21.69 dollars, sending shares up as much as 15 percent.
Why it matters Strong hospital chain earnings suggest underlying demand for hospital care remains robust despite ongoing cost and coverage pressures elsewhere in the industry.
Rule Jul 23, 2026
The American Association of Orthopaedic Surgeons said July 22, 2026 that CMS should withdraw payment cuts in its Calendar Year 2027 Medicare Physician Fee Schedule proposed rule, which cuts the conversion factor up to 1.68 percent, with comments due September 14, 2026.
Why it matters This is an early skirmish over next year's Medicare doctor pay rates; watch whether CMS revises the proposed cuts before finalizing the rule later this year.
Funding Jul 23, 2026
SAMHSA and CMS announced May 28, 2026 that ten states will start cost based prospective payment rates for community behavioral health clinics between July 2026 and July 2027, even as H.R. 1's Medicaid work reporting requirement takes effect January 1, 2027.
Why it matters More states now offer a Medicaid payment model built to sustain community mental health clinics, but a new work reporting rule could shrink the patient base that funds it starting in 2027.
Earnings Jul 23, 2026
CHS reported Q2 net income of 70 million dollars, down from 282 million dollars a year earlier, as revenue fell 9.8 percent to 2.825 billion dollars, and it now guides to a full-year diluted loss of 1.10 to 1.25 dollars a share after divesting nine hospitals in 2026.
Why it matters A hospital chain that was solidly profitable a year ago now expects to lose money for the full year, a sign of how divestitures, payor mix and cost pressure are squeezing mid-sized hospital operators; watch whether the divestiture pace continues.
Rule Jul 23, 2026
The CY2027 Physician Fee Schedule proposed rule applies the last 19.1 percent work-value increase to tobacco cessation and SBIRT codes and extends the telehealth in-person exception through December 31, 2027.
Why it matters This determines whether your therapist keeps getting paid more for certain services and whether you can keep seeing a psychiatrist by video without an extra in-person visit through 2027.
Deal Jul 23, 2026
Dassault Systemes agreed to buy the AI-native compliance platform ArisGlobal, which processes more than 12 million patient safety reports a year for over 200 life-sciences customers, for about 1.8 billion dollars in cash plus up to 200 million dollars in milestone payments, with the deal expected to close in the second half of 2026.
Why it matters A major software company is betting 1.8 billion dollars that AI-driven drug-safety compliance is a growth market, a signal worth watching as pharmacovigilance software consolidates.
Enforcement Jul 23, 2026
EyePoint disclosed in a July 17, 2026 SEC filing that it will pay $4,678,981.86, including $4,657,463.18 to the federal government, to resolve False Claims Act allegations that it ran a 2019-2023 Assurance Program reimbursing surgery centers when insurers underpaid for its post-cataract drug DEXYCU.
Why it matters This is a reminder that drugmakers offering to backstop insurance shortfalls for surgery centers can trigger federal kickback enforcement; watch for the underlying DOJ press release once accessible.
Alert · now Jul 23, 2026
Michigan health officials reported 7,171 cyclosporiasis cases as of July 22, 2026, a single day jump of 600 cases linked to Taylor Farms de Mexico iceberg lettuce served at Taco Bell, with hospitalizations more than doubling to 102 in the prior week.
Why it matters This is one of the largest foodborne illness outbreaks on record in the US, so if you ate at a Michigan Taco Bell recently and have prolonged diarrhea, watch for cyclosporiasis symptoms and seek testing.
Deal Jul 23, 2026
A federal bankruptcy judge approved a plan for Greenwood and Leflore County to donate the 25-bed hospital to the University of Mississippi Medical Center effective August 1, 2026, resolving a crisis rooted in a 5.5 million dollar Medicaid recoupment demand from June 2025.
Why it matters A rural safety-net hospital that nearly could not make payroll gets a permanent fix instead of a shutdown, a rare outcome worth watching as a model for other struggling rural hospitals.
Record Jul 23, 2026
The House Committee on Oversight and Government Reform marked up and advanced H.R. 6610, the Pharmacists Fight Back Act, on July 22, 2026, imposing new pricing transparency and markup restrictions on pharmacy benefit managers in the Federal Employees Health Benefits Program.
Why it matters This is a step toward more transparency into how PBMs price drugs for the health plan covering federal workers and retirees; watch whether it gets a Senate companion or floor vote.
Report Jul 23, 2026
The tri-agencies' fourth annual MHPAEA report found 76 of 85 requested comparative analyses got insufficiency letters on first submission, while Pennsylvania became the Counseling Compact's 40th state on July 12, 2026 though only 6 states issue interstate practice privileges.
Why it matters Most health plans reviewed could not initially prove their mental health coverage rules matched their medical coverage rules, and even though 40 states allow counselors to practice across state lines on paper, only 6 actually let them do it yet.
Rule Jul 23, 2026
DOL, HHS, and Treasury told a court on March 30, 2026 that they will not defend the 2024 MHPAEA final rule and plan to propose replacement regulations by year end, with enforcement of the rule's new provisions staying frozen and a status update due September 30, 2026.
Why it matters The rule meant to stop insurers from making therapy harder to access than a doctor visit is in limbo, but the underlying parity law is still enforceable.
Earnings Jul 23, 2026
Molina reported adjusted EPS of 1.51 dollars versus estimates near 1.39 to 1.40 dollars and raised its full-year adjusted EPS floor to 5.25 dollars, but held revenue guidance near 42 billion dollars, about 2.28 billion dollars below Wall Street's estimate, sending shares down as much as 9.2 percent in premarket trading.
Why it matters The stock drop shows investors are focused on revenue growth and Medicaid margin trends more than a one-quarter earnings beat, so watch full-year guidance updates rather than single-quarter results.
Deadline Jul 23, 2026
The Senate HELP Committee voted 17 to 5 on July 22, 2026 to advance the INSULIN Act capping monthly insulin costs at $35 for privately insured patients, and returns today to vote on CDC director nominee Erica Schwartz and two other nominations.
Why it matters This is a step toward a federal insulin price cap and a look at who will run the CDC amid vaccine policy tension with HHS Secretary Kennedy. Watch whether the committee actually advances the nominees today and whether the insulin bill gets floor time.
Deal Jul 23, 2026
Talkspace shareholders approved UHS's $835 million all-cash acquisition on May 29, 2026 with a third-quarter close still pending state regulatory approval, while MKH Capital Partners completed its purchase of the 22-location Haven Health Management SUD operator on March 31, 2026.
Why it matters A major psychiatric hospital chain is close to also owning a national virtual therapy platform, and private equity money is still flowing into addiction treatment.
Enforcement Jul 23, 2026
Federal prosecutors charged Mikia Noble of Advancing Communities Everywhere with conspiracy to commit health care fraud for allegedly paying homeless Medicaid beneficiaries for their Medicaid numbers to bill unnecessary crisis stabilization services.
Why it matters This is a reminder that Medicaid fraud enforcement is actively targeting crisis and behavioral health billing, using some of the most vulnerable patients as the vehicle.
Report Jul 23, 2026
Cardinal Health, Cencora and McKesson have collectively spent more than 16 billion dollars acquiring or taking stakes in physician-practice management organizations, concentrated in oncology, gastroenterology, ophthalmology and urology, with Cencora's 4.6 billion dollar full buyout of OneOncology in February 2026 the latest and largest example, according to analyst Drug Channels.
Why it matters The companies that distribute nearly every drug in America increasingly also own the physician practices prescribing those drugs, a vertical-integration trend worth watching for its effect on drug choice and competition.
Enforcement Jul 22, 2026
The Department of Justice agreed on July 21, 2026 to pay the Alaska Native Tribal Health Consortium $400 million, resolving a 2021 lawsuit over unreimbursed contract support costs from 2014 through 2022.
Why it matters This sets a precedent for tribal health organizations nationwide to recover costs the federal government failed to pay them; watch for more tribes filing similar claims after the 2024 Becerra ruling.
Deal Jul 22, 2026
American Industrial Partners is paying $25.00 a share in cash, a 72.1 percent premium to Avanos's pre-announcement price, with the deal expected to close by July 27, 2026.
Why it matters A medtech maker used in hospitals nationwide is leaving public markets at a large premium, a sign of what private equity will pay for undervalued healthcare companies right now.
Deal Jul 22, 2026
CareDx finalized its purchase of Naveris, maker of the only Medicare covered blood test for monitoring HPV associated head, neck and anal cancers, extending its diagnostics business beyond transplant monitoring.
Why it matters A transplant diagnostics company is betting cancer monitoring blood tests are the next growth market, which could mean wider availability of this HPV cancer surveillance test as it scales.
Rule Jul 22, 2026
CMS's CY2027 OPPS/ASC proposed rule would pay hospitals ASP minus 33.4 percent for 340B acquired drugs starting January 1, 2027, replacing the current ASP plus 6 percent rate, while also accelerating repayment of the 7.8 billion dollar 340B remedy.
Why it matters This is a proposal, not final law yet, but if it holds it directly cuts what hospitals earn on discounted cancer drugs, which could change where you get treated as hospitals reassess their infusion programs.
Report Jul 22, 2026
A federal audit posted July 21, 2026 found Colorado failed to verify personal care visits in its electronic visit verification system, recommending an immediate $8 million refund and flagging $45.7 million in additional questioned costs.
Why it matters This exposes a gap in state-level fraud detection through EVV systems that other states may share; watch for similar audits elsewhere and how much CMS ultimately recovers.
Rule Jul 22, 2026
A federal judge in Maryland stayed eight consumer cost provisions of CMS's 2027 Notice of Benefit and Payment Parameters rule on July 16, 2026, days before its July 20, 2026 effective date, in a suit brought by several cities and counties.
Why it matters This keeps consumer protections like network adequacy standards and standardized plan offerings in place while litigation continues; watch for a ruling on the case's merits.
Enforcement Jul 22, 2026
HealthLGX sued MultiPlan (now Claritev) and roughly two dozen insurers on July 9, 2026 in Illinois federal court, alleging a shared pricing methodology suppressed out-of-network reimbursement across a market the complaint says the group controls by 80 to 90 percent of dollar volume.
Why it matters A new antitrust case alleges a shared pricing algorithm quietly held down what out-of-network doctors get paid across most of that market, and its outcome could reset how those rates are set nationwide.
Report Jul 22, 2026
An OIG audit posted July 20, 2026 found Medicare contractor Novitas Solutions improperly paid about $19.5 million for evaluation and management, psychotherapy, podiatry and wound care services to nursing home residents, a 60.7 percent error rate on sampled claims.
Why it matters This shows widespread documentation errors, not fraud, drove nearly two-thirds of sampled claims to be wrong; watch for the promised provider education rollout.
Report Jul 22, 2026
An OIG report posted July 21, 2026 found state Medicaid managed care contracts set fraud referral deadlines ranging from 1 to 270 days, with some states setting no deadline or consequence at all.
Why it matters This reveals inconsistent state rules on how fast Medicaid plans must report suspected provider fraud; watch for CMS follow-up requiring enforceable rules.
Enforcement Jul 22, 2026
DOJ settled a False Claims Act suit alleging Progressive Oncology & Hematology and owner Dr. Mouhamad Bazzi billed Medicare, Medicaid and the VA for chemotherapy drugs obtained free through manufacturer assistance programs and for chemo never administered.
Why it matters This shows federal fraud enforcement is actively targeting small oncology practices over drug billing practices tied to patient assistance programs, not just large health systems.
Report Jul 22, 2026
A peer-reviewed analysis of CMS data from 2018 to 2025 found 13.6 percent of US counties lost radiation oncology treatment sites, with losses concentrated in poorer, more rural counties with fewer primary care physicians.
Why it matters This matters because where you live increasingly determines whether you can get radiation therapy without traveling far, and the gap is widening in poorer, rural areas.
Deal Jul 22, 2026
Sabra will move 22 of the facilities to Cascadia Healthcare and four to an existing tenant, raising combined annualized cash rent to about $53 million from the $41 million Avamere paid, once the transition completes in the second half of 2026.
Why it matters A nursing home operator told its landlord directly it wanted out of the skilled nursing business, and the landlord replaced it across 26 buildings and raised the rent, a sign of ongoing stress and consolidation in post-acute care.
Approval Jul 22, 2026
The FDA approved subcutaneous isatuximab-irfc (Sarclisa Escena) for three multiple myeloma combination regimens, deliverable through the CirCLIQ on-body injector or manual syringe instead of IV infusion.
Why it matters This could mean shorter, simpler treatment visits for multiple myeloma patients who currently sit through hours long infusions.
Deadline Jul 22, 2026
Absent a new agreement, UHealth's hospitals, clinics and physicians become out-of-network on August 1, 2026 for UnitedHealthcare's commercial, ACA exchange and Medicaid plan members, while Medicare Advantage plans are unaffected.
Why it matters Hundreds of thousands of patients in South Florida could lose in-network access to Miami's academic health system, including specialized cancer and eye care, if no deal is struck by July 31.
Rule Jul 21, 2026
The American College of Cardiology's own analysis found that up to 20 percent of physicians CMS selected for the mandatory Ambulatory Specialty Model may be misclassified under the cardiovascular disease specialty code CMS used to build its roughly 8,600 physician roster.
Why it matters A coding error could pull the wrong doctors into a mandatory five year Medicare risk program with payment swings of plus or minus 9 percent starting January 1, 2027. Watch whether CMS corrects its classification before rosters lock.
Report Jul 21, 2026
A JAMA Network Open study of 32 cardiology services across four major insurers found median facility fees for ICD insertion ranging from 6,674 dollars under Aetna to 36,269 dollars under UnitedHealthcare, a difference the authors trace to payer facility negotiating leverage rather than any difference in the procedure.
Why it matters The same cardiac device implant can cost insurers wildly different amounts depending only on which contract is in place, not on anything clinical. Watch for this data feeding into site neutral payment policy debates.
Report Jul 21, 2026
MedAxiom president and CEO Jerry Blackwell said private equity's footprint in cardiology is smaller than commonly portrayed, even as PwC's mid-year 2026 outlook named cardiovascular services one of the two most sought after physician specialties for the rest of 2026.
Why it matters The pitch that private equity already owns cardiology may be overstated, but deal interest in the specialty is not slowing. Watch how this framing affects negotiating leverage in upcoming practice sales.
Rule Jul 21, 2026
The public comment period on CMS-2449-P, which would cap Medicaid managed care state directed payments at 100 to 110 percent of Medicare rates, closed July 21, 2026 with CMS projecting 774.8 billion dollars in savings over 10 years.
Why it matters This rule could reshape how much money flows to hospitals and insurers through Medicaid, one of the country's largest health programs; watch for a final rule and whether the caps survive as proposed.
Alert · now Jul 21, 2026
FDA said Sunday that a lettuce sample it had reported as testing positive for Cyclospora was actually a false positive, but it is keeping the recall of Taylor Farms de Mexico iceberg lettuce in place based on other traceback and epidemiological evidence.
Why it matters Even though a key lab test in this outbreak turned out to be wrong, the recall and underlying case count of over 1,600 illnesses stand, a reminder that outbreak investigations rely on more than a single lab result.
Enforcement Jul 21, 2026
DOJ charged Dr. Jason Finkelstein of Fort Worth with health care fraud for allegedly billing about 89 million dollars for unreviewed cardiovascular tests on student athletes, including one teenager who died of cardiac arrest 24 days after Finkelstein signed off on 63 of the teen's results in about 11 seconds.
Why it matters A doctor allegedly rubber stamped tens of thousands of student athlete heart scans without reviewing them, and a teenager died weeks after one of those scans. Watch this case as part of DOJ's largest ever health care fraud takedown.
Report Jul 21, 2026
Staffing Industry Analysts projects the US healthcare staffing market will reach approximately $40.2 billion in 2026, up about 2 percent after two consecutive down years, with locum tenens growing fastest at roughly 4 percent, even as travel-nurse gross margins compressed from 20.6 percent to 19.3 percent, and smaller deals filling the consolidation gap left when the FTC blocked Aya Healthcare's $615 million bid for Cross Country Healthcare in December 2025.
Why it matters Healthcare staffing is recovering to modest growth in 2026 even without its biggest potential merger, as smaller deals reshape competition. Travel-nurse margins are still compressing while locum tenens is growing faster than the overall market.
Record Jul 21, 2026
AHA, ACC, ESC and WHF published the Second Universal Definition of Heart Failure, replacing rigid ejection fraction cutoffs with three clinical categories and resetting the lower limit of normal left ventricular ejection fraction to about 53 percent for women and 52 percent for men.
Why it matters This redefines who counts as having heart failure, which affects who qualifies for certain treatments and, down the line, which patients fall inside CMS's new mandatory cardiology risk model.
Deal Jul 21, 2026
InMode's three-member special committee told shareholders on July 20, 2026, that it is still evaluating competing acquisition proposals from Steel Partners Holdings, making its first 100 percent buyout offer, and a management-led group, with the annual shareholder meeting on July 30, 2026, as the next key decision point.
Why it matters InMode, a medical aesthetics device maker, is the subject of two competing bids to take it private, with a court deadline passing unresolved and the special committee still undecided. The July 30 shareholder meeting is the next pressure point.
Enforcement Jul 21, 2026
NeoGenomics disclosed in a July 20, 2026 securities filing that it will pay 9,813,260 dollars plus interest to resolve civil False Claims Act allegations tied to consulting and commission arrangements with referring providers.
Why it matters A national lab company is paying millions after admitting it gave doctors' offices financial perks tied to referrals, a reminder that even self-reported violations carry real settlement costs.
Record Jul 21, 2026
Novo Nordisk filed a Lanham Act suit in U.S. District Court for the District of New Jersey on July 21, 2026, alleging that a Lilly TV ad with more than 700 million impressions compared Zepbound results against an outdated lower dose of Wegovy rather than the FDA-approved 7.2 mg dose cleared in March 2026, and is seeking an injunction, corrective advertising, and damages.
Why it matters Novo Nordisk and Eli Lilly are now in litigation over TV ads in the GLP-1 weight-loss drug market. The outcome could force Lilly to pull a widely seen ad and shift prescriber and patient expectations about how the two drugs compare.
Record Jul 21, 2026
A federal judge in Chicago heard oral argument today on Health Care Services Corporation's motion to dismiss a suit by PHI Health accusing the Blue Cross Blue Shield insurer of withholding payment after losing a No Surprises Act arbitration.
Why it matters This case is testing whether the No Surprises Act's arbitration process actually forces insurers to pay when they lose, since the law set a pricing mechanism but no explicit federal payment-enforcement tool.
Rule Jul 21, 2026
AATS, ACC, HFSA, SCAI and STS filed joint comments before CMS's July 15, 2026 deadline opposing a proposal to drop the dual operator requirement for TAVR, with a final CMS decision due by September 13, 2026.
Why it matters This fight decides whether every TAVR patient must be evaluated by both a surgeon and a cardiologist before the procedure, a safeguard CMS is now reconsidering. Watch for CMS's decision memo by September 13.
Deal Jul 21, 2026
Tempus AI agreed to pay $16.25 per share, approximately $1.5 billion net enterprise value, for Personalis and its minimal residual disease cancer-recurrence blood test, with the deal expected to close in late 2026 or early 2027 pending regulatory and shareholder approval.
Why it matters Tempus AI is paying roughly $1.5 billion to fold a cancer-recurrence blood test into its AI data platform, in a market both companies size at $20 billion. Watch whether the combined company can scale MRD testing commercially after regulatory clearance and deal close.
Funding Jul 21, 2026
Tennessee closed intake July 20, 2026 on its first wave of Rural Health Transformation Program grant opportunities after receiving approximately 206.9 million dollars in Budget Period 1 funding from the federal program.
Why it matters Rural hospitals and clinics in Tennessee now wait to hear which applicants get funded from this state's share of a five-year, 50 billion dollar federal program meant to shore up rural health care nationwide.
Deal Jul 20, 2026
CBRE found first-quarter 2026 US medical outpatient building investment volume rose 78 percent year over year to 2.9 billion dollars as Big Sky Medical closed its third and fourth Fund III acquisitions, the RidgeWood Medical Center campus, on July 9, 2026.
Why it matters Capital is flowing into the outpatient buildings where more care is happening as it shifts out of hospitals, and cap rates below 7 percent for the first time since 2024 signal strong investor demand. Watch whether this pace holds through the rest of 2026.
Rule Jul 20, 2026
The draft guidance, covering the negotiation program's third cycle and its first five Part B drugs including Botox, Cimzia, Orencia and Entyvio, opens a comment period through September 18, 2026 before the negotiated prices take effect January 1, 2028.
Why it matters This is the first test of Medicare's drug price negotiation program on drugs your doctor administers in office rather than ones you pick up at a pharmacy, and the mechanics are still being worked out.
Deal Jul 20, 2026
Stockholders voted 23.4 million shares in favor versus about 12,300 against on July 16, 2026 to approve Knox Lane's $13.25-a-share all-cash offer, clearing the way for the staffing firm to go private and delist from Nasdaq in the third quarter.
Why it matters One of the largest publicly traded travel-nurse staffing firms is going private, meaning less public visibility into its finances and strategy going forward. Watch for the deal to close in Q3 2026 and Cross Country's delisting from Nasdaq.
Rule Jul 20, 2026
The proposed rule would turn the G2211 office-visit complexity add-on into a modifier worth a 16 percent E/M payment bump, add a second ACO-only modifier worth 32 percent, and require remote physiologic and therapeutic monitoring to be furnished by practice employees rather than contractors.
Why it matters Two Medicare payment changes here: a bigger bonus for complex office visits, and a tighter staffing rule for remote monitoring billing that could squeeze practices relying on contracted monitoring staff. Watch whether the RPM staffing requirement holds through the final rule.
Rule Jul 20, 2026
The CY2027 Physician Fee Schedule proposed rule would raise the prior savings adjustment scaling factor from 50 percent to 75 percent, raise the BASIC track's top shared-savings rate from 50 to 60 percent, and cut the ENHANCED track's maximum regional adjustment weight from 50 to 35 percent, with comments closing September 14, 2026.
Why it matters This rewrites how much of an ACO's own savings get folded back into next year's target, the biggest change to ACO benchmarking math in years. Watch whether the ratchet-relief and guardrail provisions survive comment unchanged by September 14.
Rule Jul 20, 2026
The Justice Department published a Federal Register notice stating its 2011 Olmstead enforcement statement, which directed states to move people with disabilities into community care instead of institutions, is no longer enforceable guidance, though the underlying Supreme Court precedent still stands.
Why it matters The Supreme Court ruling that people with disabilities have a right to community based care instead of institutionalization is unchanged, but the government just pulled the practical guidance it used to enforce it.
Record Jul 20, 2026
The two agencies signed a memorandum of understanding July 13, 2026 to coordinate clinical trial research, train providers and collect real world data on psychedelic assisted therapies ahead of any FDA approval for the more than 1 million veterans the agencies say could be affected.
Why it matters No psychedelic drug currently has FDA approval for these uses, so this agreement is about getting the infrastructure ready in case one does, not a change in what you or a veteran you know can be prescribed today.
Rule Jul 20, 2026
More than 20 Democratic state attorneys general told a federal court in California v. HHS that immigration officials shared Medicaid recipients' data with contractor Palantir and, after claiming the data was purged, found six people who still had copies a day later.
Why it matters If you or a family member is on Medicaid, this is part of an ongoing fight over whether that enrollment data can be used for immigration enforcement, and the allegation here is that deletion promises were not kept.
Rule Jul 20, 2026
Governor Hochul signed a budget provision on May 28 extending NP independent-practice authority past its scheduled July 1, 2026 sunset through July 1, 2030, while a separate bill to make it permanent died in committee before the legislature adjourned June 5.
Why it matters New York avoided letting nurse practitioner independence lapse, keeping the state aligned with the 30-plus states that already allow NPs with sufficient practice hours to see patients without a physician collaborative agreement. Watch 2030, when the sunset returns and the permanent-authority bill could resurface.
Enforcement Jul 20, 2026
The audit, running through fiscal year 2028, targets whether CCM patients actually meet the two-or-more-chronic-conditions eligibility standard rather than just whether billed minutes were documented.
Why it matters This is a narrower, harder-to-defend audit target than the usual time-tracking reviews: perfect documentation of minutes won't save a claim if the underlying diagnoses don't support CCM eligibility. Watch for enforcement actions or self-disclosures as the audit progresses through 2028.
Deal Jul 20, 2026
Valspring Capital led the round in the 21-location pediatric primary care platform with existing backer M33 Growth participating, the same week Astrana Health disclosed $120.4 million in 2024 gross shared savings across eight ACOs in MSSP and ACO REACH.
Why it matters Investors are pricing proven value-based primary care performance at a premium now, per FOCUS's estimate of double-digit EBITDA multiples for practices with strong MA or ACO track records versus 6 to 8 times otherwise. Watch which segment, pediatric or adult ACO, draws more capital next.
Report Jul 20, 2026
Rock Health found US digital health startups raised 7.4 billion dollars across 244 deals in H1 2026 while 115 corporate acquisitions closed, 71 of them in the second quarter alone.
Why it matters This is a snapshot of how much money and dealmaking is happening in digital health right now, useful for gauging whether the sector is consolidating. Watch whether acquisitions keep outrunning new funding rounds through the second half of 2026.
Rule Jul 20, 2026
The committee holds an executive session Wednesday on 13 bills including a 35 dollar monthly insulin cap and a hospital price transparency bill, then votes Thursday on three nominees including Dr. Erica Schwartz to lead the CDC.
Why it matters If either bill clears committee, a 35 dollar insulin cap for privately insured patients and new hospital price disclosure rules move a step closer to reality, though both still need floor votes.
Rule Jul 20, 2026
The Ways and Means Committee approved seven Medicare bills July 15, 2026, including one requiring Medicare Advantage insurers to disclose premium spending starting 2029, while a companion hospital and insurer price disclosure bill passed only 25 to 15 along party lines.
Why it matters One bill would force Medicare Advantage insurers to show how much of your premium goes to actual care versus overhead, and it has bipartisan support, but the broader price transparency bill does not.
Deal Jul 20, 2026
XRHealth acquired Swing Therapeutics on July 15, 2026, its sixth acquisition in two years, adding the FDA-authorized Stanza digital treatment and the Swing Care virtual clinic for fibromyalgia.
Why it matters This adds a new treatment option for fibromyalgia, a condition affecting an estimated 10 million Americans, to a platform already covered by Medicare Part B, the VA and commercial insurance. Watch whether XRHealth expands Stanza's reach beyond its current 22-state footprint.
Report Jul 19, 2026
AM Best's Best's Market Segment Report found medical professional liability insurers posted a combined 712 million dollar underwriting loss in 2025, up from 546 million dollars in 2024, even as their direct premiums written grew 3.6 percent to 9.4 billion dollars.
Why it matters The insurers who cover hospitals and doctors against malpractice claims are losing money on that coverage for a second year running, which usually shows up later as higher premiums for the health systems and physician groups who buy it. Watch renewal pricing over the next year.
Rule Jul 19, 2026
Roughly 8,600 cardiologists who treat outpatient Medicare heart failure patients in CMS-selected regions must join the mandatory, five-year Ambulatory Specialty Model starting January 1, 2027, with no opt-out and payment swings of negative 9 percent to positive 9 percent on Part B claims through 2031.
Why it matters If you or a family member sees a cardiologist for heart failure, your doctor's Medicare pay is about to swing up or down based on quality and cost performance, which could affect how care is managed. Watch whether your cardiology practice is in a selected region.
Enforcement Jul 19, 2026
Advanced Pathology Solutions, its management company APS MSO, and three owners agreed to a five year Corporate Integrity Agreement effective June 17, 2026 after DOJ alleged they paid kickbacks to gastroenterology practices and ordered unnecessary biopsy testing from 2015 through July 2022.
Why it matters This shows federal enforcement targeting kickback arrangements embedded inside physician practices, a pattern other labs doing similar business should take note of.
Rule Jul 19, 2026
The 2026 Consolidated Appropriations Act delinks Part D PBM compensation from drug price, a Department of Labor proposed rule would require claim-level pricing disclosure for employer plans, and the FTC's Express Scripts insulin settlement already bars favoring high list price drugs on standard formularies.
Why it matters If you take medication through an employer or Medicare Part D plan, these changes are aimed at stopping pharmacy benefit managers from steering you toward higher-cost drugs for their own profit, including up to 7 billion dollars in projected insulin savings over a decade. Watch whether your out-of-pocket drug costs actually move as these rules phase in.
Rule Jul 19, 2026
The CY2027 Physician Fee Schedule proposed rule (CMS-1848-P) would raise the Shared Savings Program's Basic Level E rate from 50 to 60 percent and add a retroactive spending guardrail for Performance Year 2025 that delays reconciliation payments to November 2026, with comments due September 14, 2026.
Why it matters This reshapes how Medicare's largest accountable care program splits savings, and if finalized it could delay payments many physician organizations were expecting this year.
Rule Jul 19, 2026
The CY2027 Medicare Physician Fee Schedule proposed rule would end traditional MIPS after the CY2028 performance period, making the MIPS Value Pathway framework mandatory starting CY2029, with hospital medicine getting its first dedicated pathway and comments closing September 14, 2026.
Why it matters This is a back-office Medicare billing change for physicians, not something that directly touches patient care, so minimal direct relevance if you're not a clinician. The one thing to watch is whether quality reporting changes affect which doctors are labeled high performers in public data.
Rule Jul 19, 2026
The proposed CY2027 OPPS/ASC rule would pay hospitals only 40 percent of the normal outpatient rate for basic off-campus CT, MRI, and ultrasound studies without contrast, cutting an estimated 260 million dollars in total imaging spending, with comments open through August 31, 2026.
Why it matters If you get imaging done at a hospital-owned outpatient site, this doesn't change what you pay directly, but it changes what hospitals are paid, which can influence whether they keep operating those sites. Watch for hospitals restructuring or closing off-campus imaging locations.
Approval Jul 19, 2026
The FDA approved Celcuity's gedatolisib (Revtorpyk) on July 14, 2026 for use with fulvestrant, with or without palbociclib, after the VIKTORIA-1 trial showed it cut the risk of progression or death by up to 76 percent in HR-positive, HER2-negative breast cancer.
Why it matters This gives patients with a common, hard-to-treat form of metastatic breast cancer a new option, and the trial results are notably strong; watch how quickly insurers cover it.
Deadline Jul 19, 2026
The House Energy and Commerce Committee, chaired by Rep. Brett Guthrie, will vote July 20, 2026 on 29 bills including the Lower Costs, More Transparency Act, the Prior Authorization Accountability Act, and the Expedited Access to Biosimilars Act.
Why it matters This is a legislative step, not law yet; watch which of the 29 bills clear committee since that signals what Congress may act on next.
Deal Jul 19, 2026
A Haifa District Court deadline for InMode and Steel Partners affiliate SP Strategic Holdings to respond passed on July 19 without a public ruling, leaving frozen the special committee's review of Steel's 16.75 dollar per share offer against CEO Moshe Mizrahy's rival 16.20 dollar per share bid.
Why it matters A takeover fight over who buys InMode is stuck in an Israeli court because the company's own CEO is one of the bidders, and the board cannot move on either offer until the conflict of interest question is resolved. Watch for a new hearing date.
Earnings Jul 19, 2026
Intuitive Surgical reported second-quarter 2026 revenue of 2.89 billion dollars, up 19 percent year over year, but its stock fell as much as 11 percent after US da Vinci procedure growth slowed to about 12 percent from 14 percent in the first quarter.
Why it matters This is a case of investors reading between the lines: hard numbers beat expectations but the growth rate for actual surgeries in the US is slowing, which matters more for the stock than the quarter that just closed. Watch whether the slowdown persists into Q3 or proves temporary.
Deal Jul 19, 2026
LTC Properties paid 73 million dollars for two MorningStar-operated senior living communities in Colorado and New Mexico while National Healthcare Properties closed roughly 197 million dollars in acquisitions across 16 communities since late June, together deploying about 270 million dollars into senior housing real estate in under two weeks.
Why it matters Capital keeps flowing into assisted living and memory care real estate even as investment pulls back from hospital campuses, a sign investors expect steady demand for senior housing regardless of broader healthcare volatility. Watch whether cap rates compress further as more capital chases these deals.
Enforcement Jul 19, 2026
Kirtan Patel was sentenced to 30 months and technician Christopher Lugo to 24 months on July 16, 2026 for falsifying audit documents and prescription pickup records to cover up more than $1.1 million in fraudulent Medicare and private insurer billing, with Patel owing $620,000 in restitution plus $620,000 forfeiture.
Why it matters This is a reminder that falsifying records to cover up billing fraud carries prison time, not just fines.
Report Jul 19, 2026
HHS's Office of Inspector General posted Advisory Opinion 26-16 on July 14, 2026, concluding a health center's produce box and grocery voucher program for chronically ill patients would not trigger Anti-Kickback Statute or Civil Monetary Penalties Law sanctions, though the opinion legally binds only the requesting health center.
Why it matters This signals that food as medicine programs tied to patient diagnoses can be structured to avoid kickback law risk, though the opinion only legally protects the requesting health center.
Rule Jul 19, 2026
The same private equity capital that bought into cardiology, orthopedics, radiology, and specialty pharmacy this month is now facing state transaction review laws in California, Rhode Island, and Maine, with Maine's 2027 law giving regulators up to seven months to approve, conditionally approve, or reject a deal.
Why it matters This affects how quickly and quietly private equity firms can buy up local medical practices, which can influence pricing and access in your area over time. Watch whether your state adopts a transaction review law similar to California's or Maine's.
Rule Jul 19, 2026
The FY2027 IPPS proposed rule would add three spinal fusion MS-DRGs to CMS's mandatory Transforming Episode Accountability Model, with a final rule expected around August 2, 2026, ahead of a proposed October 1 start.
Why it matters If you or a family member needs spinal fusion surgery through Medicare, the hospital performing it may soon carry financial risk for your full episode of care, which can affect care coordination after discharge. Watch for the final rule around August 2.
Report Jul 18, 2026
The Association of Organ Procurement Organizations published an eight-measure quality framework, with the first four measures already submitted for federal endorsement, to replace the two-metric system CMS uses to decide decertification.
Why it matters Nearly every US organ procurement organization is proposing new quality measures to head off intensifying CMS decertification enforcement. Watch whether CMS adopts any of the proposed measures.
Rule Jul 18, 2026
The Consolidated Appropriations Act of 2026, a pending Department of Labor disclosure rule, and an active FTC settlement each attack PBM compensation on a different timeline, from a 2028 Part D fee mandate to insulin formulary rules already in force.
Why it matters This is the biggest shake-up in years to how the middlemen managing your prescription drug benefit get paid, though each piece phases in on its own schedule so nothing changes overnight.
Rule Jul 18, 2026
Judge Brendan Hurson ruled July 16, 2026 in Columbus II that CMS likely exceeded its rulemaking authority with provisions set to take effect July 20 that CMS itself estimated could cost up to 2 million people their marketplace coverage.
Why it matters This preserves coverage for up to 2 million people who could have lost ACA marketplace subsidies. Watch whether the government appeals the ruling.
Enforcement Jul 18, 2026
CVS Health will pay the Justice Department $130 million within two weeks of final approval and the remaining $310 million by March 15, 2028, resolving a False Claims Act case a jury had valued near $950 million, contingent on Omnicare's bankruptcy sale and an August 12, 2026 court hearing.
Why it matters A major nursing home pharmacy chain is paying a nine-figure settlement for filling prescriptions without valid orders, a reminder that long-term care dispensing draws close federal scrutiny.
Alert · now Jul 18, 2026
The agencies traced 1,644 illnesses and 94 hospitalizations across Indiana, Kentucky, Michigan, Ohio, and West Virginia to shredded iceberg lettuce from Taylor Farms de Mexico, which is now pulling all central Mexico-sourced lettuce and starting a recall.
Why it matters This is a large, ongoing multi-state foodborne illness outbreak tied to a major fast food chain's supply chain. Watch for the formal recall notice and whether the case count keeps rising.
Rule Jul 18, 2026
FDA's proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List has a comment period closing July 30, 2026, while Arkansas separately appeals the injunction blocking its law banning PBMs from owning in-state pharmacies.
Why it matters If you or someone you know gets a compounded GLP-1 weight-loss or diabetes drug, this rule would close that option once finalized, since both semaglutide and tirzepatide are no longer in official shortage.
Approval Jul 18, 2026
Merck's Lipfendra (enlicitide) cut LDL cholesterol by 56 percent in a 2,904 patient trial and 59 percent in a 303 patient familial hypercholesterolemia trial, matching injectable PCSK9 inhibitors already on the market.
Why it matters This gives people with high cholesterol a once-daily pill alternative to needles for the first time in this drug class. Watch for insurer pricing and coverage decisions.
Report Jul 18, 2026
The Government Accountability Office's spotlight report cites AMA survey data showing the adoption jump over two years and warns that unverified AI errors in medical notes and coding could cause patient harm or over- and under-billing.
Why it matters A government watchdog flags fast-growing clinician use of AI for notes and billing codes, and warns unverified errors could cause harm or billing mistakes. Watch for any future CMS guidance responding to these questions.
Deal Jul 18, 2026
Steel Partners sued in Haifa District Court to block InMode's special committee from reviewing a rival $16.20 a share bid led by CEO Moshe Mizrahy, after offering $16.75 a share in cash worth about $960 million.
Why it matters Watch whether the Haifa court blocks InMode's board from moving forward with a deal led by its own CEO, since the outcome could set a precedent on executive conflicts in buyouts.
Report Jul 18, 2026
Kaufman Hall found 18 hospital and health system deals closed in Q2 2026 versus 8 a year earlier, with transacted revenue rising to $7.7 billion from $1.4 billion and nearly all buyers nonprofit.
Why it matters Watch which nonprofit systems are absorbing smaller hospitals near you, since consolidation is accelerating after a slow 2025.
Deal Jul 18, 2026
Dimerix will pay Mission Therapeutics $5 million upfront and up to $287 million in milestones plus royalties for MTX652, an acute kidney injury drug, so Mission can focus cash on its Phase 1 Parkinson's candidate MTX325.
Why it matters Watch whether Dimerix's faster manufacturing path gets MTX652 to acute kidney injury patients sooner than Mission could have alone.
Enforcement Jul 18, 2026
Ohio's Attorney General charged Roberta Acheampong and Godfred Owusu-Sekyere, former operators of One Community Mental Health, with 12 felony counts for billing Medicaid for refugee counseling never provided, part of eleven fraud cases announced the same day totaling over $9.8 million.
Why it matters A couple fled the country after allegedly stealing $9.3 million from Medicaid by billing for refugee counseling that was never given. Watch for extradition efforts and how the case proceeds.
Deal Jul 18, 2026
Peak Rock Capital completed its acquisition of Asembia LLC on July 2, 2026, the specialty pharmacy industry's dominant technology, distribution, and data services layer, the same month Warburg Pincus is finalizing a deal exceeding $7 billion for rare disease specialty pharmacy PANTHERx Rare.
Why it matters Private equity is buying up the software and distribution infrastructure behind specialty drugs, not the pharmacies themselves, a sign of where the money sees the real leverage point in prescription drug costs.
Report Jul 18, 2026
The state's Independent Fiscal Office says a budget 'cycle roll' pushes two consecutive monthly Medicaid managed care payment cycles, about $1.3 billion each, later than scheduled without setting a fixed repayment date.
Why it matters A budget accounting move delays $2.6 billion in payments to Medicaid managed care plans without fixing Pennsylvania's roughly $5 billion structural deficit. Watch for whether a repayment date ever gets set.
Report Jul 18, 2026
Benefits consultants cited in July 2026 reporting say specialty drugs, GLP-1s foremost, now account for 60 percent or more of total drug spending at many employer health plans, a figure driving this month's wave of specialty pharmacy acquisitions.
Why it matters This is the number explaining why so much deal activity is happening in specialty pharmacy right now, since specialty drugs like GLP-1s have become the majority of what employer health plans spend on medications.
Deal Jul 18, 2026
Thurston Group united its SGA, Gen4 and Modis Dental Partners portfolio companies under the SGA Dental Partners name, creating a platform spanning more than 250 practice locations, 500 dentists and 26 states.
Why it matters Watch this fast-consolidating, lightly scrutinized corner of healthcare, where large dental support platforms already back a meaningful share of practicing US dentists.
Deal Jul 18, 2026
The private equity firm is buying a controlling stake in PANTHERx Rare from Nautic Partners, General Atlantic and Vistria Group, with terms undisclosed and the deal expected to close in coming months.
Why it matters Watch whether new ownership changes how patients access rare and orphan disease drugs through PANTHERx, the largest specialty pharmacy of its kind.
Rule Jul 17, 2026
CMS announced a Risk-Based Survey approach, effective September 8, that lets top-performing nursing homes skip most routine federal inspections so surveyors can focus on lower-rated facilities.
Why it matters Federal regulators will inspect high-performing nursing homes less often starting September 8, concentrating scrutiny on troubled facilities; watch whether reduced oversight affects care quality.
Rule Jul 17, 2026
CMS released its CY2027 Medicare Physician Fee Schedule proposed rule, which includes a payment cut and the first MIPS Value Pathway designed specifically for hospitalists, with comments due September 14.
Why it matters Medicare proposed cutting physician payments again for 2027 while adding a new hospitalist-specific quality-reporting track; watch the comment period and the final conversion factor.
Rule Jul 17, 2026
In the CY2027 Hospital Outpatient PPS proposed rule, CMS proposed letting accredited hospitals have accreditation organizations, rather than only state surveyors, check their EMTALA paperwork compliance, with comments due August 31.
Why it matters CMS proposed letting private accreditors review hospitals' EMTALA emergency-care paperwork; watch whether that eases or weakens oversight of the duty to screen and stabilize patients.
Report Jul 17, 2026
GAO found CMS lacks sufficient controls to verify consumer authorization for agent and broker changes, that confirmed unauthorized-enrollment complaints more than quadrupled since 2023, and that at least 160,000 federal marketplace applications in 2024 had likely unauthorized changes.
Why it matters A federal watchdog says marketplace enrollments can be changed without consumer consent, pointing to tighter enrollment-integrity rules and unwound plan switches ahead.
Rule Jul 17, 2026
The Consolidated Appropriations Act of 2026 extended CMS's Acute Hospital Care at Home waiver for five years, through September 30, 2030, giving hospitals long-term certainty to run inpatient-level care in patients' homes.
Why it matters Congress locked in Medicare's hospital-at-home program through 2030, letting hospitals keep treating inpatient-level patients at home; watch how programs scale with multi-year certainty.
Record Jul 17, 2026
A House Energy and Commerce subcommittee advanced three bills targeting illicit fentanyl pill-press and manufacturing equipment to the full committee.
Why it matters Congress is advancing bills to choke off illicit fentanyl manufacturing equipment; a supply-side enforcement move, not a coverage or payment change.
Rule Jul 17, 2026
The American Hospital Association filed comments disputing HRSA's estimate of the administrative burden that its proposed 340B Rebate Model Pilot Program would place on hospitals.
Why it matters Hospitals are fighting a proposed change that would run 340B drug discounts through rebates instead of upfront discounts, arguing the paperwork burden is far bigger than the government claims; watch whether HRSA revises the pilot.
Rule Jul 17, 2026
CMS reduced the federal No Surprises Act independent dispute resolution administrative fee from $115 to $15 per party, effective June 11, lowering the cost of entering payment disputes over out-of-network bills.
Why it matters The cost to file a federal surprise-billing payment dispute dropped from $115 to $15, making it far cheaper to challenge out-of-network payments; watch for a rise in dispute volume.
Deal Jul 17, 2026
IPG Photonics Corporation made a binding offer to acquire Lumibird Medical for 300 million euros plus an earnout of up to 50 million euros, for total consideration of up to 350 million euros, expanding into ophthalmology and urology lasers.
Why it matters A laser technology company is buying a medical laser maker to move deeper into ophthalmology and urology devices, a bet on medtech growth built on its core laser expertise.
Deal Jul 17, 2026
Jasper Therapeutics agreed to an all-stock merger with Kira Pharmaceuticals to build a complement-focused immune disease pipeline, paired with an approximately $132 million private placement to fund the combined company.
Why it matters Two small biopharma companies are combining and raising about $132 million to push complement therapies for immune disease; watch whether the cash runway is enough to reach clinical milestones.
Deal Jul 17, 2026
Medtronic closed its $650 million all-cash acquisition of SPR Therapeutics, adding SPR's minimally invasive, non-opioid peripheral nerve stimulation technology for chronic and acute pain to its neuromodulation portfolio.
Why it matters A medtech giant is buying its way deeper into non-opioid pain treatment; watch whether wider distribution expands access to drug-free pain devices.
Rule Jul 17, 2026
The National Family Planning and Reproductive Health Association and the ACLU filed for summary judgment seeking to block new HHS screening rules for Title X family planning grants.
Why it matters A family-planning group and the ACLU are asking a court to strike down new eligibility-screening rules for federal family-planning grants; watch the ruling for whether Title X funds keep flowing under the new terms.
Enforcement Jul 17, 2026
The HHS OIG kept active a Work Plan audit of Medicare high-level emergency department E/M billing, tied to an admission-status kickback theory behind recent settlements including Oroville Hospital's $10.25 million deal.
Why it matters Federal auditors are still scrutinizing hospitals that bill the highest-level emergency department visit codes; watch for more settlements as the audit continues.
Record Jul 17, 2026
REGENXBIO priced a $100 million public offering of common stock after its shares sold off on dilution concerns, raising cash that further dilutes existing shareholders.
Why it matters A gene-therapy developer is raising $100 million by issuing new stock, a move that dilutes current holders; watch what the cash funds and how the market reacts.
Deal Jul 17, 2026
Skagit Regional Health switched its hospitalist staffing contract from Sound Physicians to Vituity, and some physicians are leaving over the change.
Why it matters A Washington health system swapped its hospitalist staffing vendor from Sound Physicians to Vituity, prompting some doctor departures; watch for continuity-of-care disruption during the transition.
Enforcement Jul 17, 2026
Tactile Systems Technology agreed to pay $550,959 to resolve False Claims Act allegations that it submitted falsified Medicare claims for compression devices.
Why it matters A medical-device maker is paying $550,959 to settle claims it billed Medicare using falsified compression-device claims; a reminder that device documentation is under enforcement scrutiny.
Deal Jul 16, 2026
Big Sky Asset Management acquired HealthCap Partners, LLC, whose portfolio spans more than 150 healthcare properties across 28 states and more than $2.5 billion in transaction volume over nearly 30 years.
Why it matters A national medical real estate platform just got bigger, reflecting continued investor appetite for medical outpatient buildings as care keeps shifting out of hospitals into ambulatory settings.
Rule Jul 16, 2026
CMS published a Request for Information seeking input on the first major update to Clinical Laboratory Improvement Amendments regulations since 1992, with comments due September 14, 2026.
Why it matters Federal officials are reconsidering the decades-old rules that govern clinical lab quality and oversight, an early step that could reshape how labs are regulated for the first time in over 30 years.
Rule Jul 16, 2026
The DEA closed the evidentiary record on July 15 in its administrative hearing over moving marijuana from Schedule I to Schedule III, after proceedings that began June 29.
Why it matters The formal fact-finding phase of the long-running federal marijuana rescheduling case is now complete, moving the decision closer while leaving the ultimate outcome and timing uncertain.
Enforcement Jul 16, 2026
Forty-eight state attorneys general reached a $29.6 million settlement with Glenmark Pharmaceuticals over generic drug price-fixing, with New York securing more than $29 million of the total.
Why it matters State prosecutors extracted another settlement in the sprawling generic drug price-fixing cases, keeping pressure on manufacturers accused of coordinating to inflate the prices of everyday medicines.
Rule Jul 16, 2026
The House Ways and Means Committee voted 42 to 0 to advance the Improving Seniors' Timely Access to Care Act (H.R. 3514), a Medicare Advantage prior authorization reform bill, as part of a seven-bill health markup on July 15.
Why it matters A prior authorization reform bill aimed at Medicare Advantage cleared committee with unanimous bipartisan support, a strong signal that streamlining MA prior authorization has real momentum in Congress.
Earnings Jul 16, 2026
Johnson & Johnson and Abbott both beat Q2 2026 estimates and raised full-year guidance, with J&J lifting its outlook to about $101.1 billion in sales and Abbott raising adjusted EPS guidance to $5.45 to $5.60.
Why it matters Two of the largest diversified health companies posted strong quarters and raised their forecasts, a signal that demand for drugs and medical devices stayed healthy heading into the second half of 2026.
Enforcement Jul 16, 2026
Laboratory Corporation of America agreed to pay $14.5 million to resolve False Claims Act allegations that it billed federal programs for medically unnecessary urine drug testing.
Why it matters A major national lab settled claims it billed the government for unnecessary urine drug tests, underscoring continued federal scrutiny of high-volume drug-testing billing.
Deal Jul 16, 2026
Eli Lilly agreed to acquire AtaiBeckley Inc. for $6.75 per share in cash, about $2.8 billion upfront, plus a contingent value right of up to $2.50 per share tied to milestones, for total consideration of up to about $3.8 billion.
Why it matters A major pharma company is buying into psychedelic-derived treatments for treatment-resistant depression, a sign that mainstream drugmakers now see this once-fringe category as a serious pipeline bet.
Rule Jul 16, 2026
The Trump administration filed its defense on July 15 against a 26-state lawsuit challenging CMS and HHS's Medicaid work requirement interim final rule and its medically frail exemption, which is set to take effect July 31, 2026.
Why it matters A legal fight is underway over new Medicaid work requirements and how narrowly the medically frail exemption is defined, with 26 states suing to block a rule scheduled to take effect at the end of July.
Earnings Jul 16, 2026
UnitedHealth Group beat Q2 2026 estimates and raised full-year adjusted EPS guidance to $19.50 to $20.00, as its medical care ratio fell to 86.7 percent of premiums from 89.4 percent a year earlier.
Why it matters The largest US health insurer reported a sharp drop in the share of premiums paid out as medical claims and raised its outlook, a closely watched signal about medical cost trends across the industry.
Enforcement Jul 15, 2026
Aesculap Implant Systems agreed to pay 38.5 million dollars and entered a non prosecution agreement to resolve False Claims Act allegations that it failed to disclose an elevated failure rate for its knee implants.
Why it matters A knee implant maker paid 38.5 million dollars over allegations it hid a higher device failure rate, underscoring disclosure duties for implant makers; watch for related patient and provider claims.
Deal Jul 15, 2026
Atrium Health and OrthoCarolina in North Carolina formed a clinical affiliation and ambulatory surgery center joint venture in which Atrium takes no equity stake and OrthoCarolina remains physician-owned.
Why it matters A large health system and an independent orthopedic group are building an ortho destination through affiliation and shared ASCs rather than an outright buyout, a model that keeps physicians independent while moving surgical volume to lower-cost outpatient sites.
Rule Jul 15, 2026
CMS proposed cutting the Medicare physician fee schedule conversion factor for calendar year 2027 in its proposed rule (CMS 1848 P), published July 14, 2026 with comments due September 14 and an ACO Part B waiver provision starting April 2027.
Why it matters Medicare proposed lowering the base rate that sets physician payments for 2027, renewing the annual fight over doctor pay; watch the comment period and any congressional fix.
Earnings Jul 15, 2026
Elevance Health beat second quarter 2026 estimates and raised full year guidance even as its medical loss ratio rose 80 basis points to 89.7 percent and medical membership fell to about 44.9 million, down 469,000 from the prior quarter.
Why it matters A major insurer topped estimates and lifted guidance despite rising medical costs and membership losses, a sign it is pricing higher claims trend while shedding lives; watch whether the MLR keeps climbing.
Rule Jul 15, 2026
The FDA finalized guidance on designing psychedelic drug clinical trials and opened a request for information on care delivery models, with comments due August 13, a registration deadline of August 21, and a hearing set for September 14, 2026.
Why it matters The FDA laid out how it will evaluate psychedelic therapies and is seeking input on how such treatments would be delivered, a step toward possible approvals; watch the September hearing.
Enforcement Jul 15, 2026
The FTC settled its antitrust case against CVS Caremark over rebating practices it said inflated insulin list prices, securing up to 8.5 billion dollars in projected consumer savings over 10 years and a new 25 dollar monthly insulin cap program.
Why it matters A top pharmacy benefit manager settled federal claims that its rebate practices drove up insulin prices, adding a 25 dollar monthly cap and billions in projected savings; watch whether other PBMs face similar pressure.
Enforcement Jul 15, 2026
The FTC fined Edwards Lifesciences 10 million dollars and Genesis MedTech 2 million dollars, 12 million total, for structuring a 2024 heart device deal to fall just under the Hart Scott Rodino premerger notification threshold and avoid antitrust review.
Why it matters Regulators penalized two device makers for engineering a deal to dodge premerger antitrust review, signaling tougher enforcement of filing rules; watch for more merger scrutiny of device deals.
Rule Jul 15, 2026
Hawaii's governor signed Senate Bill 3025 (Act 220), creating a Medical Debt Acquisition and Forgiveness Program that could erase about 91 million dollars in medical debt for roughly 50,000 residents.
Why it matters Hawaii became the latest state to buy and cancel residents' medical debt for pennies on the dollar; watch whether more states copy the model.
Earnings Jul 15, 2026
HCA Healthcare cut its full year 2026 guidance, now estimating a 1.0 billion to 1.2 billion dollar hit from ACA exchange membership shifts, up from a prior 600 million to 900 million dollar estimate.
Why it matters A large hospital operator warned that shrinking ACA exchange enrollment will cost it more than expected, an early read on how coverage losses hit provider revenue; watch other systems' exposure.
Rule Jul 15, 2026
The HHS Administration for Children and Families finalized rescission of the 2024 rule that set designated placement requirements for LGBTQI+ children in Titles IV E and IV B foster care, effective July 14, 2026.
Why it matters The federal government reversed a 2024 rule that had required specific safe placement standards for LGBTQI+ foster youth; watch for legal challenges and state level responses.
Deadline Jul 15, 2026
The House Energy and Commerce Health Subcommittee marked up three bills, the PRESS Act (H.R. 7184), the Fight Illicit Pill Presses Act (H.R. 5880), and the Stop Pills That Kill Act (H.R. 8005), aimed at illicit fentanyl pill press importers and manufacturers.
Why it matters Congress is advancing bills to choke off illicit fentanyl manufacturing equipment, a supply side enforcement move, not a coverage or payment change.
Deal Jul 15, 2026
Indiana's Orthopedic and Balance Therapy Specialists was acquired by an unnamed national rehabilitation platform, in a sector where deals are reported running roughly 8 to 12 times EBITDA.
Why it matters Another independent physical therapy practice was absorbed into a national platform, part of the ongoing roll-up of outpatient rehab into private-equity-backed chains that consolidates local providers under larger owners.
Rule Jul 15, 2026
The HHS Office of Inspector General issued Advisory Opinion 26 16 approving a food as medicine program, finding that providing medically tailored food would not trigger fraud and abuse sanctions.
Why it matters A federal watchdog gave a green light to a program providing medically tailored food, easing anti kickback worries and opening a path for more such initiatives; watch for copycat programs.
Report Jul 15, 2026
AAOS 2026 Annual Meeting research found that prior authorization delayed elective spine surgery without producing payer cost savings, and that 80 percent of the denials examined were reversed on appeal.
Why it matters A first-of-its-kind study says prior authorization on spine surgery mostly delays care rather than saving money, adding clinical evidence to the political push to scale back these controls.
Report Jul 15, 2026
Rock Health reported that US digital health startups raised 7.4 billion dollars across 244 deals in the first half of 2026, with mega deals of 100 million dollars or more taking 45 percent of the capital in 8 percent of deals, and 115 M&A exits concentrated in revenue cycle management and metabolic health.
Why it matters Digital health funding is flowing to fewer, larger deals while consolidation clusters in billing tech and metabolic care; watch whether smaller startups get squeezed out.
Enforcement Jul 15, 2026
SpineFrontier's former CFO Aditya Humad pleaded guilty to conspiring to pay surgeons more than $540,000 in kickbacks disguised as consulting fees, with sentencing set for August 6 in Massachusetts.
Why it matters A spinal device executive admitted to a kickback scheme dressed up as consulting payments, a reminder that sham consulting arrangements between device makers and surgeons remain a top enforcement target.
Rule Jul 15, 2026
In the FY 2027 IPPS proposed rule, CMS proposed adding spinal fusion to the mandatory Transforming Episode Accountability Model bundles, with comments that closed June 9 and a proposed effective date of October 1, 2026.
Why it matters CMS wants to make hospitals financially accountable for the full episode cost of spinal fusion under its mandatory bundled payment model, extending value-based risk into one of the most expensive surgical categories.
Report Jul 14, 2026
Bloomberg Law reported that surgical device maker CONMED is working with advisers on a possible sale after drawing private equity takeover interest, sending shares up about 10 percent; no bidders or formal process have been disclosed and CONMED has not confirmed a sale.
Why it matters A mid-size maker of surgical devices may be up for sale, an early and unconfirmed sign of renewed buyout interest in medtech.
Rule Jul 14, 2026
In the CY2027 Hospital OPPS/ASC proposed rule, CMS proposes a site-neutral cut that would pay off-campus hospital imaging at 40 percent of the standard outpatient rate; comments close August 31, 2026.
Why it matters CMS wants to pay hospital-owned imaging done at off-campus sites far less, aiming to stop patients from being charged more for the same scan based on where it is done.
Rule Jul 14, 2026
The DEA's administrative hearing on moving marijuana from Schedule I to Schedule III closed its evidentiary record on July 14, 2026, a procedural step before the agency issues a decision.
Why it matters The long-running federal effort to loosen marijuana's controlled-substance status cleared a key procedural milestone, moving it closer to a decision that could ease research and taxation.
Approval Jul 14, 2026
The FDA approved the first at-home starting dose for Eisai's Alzheimer's drug Leqembi Iqlik, a lecanemab-irmb subcutaneous injection, for early Alzheimer's disease with mild cognitive impairment or mild dementia.
Why it matters Patients starting the Alzheimer's drug Leqembi can now begin treatment with an at-home injection rather than only in a clinic, a convenience step for early-stage patients and caregivers.
Deal Jul 14, 2026
An Israeli court in Haifa froze an InMode board decision amid a contested takeover fight, as Steel Partners Holdings pursues an unsolicited $16.75-per-share all-cash bid for the aesthetic device maker against a rival CEO-led buyout.
Why it matters A courtroom fight over control of aesthetic-device maker InMode pits an outside cash bidder against management, with a judge freezing a board move.
Report Jul 14, 2026
Kaufman Hall reported hospital M&A had its strongest second quarter since 2018, with 18 transactions and $7.7 billion in transacted revenue, more than five times the $1.4 billion a year earlier, with nearly all buyers being nonprofit systems rather than private equity or for-profit chains.
Why it matters Hospital dealmaking rebounded sharply, with nonprofit systems doing most of the buying, meaning more local hospitals are joining larger networks.
Rule Jul 14, 2026
Missouri Governor Kehoe signed a package of six health care bills, including an expansion of Medicaid coverage for doula services, with most provisions effective August 28, 2026.
Why it matters Missouri added Medicaid coverage for doula support and several other health measures, expanding maternal-care benefits for the state's Medicaid population starting late August.
Enforcement Jul 14, 2026
Mobile PET scan provider Modern Nuclear Inc agreed to pay $8,334,350.71 plus a share of future revenue to settle DOJ False Claims Act allegations that it paid inflated physician supervision fees, an Anti-Kickback Statute violation, to induce referrals for PET scans.
Why it matters A mobile PET imaging company is paying more than $8.3 million to settle claims it disguised kickbacks as inflated physician supervision fees to win scan referrals.
Report Jul 14, 2026
The Neiman Health Policy Institute reported that radiologist practice turnover rose 61 percent from 2013 to 2022, with the likelihood of a job change accelerating around 12,940 annual wRVUs overall, 13,380 for nonacademic and 8,820 for academic radiologists.
Why it matters A decade of data ties radiologist departures to workload, flagging burnout driven turnover as reading volumes climb; watch whether staffing and AI capacity relieve the pressure.
Report Jul 14, 2026
The HHS Office of Inspector General's Spring 2026 semiannual report says it recovered or saved $5.56 billion from Medicare and Medicaid over six months from October 2025 to March 2026, a $12.70 return per dollar spent, built on 604 criminal and civil actions and 1,212 program exclusions.
Why it matters The federal healthcare watchdog reported billions in recoveries and more than a thousand exclusions in six months, signaling aggressive ongoing enforcement across Medicare and Medicaid.
Rule Jul 14, 2026
The HHS Office of Refugee Resettlement published a notice, effective immediately on July 14, 2026, doubling the eligibility period for Refugee Cash Assistance and Refugee Medical Assistance to eight months.
Why it matters Newly arrived refugees can now receive federal cash and medical assistance for eight months instead of a shorter window, extending short-term coverage during resettlement.
Report Jul 14, 2026
An ACR analysis of CMS data found providers win 88 percent of No Surprises Act IDR disputes with 87 percent of awards above the qualifying payment amount, Radiology Partners posted a median prevailing offer of 631 percent of QPA in the first half of 2024, and new batching rules effective May 2026 cut per claim administrative fees.
Why it matters Independent dispute resolution is paying providers far above insurer benchmark rates, undercutting the No Surprises Act goal of restraining out of network costs; watch whether CMS revisits the QPA methodology.
Deal Jul 14, 2026
RadNet agreed to pay up to 270 million dollars for radiology AI firm Gleamer as part of over 340 million dollars in 2026 acquisitions, including 13 Southwest Florida imaging centers and six Indianapolis centers.
Why it matters A large imaging operator is buying AI capability and physical centers at scale, signaling consolidation and vertical integration in radiology; watch how AI ownership reshapes reading productivity.
Deal Jul 14, 2026
ResMed agreed to sell its MatrixCare post-acute health IT business to Frazier Healthcare Partners for $490 million, less than two-thirds of the $750 million ResMed paid for MatrixCare in 2018.
Why it matters ResMed is exiting post-acute care software at a loss versus its 2018 purchase price, handing MatrixCare to a private equity buyer.
Rule Jul 14, 2026
The bipartisan Radiology Outpatient Ordering Transmission (ROOT) Act would revive the Medicare appropriate use criteria program for advanced imaging that CMS shelved when it rescinded AUC claims reporting effective January 2024.
Why it matters Lawmakers want to restart a shelved program requiring doctors to consult appropriate use criteria before ordering advanced imaging; watch whether it clears committee after May 2026 testimony.
Record Jul 13, 2026
A whistleblower lawsuit alleges Alignment Healthcare used accounting maneuvers to manufacture its first profitable year, according to a report on the Kardes complaint.
Why it matters A former insider is accusing a publicly traded Medicare Advantage insurer of dressing up its books to show a profit; the claims are unproven allegations for now.
Rule Jul 13, 2026
CMS finalized the Ambulatory Specialty Model, a mandatory program running January 1, 2027 through December 31, 2031 that puts participating cardiologists and other specialists into two-sided financial risk.
Why it matters Starting in 2027, a mandatory Medicare model will hold certain specialists, including cardiologists, financially accountable for the cost and quality of care, marking a big step in required value-based payment.
Report Jul 13, 2026
Astrana Health disclosed in an 8-K that all eight of its Medicare ACOs, five in the Medicare Shared Savings Program and three in ACO REACH, generated net and gross shared savings totaling about $120.4 million for the 2024 performance year.
Why it matters A value-based care company reported that every one of its eight Medicare ACOs earned savings in 2024, a strong result in a program where many organizations fall short.
Report Jul 13, 2026
MedAxiom's 2024 data show median total compensation for hospital-integrated cardiologists topped $700,000 for the first time while private-practice cardiologists fell to a median of $588,479, opening a $112,475 gap, the widest in more than five years.
Why it matters A pay gap this wide signals that hospital employment keeps pulling cardiologists out of independent practice, which shapes where you can get heart care and at what facility rates.
Report Jul 13, 2026
MedAxiom reports that close to 50 percent of private-practice cardiology groups now carry private equity ownership, up from effectively zero a few years ago, while Humana separately expanded its value-based cardiology partnerships to four platforms for Medicare Advantage members.
Why it matters Independent cardiology has flipped from physician-owned to nearly half private-equity backed in just a few years, changing who controls a large slice of US heart care.
Rule Jul 13, 2026
CMS is taking comment on an OBBBA-driven policy that would cap Medicaid state directed payments at Medicare rates and add a quality metric requirement, with comments due July 21.
Why it matters The federal government wants to limit how much extra states can pay Medicaid providers, capping those payments at Medicare rates; comments are due July 21.
Rule Jul 13, 2026
In the CY2027 Hospital OPPS/ASC proposed rule, CMS proposes removing cardiovascular procedures from the inpatient-only list starting in 2028, which would let them be paid in outpatient and ambulatory settings; comments close August 31, 2026.
Why it matters CMS wants to let more heart procedures be done as outpatient rather than requiring a hospital admission, which could shift where you have cardiac procedures and how much they cost.
Rule Jul 13, 2026
The DEA administrative hearing on rescheduling marijuana from Schedule I to Schedule III is expected to close around July 15, with no deadline set for a final ruling.
Why it matters The federal hearing that could reclassify marijuana is nearly finished, but there is still no set date for an actual decision.
Approval Jul 13, 2026
The FDA approved Sanofi's Sarclisa Escena (isatuximab-irfc), the first on-body injector cancer drug, for newly diagnosed and relapsed or refractory multiple myeloma in combination regimens.
Why it matters The FDA cleared the first cancer drug delivered by a wearable on-body injector, giving multiple myeloma patients a new administration option that could reduce infusion-chair time.
Enforcement Jul 13, 2026
Health Canada placed new operating conditions on 16 Grifols plasma collection centers after citing recurring systemic deficiencies, including donors who should have been deferred over Creutzfeldt-Jakob disease risk, following two donor deaths at a Winnipeg clinic.
Why it matters Canadian regulators tightened oversight of a major plasma company after two donor deaths and repeated safety lapses, raising questions about a large public plasma collection contract.
Enforcement Jul 13, 2026
Louisiana's Medicaid Fraud Control Unit secured sentences against two Camellia Drive Community Home employees for abusing a disabled Medicaid resident, part of a broader sweep that has produced 105 convictions and more than $73 million in ordered restitution.
Why it matters Two care-home workers were sentenced for abusing a disabled Medicaid resident, part of a wider Louisiana crackdown that has racked up 105 convictions and over $73 million in restitution.
Enforcement Jul 13, 2026
A Memphis gynecologist, Sanjeev Kumar, was sentenced to 240 months in prison for adulterating and misbranding medical devices and health care fraud after reusing single-use devices in a scheme that billed more than $41 million and netted over $4.8 million from Medicare and Medicaid.
Why it matters A gynecologist got 20 years for reusing medical devices meant for single use and defrauding federal programs of millions, a rare and severe sentence signaling patient-safety stakes.
Record Jul 13, 2026
Regional One Health is closing its Regional One Extended Care hospital in Memphis and laying off more than 100 employees, cutting 103 jobs.
Why it matters A Memphis health system is shutting an extended-care hospital and cutting 103 jobs, reducing local post-acute capacity.
Deal Jul 13, 2026
The Minnesota Attorney General held a public hearing on Sutter Health's proposed merger with Allina Health, a deal that would create a roughly $26 billion nonprofit system with 39 hospitals and a pledge to invest more than $2 billion in Minnesota and western Wisconsin.
Why it matters A large hospital merger that would form a $26 billion, 39-hospital nonprofit system is getting public scrutiny from Minnesota's attorney general before any approval.
Rule Jul 13, 2026
CMS proposes eliminating the hospital and operator volume minimums in its TAVR national coverage determination, which would let more hospitals start or continue TAVR programs; the comment period closes July 15, 2026, with a final decision expected September 13, 2026.
Why it matters CMS may drop the case-count rules that limit which hospitals can perform the TAVR heart-valve procedure, potentially expanding access to more, including smaller and rural, hospitals.
Enforcement Jul 13, 2026
Tri-City Cardiology and three physicians agreed to pay $4.75 million, with $4,606,247.22 to the federal government and $143,752.78 to Arizona, to resolve DOJ False Claims Act allegations that they billed for medically unnecessary vein ablation procedures.
Why it matters A Phoenix cardiology group is paying $4.75 million to settle claims it performed and billed unnecessary vein procedures, a reminder that medical-necessity billing is under active federal scrutiny.
Report Jul 12, 2026
The Peterson-KFF Health System Tracker finds ACA marketplace insurers are requesting a median 14 percent premium increase for 2027, a second straight double-digit year driven by roughly 10 percent medical trend, GLP-1 utilization, labor costs, and the loss of enhanced premium tax credits.
Why it matters Marketplace insurers want another double-digit premium hike for 2027; watch how much regulators approve and whether higher costs push healthier enrollees to drop coverage.
Enforcement Jul 12, 2026
California secured a court-approved settlement and permanent injunction against First Call Telemedicine, Trinity HealthShare, Aliera, and their operators over a sham health cost-sharing ministry that kept about 84 percent of consumer contributions, with more than 5.1 million dollars in civil penalties partly suspended.
Why it matters California shut down a sham health-sharing ministry that pocketed most of members' money; watch for continued state crackdowns on fake or misleading coverage products.
Record Jul 12, 2026
Centene announced it will exit the Arkansas ARHOME Medicaid expansion program in 2027, dropping the state's private-option coverage line.
Why it matters A major Medicaid insurer is pulling out of Arkansas's expansion program; watch where affected members land and whether other insurers follow in shaky Medicaid markets.
Deal Jul 12, 2026
Clarivate agreed to sell its Life Sciences and Healthcare data segment to private equity firm Altaris for 600 million dollars, structured as 500 million cash at closing plus 25 million deferred and a 75 million dollar seller note.
Why it matters Clarivate is divesting its health data business to a PE buyer for 600 million dollars; watch whether new ownership changes pricing or service for customers of that data.
Rule Jul 12, 2026
CMS proposed a 2.4 percent update to Medicare hospital outpatient and ASC payments for calendar year 2027, worth about $9.5 billion, with comments due August 31, 2026.
Why it matters Medicare is proposing to pay more for outpatient and same-day surgical care in 2027; the exact rate is not final until after the August 31 comment window closes.
Rule Jul 12, 2026
The DEA administrative hearing on moving marijuana from Schedule I to Schedule III is nearing its expected July 15 close, but no deadline has been set for a final ruling.
Why it matters A long-running federal process that could reclassify marijuana is wrapping up its hearing phase, but there is still no timeline for an actual decision.
Deal Jul 12, 2026
IKS Health closed its 557 million dollar acquisition of health IT and revenue cycle company TruBridge at 26.25 dollars a share in cash, completing the deal on July 9, 2026.
Why it matters IKS Health took TruBridge private in a 557 million dollar deal; watch whether the combination reshapes revenue cycle and EHR services for community providers.
Rule Jul 12, 2026
Twenty-six states asked a federal court to rule by July 31 on their challenge to CMS's interim final rule narrowing the medically frail exemption from Medicaid work requirements, which take effect January 1, 2027.
Why it matters States are fighting a federal rule that would make it harder for sick and disabled people to be exempt from Medicaid work requirements; a court ruling is requested by July 31 ahead of a January 2027 effective date.
Record Jul 12, 2026
Memorial Hermann is shutting down its entire commercial health insurance business, ending its role as a payer in that market.
Why it matters A large Texas health system is exiting commercial insurance entirely; watch how members are transitioned and whether more provider-owned plans retreat from the payer business.
Enforcement Jul 12, 2026
A Jersey City office manager, Janet Tadros, pleaded guilty to conspiring to commit health care fraud and violate the Anti-Kickback Statute by taking roughly $3,000 a week in cash to funnel unauthorized prescriptions to pharmacies in a scheme that cost Medicare and Medicaid about $20.7 million.
Why it matters A guilty plea in a $20.6 million New Jersey kickback and prescription-fraud case shows federal prosecutors continuing to target cash-for-prescriptions referral schemes.
Deadline Jul 12, 2026
More than 450,000 New Yorkers in the 200 to 250 percent poverty tier lost Essential Plan eligibility on July 1, 2026 after the One Big Beautiful Bill Act ended premium tax credit eligibility for most lawfully present immigrants, and they have until August 30 to enroll in a Qualified Health Plan with retroactive coverage to avoid a gap.
Why it matters A federal law change dropped hundreds of thousands of New Yorkers from the Essential Plan, and they have an August 30 deadline to pick a new plan or risk a coverage gap.
Deal Jul 11, 2026
Ascension, through Ascension Saint Thomas, agreed to acquire Tennessee's Williamson Health for a 700 million dollar purchase price plus 250 million dollars in additional capital investment over 10 years, a deal valued near 950 million dollars.
Why it matters One of the largest Catholic health systems is buying a Tennessee hospital in a nearly 1 billion dollar deal, continuing hospital consolidation; watch for effects on local prices and competition.
Rule Jul 11, 2026
CMS's proposed CY2027 Home Health Prospective Payment System rule pairs a roughly 420 million dollar net payment increase with new authority to claw back improper payments, with comments open until August 31, 2026.
Why it matters CMS is proposing to raise home health pay while arming itself to recover fraudulent payments; watch the August 31 comment close and how the clawback powers are defined.
Rule Jul 11, 2026
CMS's proposed CY2027 OPPS and ASC rule would cut Medicare payment for 340B-acquired drugs to hospitals by nearly 40 percent, with comments open until August 31, 2026.
Why it matters A federal proposal would sharply reduce what Medicare pays 340B hospitals for drugs; watch the August 31 comment close and whether the cut survives to a final rule.
Enforcement Jul 11, 2026
CVS agreed to pay 36.5 million dollars, including 25.1 million to state and federal Medicaid programs, to settle False Claims Act allegations that it systematically over-dispensed insulin pens to Medicaid patients from 2010 to 2020.
Why it matters CVS is paying 36.5 million dollars to resolve claims it over-dispensed insulin pens to Medicaid; watch for continued state and federal scrutiny of pharmacy dispensing practices.
Rule Jul 11, 2026
The DEA is moving to temporarily place concentrated kratom extract 7-hydroxymitragynine (7-OH) above a set threshold into Schedule I, with comments due July 31, 2026.
Why it matters The DEA wants to make concentrated 7-OH kratom extract a Schedule I substance; watch the July 31 comment close and whether the temporary scheduling is finalized.
Report Jul 11, 2026
Galen Growth reports H1 2026 global digital health funding held flat at 22.6 billion dollars across 608 rounds even as deal count fell 38 percent, with capital concentrating in fewer, larger, more mature companies.
Why it matters Digital health money is holding steady in dollars but flowing to fewer, bigger deals; watch whether early-stage founders get starved as capital concentrates in mature players.
Report Jul 11, 2026
The FTC and DOJ FY2025 Hart-Scott-Rodino report shows 18 merger challenges, 2,006 notified transactions with nearly 32 percent above 1 billion dollars, 41 Second Requests, and healthcare named a priority under the FTC Healthcare Task Force.
Why it matters Antitrust regulators are naming healthcare a priority enforcement sector; watch for longer reviews and more challenges on hospital, insurer, and pharma deals.
Rule Jul 11, 2026
The HHS Office for Civil Rights Section 504 requirement for accessible medical equipment, including exam tables and weight scales, took effect July 8, 2026 under the 2024 disability nondiscrimination final rule.
Why it matters Federally funded providers now must have accessible exam tables and weight scales in place; watch for OCR complaints and enforcement against facilities that fall short.
Deal Jul 11, 2026
Private equity firm Knox Lane cleared the final regulatory hurdle to acquire staffing company Cross Country Healthcare for 437 million dollars, or 13.25 dollars a share.
Why it matters A major healthcare staffing firm is going private in a 437 million dollar deal; watch whether new ownership reshapes contract labor pricing and availability.
Enforcement Jul 11, 2026
Gwendolyn Singleton of Greensboro pleaded guilty to health care fraud for billing North Carolina Medicaid roughly 1.7 million dollars through Joelle's Center of Hope for urine drug tests that were never performed.
Why it matters A North Carolina operator admitted billing Medicaid 1.7 million dollars for drug tests never done; watch continued enforcement focus on urine drug testing fraud.
Deal Jul 11, 2026
Vertex Pharmaceuticals agreed to acquire endocrinology drugmaker Crinetics Pharmaceuticals for about 10 billion dollars, or 85 dollars a share all cash, including 4.5 billion dollars of bridge financing.
Why it matters Vertex is paying roughly 10 billion dollars to move into endocrinology; watch whether it signals more large biopharma dealmaking after a slow stretch.
Deal Jul 10, 2026
The funds completed a sale-leaseback-style acquisition of 12 acute-care hospitals from Spire Healthcare on July 8, 2026, financed by a secured term loan from Standard Chartered, Natixis, and Credit Agricole, with Spire remaining as tenant.
Why it matters This shows US alternative-asset money continuing to move into overseas hospital real estate rather than US assets. Watch whether Blue Owl extends this net-lease strategy to more hospital portfolios, including in the US.
Rule Jul 10, 2026
CMS proposed rule CMS-2449-P would require states to file Medicaid managed-care state-directed payments prospectively, with the comment period closing July 21, 2026.
Why it matters CMS wants tighter, up-front oversight of the state-directed payments that funnel billions of extra Medicaid dollars to providers; a technical but high-stakes change to watch, with comments due July 21.
Enforcement Jul 10, 2026
Done Global founder Ruthia He was sentenced to 72 months and a 1 million dollar fine and clinical president David Brody to 24 months for a 90 million dollar scheme that shipped over 37 million Adderall pills through a telehealth platform.
Why it matters Two executives of a telehealth ADHD startup got prison time for a 90 million dollar scheme that flooded the market with Adderall prescriptions; a landmark case signaling tougher scrutiny of online stimulant prescribing.
Deal Jul 10, 2026
The Taiwan-based long-term care operator signed a Business Combination Agreement with RF Acquisition Corp III on July 9, 2026, targeting a fourth-quarter close pending shareholder and SEC review.
Why it matters This creates one of the only pure-play post-acute listings on a US exchange, giving investors a way to bet directly on long-term care outside Taiwan. Watch for the SEC's review of the Form F-4 and the shareholder vote before the deal is final.
Enforcement Jul 10, 2026
Memphis gynecologist Dr. Sanjeev Kumar was sentenced to 20 years in federal prison for reusing unsterilized biopsy devices and health care fraud, after billing more than 41 million dollars and netting over 4.8 million from Medicare and Medicaid.
Why it matters A gynecologist got 20 years for reusing single-use biopsy devices on patients and defrauding federal programs; an extreme patient-safety and fraud case that underscores device and billing oversight.
Rule Jul 10, 2026
Montana and Arkansas became the first states to launch Medicaid 80-hour-a-month community-engagement work requirements on July 1, 2026, ahead of a January 1, 2027 deadline for all states.
Why it matters Two states switched on Medicaid work requirements, the leading edge of a nationwide mandate arriving by January 2027; watch for coverage losses as enrollees navigate reporting rules.
Enforcement Jul 10, 2026
HHS-OIG denied recertification and suspended about 60 million dollars a year in federal funding for the New York State Medicaid Fraud Control Unit effective July 1, 2026.
Why it matters Federal regulators cut off funding to New York's Medicaid fraud-fighting unit, an unusual move that could weaken oversight of the nation's largest Medicaid program; watch how the state responds.
Deal Jul 10, 2026
The physician-led fertility and longevity provider, backed by Humania Capital and ARTIS Ventures, acquired clinical decision support and patient-intake software maker Levy Health on July 7, 2026, with terms undisclosed, as it expands from the US into the Gulf Cooperation Council.
Why it matters This is a small, undisclosed-terms deal aimed at standardizing fertility workups as Onto expands into the Middle East. Watch for how Onto scales the technology across its growing footprint.
Record Jul 10, 2026
Bloomberg reported that EQT, Advent, and KKR are each studying a possible bid for the 7.85 billion dollar diagnostics maker, sending its shares up more than 10 percent in Frankfurt trading.
Why it matters This is unconfirmed, early-stage takeover chatter, not a deal. Watch for a formal bid or Qiagen confirming it received an offer before treating this as real.
Deal Jul 10, 2026
Peak Rock Capital closed its acquisition of group-purchasing and commercialization firm Asembia on July 2, 2026, while Cigna's Evernorth separately launched a 100 million dollar AI initiative called Pharmacy Forward at its own specialty pharmacy, Accredo.
Why it matters Specialty drugs are now more than 60 percent of drug spending at many health plans, and this is the backdrop for both moves. Watch for more acquisitions in specialty pharmacy as Peak Rock has said it plans further deals.
Rule Jul 9, 2026
CMS finalized a rule barring hospital accrediting organizations from selling consulting services to the same facilities they inspect, effective June 16, 2027.
Why it matters CMS is closing a conflict-of-interest loophole where accreditors both graded and advised hospitals; a governance tightening that could make accreditation surveys tougher and more independent.
Deadline Jul 9, 2026
Colorado's General Assembly Commission on Medicaid opened a formal review of state Medicaid spending, utilization, and administration, with a recommendations report due December 11, 2026.
Why it matters Colorado is formally studying how to rein in Medicaid spending, an early step that could reshape the state's program; watch the December 11 report for the direction of cuts or reforms.
Rule Jul 9, 2026
Elevance sued CMS on July 1, 2026 over its 2026 Medicare Advantage star ratings methodology, with about 115 million dollars in quality bonus payments at stake, following favorable rulings for Clover and BCBS Louisiana.
Why it matters Another big insurer is suing CMS over how star ratings are calculated, part of a wave of legal challenges that has already won for some plans; the outcome affects billions in Medicare Advantage bonus money.
Report Jul 9, 2026
GAO reported that Medicare and Medicaid spent about 12 billion dollars on assisted living in 2024, while Medicaid still cannot cover the room and board that keeps most seniors out of nursing homes.
Why it matters A federal watchdog put a 12 billion dollar price tag on assisted-living spending and flagged that Medicaid's inability to pay room and board pushes seniors toward costlier nursing homes; watch for reform proposals.
Rule Jul 9, 2026
The 8th Circuit on July 1, 2026 upheld Missouri Senate Bill 751, keeping alive the state law that bars drugmakers from restricting 340B discounts through contract pharmacies.
Why it matters A federal appeals court let Missouri's 340B contract-pharmacy protections stand, a win for safety-net providers in the long fight with drug manufacturers over discounts; watch for similar rulings in other circuits.
Enforcement Jul 9, 2026
TRUST LLC, representing NCPA-affiliated pharmacies, filed suit July 2 in federal court in Washington state alleging a 2019 arrangement let Prime Therapeutics adopt Express Scripts' lower reimbursement structure in exchange for network access.
Why it matters This is a major antitrust test of how much coordination is allowed between two of the largest pharmacy benefit managers. Watch how the case proceeds in discovery and whether other PBMs face similar suits.
Deal Jul 9, 2026
NHI completed the related-party sale of 32 skilled nursing facilities and 3 independent-living properties to entities controlled by National HealthCare Corporation on July 1, cutting NHI's skilled-nursing exposure to about 12.2 percent of its portfolio while raising its senior-housing operating share to about 22 percent.
Why it matters This shows a large nursing-home REIT deliberately shrinking its skilled-nursing exposure in favor of senior housing even as SNF occupancy has been rising. Watch whether other REITs follow the same shift.
Deal Jul 9, 2026
The July 6 announced deal gives Novartis Myricx Bio's oncology antibody-drug conjugate pipeline, built on a novel NMTi payload technology, for about 1.1 billion dollars upfront plus development and sales milestones.
Why it matters This is another large pharma bet on next-generation antibody-drug conjugates for cancer treatment. Watch how the NMTi payload technology performs in clinical development versus existing ADC platforms.
Deal Jul 9, 2026
Pacifica Hospital of the Valley Corporation filed for Chapter 11 protection July 4 in Delaware bankruptcy court, listing 100 million to 500 million dollars in debt and citing COVID-era losses, a lender dispute, and seismic-retrofit compliance costs.
Why it matters A safety-net hospital serving the Sun Valley area is now in bankruptcy proceedings. Watch whether the facility keeps operating through the reorganization or faces closure or sale.
Deadline Jul 9, 2026
Moffitt Cancer Center has been out of Humana Medicare Advantage networks since July 1, a UnitedHealthcare dispute is set to drop 1,900 Brown University Health patients in Rhode Island, and University of Miami Health System's UnitedHealthcare contract for commercial and Medicaid lines expires July 31.
Why it matters Patients in Florida and Rhode Island covered by these plans could lose in-network access to major providers within weeks. Watch whether last-minute deals get struck before the deadlines hit.
Alert · now Jul 9, 2026
FDA and CDC linked an E. coli outbreak with 12 cases across Florida and Georgia to GreenWise frozen organic blueberries, which were recalled from Publix.
Why it matters A recalled batch of frozen organic blueberries sold at Publix is behind an E. coli outbreak in Florida and Georgia; a food-safety alert to heed if you have the product at home.
Funding Jul 9, 2026
SAMHSA opened more than 281 million dollars in behavioral health grant funding across 15 programs, including medication-assisted opioid treatment and school mental health, on a rolling application basis.
Why it matters The federal behavioral-health agency is putting 281 million dollars into addiction, overdose, and mental-health programs; a funding opportunity to watch if you run or partner with treatment services.
Enforcement Jul 9, 2026
The hospital's July 8 complaint alleges Lilly's new claims-data-submission requirement for 340B discounts raised its Mounjaro cost per unit from 750.52 dollars to 1,019.74 dollars, a 35.9 percent increase, and violates Florida's consumer protection law.
Why it matters This is the first lawsuit challenging a drugmaker's data-reporting condition on 340B discounts, a fight that could reshape how much safety-net hospitals pay for brand-name drugs. Watch whether other 340B hospitals file similar suits against Lilly or other manufacturers.
Rule Jul 8, 2026
Arizona became the 25th state to sue over the CMS Medicaid Community Engagement Requirement interim final rule, which was published June 3, 2026, closes comment July 31, and requires work or engagement starting January 1, 2027.
Why it matters Half the states are now suing to block Medicaid work requirements before they start in 2027; watch the litigation and the July 31 comment close.
Deadline Jul 8, 2026
CMS reopened its computer matching program with the VA to verify Medicaid applicants' other coverage and opened public comment through August 6, 2026.
Why it matters CMS is restarting data-sharing with the VA to check whether Medicaid applicants have other coverage; watch the August 6 comment deadline and privacy considerations.
Approval Jul 8, 2026
FDA approved the first BAFF/APRIL dual inhibitor to reduce proteinuria in adults with primary IgA nephropathy who are at risk of rapid disease progression.
Why it matters FDA cleared a first-in-class drug for a serious kidney disease; watch adoption and pricing as a new mechanism enters the IgA nephropathy market.
Approval Jul 8, 2026
CMS launched a Medicare GLP-1 Bridge coverage pathway that lets beneficiaries get weight-loss drugs for a flat 50 dollar copay.
Why it matters Medicare is opening a route to cover GLP-1 drugs for obesity at a low fixed copay, a major expansion of who can access these medicines and a signal of rising federal drug spend to watch.
Rule Jul 8, 2026
New York's Nurse Practitioner Modernization Act independent-practice provision sunset on July 1, 2026, so experienced NPs in the state lose the ability to practice without a physician collaboration agreement.
Why it matters New York let its independent nurse-practitioner authority expire, rolling back scope of practice for NPs and adding friction to primary-care access; watch whether the legislature renews it.
Enforcement Jul 8, 2026
CVS Caremark, Express Scripts, and Optum Rx all settled the FTC's insulin-pricing cases, and on July 1, 2026 the 8th Circuit dismissed the PBMs' countersuit against the agency.
Why it matters The three biggest pharmacy-benefit managers settled federal claims that their rebate practices inflated insulin prices, a milestone in the fight over drug-pricing middlemen; watch what the settlements require them to change.
Rule Jul 7, 2026
CMS proposed cutting Medicare outpatient payments for 340B-acquired drugs by nearly 40 percent in the CY 2027 OPPS/ASC rule and would add botulinum toxin prior authorization effective July 1, 2027, with comments due August 31, 2026.
Why it matters CMS wants to sharply reduce what it pays hospitals for discounted 340B drugs; watch the August 31 comment close and the effect on safety-net hospital finances.
Approval Jul 7, 2026
FDA expanded approval of Casgevy (exagamglogene autotemcel) gene therapy for sickle cell disease to patients as young as 2 years old, effective July 1, 2026.
Why it matters FDA cleared a one-time sickle cell gene therapy for young children for the first time; watch access and payment given the multimillion-dollar price of these therapies.
Enforcement Jul 7, 2026
The FTC and four states sued the World Professional Association for Transgender Health, alleging it made deceptive claims about the safety and effectiveness of pediatric gender-transition treatment.
Why it matters Federal and state regulators are challenging a major clinical group's guidance on youth gender care as deceptive; watch how the case affects treatment standards and provider liability.
Rule Jul 7, 2026
CMS's Innovation Center launched the ACCESS Model on July 5, 2026, activating a new Medicare payment code for chronic-care coordination, with application entry dates of August 17 and October 1, 2026.
Why it matters CMS started a new payment model rewarding coordinated chronic-care management; watch the August 17 and October 1 application windows for participants.
Rule Jul 7, 2026
The House Ways and Means Committee advanced the Tax Exempt Hospital Transparency Act (H.R. 9504) by a 25 to 15 vote on July 1, 2026, moving new community-benefit and charity-care reporting requirements for nonprofit hospitals toward the House floor.
Why it matters Congress is advancing a bill to make nonprofit hospitals disclose more about their charity care and tax-exempt community benefit; watch whether it reaches a floor vote.
Rule Jul 7, 2026
Virginia (S.B. 669), California (new PBM licensing), and Ohio (H.B. 229) all tightened pharmacy benefit manager regulation in the same week, with Virginia effective July 1, 2026, California licenses due by January 1, 2027, and Ohio phasing in July 1, 2027.
Why it matters Three states moved at once to rein in pharmacy benefit managers; watch this as part of a broader multistate push to regulate drug-pricing middlemen.
Rule Jul 6, 2026
CMS released its proposed CY 2027 Home Health Prospective Payment System rule, updating home health rates and adding new durable medical equipment supplier enrollment requirements, with comments due August 31, 2026.
Why it matters CMS is setting next year's home health payment and tightening who can bill Medicare for durable medical equipment; watch the comment period closing August 31 for the final rate.
Rule Jul 6, 2026
DEA and HHS issued a fourth temporary extension of the COVID-era telemedicine flexibilities, letting clinicians prescribe controlled substances via telehealth without an in-person visit through December 31, 2026.
Why it matters The rules letting doctors prescribe controlled medications over telehealth stay in place through the end of 2026; watch for whether a permanent rule replaces this fourth stopgap.
Enforcement Jul 6, 2026
DOJ and HHS OIG announced the 2026 National Health Care Fraud Takedown, charging 455 defendants in schemes totaling $6.5 billion, suspending 1,079 providers and revoking 1,403 billing privileges.
Why it matters Federal prosecutors ran their largest annual health care fraud sweep, signaling aggressive enforcement; watch which scheme types, such as telehealth, DME, and genetic testing, drew the charges.
Deadline Jul 6, 2026
Florida opened statewide enrollment in its IDD Comprehensive Managed Care program for iBudget and SMMC long-term care waiver enrollees on July 1, 2026, while 16,996 people remain on the iBudget waitlist.
Why it matters Florida is moving intellectual and developmental disability waiver services into managed care statewide, but nearly 17,000 people still wait for a slot; watch how the transition affects access.
Rule Jul 6, 2026
HHS opened a public comment docket on temporarily placing 7-hydroxymitragynine, a kratom compound, into Schedule I above a specified threshold, with comments due July 31, 2026.
Why it matters Federal health officials are moving toward restricting a potent kratom compound as a Schedule I substance; watch the July 31 comment close and whether DEA follows with scheduling.
Rule Jul 6, 2026
CMS finalized the Contract Year 2027 Medicare Advantage and Part D Rate Announcement, delivering a net payment increase estimated around $13 billion for MA plans.
Why it matters Medicare Advantage insurers are getting a sizable pay raise for 2027; watch how plans translate the increase into benefits, bids, or margins.
Rule Jul 6, 2026
CMS is moving to annual AI-assisted RADV audits of every Medicare Advantage contract while its 2023 rule allowing extrapolated clawbacks remains in litigation after a court vacated extrapolation in September 2025 and HHS appealed.
Why it matters CMS wants to audit every Medicare Advantage plan yearly using AI to recover overpayments, even as courts weigh whether it can extrapolate the findings; watch the appeal outcome.
